<SEC-DOCUMENT>0001022079-22-000140.txt : 20221021
<SEC-HEADER>0001022079-22-000140.hdr.sgml : 20221021
<ACCEPTANCE-DATETIME>20221021163120
ACCESSION NUMBER:		0001022079-22-000140
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221021
DATE AS OF CHANGE:		20221021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		221324100

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dgx-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:18deedef-37c4-4d4c-a3c0-638e0a05a492,g:42e53fcd-5b3b-4fb8-92f9-d69b94944099,d:9396b6ccfb5c492fae93ffab319e2ada--><html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dgx="http://questdiagnostics.com/20220930" xmlns:srt="http://fasb.org/srt/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF8xLTEtMS0xLTY4Mzgy_d76c9d72-41ee-4e5e-a45f-c4e87412fe31">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF8yLTEtMS0xLTY4Mzgy_638e2a7f-2765-4cc6-8e61-d96983a7af3a">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF8zLTEtMS0xLTY4Mzgy_9a15ccf5-11f8-4cd7-93fe-ff646bca4019">2022</ix:nonNumeric><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF80LTEtMS0xLTY4Mzgy_554819cb-146f-4d9c-bc84-66ce669dbae0">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF81LTEtMS0xLTY4Mzgy_94eca8a2-fc42-4236-b0cc-1a703459741b">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie411d34972bb419285874be10c5557a1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3af3b79934d24fb1bd1cbb0bcbf27618_I20221014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib247069292a644faa219725ce24814d2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0339863356d84ed3995b604e24b5634d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52dab5247a1c4bbcb053e10c176ecba6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id28568ccefa145d1b82a58a63eaad5a4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia66110999ebf47e489970ea681e28bc9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i133ede9bcd2547d88ad254bf768df343_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f52678681d643878109e96f1420975f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77f7c6bfef074498a4e11de614453204_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85ffac6808545d2a1e4b4b8d588cbca_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71f8587b94614e62972a571a0db167fb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6601d4f897bd4dad9874662aa4fe198e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9f8b7df600b4b878bba187286fd791b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38982359ccf14cb991b0c3db0e12289b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i446ca4eb05494f1993ef7b2e312c2037_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c1a402b7edc4bada7fe43b8bed57c9e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id81266202c6f4daaa1fe7d11c3466090_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8fcb85a255b4d078c7675e41fd05fb7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8691d08785574903bd93ee4dfa5db854_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fa63970b08847edb23879db454cfd5a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d44b0c7e6764a3690dac72ba9bceeb6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6123cf684d748bfaeb9d6c407ab233d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibee26b45b4834d788993956547c7876e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a5de51ccdd040f8bc396f5bbb026e33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a33f90cea9e41bebf5bc6e0fb60699f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ebb219cb475425591cf0155edc1d443_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebfd0201851442908146535dd57ca675_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i541597114f5944418a137ab87cea7f3b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3118010a65e94107930187af0b9032e2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3680833c24d343c4b94154c01f3fad0f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i430a0954dff34ed2abd3bbf6af3ce92e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d22acbc549640a3bcff1331465f4490_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a2d9b7a5804534a11a487194d959d8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e937069022b4224ae54a53549450dfe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id99280e00773483bbeab37f6250f0a64_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd61be3e49b417b94fe98d76f276f90_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ebde6c314dc416a9d24bf9416554a5a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfcdafe6ec384c35ae912ea54a83b7b3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id58c37cc4057489f93440a4c2f4ad37e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e96229aac640a599fd3d48159fd084_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7a467583ec46aa992fbd14a917bb43_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055da741a38a425dae638290e29c8807_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia920ca1912e3480ebb55fdc231a8da19_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d3e5ccd81e9421e810e21a4bfa68ce7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b59fb6a60d4941848525e7d490105d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0079fdb1f79341858ac4900a117a3803_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58732cf05c7043b6a8e12b54db21de24_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0089fadb633a4032ac4aaef0b0d2b75e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93981161fc924e7fbcc2631956508614_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eef6a2ec94d4ff289ccf2404dd21a9a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe1208f398b44195af87535925e86927_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589ae2a45c0c438dbc9b633c7ad6ae33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840e894a7ef144038ef94728d7daa256_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ffd0c3e5b9546b8bfe16c9eb1ec2e7d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f9453dbd4c9422baa1dba8fb9a308cf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77ef3821374f4ec68ef2864dd77fedec_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89534177306a427980b6ebbaeab041c4_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a00a453622d4c80b1907306cdca3d9b_I20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bc9e3bbed0e42539b9efaaf04edba4d_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9042842adea48d68f78ed59ef1a76de_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08caf8d530cf43008af3a0306e3e477c_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibcef44e271aa4680b8911a11902d9a4a_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf27417747054ef395ca09d3516e7989_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i663fdcd70d744b64b639798c418155da_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i298386f964ec4ef8adea12f70e3a5da7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45473dab00a64ee98b363794ddc1df50_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0eaed39b10c4747a4466534a16d4ed4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12e12ac865714887ac216f5d036b7039_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3b4e217688f484da0874a661078f82f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic744a596e51e4fda9a38522d60c59682_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b707eca9294fdaa61759b2009a7077_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i762312568e8b4ea9bdfe5e9cb82f2fe5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dgx:MeasurementInputComparableCompanyRevenueVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3891771b03b74ae6bf6f1e347f984954_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7cdccc5b8b4351a6c84a3102569a41_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46b26dd13b5045219577db6205b830a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2dd843e91d24830a207e5a623c8c5f5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i109ee53a89994956b1b78b0354ad068a_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic04fac321a00460b82d13cb06da4f28d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibebd5d13929a45809fca7b3d45a757d1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89346c0905d2439297816ae363b1ed66_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c7345fe4fd94293946d0bf7c21a7d80_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8205d967b9d04f0592030979d313578e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia888a55675b34c1da6c98058a0bfbb00_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i052af85eec62405eb656914f67d3a176_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i193a25bf19ea41e690356bc8c5ce3380_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c162a22bd874f5a8997350a100e5b4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1465ba55b394e54ae2154b81d8f51fb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafe0e5ae893b40efa9626f66a5e78820_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67dee3f585f1452888374d9ee3dba34c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic279fc9d23034639855e69aafe143991_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7998a056fa014b5b93a343c7b3bc409c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee3230ab4d945ffa507522cd478b188_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39c1dcdf5ded4bc5be532f869db993b6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8892d167ced44fed893e191b22d3989c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1102df7028da465093e08195001df34c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29663b176c084c83ba8d49b48433f6a7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if16effd867954c738404b7b96d2e8eae_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67d9eea602464d4fab91b47e890a65ff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb3a7eac45ff47d6b334f694b10c9c80_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973ec05c00df4ad6a2a4472b1d8d2332_D20220201-20220201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0af15cd6ca4d4d5a9a34b91873ffc960_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c0f85b320f34c5db62f1f89cba5a333_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fa78c23eb41439b8bceb72de57816d2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i191fbddd79df46e9b0198928feb36a29_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dgx:TriggeringEventAxis">dgx:AmendedRealEstateLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f0c266cfabc4117a5db448c8bd6d03f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b2ee25f2ed8463cb9acb8e346af111a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1a4fda1687b418eb6a88b57bee7ee91_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71bd2faa4dcb410aac7083d1314895b2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2429a6bcd9bd4c65a106279746ec156f_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:A401kPlanLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="ib3f4b1ab656b429792e65b699bbd3194_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:DataSecurityIncidentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad21a9259c74090ab33049d5d123cd2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i049e3ca5238248948e41058b0359b2cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6780bd5df0e2405c8a5497be06f79406_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i778d30c2a5f04d5bbd79b50d49dff45b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35233092ea214d52af667521fd4f34ba_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2022fe35c0ed49ce8cbcf4e5663b9586_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f82d92935446eda7827eecbc1d0446_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd75de4a9a04a92817af7be460230d6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54292d821ae48a68d7b57aa83ce30d5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e38360cd91846de82063fcaaf58e127_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedba8be9e6d9474cbeea5e69c3817a44_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2213ad4f9e044d1f9f73b935280a85d0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05844d0d291141408b4c5e911aa1a773_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc81340b331406aaaa1e47f50446a3a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2262f05753a4ec9afdc14f6b0ffdd09_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba791edd92545c5a2aef512c9a4b212_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3982f629690f495cbf0e0ba3db8ad100_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b2ec2a973ec44539d673cf6d99f87ec_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfa3c11aef7e473182161c33c456b37b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeb59228d7c345f18c522deada6d4507_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf3b88fd5ccc4285a63afa1e6f852f11_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882d231dd7374595abf2c323937f41ba_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33932a80efde433c898a298b0df7e2c0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d4b2c0774334fd9bff7edabc3b2f8d4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id771340b26ba466d84857e28e997aad7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5981a21f65c64729863e38afe9d108b6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d569efaaa7146efa0ff3406897b8dbc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c9489e8daf9452f86f8ce2d6e8b66d4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c6fc5be8aa4490a60a9c8eb3f467ff_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b74cfcfe6b74088a041cf19f39f8bfd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac9122b4d044d2aac6ae108cb25b79d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a4fa9bc40c5420697f812025c278d5f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2463ba51e264dbbb561f3ebd2a7ae68_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4bb02bf9fa849cb99832a402efd5409_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icafe184efc93430796a2beab39669d01_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i229509c7231549db925bf29fdce1531d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff5758981e1444b4b9fd02f8aa63d7bf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice963a3c871a4964b7fada36abe521f5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe66bde611c3455b968735afb276accc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb2da7bb5bdf450d94c7cb844900e0b1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9ec7b61dbc848dc972c1fd56b0ab080_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedddff22ba5b4fb0a008f2787a6212e5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7efe5928604ef39c7c110d8e85cdaa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dee333059084814b53e9d3f76a165f5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8f803ca658f4d9ca283e32e2641679d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0abea2ff94d74055876d608a5384541f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c844b73612e4d969c32144072e69482_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70b790ee8c6b4795a8b810a63f6d3fbf_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfc6ae7ce5004bf1a030a03d500851b6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie972687548c145bea8a73606c134780f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic36a1aa9ec14411bbb9b140920cd721e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb786a9417bf40a9a53c78abcd60b86a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5ab3f4c5668458b9be3e667d579e95d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a3b7e0a1ab747b4a88ba384b9c6f5e3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if614926c685244ce8994f73e3407170e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c24d1fe9e0422f98322342e1b600dc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80681a5902484c9794b52f9ce9a0fe75_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36f1feca4ebc4193a027d4329c6dbdb5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2ee8ab6bcc5441f948edbcabba5af31_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2443278408344ab88c125996c678332_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5550fc4948864d109a0e41c607884cf3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f4871ad170844a7986509f75afcd399_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ea4dfa98d0b49eeaaccda4c4ae455f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice796a3655d941feb767f6c8fe65158b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e911465833a4a6798f86e6b37692664_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ec2390c17341c28ef60e2177b55f77_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56774b5505024ca583c3885fc53e3512_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9c25981e2a4d4bac14a20a91cdad7f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ba474b936bc4d4ab84b4dc85c5d37f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d1825da4ab49a8b78821022de2b6e8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9190b150986345cd97cfc2aebc94c2c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cef2104bcc84b258c94c1efe866d9b3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i913e83ce0c8349688375d506afd9d9ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib54a2680ca68495bb80170fdfa0a42bd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50a1c819b1b44a4aa7ad7742dca1f94f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d1ee32d81244fcbd386f76884c5ada_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id12e6b7fc3d84f40ab1168ad2af450f4_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie53b722a57ce4b9daa9771d76111e184_D20221001-20221021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0810507aff24122a43695ca80ce0367_I20221021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife2cffd951d24830bd6a215df4ae3b0b_I20221021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dgx:LoanCommitmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cee0dfd60be4a578a2484c1cd2ed559_I20221021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cc95a9c78fc4bcb85da10d7ada37895_D20221001-20221021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperAndTermSecuredOvernightFinancingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04cac7194168497fb90bd4b4e067a6cc_D20221001-20221021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperAndTermSecuredOvernightFinancingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-21</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE5_69d0a337-48a1-4fe3-9c58-4f108dbd90ea">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTEy_d7bab964-a095-4f2b-8c11-c4b1a3b187c8">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xNTI_2d771878-7ae5-47bc-91bc-523a17cd41b8">September 30, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTEz_202fa6ec-ef2a-4b19-b89b-ee90a4280c6a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE0_bfb267f4-7695-4bc1-853f-537abaeca0ad">001-12215</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE1_1739c9af-182a-4116-b3b3-f109261466c4">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:519.00pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18wLTAtMS0xLTY4Mzgy_8bdee25e-acb0-4f72-a7e6-1b016ab5128c">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18wLTUtMS0xLTY4Mzgy_6c8c61ac-0d3e-4de3-81f6-680a7f33a78e">16-1387862</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18yLTAtMS0xLTY4Mzgy_63403d7f-bfe6-4f50-aa6b-a262a02bea94">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18zLTAtMS0xLTY4Mzgy_59942a1d-0e70-464a-931c-ad81c43d0189">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18zLTEtMS0xLTY4Mzgy_ec579fc4-1fe6-4451-997e-43829488f98f">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18zLTItMS0xLTY4Mzgy_5fbcbde0-9cf7-4eaf-867c-d9106ba38ca6">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y180LTAtMS0xLTY4Mzgy_e3cbc3e6-96fc-441d-b2db-71aeff2d8093">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y180LTEtMS0xLTY4Mzgy_4c778685-5f26-4e42-9326-13126863e7c7">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.055%"><tr><td style="width:1.0%"></td><td style="width:30.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6MjQ5Zjc0MjA3YWM5NGQxNTg3YjgwZTY0ZjZmY2M4OGMvdGFibGVyYW5nZToyNDlmNzQyMDdhYzk0ZDE1ODdiODBlNjRmNmZjYzg4Y18xLTAtMS0xLTY4Mzgy_e27e5474-cd49-40d7-b3b3-5da1a1c2e99b">Common Stock, $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6MjQ5Zjc0MjA3YWM5NGQxNTg3YjgwZTY0ZjZmY2M4OGMvdGFibGVyYW5nZToyNDlmNzQyMDdhYzk0ZDE1ODdiODBlNjRmNmZjYzg4Y18xLTEtMS0xLTY4Mzgy_354db2d3-e5dc-4253-bf3d-560866d1d8ae">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6MjQ5Zjc0MjA3YWM5NGQxNTg3YjgwZTY0ZjZmY2M4OGMvdGFibGVyYW5nZToyNDlmNzQyMDdhYzk0ZDE1ODdiODBlNjRmNmZjYzg4Y18xLTItMS0xLTY4Mzgy_ff64836e-8145-4460-aad5-d9832811bdc5">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE2_0c914571-70e1-4264-b9af-9c33b9961b4c">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE3_63539e8c-e716-429c-a93a-835d29309551">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.166%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6NDdjMTdlMWI4MjUyNDcyNDg5ZWFkMGUxYWQ3MTI4NzcvdGFibGVyYW5nZTo0N2MxN2UxYjgyNTI0NzI0ODllYWQwZTFhZDcxMjg3N18wLTAtMS0xLTY4Mzgy_4a77e06d-906b-41c8-94c9-a89d2e3de509">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6NDdjMTdlMWI4MjUyNDcyNDg5ZWFkMGUxYWQ3MTI4NzcvdGFibGVyYW5nZTo0N2MxN2UxYjgyNTI0NzI0ODllYWQwZTFhZDcxMjg3N18xLTMtMS0xLTY4Mzgy_3f8bc1fd-c8ea-4560-ac09-1ba195958809">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6NDdjMTdlMWI4MjUyNDcyNDg5ZWFkMGUxYWQ3MTI4NzcvdGFibGVyYW5nZTo0N2MxN2UxYjgyNTI0NzI0ODllYWQwZTFhZDcxMjg3N18yLTMtMS0xLTY4Mzgy_64b7eafb-ee61-421e-9731-efa6abeb96ae">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE4_9701379d-3a13-41dd-bcd0-ca2ade33af46">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;14, 2022, there were outstanding <ix:nonFraction unitRef="shares" contextRef="i3af3b79934d24fb1bd1cbb0bcbf27618_I20221014" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xODU0_06da57c9-35f7-4173-8198-b72623a14a23">113,887,466</ix:nonFraction> shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1. Financial Statements (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Index to unaudited consolidated financial statements filed as part of this report:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_13">Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_16">Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_19">Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_22">Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_25">Consolidated Statements of Stockholders&#8217; Equity for the Three and Nine Months Ended September 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_28">Notes to Consolidated Financial Statements</a> (unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_73">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_73">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_88">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_73">See Item 2. &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_88">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_91">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_91">36</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2022 AND 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_13"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi0xLTEtMS02ODM4Mg_1d204d9a-5319-49b9-94f4-69fa4fd39694">2,486</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi0zLTEtMS02ODM4Mg_92e86e86-63c6-4965-8cd0-34fa1cbbaa37">2,774</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi01LTEtMS02ODM4Mg_5b50951c-7b80-47f5-ac76-767ab23e37c1">7,550</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi03LTEtMS02ODM4Mg_e3fc457f-b7c8-4c7d-a104-f2d0e1537fa0">8,044</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS0xLTEtMS02ODM4Mg_c48e42d1-34d1-4d7b-9864-5acdc618240d">1,618</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS0zLTEtMS02ODM4Mg_f4401a57-1ebd-4d35-bba9-0712f63f3118">1,670</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS01LTEtMS02ODM4Mg_a00b9a98-f4a4-45ba-9f61-457ca45cf045">4,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS03LTEtMS02ODM4Mg_02e0dfdd-ce8c-40d8-8f47-0d14444eaf0a">4,861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi0xLTEtMS02ODM4Mg_d5f575ed-133f-4436-9ce6-026f8425aedf">464</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi0zLTEtMS02ODM4Mg_0e76af64-7056-4518-b08c-bb095af48b96">427</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi01LTEtMS02ODM4Mg_8f3a0aff-c258-4613-af4a-5dcfab52085a">1,311</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi03LTEtMS02ODM4Mg_c3c8efd3-1aed-4ada-965d-5f4f7e24f8fe">1,263</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy0xLTEtMS02ODM4Mg_eef4ee17-d683-4022-8fda-6d75db956051">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy0zLTEtMS02ODM4Mg_8b3903b8-e8e6-4e50-b91f-0b546742fd3e">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy01LTEtMS02ODM4Mg_680e0a6f-8742-47d9-a1c4-7885bdb704d8">81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy03LTEtMS02ODM4Mg_262041bb-6050-49ee-a8cc-aaafea7624dd">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS0xLTEtMS02ODM4Mg_a068dd77-0c1b-4fd4-a07d-bf9a6c3add55">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS0zLTEtMS02ODM4Mg_6dcbecbd-d733-4d01-b9b8-db2caa271982">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS01LTEtMS02ODM4Mg_54f3bf16-d9f8-4e69-bb4f-960617b77dce">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS03LTEtMS02ODM4Mg_33f0f801-1cdf-455b-af76-ccc0ed045684">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtMS0xLTEtNjgzODI_131ebed0-1b69-4591-9cd3-0ca4afb54719">2,094</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtMy0xLTEtNjgzODI_61e0ab6f-d498-445b-ba2d-4e9595cf7749">2,122</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtNS0xLTEtNjgzODI_450e13c4-8a84-41ba-8950-19693a9d12e2">6,257</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtNy0xLTEtNjgzODI_6a560da9-dfde-4efa-8c1e-0a550e5488e6">6,199</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItMS0xLTEtNjgzODI_95d2d2c3-ba8f-4ec1-b7a8-65dce7c00074">392</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItMy0xLTEtNjgzODI_521bd912-9f83-4384-942f-6b088ff5b3b2">652</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItNS0xLTEtNjgzODI_2fddf2bf-ebae-4f29-a175-52dec7348615">1,293</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItNy0xLTEtNjgzODI_4b9d2f43-b428-4fc3-8882-469aed0ed64a">1,845</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtMS0xLTEtNjgzODI_cc0141cc-c0b9-410a-8752-c4a82eeb4ce9">33</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtMy0xLTEtNjgzODI_00b868dc-a02b-46f0-a659-4d40d256791e">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtNS0xLTEtNjgzODI_5be72f81-5fd2-4c0d-8dcb-654e8a9f7f59">106</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtNy0xLTEtNjgzODI_03e0c0ab-f6ab-47a7-afc0-33d51bf970c7">114</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtMS0xLTEtNjgzODI_e8e88dde-6a60-469f-aa6c-60364cb76973">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtMy0xLTEtNjgzODI_d1aa0808-6ecb-4fdf-adbe-14d2e10760a4">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtNS0xLTEtNjgzODI_5230e4b2-2f4e-430a-a26c-c14610972137">61</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtNy0xLTEtNjgzODI_dcba9cf4-b43a-40ba-b178-d4040b0f0032">366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating (expense) income, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctMS0xLTEtNjgzODI_88080f73-0777-44dd-9e01-2eb2dd483743">41</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctMy0xLTEtNjgzODI_51f3a2ed-df02-4898-8961-1b2170f7a375">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctNS0xLTEtNjgzODI_4c7e7711-f6d0-46d6-b9e0-460e9d74a940">167</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctNy0xLTEtNjgzODI_6a516a5c-7282-42fa-889f-df4c91f6705a">252</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktMS0xLTEtNjgzODI_65ddfe60-a419-46c0-8b62-c6d24f5024a7">351</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktMy0xLTEtNjgzODI_32918cb4-da4d-43f7-bfdf-47037ef6132c">654</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktNS0xLTEtNjgzODI_32dc352d-ccdb-433e-bb21-8bf22ebd449c">1,126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktNy0xLTEtNjgzODI_99a4bfd9-da23-474d-a508-fd5ae04d899a">2,097</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtMS0xLTEtNjgzODI_151987d9-ecc8-4563-a6a2-76c814f46a34">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtMy0xLTEtNjgzODI_9e76fd08-9f6f-4115-8202-a2fa10e4fece">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtNS0xLTEtNjgzODI_ab827632-f527-41b4-ac80-1d39be642727">268</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtNy0xLTEtNjgzODI_6680b582-d998-4251-b199-733ff2eb2dcd">483</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtMS0xLTEtNjgzODI_0c8925c5-7333-467e-952b-a62c47feca2c">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtMy0xLTEtNjgzODI_e2c0aa41-f9f9-4c9a-bbce-e8f546c47117">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtNS0xLTEtNjgzODI_cfbd7f53-7950-4ec3-93c8-e6cec3b60275">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtNy0xLTEtNjgzODI_e7a97980-092c-41b4-8123-ecdce68b9aaa">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtMS0xLTEtNjgzODI_7e2749fd-c906-44b7-9045-683f14963fab">276</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtMy0xLTEtNjgzODI_48491f4a-1e1c-4f0c-b3bf-a6d99a443b9e">527</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtNS0xLTEtNjgzODI_61431ae7-0fde-4acf-ac90-c0f9b29996b7">899</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtNy0xLTEtNjgzODI_5084862b-0006-4aa8-9a45-2a0524b8c18e">1,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtMS0xLTEtNjgzODI_5c515df2-d40b-40ca-b776-2121828d00ca">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtMy0xLTEtNjgzODI_97549feb-1b39-40e1-a781-c6820d95f740">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtNS0xLTEtNjgzODI_12d66b37-92e7-4365-8110-154c29fae806">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtNy0xLTEtNjgzODI_01c5b90e-4a28-4d85-a446-bc805819e641">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtMS0xLTEtNjgzODI_750f8746-396d-44d7-a064-34b8c1293e17">256</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtMy0xLTEtNjgzODI_e586363c-46e9-475e-b01f-b94161abfc0e">505</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtNS0xLTEtNjgzODI_bc876f59-ada6-40b2-9f27-50b29033e5c5">845</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtNy0xLTEtNjgzODI_7f2148d1-1c24-4280-af40-d1c4dfe3f735">1,605</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtMS0xLTEtNjgzODI_fa6464cd-8958-4ab8-b0a6-5ecb05beab34">2.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtMy0xLTEtNjgzODI_852e199a-b17b-4f2e-9052-ececbf49b01a">4.11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtNS0xLTEtNjgzODI_6a759c08-a398-4eff-b836-76859785b281">7.17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtNy0xLTEtNjgzODI_696aaac0-fa9a-42ad-92e0-a68532f16f48">12.63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtMS0xLTEtNjgzODI_d97c6210-8929-4830-a202-36f6e60ae1e4">2.17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtMy0xLTEtNjgzODI_f3039175-fbb9-4100-8e9b-dcd0d2b43471">4.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtNS0xLTEtNjgzODI_200d991e-4bd4-4cc2-9b3c-bb46d2315429">7.05</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtNy0xLTEtNjgzODI_8df072cf-9f41-4fe4-bf7b-56ceff202e3d">12.41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtMS0xLTEtNjgzODI_8138ab62-9dbc-4fb6-89e5-3130730892a6">116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtMy0xLTEtNjgzODI_14a36b42-9fb6-4be1-8196-62ab7aaf8fb6">123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtNS0xLTEtNjgzODI_e6137305-c2d5-40d7-880a-8167ac3d2aae">117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtNy0xLTEtNjgzODI_86cce5dc-bc51-4f7f-9eb2-db88988efffe">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtMS0xLTEtNjgzODI_a557d1ed-8eaa-4063-80c9-caf6bf737907">118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtMy0xLTEtNjgzODI_c44dfead-fc16-4ac0-b65f-67e9ba8fef49">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtNS0xLTEtNjgzODI_ea398523-2a8e-42bd-989e-370f1ecd9424">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtNy0xLTEtNjgzODI_6b5303a2-692d-47a3-a1a1-4bcf7960dbbe">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2022 AND 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi0xLTEtMS02ODM4Mg_7e2749fd-c906-44b7-9045-683f14963fab">276</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi0zLTEtMS02ODM4Mg_48491f4a-1e1c-4f0c-b3bf-a6d99a443b9e">527</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi01LTEtMS02ODM4Mg_61431ae7-0fde-4acf-ac90-c0f9b29996b7">899</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi03LTEtMS02ODM4Mg_5084862b-0006-4aa8-9a45-2a0524b8c18e">1,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS0xLTEtMS02ODM4Mg_ce974f26-0239-43c2-8ee3-7efa4dafad6b">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS0zLTEtMS02ODM4Mg_613ee4f1-cee4-4068-8a7d-dbe0cda17fad">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS01LTEtMS02ODM4Mg_bd71adcf-62a8-40b3-83a9-3c4f18274fb3">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS03LTEtMS02ODM4Mg_2219934c-a0b4-4aa0-ae26-6f0b428d179b">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in available-for-sale debt securities, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi0xLTEtMS02ODM4Mg_4a20e24b-a013-4da2-9e9d-754c64c0a752">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi0zLTEtMS02ODM4Mg_0a01e24f-7389-4a31-ba7e-7377688dc788">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi01LTEtMS02ODM4Mg_1c616193-0439-43ab-821b-eba55369fb46">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi03LTEtMS02ODM4Mg_c4b5ae56-886e-4a52-86c2-9d289526a30d">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred gain on cash flow hedges, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy0xLTEtMS02ODM4Mg_93dd0be4-959b-4dc6-9513-535a908cd85d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy0zLTEtMS02ODM4Mg_8aa20d30-81db-40be-95c7-3ee7fe07a92a">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy01LTEtMS02ODM4Mg_2a7186d7-043b-45f3-99c1-cf5621e4e556">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy03LTEtMS02ODM4Mg_7bd6ef5c-179f-4f72-9b54-37efe2056343">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS0xLTEtMS02ODM4Mg_596ad227-b71a-4018-a75d-0a0e7bfb06ad">8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS0zLTEtMS02ODM4Mg_21bc9819-3d81-4533-a090-e8610459678f">3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS01LTEtMS02ODM4Mg_cee450e6-6a2c-4369-afd4-4f848dcec8aa">17</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS03LTEtMS02ODM4Mg_f1399c6b-a91c-4f44-a8b0-3760eb28f97a">8</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtMS0xLTEtNjgzODI_3d39a547-da39-4e6d-960a-8796a636e92c">268</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtMy0xLTEtNjgzODI_9662d735-726a-489d-8397-2bd166e831b2">524</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtNS0xLTEtNjgzODI_ca398a72-9884-4dee-994d-4bfbeec95ccb">882</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtNy0xLTEtNjgzODI_77538e19-e78e-4143-acaa-1e1e0c6c5be2">1,675</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItMS0xLTEtNjgzODI_cbe9567a-073d-4adc-8a12-62e20b5a1d4e">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItMy0xLTEtNjgzODI_32b924ae-642e-48f7-999b-f95ea091489c">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItNS0xLTEtNjgzODI_f40fe8a5-6bdf-4a92-b728-c39ce80742d7">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItNy0xLTEtNjgzODI_e47be4a4-0244-4a7b-89b7-9d5698f79d8e">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtMS0xLTEtNjgzODI_04a8fd3d-0296-4da2-a55a-8c02e24cf52c">248</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtMy0xLTEtNjgzODI_4c930a38-8468-4a92-b563-4b16e01fb80c">502</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtNS0xLTEtNjgzODI_13d7d20c-8101-4ab1-9035-4e54e2b6092f">828</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtNy0xLTEtNjgzODI_7e949290-4467-4e6e-b9c8-3ac774c9c76b">1,613</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_19"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEPTEMBER&#160;30, 2022 AND DECEMBER&#160;31, 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMy0xLTEtMS02ODM4Mg_d0a0c2a9-3403-4990-891f-112ee61915ee">700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMy0zLTEtMS02ODM4Mg_c3852abb-d768-4f63-aa46-cc208ce1129c">872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0wLTEtMS02ODM4Mi90ZXh0cmVnaW9uOjI2NDdhZWY5M2U1MzRkNjI4NzQ4NWNiMzU2ZmJmZTY5XzYz_e0c53c7b-1bb8-4a15-a006-996b1dde2c09">29</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0wLTEtMS02ODM4Mi90ZXh0cmVnaW9uOjI2NDdhZWY5M2U1MzRkNjI4NzQ4NWNiMzU2ZmJmZTY5Xzcw_05b769ca-399b-4fd5-a0d4-7e19b03a9300">31</ix:nonFraction> as of September&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0xLTEtMS02ODM4Mg_354b244a-2187-4958-918c-1fc9395081cc">1,280</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0zLTEtMS02ODM4Mg_fa082474-4e46-478f-a2fa-5b65d63d95fd">1,438</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNS0xLTEtMS02ODM4Mg_e0db085e-3738-4d19-af10-ba4808ed3106">183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNS0zLTEtMS02ODM4Mg_5e19a25a-483d-418f-94d4-8efa1372c07e">208</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNi0xLTEtMS02ODM4Mg_0349399f-d210-45f2-8c79-887258971329">171</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNi0zLTEtMS02ODM4Mg_b000efe8-717a-4a7c-bafe-d45e894a7247">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOC0xLTEtMS02ODM4Mg_303c8c89-9070-47f3-b9f9-abb6a8fd345c">2,334</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOC0zLTEtMS02ODM4Mg_c6a81ab2-1c97-4126-8189-00e69bd395df">2,741</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOS0xLTEtMS02ODM4Mg_6b8ed43b-3e37-4d7f-9056-0af2e39948f4">1,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOS0zLTEtMS02ODM4Mg_8ea596b5-576b-4fd8-a48c-00c52bd665d7">1,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTAtMS0xLTEtNjgzODI_677c5632-6798-4430-a353-07442cf7a88c">607</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTAtMy0xLTEtNjgzODI_9e6a42d1-67da-44a2-8650-dddbce5e8ef7">597</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTEtMS0xLTEtNjgzODI_becf113e-312c-4730-b9bd-30ecd3d811ae">7,190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTEtMy0xLTEtNjgzODI_5e00d998-ee68-49e3-87a2-3ecc6fbd9cd8">7,095</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTItMS0xLTEtNjgzODI_b64169be-9ef5-4b8f-8397-0f1100eae422">1,115</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTItMy0xLTEtNjgzODI_49d4a430-cda0-4b03-a672-d2409c5d3a0f">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTMtMS0xLTEtNjgzODI_803bb143-dd28-45d2-bc64-3741a6a8e2c0">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTMtMy0xLTEtNjgzODI_49c8b43a-6d72-4e75-ad24-3b7bd66974c4">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTQtMS0xLTEtNjgzODI_b8459ef9-6b23-457a-9acc-92812ad90156">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTQtMy0xLTEtNjgzODI_3682dfa0-f667-48bb-9fd7-4499ea0fe4b3">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTYtMS0xLTEtNjgzODI_57967f05-bd7e-4fe9-8a15-be2a86b7653b">13,223</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTYtMy0xLTEtNjgzODI_1fd0fb07-2229-4bac-be9e-96efd407a9ea">13,611</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjAtMS0xLTEtNjgzODI_292f61f9-898f-4930-8b94-4cbbe7f68c0a">1,447</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjAtMy0xLTEtNjgzODI_bdb83532-f301-4871-8871-a168ae742392">1,600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjEtMS0xLTEtNjgzODI_7e8d5144-1b56-4bbc-ac47-41ae66dcf51e">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjEtMy0xLTEtNjgzODI_a603417f-1c3f-4f67-9a51-593c6b5272f6">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjItMS0xLTEtNjgzODI_62f8bc65-3e19-4a1f-b238-92de5a97ffb0">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjItMy0xLTEtNjgzODI_13b42da3-abda-47ca-93ac-b92b1830599c">151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjQtMS0xLTEtNjgzODI_bdf8270d-58a2-449e-a610-11fd222eef74">1,602</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjQtMy0xLTEtNjgzODI_882213ab-648a-47a4-8a4f-5adbd8e53f9e">1,753</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjUtMS0xLTEtNjgzODI_96f3452c-7fa6-4e45-90a9-346f4cbe3e3b">3,980</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjUtMy0xLTEtNjgzODI_15b1957c-8a22-4beb-aa85-e519d9d3c142">4,010</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjYtMS0xLTEtNjgzODI_6585973f-c46b-422e-b00c-e1ea9c56cd09">505</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjYtMy0xLTEtNjgzODI_e0c1bc96-d1ee-4e41-95d9-f953c635f6b1">494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjctMS0xLTEtNjgzODI_4c406989-4d7e-4ca9-b67e-bc393476c672">787</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjctMy0xLTEtNjgzODI_2c3567cd-516d-41fa-a35c-edf74c09e804">792</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjktMS0xLTEtNjgzODI_2b6a8261-4a01-4e86-8325-05e9104442ab"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjktMy0xLTEtNjgzODI_ac03faf5-e6ba-4611-bb31-a125ff5ed726"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzAtMS0xLTEtNjgzODI_69e7f3fb-45ef-4e6d-b3cb-62eceb291f37">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzAtMy0xLTEtNjgzODI_f2827e29-6319-49df-8e07-d3bb66c45e5e">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8yOA_79b23141-03d1-4d66-a8ce-045a5bd2c9c7"><ix:nonFraction unitRef="usdPerShare" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8yOA_9dd5baf3-9e5c-4120-9f17-2fb89ea887b2">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV80Mg_916f4f77-89c0-49dd-9d16-b974208f118c"><ix:nonFraction unitRef="shares" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV80Mg_db1699cb-9c73-44fe-8e19-d21ec7fabaf4">600</ix:nonFraction></ix:nonFraction> shares authorized as of both September&#160;30, 2022 and December&#160;31, 2021; <ix:nonFraction unitRef="shares" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8xMTE_b3dade48-07f3-4860-833f-1dc5d536fe3d"><ix:nonFraction unitRef="shares" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8xMTE_bddcf38c-5eed-4ad2-a9ba-d3a54cfc4f4c">162</ix:nonFraction></ix:nonFraction> shares issued as of both September&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMS0xLTEtNjgzODI_b502fe12-f231-48db-8a69-abde6fc50da9">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMy0xLTEtNjgzODI_6c2d4012-09dd-45cc-be1d-0d0b0bb194bf">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzQtMS0xLTEtNjgzODI_9dfe7c68-9928-4fc3-89f9-33e0d432c0ac">2,272</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzQtMy0xLTEtNjgzODI_4b4ed76f-7992-45ed-8327-419c6ffc9996">2,260</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzUtMS0xLTEtNjgzODI_1251dcf6-eee4-4c89-b32d-74c4ecc9e55a">8,263</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzUtMy0xLTEtNjgzODI_77898ff9-a919-4284-b5dd-2f31bac2082a">7,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzYtMS0xLTEtNjgzODI_c6ed925c-ac5c-40ca-b0b9-501ac5c56b62">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzYtMy0xLTEtNjgzODI_392e65a5-f706-4871-87c0-700f069cca1d">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjo1NTI5ODQzMTc2NTE0OTI4YjMzODg5NTY5ZGI4OTgwZV8yOQ_3546cbc0-5662-452a-ab9b-95b31f9fe904">48</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjo1NTI5ODQzMTc2NTE0OTI4YjMzODg5NTY5ZGI4OTgwZV8zNg_261d91cf-f7da-44f5-8a72-4600cd20e089">43</ix:nonFraction> shares as of September&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMS0xLTEtNjgzODI_f4da91fb-890f-40bf-ac9c-7cbf1e78bec5">4,271</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMy0xLTEtNjgzODI_167bdbd0-3228-4443-aabe-24311960496b">3,453</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzgtMS0xLTEtNjgzODI_8dba03b1-28bc-4bad-a892-cd9bd1da37f5">6,235</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzgtMy0xLTEtNjgzODI_1b787ff1-7363-45cb-8d36-1aa6c26262f8">6,444</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzktMS0xLTEtNjgzODI_082dfaa0-7ea7-4153-8561-c6eb01915b11">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzktMy0xLTEtNjgzODI_8e557095-6a84-4bc0-a8be-a353510d857c">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDAtMS0xLTEtNjgzODI_39af5a1b-852b-4dd0-adac-eceb52558924">6,272</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDAtMy0xLTEtNjgzODI_4ae78553-e6cc-4fa3-8d77-23752e9dff0a">6,483</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDEtMS0xLTEtNjgzODI_908be517-07d0-4313-b5b0-82c94efc68d0">13,223</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDEtMy0xLTEtNjgzODI_36ae775e-452b-4240-abba-9d3fc7a66b77">13,611</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE NINE MONTHS ENDED SEPTEMBER&#160;30, 2022 AND 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions) </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMy0xLTEtMS02ODM4Mg_61431ae7-0fde-4acf-ac90-c0f9b29996b7">899</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMy0zLTEtMS02ODM4Mg_5084862b-0006-4aa8-9a45-2a0524b8c18e">1,667</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNS0xLTEtMS02ODM4Mg_1b076d3c-fdf7-4003-a7b7-173a63b96712">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNS0zLTEtMS02ODM4Mg_fcd3382d-abdb-4320-a7b1-fe117009f5aa">302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNi0xLTEtMS02ODM4Mg_c16462d4-7366-4f0d-9031-ac26c5c32b58">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNi0zLTEtMS02ODM4Mg_ae856e5f-5438-4d87-974f-1fd596d57800">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision (benefit)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNy0xLTEtMS02ODM4Mg_6bab9e61-ed87-43c0-a92a-b877f6c0c94f">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNy0zLTEtMS02ODM4Mg_f33c92da-0eaf-4fda-9144-ae850ed8f0cc">87</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfOC0xLTEtMS02ODM4Mg_6efda924-fec5-4e9f-9b39-180b27081727">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfOC0zLTEtMS02ODM4Mg_1f5eba1d-fb62-4680-a31f-8819e5904427">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposition of joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="dgx:GainLossOnDispositionOfJointVenture" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTAtMS0xLTEtNjgzODI_2f65e40d-9b81-44a4-9765-625a5ca0a374">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="dgx:GainLossOnDispositionOfJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTAtMy0xLTEtNjgzODI_b2b4cae2-ecac-4037-a6e6-853f8e211533">314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTEtMS0xLTEtNjgzODI_3c38389c-ff8e-412b-81e9-9503fd18da32">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTEtMy0xLTEtNjgzODI_207c7685-840d-4513-b617-3ca1a133d1d3">48</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTMtMS0xLTEtNjgzODI_34f00886-b744-4d46-8a0b-74c6add5c9a9">162</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTMtMy0xLTEtNjgzODI_1a20aedf-aacc-4ec4-b6d0-dccc079be431">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTQtMS0xLTEtNjgzODI_9bdf29b8-5d97-4a2c-9372-5d11e0d718f7">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTQtMy0xLTEtNjgzODI_c967c2fd-406d-47d6-b8e5-028c42fa81ed">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTUtMS0xLTEtNjgzODI_99a007a6-9b96-4bba-8c13-dc7b0f0286f6">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTUtMy0xLTEtNjgzODI_80f57a97-eb78-4e5e-aae4-a26559a0d222">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTctMS0xLTEtNjgzODI_34a46e80-807c-4bbb-a857-8993f3899544">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTctMy0xLTEtNjgzODI_d607edcf-674f-4b5c-ab85-0255a11da627">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTgtMS0xLTEtNjgzODI_9968b376-9d07-4876-88ee-27f065b50aec">1,384</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTgtMy0xLTEtNjgzODI_fbedce14-9e02-46a2-9a38-204bd2b5b2e8">1,752</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjEtMS0xLTEtNjgzODI_bcd7cf5f-1dc4-42de-a991-9b80b9e6afbf">106</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjEtMy0xLTEtNjgzODI_1e3ac586-e66e-4bb8-8f6f-6de0e68ccc6a">251</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjQtMS0xLTEtNjgzODI_c791ee01-ba4d-4e8b-a8c2-57cd3e83f588">257</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjQtMy0xLTEtNjgzODI_9e355b61-b99d-46ee-96dd-2f9d50a2dffe">259</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from disposition of joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjYtMS0xLTEtNjgzODI_36fa2b1d-8850-4bfe-91b8-35b24d6a1a91">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjYtMy0xLTEtNjgzODI_928250eb-e100-4e34-ad33-b7c0f4a26070">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Increase) decrease in investments and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjctMS0xLTEtNjgzODI_55adb015-f54a-44e6-8535-298bce412e82">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjctMy0xLTEtNjgzODI_8faffaa4-5455-4f1f-9a53-ae65a896fbcf">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjgtMS0xLTEtNjgzODI_17b58fce-9785-47b8-9124-0dc5330ad22d">369</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjgtMy0xLTEtNjgzODI_fef78cce-c029-4cae-93d4-6b08857b432f">248</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzItMS0xLTEtNjgzODI_1feaf213-9a2f-4436-81dc-baf5c60aa085">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzItMy0xLTEtNjgzODI_7bf3b086-7944-4816-9cd4-d906a08adfa8">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzMtMS0xLTEtNjgzODI_f8f02970-6425-404b-856f-d7380c63ecb0">947</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzMtMy0xLTEtNjgzODI_03499fa5-17c3-46a6-907a-416378f2c4f9">1,910</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzQtMS0xLTEtNjgzODI_212c5d53-2be2-4034-9921-80c44b833bac">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzQtMy0xLTEtNjgzODI_b74d71f4-cc14-4c0f-ab26-4697e0c08f43">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzUtMS0xLTEtNjgzODI_013c79bd-f1f9-4d6b-94be-6c537571d55d">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzUtMy0xLTEtNjgzODI_24668a11-ff38-4e2a-8318-29aef9f9f61c">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzYtMS0xLTEtNjgzODI_67bad9c8-6550-431c-8c8a-34164fdaa515">230</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzYtMy0xLTEtNjgzODI_69517525-6f4b-4c4e-a016-eb506e3d6746">232</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzctMS0xLTEtNjgzODI_003fd28c-85f1-4daa-846f-793a4a771f58">58</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzctMy0xLTEtNjgzODI_ff080b61-4024-49d2-aa89-fe13d3010e54">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDAtMS0xLTEtNjgzODI_6e9ecdad-9e39-4ee1-8fe5-80104295e508">19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDAtMy0xLTEtNjgzODI_ac124e68-ae01-4c55-b626-277baca7b6b6">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDEtMS0xLTEtNjgzODI_a65c7b8a-a0c1-47a9-8b3a-fdb54204a480">1,187</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDEtMy0xLTEtNjgzODI_0b73c16f-c44b-4fd1-8fae-b846400c324a">2,171</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDMtMS0xLTEtNjgzODI_24512018-598b-4303-9c56-cb2f262d5616">172</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDMtMy0xLTEtNjgzODI_be0a7974-39ee-47eb-b78f-6aeff1b984a3">171</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDUtMS0xLTEtNjgzODI_068a875d-2144-4b39-ade9-56dd1bccf49b">872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDUtMy0xLTEtNjgzODI_dd3649a7-7fd9-408e-8589-02a8e3318e79">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDYtMS0xLTEtNjgzODI_cdc1e327-feec-4e9b-b9cb-8a1665068ef8">700</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDYtMy0xLTEtNjgzODI_efbc541f-a6a2-4c8d-b67d-ff025c90655c">987</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2022 AND 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia66110999ebf47e489970ea681e28bc9_I20220630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xLTEtMS02ODM4Mg_02463d09-7a54-4772-9673-495e88c76a49">117</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66110999ebf47e489970ea681e28bc9_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0zLTEtMS02ODM4Mg_6b46f57e-ac60-47b1-aa9f-720d909ea577">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133ede9bcd2547d88ad254bf768df343_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi01LTEtMS02ODM4Mg_f2f0c7ce-fa68-4625-9e9e-9d4a2cfa5fe0">2,250</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f52678681d643878109e96f1420975f_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi03LTEtMS02ODM4Mg_a0c72a7e-9089-4b30-94bf-931d4c723bcd">8,083</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77f7c6bfef074498a4e11de614453204_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi05LTEtMS02ODM4Mg_b7fb2e9d-d99a-4c47-80af-f65decb4f03e">23</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if85ffac6808545d2a1e4b4b8d588cbca_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xMS0xLTEtNjgzODI_b6eea336-4dc6-4a8d-8d8d-bdee04480d74">3,901</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71f8587b94614e62972a571a0db167fb_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xMy0xLTEtNjgzODI_f2671754-9781-495b-8602-54ee76d7936e">39</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6601d4f897bd4dad9874662aa4fe198e_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xNS0xLTEtNjgzODI_770cf9fc-5522-4883-80dc-2f387c0ce847">6,450</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6601d4f897bd4dad9874662aa4fe198e_I20220630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xOC0xLTEtNjgzODI_2a9c0b9a-20d6-4e82-8251-38be356c2e54">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f8b7df600b4b878bba187286fd791b_D20220701-20220930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy03LTEtMS02ODM4Mg_1567b1cf-2bdb-4aa6-9db6-3149c918b1b6">256</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38982359ccf14cb991b0c3db0e12289b_D20220701-20220930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy0xMy0xLTEtNjgzODI_e48c6c67-b3ed-48fd-b933-7136ceefbfc5">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy0xNS0xLTEtNjgzODI_02a45580-57b2-4b05-b5c3-7ca5dd57544f">275</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy0xOC0xLTEtNjgzODI_1b2a63f2-cfad-42d6-851a-52ee9c69f4e2">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i446ca4eb05494f1993ef7b2e312c2037_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNC05LTEtMS02ODM4Mg_315ccdb6-9e10-4bef-9603-fc27dca8dd05">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNC0xNS0xLTEtNjgzODI_2d5057e4-11a0-49d6-8721-59719cdc9ce1">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9f8b7df600b4b878bba187286fd791b_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNS03LTEtMS02ODM4Mg_f09a90f9-2320-4912-a23e-cc2efd950fed">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNS0xNS0xLTEtNjgzODI_99b70328-024f-436a-9361-e16949e3c9d6">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38982359ccf14cb991b0c3db0e12289b_D20220701-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNi0xMy0xLTEtNjgzODI_3f3f68d5-db00-4848-8f4a-0bc0e300e244">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNi0xNS0xLTEtNjgzODI_d564480d-c2c7-4aed-a8cb-52369bbb641e">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNi0xOC0xLTEtNjgzODI_e687866f-b40b-4bbe-a065-f72fd62974ea">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNy01LTEtMS02ODM4Mg_87b015c3-2471-4af4-a663-1fc8606b4abb">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNy0xMS0xLTEtNjgzODI_6793272c-4cd0-48d1-9b1b-81cb9df35847">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNy0xNS0xLTEtNjgzODI_2b52a5e7-40b6-406e-86af-54376ec704e2">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOC01LTEtMS02ODM4Mg_13903caa-0f86-4450-b3d8-916996b9daba">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOC0xNS0xLTEtNjgzODI_dc8eed1f-6366-484c-8852-aaed29abbc85">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOS01LTEtMS02ODM4Mg_5dece60f-b68a-4806-bb3e-c9bdbcd8b8fb">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOS0xMS0xLTEtNjgzODI_4730b794-c1f9-44b7-a8b0-2a5fd332d7b3">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOS0xNS0xLTEtNjgzODI_fbb1d804-8fa7-4d89-8eaf-b615443d5ccf">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTAtMTEtMS0xLTY4Mzgy_83f0456d-bef8-470a-b59a-0ee52d13b426">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTAtMTUtMS0xLTY4Mzgy_c0abd9fb-82b7-41e0-8c9b-3f3b8968acb0">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8c1a402b7edc4bada7fe43b8bed57c9e_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTEtMS0xLTEtNjgzODI_1be86e5b-f834-4c53-8f20-e5fa7d62458c">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTEtMTEtMS0xLTY4Mzgy_5b68ca63-86eb-49de-b387-0abcbaef2897">400</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTEtMTUtMS0xLTY4Mzgy_f488279f-ffbf-4c78-af84-829068d26e07">400</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMS0xLTEtNjgzODI_2679d8e2-c696-4d27-a00a-2c32d33b3f53">114</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMy0xLTEtNjgzODI_ba0c4977-6676-4915-916d-a3b5d204eea6">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81266202c6f4daaa1fe7d11c3466090_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtNS0xLTEtNjgzODI_4c05dca2-ebad-4cdb-a412-e97d42b84c0c">2,272</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8fcb85a255b4d078c7675e41fd05fb7_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtNy0xLTEtNjgzODI_995ec749-67bc-457c-b235-3632f48b5b6d">8,263</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8691d08785574903bd93ee4dfa5db854_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtOS0xLTEtNjgzODI_295fbe76-1f03-46c0-8e33-391204909d9b">31</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa63970b08847edb23879db454cfd5a_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTEtMS0xLTY4Mzgy_90f6606e-349f-4916-9525-b974b9f01683">4,271</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d44b0c7e6764a3690dac72ba9bceeb6_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTMtMS0xLTY4Mzgy_253cc517-9e48-4d3c-bea3-0eb67a9c8759">37</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTUtMS0xLTY4Mzgy_8deab2e5-e019-4ba8-8a99-927fecdb7618">6,272</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTgtMS0xLTY4Mzgy_fce1cdc0-2a91-43e7-8180-a0a0543b76e6">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6123cf684d748bfaeb9d6c407ab233d_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMS0xLTEtNjgzODI_68776a98-a0a4-463e-9505-bb34ab01dd4a">119</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6123cf684d748bfaeb9d6c407ab233d_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMy0xLTEtNjgzODI_5368bcf9-6e46-4a05-a149-73942c781317">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee26b45b4834d788993956547c7876e_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctNS0xLTEtNjgzODI_2e134013-1fb3-420b-b3d4-8e4cc06baffa">2,260</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5de51ccdd040f8bc396f5bbb026e33_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctNy0xLTEtNjgzODI_b0fc7b54-7c9c-420f-ba00-9099c14e391c">7,649</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a33f90cea9e41bebf5bc6e0fb60699f_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctOS0xLTEtNjgzODI_7b49beba-39e6-4baf-8bba-248ea1a953b0">14</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ebb219cb475425591cf0155edc1d443_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTEtMS0xLTY4Mzgy_2a813882-c6de-4fcb-8de1-50f9e93bc3af">3,453</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebfd0201851442908146535dd57ca675_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTMtMS0xLTY4Mzgy_cef7d9e1-1962-424f-b3af-b3d10cdad78b">39</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTUtMS0xLTY4Mzgy_2198ba10-6560-4e99-a3f0-d8db2d6ce684">6,483</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTgtMS0xLTY4Mzgy_17a54f60-145a-4cf4-a32a-71dd23111ede">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i541597114f5944418a137ab87cea7f3b_D20220101-20220930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtNy0xLTEtNjgzODI_f819598e-408e-42ec-97c8-1f8bbef50e7c">845</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3118010a65e94107930187af0b9032e2_D20220101-20220930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtMTMtMS0xLTY4Mzgy_12f3f1e6-ffb4-4daa-8e1e-0c7dedc84589">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtMTUtMS0xLTY4Mzgy_531110c2-9c7a-489c-a64e-5abe2f2dcede">894</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtMTgtMS0xLTY4Mzgy_69a81bf0-3c08-4baf-acf6-ba9dd2f40fca">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3680833c24d343c4b94154c01f3fad0f_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTktOS0xLTEtNjgzODI_6a92ccbf-edb0-45d9-830d-5186bb4e5bc8">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTktMTUtMS0xLTY4Mzgy_385df9c7-fc53-451f-8338-595f46fcbc74">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i541597114f5944418a137ab87cea7f3b_D20220101-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjAtNy0xLTEtNjgzODI_df98dd98-3683-4890-9b2e-9325b3c39a7a">231</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjAtMTUtMS0xLTY4Mzgy_cd4dcc28-aade-44de-9712-84aca7bf12a9">231</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3118010a65e94107930187af0b9032e2_D20220101-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjEtMTMtMS0xLTY4Mzgy_a7a7a5b9-89ee-4842-bff0-ac280ae50ba2">51</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjEtMTUtMS0xLTY4Mzgy_19e19ea4-241e-4437-989a-4b017639b3bc">51</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjEtMTgtMS0xLTY4Mzgy_fd0b5e48-6cf4-4064-8af3-e0948de5cdba">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItMS0xLTEtNjgzODI_10a3e2de-499f-4f58-9677-199f517c5a1f">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItNS0xLTEtNjgzODI_d0599403-1630-449b-af46-1d226c6b673e">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItMTEtMS0xLTY4Mzgy_69fb9dfd-5d86-49bc-acb0-a64bbf5438b8">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItMTUtMS0xLTY4Mzgy_f7db0112-3e41-4aa4-9d1c-91404546a35f">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjMtNS0xLTEtNjgzODI_192d314b-e191-41a9-9ad3-4a2709c9623e">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjMtMTUtMS0xLTY4Mzgy_361c8f4a-71df-46fe-a811-dac810c4bc1f">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtMS0xLTEtNjgzODI_09a431b1-6d78-4888-bebe-8a9eba5e4825">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtNS0xLTEtNjgzODI_3a06a975-b16e-4707-bae5-ce15c70ef522">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtMTEtMS0xLTY4Mzgy_7f5cf1c7-1642-4861-bbc2-05a085458186">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtMTUtMS0xLTY4Mzgy_f02abb3b-de3e-4296-af71-619301def00f">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjUtNS0xLTEtNjgzODI_f8d69a38-67c3-412e-a295-9d609623f7d5">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjUtMTEtMS0xLTY4Mzgy_aa3cdc40-4599-4808-b425-e25eeb219e6b">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjUtMTUtMS0xLTY4Mzgy_1605d943-438b-4680-afcd-f9d3e72f1365">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjYtMS0xLTEtNjgzODI_cd5c3131-23ce-4b48-9de4-042e5f5fd67b">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjYtMTEtMS0xLTY4Mzgy_2492740f-5658-4460-a84e-5724cac5eaae">950</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjYtMTUtMS0xLTY4Mzgy_11c1db76-c954-45e6-94f1-3b1e04aab5a0">950</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2022</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMS0xLTEtNjgzODI_132d5398-b620-44af-8899-b4f13420e4f2">114</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMy0xLTEtNjgzODI_d3a2f04c-8305-4008-9eb4-52deac46eb19">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81266202c6f4daaa1fe7d11c3466090_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtNS0xLTEtNjgzODI_a6a5e426-053b-4fae-8241-278df7aee590">2,272</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8fcb85a255b4d078c7675e41fd05fb7_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtNy0xLTEtNjgzODI_bce5c8e9-46b4-4843-add5-1a9641b26c10">8,263</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8691d08785574903bd93ee4dfa5db854_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtOS0xLTEtNjgzODI_be07002c-7adc-4997-b699-2062d37d91fe">31</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fa63970b08847edb23879db454cfd5a_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTEtMS0xLTY4Mzgy_a0379805-14e7-4a2e-8b71-1668130c7dee">4,271</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d44b0c7e6764a3690dac72ba9bceeb6_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTMtMS0xLTY4Mzgy_09319c38-2c4f-4c98-aa33-b73d7878cdac">37</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTUtMS0xLTY4Mzgy_48bce5b9-a9e3-4d6a-a644-8bfa4c29170f">6,272</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTgtMS0xLTY4Mzgy_e7a62003-45d0-49ed-a777-a62be470938e">77</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2022 AND 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.025%"><tr><td style="width:1.0%"></td><td style="width:28.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i430a0954dff34ed2abd3bbf6af3ce92e_I20210630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xLTEtMS02ODM4Mg_038aa26c-cd03-4fac-9e3d-33936178d77c">122</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430a0954dff34ed2abd3bbf6af3ce92e_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0zLTEtMS02ODM4Mg_4a87963f-4574-4133-94a9-e9ad0353123f">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d22acbc549640a3bcff1331465f4490_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi01LTEtMS02ODM4Mg_6de54e9b-200e-49a7-bc47-36c0284bad18">2,555</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a2d9b7a5804534a11a487194d959d8_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi03LTEtMS02ODM4Mg_51a9e0f6-13a8-494c-93f1-2c4b33af496a">10,246</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e937069022b4224ae54a53549450dfe_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi05LTEtMS02ODM4Mg_6fbe087b-d76c-45d6-b6f4-a4404642415d">10</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id99280e00773483bbeab37f6250f0a64_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xMS0xLTEtNjgzODI_cbc4163f-cdd3-4fc4-9e6a-377923702ae5">6,894</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd61be3e49b417b94fe98d76f276f90_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xMy0xLTEtNjgzODI_2cece0ae-5ffe-41e6-8bd9-174b7356f0ed">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ebde6c314dc416a9d24bf9416554a5a_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xNS0xLTEtNjgzODI_c165865f-1fd0-461a-9fd7-37bd082737ad">5,940</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ebde6c314dc416a9d24bf9416554a5a_I20210630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xOC0xLTEtNjgzODI_43730ef3-aeb1-450e-b52f-2cd8a58cd485">78</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy03LTEtMS02ODM4Mg_3dd21f12-42d8-4ac1-90b7-f90830c26fad">505</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfcdafe6ec384c35ae912ea54a83b7b3_D20210701-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy0xMy0xLTEtNjgzODI_1ef76042-4765-4caa-9c8c-b4c08a9c0f7f">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy0xNS0xLTEtNjgzODI_ba7a3cee-2fcb-4249-b25e-4f2be67c77cb">524</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy0xOC0xLTEtNjgzODI_d79f1230-8181-4d52-b5ef-ca9a4dd93def">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id58c37cc4057489f93440a4c2f4ad37e_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNC05LTEtMS02ODM4Mg_a533ec43-ef13-428b-8d71-f78f7d48bac0">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNC0xNS0xLTEtNjgzODI_4b6d3b4c-c129-489a-a264-7b328c524c66">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNS03LTEtMS02ODM4Mg_2307b3b3-c4b0-43c1-8320-d6c00194931a">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNS0xNS0xLTEtNjgzODI_e5e3c179-23a0-4c63-9783-d0c753513c12">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfcdafe6ec384c35ae912ea54a83b7b3_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNi0xMy0xLTEtNjgzODI_5c48ff65-96d8-4d59-8344-69fa282f360c">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNi0xNS0xLTEtNjgzODI_7f85b300-3ec4-4e73-84ce-d3b94d2adc5a">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNi0xOC0xLTEtNjgzODI_8623b6b2-7d15-4888-a646-ec63be253ed0">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNy01LTEtMS02ODM4Mg_1d8918ed-8110-4b03-8fcb-e4680c5c09c0">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNy0xMS0xLTEtNjgzODI_98e5c6d8-884f-461e-86b0-222dc49bcdf3">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNy0xNS0xLTEtNjgzODI_c776ee73-86e7-44ad-908a-e6f13ade4b11">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOC01LTEtMS02ODM4Mg_4a709e28-49e4-459b-b1f8-a2af13c5a3bc">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOC0xNS0xLTEtNjgzODI_7fda095b-0a05-4f1b-96e5-ca567a890826">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63e96229aac640a599fd3d48159fd084_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS0xLTEtMS03MDE4OA_189f4095-aff3-418d-9ea3-7758e53f7445">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS01LTEtMS02ODM4Mg_3f154041-d1b9-4bb1-8727-a6807a075ac0">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS0xMS0xLTEtNjgzODI_0f622f88-c5ce-44de-a449-a5e0e061b3f0">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS0xNS0xLTEtNjgzODI_84a3f08e-f18a-4e30-a2ad-d0f01208983e">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNS0xLTEtNzAyNDc_ab21f54a-f9dd-4a34-b06f-978616635161">649</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNy0xLTEtNzAyNjI_23cb238b-75b1-41ca-a06e-85a0b04a3d52">3,342</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTEtMS0xLTcwMjg3_90e67bd0-3eda-4d72-a833-cba6dd899be3">3,991</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTUtMS0xLTcwNDIw_fd44ff90-dc1f-4109-a056-0077bff0dce1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMS0xLTEtNjgzODI_909f467b-91a4-4322-b85e-d1781f725ad4">123</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMy0xLTEtNjgzODI_8a9fd783-1320-4f63-8122-875f3b8c83e4">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055da741a38a425dae638290e29c8807_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNS0xLTEtNjgzODI_c6b7c1c5-27c5-4680-b265-42dc49351932">1,936</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia920ca1912e3480ebb55fdc231a8da19_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNy0xLTEtNjgzODI_18d69334-e559-48fe-9b4c-37cc495ceb37">7,333</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d3e5ccd81e9421e810e21a4bfa68ce7_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItOS0xLTEtNjgzODI_ee9a31e0-69de-470a-ae18-f50f86d91e73">13</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95b59fb6a60d4941848525e7d490105d_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTEtMS0xLTY4Mzgy_54f23bf3-de6a-4b3d-8e97-01f10b79a0be">2,866</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0079fdb1f79341858ac4900a117a3803_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTMtMS0xLTY4Mzgy_b7d9d93c-f98c-44ff-a34b-69319ba8ad7e">40</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTUtMS0xLTY4Mzgy_2d429e9c-91e9-4bc3-8e3e-624b996b4125">6,432</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTgtMS0xLTY4Mzgy_b6a2d9fd-b8bb-4be1-a481-44ede033bbd5">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58732cf05c7043b6a8e12b54db21de24_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMS0xLTEtNjgzODI_cfb03ec7-7b58-47ea-a708-9b15e4fc908e">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58732cf05c7043b6a8e12b54db21de24_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMy0xLTEtNjgzODI_44cd9597-326f-49f5-90a1-12fca6d717d0">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0089fadb633a4032ac4aaef0b0d2b75e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtNS0xLTEtNjgzODI_2a1fea34-6f64-430f-aa7a-605330cf2b42">2,841</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93981161fc924e7fbcc2631956508614_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtNy0xLTEtNjgzODI_a19680f5-3e40-440b-976d-fa0a87ab1b1f">9,303</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6eef6a2ec94d4ff289ccf2404dd21a9a_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtOS0xLTEtNjgzODI_e2bc22c9-6558-4aab-a53b-8512e659a69b">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe1208f398b44195af87535925e86927_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTEtMS0xLTY4Mzgy_9665c1f0-6734-43d1-bca0-966b40e5d62a">5,366</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589ae2a45c0c438dbc9b633c7ad6ae33_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTMtMS0xLTY4Mzgy_abdf760c-d8df-4446-b0bd-58ef45d6799c">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTUtMS0xLTY4Mzgy_34f5e26b-bf8d-411b-b0b5-ed69f0af1c37">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTgtMS0xLTY4Mzgy_d50879cd-fda1-44e4-938f-9ead6127e42a">82</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840e894a7ef144038ef94728d7daa256_D20210101-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctNy0xLTEtNjgzODI_7fde0912-b0a8-43f9-b846-d69916ec350f">1,605</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ffd0c3e5b9546b8bfe16c9eb1ec2e7d_D20210101-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctMTMtMS0xLTY4Mzgy_6b737e7c-b1b4-4d88-be07-699ff858cfbb">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctMTUtMS0xLTY4Mzgy_9d584e7a-59d9-4230-b947-286b4db3a217">1,658</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctMTgtMS0xLTY4Mzgy_418f8691-8fd7-49ae-a401-a8d83a988add">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9453dbd4c9422baa1dba8fb9a308cf_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTgtOS0xLTEtNjgzODI_2befb711-ddd0-45c5-bc9f-4a8cf4aef9a9">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTgtMTUtMS0xLTY4Mzgy_30431ae5-cf57-4b63-a8f1-4c5a85e627bd">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i840e894a7ef144038ef94728d7daa256_D20210101-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTktNy0xLTEtNjgzODI_35e6662e-c6aa-407c-9b16-4ec9512adea6">233</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTktMTUtMS0xLTY4Mzgy_5fb0ef91-6135-4da1-9b64-99e86f9e72c3">233</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ffd0c3e5b9546b8bfe16c9eb1ec2e7d_D20210101-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjAtMTMtMS0xLTY4Mzgy_ba788c08-48ee-431a-96d9-631d56fc95d8">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjAtMTUtMS0xLTY4Mzgy_59003420-5424-49a1-8270-677a81c90197">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjAtMTgtMS0xLTY4Mzgy_2f75c98c-cc5f-4e02-a8ed-0c9d30a79a8b">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjEtNS0xLTEtNjgzODI_0e799733-61b6-427b-8d6d-3825343b920b">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjEtMTEtMS0xLTY4Mzgy_77cb941d-c45d-47ae-9302-32bcca14dddb">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjEtMTUtMS0xLTY4Mzgy_8a45551e-5d76-4e51-b243-1d3bce17574c">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjItNS0xLTEtNjgzODI_6674fe73-dedd-4ba0-acf1-7e2b566902d8">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjItMTUtMS0xLTY4Mzgy_14cc5bca-6b79-4b20-8df1-a170d822b227">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77ef3821374f4ec68ef2864dd77fedec_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtMS0xLTEtNjgzODI_5d045198-b7f2-4deb-9cc7-4c63aec12495">2</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtNS0xLTEtNjgzODI_1ba510dd-e8a8-48ed-85bb-e1a7ea7344a1">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtMTEtMS0xLTY4Mzgy_47e3bbc6-6ad4-4b71-8be8-8ed31d52e9d5">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtMTUtMS0xLTY4Mzgy_974ce67d-112b-4b99-bd63-19b845d1d9e6">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjQtNS0xLTEtNjgzODI_f892c2f1-7e88-49eb-aa03-e42f601e66e2">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjQtMTEtMS0xLTY4Mzgy_f74e09b1-6cba-4169-a7ea-dd8c62f9d40f">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjQtMTUtMS0xLTY4Mzgy_b6d02264-da61-476b-8b2e-a65d66a06558">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i77ef3821374f4ec68ef2864dd77fedec_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtMS0xLTEtNjgzODI_29c31369-1932-4aad-9108-f4d421e00def">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtNS0xLTEtNjgzODI_6e306e8f-a899-4e85-9d27-1ac6bdf4d971">300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtMTEtMS0xLTY4Mzgy_ceb5dbfb-99a1-4009-9288-24011ebb2cd6">1,610</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtMTUtMS0xLTY4Mzgy_12030ddc-50b7-4fc9-b909-cc47bfef3e48">1,910</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctNS0xLTEtNzAzNDg_f7040a75-ab4d-416c-b9e2-e293458a59e9">649</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i840e894a7ef144038ef94728d7daa256_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctNy0xLTEtNzAzNzE_331d001c-40f1-4809-8e82-a405306133de">3,342</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctMTEtMS0xLTcwMzk2_85724da8-8362-4cd4-b3ca-9b2ba4ceefa7">3,991</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctMTUtMS0xLTczMzMz_e6c0162a-d531-4b12-9c03-764465f1b041">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMS0xLTEtNjgzODI_1ad9c215-ef2d-431a-bbfa-d9086cc08095">123</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMy0xLTEtNjgzODI_00ad7ef4-10fd-4cdf-962b-4db06113150a">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055da741a38a425dae638290e29c8807_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtNS0xLTEtNjgzODI_5dc5bc1a-a765-464a-bfa7-62e6c0129327">1,936</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia920ca1912e3480ebb55fdc231a8da19_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtNy0xLTEtNjgzODI_c01a3c16-ef76-40a2-a7c1-888c2f76b77d">7,333</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d3e5ccd81e9421e810e21a4bfa68ce7_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtOS0xLTEtNjgzODI_124396d4-d937-4d1a-8a5b-d379bda66b93">13</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95b59fb6a60d4941848525e7d490105d_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTEtMS0xLTY4Mzgy_40536817-f9c3-4c81-a41f-112bc37a42f7">2,866</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0079fdb1f79341858ac4900a117a3803_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTMtMS0xLTY4Mzgy_5b1433b0-2a4f-4820-bab6-f9f5dd260307">40</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTUtMS0xLTY4Mzgy_edb809d8-0b01-4163-8c1b-d3c9f8af0afc">6,432</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTgtMS0xLTY4Mzgy_27b83c78-281f-44f3-85a6-5c27daee4c16">79</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:28.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_28"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zMS9mcmFnOjNiYjIzYzdmYzQ3MDRiN2JhOTMyZGZkZTI2OWYzMDE0L3RleHRyZWdpb246M2JiMjNjN2ZjNDcwNGI3YmE5MzJkZmRlMjY5ZjMwMTRfMTY5OQ_fa899b37-a76e-4a1d-bc37-8aed16528cd8" continuedAt="i8efdc1ab21da48b4adfbe6a5ee4f65cb" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i8efdc1ab21da48b4adfbe6a5ee4f65cb" continuedAt="i9bffc256152b47a4959dd535b4b26030"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9bffc256152b47a4959dd535b4b26030">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, and accountable care organizations ("ACOs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI3NA_d5661c8f-a891-4045-8447-9b6b197bbb6c" continuedAt="idb0422d6e9d94728826e5f5548fc28b5" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div style="text-indent:29.25pt"><span><br/></span></div><ix:continuation id="idb0422d6e9d94728826e5f5548fc28b5" continuedAt="idb9ff415c1f84d2896db5c820a945996"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI5NQ_26f0e654-16df-4131-ad66-8abea3fa0c0f" escape="true">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of significant demand for COVID-19 testing.  As a result, operating results for the three and nine months ended September&#160;30, 2022 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDMwMg_16fa2743-293c-4110-aa3c-d1d9351856e5" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI4MA_b6c90af4-79b4-4be1-89c7-047f7f07ba8a" continuedAt="i7ac0ec31bb4641a38da2cbf99436bc64" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="idb9ff415c1f84d2896db5c820a945996"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ac0ec31bb4641a38da2cbf99436bc64">dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI3MQ_fafc62a3-09c6-42c3-a542-bdf536016d96" escape="true">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RleHRyZWdpb246ZWI3ZTM2ZTM3N2FlNDEwNWI3YzdkYjc3Yjc4NjgwYTVfNzUx_67b0635e-7ba7-4c71-a876-fab137d7208a" continuedAt="i82289e5de5f7473c9724decbd0d43724" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i82289e5de5f7473c9724decbd0d43724" continuedAt="if9781711912a4e5abb5e09544915defc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RleHRyZWdpb246ZWI3ZTM2ZTM3N2FlNDEwNWI3YzdkYjc3Yjc4NjgwYTVfNzUy_b24cb53c-a979-4321-a1df-287aae1fb081" continuedAt="i07d4421f526447b4a605589a1301d6e2" escape="true">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i07d4421f526447b4a605589a1301d6e2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy0xLTEtMS02ODM4Mg_2c138ee6-b99d-4fd0-976a-4a40892ed810">256</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy0zLTEtMS02ODM4Mg_ecdddcb3-3992-4ebe-ae30-b7a8e546ac65">505</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy01LTEtMS02ODM4Mg_12c4e3fb-4833-44b1-a4f7-a86f489c14cc">845</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy03LTEtMS02ODM4Mg_f3799f67-1622-4a83-8b97-d333f717011e">1,605</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC0xLTEtMS02ODM4Mg_055d543a-8c46-4906-bf0d-755540e05413">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC0zLTEtMS02ODM4Mg_0dafadf2-a74e-4889-9c4f-2d10841ac737">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC01LTEtMS02ODM4Mg_f5ef24ca-db99-49c1-bbb4-9b3bf102793a">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC03LTEtMS02ODM4Mg_0210ede0-173c-44a8-ba4c-2411dc3753e6">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS0xLTEtMS02ODM4Mg_57b175a1-e750-453a-970b-760baf6298c7">254</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS0zLTEtMS02ODM4Mg_f60096aa-4fd5-4b07-85a9-e9c063e7abd6">503</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS01LTEtMS02ODM4Mg_0ce2d755-8b5d-41f3-9866-9f84efc229ff">841</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS03LTEtMS02ODM4Mg_b1bea801-ebcf-4d13-b482-2d76298e8e7d">1,599</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtMS0xLTEtNjgzODI_8138ab62-9dbc-4fb6-89e5-3130730892a6">116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtMy0xLTEtNjgzODI_14a36b42-9fb6-4be1-8196-62ab7aaf8fb6">123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtNS0xLTEtNjgzODI_e6137305-c2d5-40d7-880a-8167ac3d2aae">117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtNy0xLTEtNjgzODI_86cce5dc-bc51-4f7f-9eb2-db88988efffe">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtMS0xLTEtNjgzODI_8ed8ed4a-d9fd-43e9-b5ce-204cc618f10c">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtMy0xLTEtNjgzODI_e1afd929-11bf-4dfb-97c7-10de8b226152">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtNS0xLTEtNjgzODI_4dd8cc18-4b53-4923-aecf-9e07a528715c">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtNy0xLTEtNjgzODI_ad118807-b562-460f-82fa-92db3c4bee06">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtMS0xLTEtNjgzODI_a557d1ed-8eaa-4063-80c9-caf6bf737907">118</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtMy0xLTEtNjgzODI_c44dfead-fc16-4ac0-b65f-67e9ba8fef49">125</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtNS0xLTEtNjgzODI_ea398523-2a8e-42bd-989e-370f1ecd9424">119</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtNy0xLTEtNjgzODI_6b5303a2-692d-47a3-a1a1-4bcf7960dbbe">129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctMS0xLTEtNjgzODI_342f6e9e-06d0-464a-b1be-c7539e2a08cc">2.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctMy0xLTEtNjgzODI_d4b87099-cf52-43c3-a38f-f9742d404843">4.11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctNS0xLTEtNjgzODI_b68f645b-1001-4bcf-adb9-5225067c0380">7.17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctNy0xLTEtNjgzODI_e67e4dcf-fa6e-4636-9bb8-c7fd7eb9462f">12.63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItMS0xLTEtNjgzODI_faf847b9-c49e-46b9-88cb-fab8da89fdb5">2.17</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItMy0xLTEtNjgzODI_8afb246d-c753-430b-b4b0-f120b0d7c150">4.02</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItNS0xLTEtNjgzODI_b95faf30-4ca6-4434-b38a-8d1b65d24b43">7.05</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItNy0xLTEtNjgzODI_804d421d-417b-4adc-aad8-e2a4e85a4d79">12.41</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RleHRyZWdpb246ZWI3ZTM2ZTM3N2FlNDEwNWI3YzdkYjc3Yjc4NjgwYTVfNzU2_4f331f6d-fdc6-4882-ab0f-246453263e0f" continuedAt="i9ced656946ea40288f9d24d2a0d80212" escape="true">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i9ced656946ea40288f9d24d2a0d80212"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi0xLTEtMS02ODM4Mg_ff245f90-1bf2-4e8c-87b0-969b09bffe00">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi0zLTEtMS02ODM4Mg_f2ac4203-0405-4041-b0df-f6abeff59145">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi01LTEtMS02ODM4Mg_b4affb8a-e0af-4baa-a630-7b6734d0cd26">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi03LTEtMS02ODM4Mg_c41f9c6c-eb1b-42ba-9110-7dfac44c2d64">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if9781711912a4e5abb5e09544915defc">&#160;&#160;&#160;&#160;The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first three quarters of 2021 did not equal the total for the nine months ended September&#160;30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of share repurchases (see Note 9 for further details regarding the Company's share repurchases).</ix:continuation>&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjkyMw_06532897-6708-4b2f-a1ef-9460add81165" continuedAt="id00f4853830d4cb7aaa17bd640149207" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id00f4853830d4cb7aaa17bd640149207" continuedAt="ie9a28fac10d84c67a427ca775317bd0c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i89534177306a427980b6ebbaeab041c4_D20220201-20220201" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjQw_fc8a5c98-bf4d-4060-b773-f5d8966148e3">123</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="i89534177306a427980b6ebbaeab041c4_D20220201-20220201" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjUx_975f778d-445b-4691-ab5a-b1953eefc15b">4</ix:nonFraction>&#160;million cash acquired, which consisted of cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i89534177306a427980b6ebbaeab041c4_D20220201-20220201" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMzEw_0cf327c6-9645-424a-b6b2-7097d7c1b4b1">105</ix:nonFraction>&#160;million and contingent consideration initially estimated at $<ix:nonFraction unitRef="usd" contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMzY1_3dcd174b-e5b4-4fa1-b7b2-f86209f01a7c">18</ix:nonFraction>&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $<ix:nonFraction unitRef="usd" contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNjgw_4a4362df-71ed-4157-b17e-3846d5caa4a3">96</ix:nonFraction>&#160;million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzA1_7b86cac1-7d01-4b05-a257-9eb470e5c8ae">78</ix:nonFraction>&#160;million is tax-deductible), $<ix:nonFraction unitRef="usd" contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzI4_01374ca7-849e-4f23-9404-bd136d0d7e67">30</ix:nonFraction>&#160;million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzUz_9fdbb51b-278f-4aa0-9abc-5aa4a2758adb">5</ix:nonFraction>&#160;million of operating lease right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201" decimals="-6" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzk2_00a23941-c2f5-4c8a-b683-0819fe47cf42">5</ix:nonFraction>&#160;million of operating lease liabilities and $(<ix:nonFraction unitRef="usd" contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201" decimals="-6" sign="-" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfODM0_942659dd-039f-4d17-a97d-f52bfb199611">3</ix:nonFraction>)&#160;million of working capital. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="i8bc9e3bbed0e42539b9efaaf04edba4d_D20220201-20220201" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfOTcy_4a610bd3-f8eb-4140-8615-8688f664a2ff">15</ix:nonNumeric> years. For further details regarding the fair value of the contingent consideration, see Note 6.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On December 13, 2021, the Company completed the acquisition of assets of Labtech Diagnostics, LLC ("Labtech"), an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, and recorded the assets acquired and liabilities assumed based on a preliminary purchase price allocation. During the nine months ended September&#160;30, 2022, the Company revised its purchase price allocation and recorded an $<ix:nonFraction unitRef="usd" contextRef="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjM5MA_9a11d0c9-0f4f-4824-b85f-da2bdaa45baa">8</ix:nonFraction>&#160;million increase to goodwill, a $<ix:nonFraction unitRef="usd" contextRef="ic9042842adea48d68f78ed59ef1a76de_D20220101-20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjQxNw_4bbf3c6a-fadb-4115-83bf-13dbf7394f75">3</ix:nonFraction>&#160;million increase to customer-related intangible assets, a $<ix:nonFraction unitRef="usd" contextRef="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930" decimals="-6" sign="-" name="dgx:InventoryPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjQ3MA_4be5a6b6-c1d8-4d7f-b9d4-9d47609c73cf">1</ix:nonFraction>&#160;million decrease to inventories and a $<ix:nonFraction unitRef="usd" contextRef="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930" decimals="-6" name="dgx:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjUwMw_616f62cb-ab1f-41d2-9d8d-b3ee9b023545">10</ix:nonFraction>&#160;million increase to the estimated contingent consideration accrual. These adjustments did not have a material impact on the Company's consolidated results of operations. For further details regarding the fair value of the contingent consideration, see Note 6.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie9a28fac10d84c67a427ca775317bd0c">&#160;&#160;&#160;&#160;For details regarding the Company's 2021 acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfOTgy_8df21730-8aa2-476b-9350-a887454c39aa" continuedAt="ic34c40a3da344d85abe951e7cd1a731a" escape="true">DISPOSITION</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ic34c40a3da344d85abe951e7cd1a731a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="i08caf8d530cf43008af3a0306e3e477c_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfNjE_bdb6d20b-c700-4642-88b1-e1d29633a1f8">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc., its joint venture partner, for $<ix:nonFraction unitRef="usd" contextRef="ibcef44e271aa4680b8911a11902d9a4a_D20210401-20210401" decimals="-6" name="dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfMjQ3_66681f86-fa06-4fc0-bc0b-edd994f4295c">760</ix:nonFraction>&#160;million in an all-cash transaction. Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the nine months ended September&#160;30, 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ibf27417747054ef395ca09d3516e7989_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfNDcx_0d7af0ae-de03-476f-9e5c-65198408f7a3">314</ix:nonFraction>&#160;million pre-tax gain in other (expense) income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $<ix:nonFraction unitRef="usd" contextRef="i663fdcd70d744b64b639798c418155da_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfNjY5_77e04f91-ca39-4da6-8ee9-fd279a2b2eac">20</ix:nonFraction>&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss. During the nine months ended September&#160;30, 2021, the Company also recorded $<ix:nonFraction unitRef="usd" contextRef="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfODM0_a0681ff6-9798-408e-a741-3de2ee0be412">55</ix:nonFraction>&#160;million of income tax expense related to the gain, consisting of $<ix:nonFraction unitRef="usd" contextRef="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfODk0_99a43f97-0a78-4fa8-9c76-d1b48b6afc70">127</ix:nonFraction>&#160;million of current income tax expense, partially offset by $<ix:nonFraction unitRef="usd" contextRef="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfOTQ4_a6a30af1-fcf2-494d-9215-c0a4e4cb6e33">72</ix:nonFraction>&#160;million of deferred income tax benefit.</span></ix:continuation></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_46"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjQ0Mw_bf2a3fb4-f871-46cd-a825-f65388da351c" continuedAt="iae0452c120b24fac9d07aa006e66424d" escape="true">FAIR VALUE MEASUREMENTS  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iae0452c120b24fac9d07aa006e66424d" continuedAt="id8193208d38c4b00a365da33234a6df1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjQ0Ng_628b23c3-6d32-4f97-92f1-f394b3589a40" continuedAt="ic30a8fff4a254d1dae74a09ab4b42772" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><ix:continuation id="ic30a8fff4a254d1dae74a09ab4b42772"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi0xLTEtMS02ODM4Mg_f8a3e0a9-6520-40aa-b538-e6f6d9617776">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi0zLTEtMS02ODM4Mg_dd4def8b-9a33-42e0-a6a5-bde8d722b8b9">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi01LTEtMS02ODM4Mg_bc0a9fc9-8be6-40c6-8484-eaf75b0a874b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi03LTEtMS02ODM4Mg_8f8088fd-7a2a-4f66-9dc5-3bc568f5aec8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy0xLTEtMS02ODM4Mg_56e6365a-b836-4c11-8ae7-7a41c46a4506">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy0zLTEtMS02ODM4Mg_60a9d861-5f80-454e-8ee2-e7024bb93df6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy01LTEtMS02ODM4Mg_7b5adcd3-056d-40ee-b217-5dce31f21af9">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy03LTEtMS02ODM4Mg_2c70df5e-5374-4813-88a2-69969ac36b35">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC0xLTEtMS02ODM4Mg_757a1832-a8c3-4d8d-8b84-65485b088f34">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC0zLTEtMS02ODM4Mg_27f01a78-e7f5-4eea-851d-f0a5d9467add">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC01LTEtMS02ODM4Mg_cab2a405-f773-4135-97f7-c722ff041006">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC03LTEtMS02ODM4Mg_5a508c5c-4278-4382-8c9b-223f6a7c1379">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItMS0xLTEtNjgzODI_62bf9538-ccf9-4ff2-84ba-2c17f28c4c4b">120</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItMy0xLTEtNjgzODI_d7aa6801-00c6-465d-aa57-416d250a658b">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItNS0xLTEtNjgzODI_8d77bc45-806e-4270-85b9-70a2321e9a48">43</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItNy0xLTEtNjgzODI_49d0dab8-faa4-411c-ac56-0de9fbe2cbc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtMS0xLTEtNjgzODI_4140cfdd-1fa0-4580-992f-f497d9f6d3ac">113</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtMy0xLTEtNjgzODI_7fd46be7-71fc-4793-bfd4-26b1a5ae0b9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtNS0xLTEtNjgzODI_f96626bd-dbc1-4ea9-9d56-db4fa3d46a20">113</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtNy0xLTEtNjgzODI_90f2f5de-2153-417c-92fe-dc51257dbb33">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtMS0xLTEtNjgzODI_8fbd44ec-c695-4a71-a380-8c99008aff6f">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtMy0xLTEtNjgzODI_ddce91b6-f27b-4ff0-83d7-3fc573212ed6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtNS0xLTEtNjgzODI_602e5eae-0c9a-4e71-95bc-96939b8b9299">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtNy0xLTEtNjgzODI_9fb062ed-bd86-4d7e-92d8-59a46ccb4b68">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtMS0xLTEtNjgzODI_f8ce4aea-65fd-4cfd-96fc-fef95e0a3cac">130</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtMy0xLTEtNjgzODI_5bd91181-769b-4332-aa32-fbe0b0dc313c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtNS0xLTEtNjgzODI_50cf3ba5-831f-44ca-884d-086f6a43d164">113</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtNy0xLTEtNjgzODI_2429a6b2-6ac6-497a-a389-9bcb7e7777ac">17</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjItMS0xLTEtNjgzODI_8e7b074a-5aca-4129-84e3-ba89d521d0d1">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjItMy0xLTEtNjgzODI_720e4c23-84f0-4313-ba00-6157fc044fd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjItNy0xLTEtNjgzODI_e85a6699-dfa8-489c-8927-71ca6d3ca5b8">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy0xLTEtMS02ODM4Mg_436969e4-0113-4194-ba03-948d316d6780">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy0zLTEtMS02ODM4Mg_c19dbd5a-4e55-44f4-8fb9-035142ade902">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy01LTEtMS02ODM4Mg_1f499a2a-bbcd-48f7-a4f1-59bfaa13373c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy03LTEtMS02ODM4Mg_08be0986-1392-4370-92dd-636241b9ec1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC0xLTEtMS02ODM4Mg_854a7e3e-2a23-4204-806c-4cc4a5405183">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC0zLTEtMS02ODM4Mg_170e659f-b19d-4327-8bb5-b2c9683b0f4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC01LTEtMS02ODM4Mg_38d80a29-d523-4c9f-8401-3e044e1de245">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC03LTEtMS02ODM4Mg_3346ddef-8e89-4450-a58f-bc42cc94dd59">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS0xLTEtMS02ODM4Mg_6bca3e9b-1939-499e-80bf-eb2a2655ba97">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS0zLTEtMS02ODM4Mg_6d88d05e-eb18-45b9-bc76-a415695265d9">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS01LTEtMS02ODM4Mg_6177def1-7517-4f0d-b95b-7fcd43ea816e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS03LTEtMS02ODM4Mg_83300846-7fbd-4271-b8b7-16e6c90e9d26">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi0xLTEtMS02ODM4Mg_9cddf1e2-15c2-4b47-b65c-44dcc6c3af19">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi0zLTEtMS02ODM4Mg_3f761d2e-cfe4-41b2-94e6-8739fd953164">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi01LTEtMS02ODM4Mg_f857405a-04c6-4fd9-9ba5-582dfd3fd7da">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi03LTEtMS02ODM4Mg_e776a03f-6671-441a-82d8-877dc22573b1">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtMS0xLTEtNjgzODI_0c593724-bb61-4820-818b-d944396dca68">179</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtMy0xLTEtNjgzODI_b1176e6c-e6f2-4acf-9ab6-86771cf26564">121</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtNS0xLTEtNjgzODI_6966c77c-73d3-4388-b510-9e6167f46028">57</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtNy0xLTEtNjgzODI_92394f26-420e-4347-acdc-da3e1f030831">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtMS0xLTEtNjgzODI_d2176748-df04-49b3-8e39-17d7442fd3cf">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtMy0xLTEtNjgzODI_2368dd59-3fa8-4b28-900e-624f24573f8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtNS0xLTEtNjgzODI_af590607-ab5a-45bd-984b-fabacd1fed8c">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtNy0xLTEtNjgzODI_2fcd815f-6f49-4e23-85bf-ae2af6f7edad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtMS0xLTEtNjgzODI_4068b5fb-ea97-4409-853d-c61b86f4a06b">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtMy0xLTEtNjgzODI_e25b8f8b-a08e-4bdf-a769-623808aef093">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtNS0xLTEtNjgzODI_4fea6d32-caa6-4c41-a3fa-fc419607c52a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtNy0xLTEtNjgzODI_e0a4fe2c-5bcc-4878-bb6d-b2b7430ef49b">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktMS0xLTEtNjgzODI_ee4e5a7b-3c8e-4897-bdcb-859da2204e50">148</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktMy0xLTEtNjgzODI_f0d1a601-9af4-4b23-834b-634cdbe7b3e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b4e217688f484da0874a661078f82f_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktNS0xLTEtNjgzODI_af88456a-6567-4358-983f-c139b449a8d6">143</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktNy0xLTEtNjgzODI_416eb141-4068-4d18-b3e5-49baeed13fb3">5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMjEtMS0xLTEtNjgzODI_ad9914ea-5f4c-4e7a-83a2-d4f10bbbc48c">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e12ac865714887ac216f5d036b7039_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMjEtMy0xLTEtNjgzODI_d5997442-2c5b-43e0-bbab-80f14e076393">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMjEtNy0xLTEtNjgzODI_df90a2e1-e6b6-4c78-a67c-919f012b4115">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="id8193208d38c4b00a365da33234a6df1" continuedAt="i67d373800d7644cbae3e9f4e30db7f41"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Such equity investments are classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the acquisitions of Pack Health and Labtech, the Company has contingent consideration obligations, with a potential maximum aggregate payment of $<ix:nonFraction unitRef="usd" contextRef="ib0b707eca9294fdaa61759b2009a7077_I20220930" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfMzkwNw_e5a9a4d1-0875-4620-9abb-d01846ead180">40</ix:nonFraction>&#160;million, that are to be paid based on the achievement of certain testing volume or revenue benchmarks.  Contingent consideration accruals are measured at fair value using either an option-pricing method or a Monte Carlo method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume or revenue and other market inputs, including comparable company revenue volatility (<ix:nonFraction unitRef="number" contextRef="i762312568e8b4ea9bdfe5e9cb82f2fe5_I20220930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDUwNw_7ef18834-336f-4acd-bf7e-c41113f43069">7.5</ix:nonFraction>%) and a discount rate (ranging from <ix:nonFraction unitRef="number" contextRef="i3891771b03b74ae6bf6f1e347f984954_I20220930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDU0NQ_5eda8a26-d0ae-4a6c-9ada-02a677441e26">2.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i3a7cdccc5b8b4351a6c84a3102569a41_I20220930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDU1MQ_88605cdd-8b4c-4478-8c9a-d97bf208a220">3.0</ix:nonFraction>%).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding the Company's acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 4.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjQ1Mg_24b1c48a-bb58-4ea3-9d2f-a507e069a53c" continuedAt="i6765c58471c94b4db014065104d68991" escape="true">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i6765c58471c94b4db014065104d68991"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b26dd13b5045219577db6205b830a5_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfMi0xLTEtMS02ODM4Mg_3b09a408-d6cb-4917-8a55-1aa9fca0e4f5">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930" decimals="-6" name="dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfMy0xLTEtMS02ODM4Mg_84d0e03f-df5a-4812-8532-ab7582feb182">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfNC0xLTEtMS02ODM4Mg_3930f288-829f-4e42-88c1-aa8299c6ae90">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value adjustments included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfNS0xLTEtMS02ODM4Mg_a8f2a905-82b6-4944-b401-378717ff0f0b">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, September 30, 2022</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2dd843e91d24830a207e5a623c8c5f5_I20220930" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfOC0xLTEtMS02ODM4Mg_a4fc7cbd-c381-4830-9cc1-fbe33f1045e7">17</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The $<ix:nonFraction unitRef="usd" contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDk0NzgwMjMzMjc0MA_6065b824-88cd-40e4-bd3b-589135348832">1</ix:nonFraction>&#160;million net gain included in earnings associated with the change in the fair value of contingent consideration for the nine months ended September 30, 2022 is reported in other operating income, net.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i67d373800d7644cbae3e9f4e30db7f41"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i109ee53a89994956b1b78b0354ad068a_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNTExNA_2fd2bf05-f18e-410e-a16f-c846231a02c8">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of September&#160;30, 2022, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments. As of September&#160;30, 2022 and December&#160;31, 2021, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjA3NA_81c57c6e-3ad5-4351-8a00-194b663c29fc">3.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjA4MQ_c224b7bb-c6d6-46df-9d00-4a3b8c00107b">4.4</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTE1OA_dba60658-47c7-4403-8ab4-3af37a3f8443" continuedAt="i1c7304dcf1e54666a295e6afa27ff147" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1c7304dcf1e54666a295e6afa27ff147" continuedAt="i2284e038fbdb4ed0a75ad96bd691ade2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTE2MA_f3d9391f-d08a-4453-95fb-5c89aeb7f942" continuedAt="i89b2a11d0cc645ee8e7dcf723267bffc" escape="true">The changes in goodwill for the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i89b2a11d0cc645ee8e7dcf723267bffc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:57.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMS0xLTEtMS02ODM4Mg_a7ff36c4-341e-448e-9c81-2b4005be12b8">7,095</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMS0zLTEtMS02ODM4Mg_c55483d8-9d88-41b1-bf7b-dd1c47433d0d">6,873</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMi0xLTEtMS02ODM4Mg_3e0ac40a-aa15-4fb4-b999-59cd914b9a8d">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04fac321a00460b82d13cb06da4f28d_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMi0zLTEtMS02ODM4Mg_6247172f-38d0-4462-9e36-9ac41d4ddf95">228</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMy0xLTEtMS02ODM4Mg_ba70ea9f-35c9-4cbe-afd0-0b1345addf5c">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic04fac321a00460b82d13cb06da4f28d_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMy0zLTEtMS02ODM4Mg_c21e1755-5171-4a87-a16a-bd5d2773812c">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfNy0xLTEtMS02ODM4Mg_3343e061-7d10-421b-8369-dfdb90b26e62">7,190</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfNy0zLTEtMS02ODM4Mg_bd3bd1fe-b1ba-4426-a269-07ca1e494ddd">7,095</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of September&#160;30, 2022 and December&#160;31, 2021 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, goodwill acquired was principally associated with the acquisition of Pack Health, and adjustments to goodwill primarily related to foreign currency translation, largely offset by an adjustment of the purchase price allocation for Labtech (see Note 4). For the year ended December&#160;31, 2021, goodwill acquired was principally associated with the acquisitions of the assets of the outreach laboratory services business of Mercy Health and the assets of Labtech (see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K), and adjustments to goodwill related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2284e038fbdb4ed0a75ad96bd691ade2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTE1NA_b6079e24-66b7-400c-935f-e0c233715164" continuedAt="if42aa8529dd74577a79a8bf6c58e5515" escape="true">Intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="if42aa8529dd74577a79a8bf6c58e5515"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.727%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibebd5d13929a45809fca7b3d45a757d1_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0xLTEtMS02ODM4Mg_889176d2-9194-4a78-b2aa-2a441e9474a5">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89346c0905d2439297816ae363b1ed66_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0zLTEtMS02ODM4Mg_b49e6809-8503-4e5d-a809-b4716abd882d">1,608</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89346c0905d2439297816ae363b1ed66_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy01LTEtMS02ODM4Mg_59b2d3ec-45f8-49e6-9be4-7bb31dae59dd">796</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89346c0905d2439297816ae363b1ed66_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy03LTEtMS02ODM4Mg_64335d80-3a97-418c-8df9-c56796cd96bf">812</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy05LTEtMS02ODM4Mg_32b1b78b-0346-43f9-8654-27e2de1c3325">1,581</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0xMS0xLTEtNjgzODI_e0da9d7c-a83a-47e1-82b0-8db1825224b3">726</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0xMy0xLTEtNjgzODI_4db303bb-ae90-4aad-a8a4-02c6ff9108c4">855</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c7345fe4fd94293946d0bf7c21a7d80_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0xLTEtMS02ODM4Mg_c571b94b-c153-40c2-a1f7-6e2aa0a0ceb4">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0zLTEtMS02ODM4Mg_3be7e5a8-a56a-4500-85b8-f32696808d47">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC01LTEtMS02ODM4Mg_38fd1ea1-b61d-4a98-92f0-7b7f66472cd4">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC03LTEtMS02ODM4Mg_34b1866e-cd07-4b41-b452-9d4ccf0aff6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC05LTEtMS02ODM4Mg_9ed264c3-3cf7-43db-bd6f-f1260b280d22">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0xMS0xLTEtNjgzODI_1a54ea28-28d6-428a-a127-4d141982effd">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0xMy0xLTEtNjgzODI_286ec22c-4b2b-4ac9-b52e-8dcf88780c86">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8205d967b9d04f0592030979d313578e_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0xLTEtMS02ODM4Mg_1fa22576-d86e-4057-a3dc-dc9ab51454b8">15</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia888a55675b34c1da6c98058a0bfbb00_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0zLTEtMS02ODM4Mg_b62c93ce-be34-47bd-829c-cc3ef0c60be5">137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia888a55675b34c1da6c98058a0bfbb00_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS01LTEtMS02ODM4Mg_50ab64b2-7f53-49e2-989f-bca0f4eeba44">80</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia888a55675b34c1da6c98058a0bfbb00_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS03LTEtMS02ODM4Mg_86269440-edd8-46e9-a02f-ce90dfef7e8b">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS05LTEtMS02ODM4Mg_b3dccec8-5999-43c9-ae44-a58cc9854a41">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0xMS0xLTEtNjgzODI_9f37b754-ef31-4977-a330-0c63b2576e8c">74</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0xMy0xLTEtNjgzODI_335135f4-36ed-4655-8f6c-d336a19cb9d6">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i052af85eec62405eb656914f67d3a176_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0xLTEtMS02ODM4Mg_8a07de3d-8eef-4d54-8a75-47ea6964c895">6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193a25bf19ea41e690356bc8c5ce3380_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0zLTEtMS02ODM4Mg_5a1f3ebf-aeb3-4a48-9888-904b836cf5bf">114</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i193a25bf19ea41e690356bc8c5ce3380_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi01LTEtMS02ODM4Mg_7e8aca3e-1826-4945-bf30-411008323a69">104</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193a25bf19ea41e690356bc8c5ce3380_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi03LTEtMS02ODM4Mg_def5d8eb-0536-4b0a-bbee-3bdbf25d57c0">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c162a22bd874f5a8997350a100e5b4a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi05LTEtMS02ODM4Mg_808d086c-b3b4-48f5-bcc2-2f1db6e580eb">109</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c162a22bd874f5a8997350a100e5b4a_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0xMS0xLTEtNjgzODI_237ab8ea-45dc-4c55-9325-a027ae53d228">101</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c162a22bd874f5a8997350a100e5b4a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0xMy0xLTEtNjgzODI_6227428b-5caa-456d-8b4d-a5a08248402f">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1465ba55b394e54ae2154b81d8f51fb_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0xLTEtMS02ODM4Mg_f00a47b3-1ecc-43cd-a7ec-3572322eaa87">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0zLTEtMS02ODM4Mg_6489e22a-b3c6-415c-a392-0e4820dd3b66">1,862</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy01LTEtMS02ODM4Mg_9d32d13e-3f7a-4769-aefb-c112db7eb345">983</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy03LTEtMS02ODM4Mg_86def8ab-6f00-4eaf-b92d-b1b4415afce5">879</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafe0e5ae893b40efa9626f66a5e78820_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy05LTEtMS02ODM4Mg_1842e853-8dc5-48d8-8ce3-9747e83038c2">1,834</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafe0e5ae893b40efa9626f66a5e78820_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0xMS0xLTEtNjgzODI_86c212a8-cf51-415b-b850-12ed337e4df7">903</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafe0e5ae893b40efa9626f66a5e78820_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0xMy0xLTEtNjgzODI_625ef06b-a356-4d8c-967f-55144d24c1b9">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67dee3f585f1452888374d9ee3dba34c_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtMy0xLTEtNjgzODI_fc6478ff-d2d0-4c11-b8ff-2264933ac0e1">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67dee3f585f1452888374d9ee3dba34c_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtNy0xLTEtNjgzODI_86dd8c42-2f97-47da-a0c1-f3fb8a8f07eb">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic279fc9d23034639855e69aafe143991_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtOS0xLTEtNjgzODI_d5cacb26-edd5-4128-a97a-fc7c27185b3b">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic279fc9d23034639855e69aafe143991_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtMTMtMS0xLTY4Mzgy_b8b3d378-3fb6-4052-935f-1617e6bdc5fe">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7998a056fa014b5b93a343c7b3bc409c_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItMy0xLTEtNjgzODI_8b72efd9-9353-485d-b732-48644ec6b307">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7998a056fa014b5b93a343c7b3bc409c_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItNy0xLTEtNjgzODI_df76cb7b-e660-440a-83db-c1ff45131c40">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee3230ab4d945ffa507522cd478b188_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItOS0xLTEtNjgzODI_32374557-f9f9-4d8b-88e0-112cb20e31af">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee3230ab4d945ffa507522cd478b188_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItMTMtMS0xLTY4Mzgy_a08d011b-e480-4493-b049-707495e56b0b">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtMy0xLTEtNjgzODI_103bd451-ebd5-4d5b-b31c-d72d685901be">2,098</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtNS0xLTEtNjgzODI_5cf174df-8a27-4721-9864-fe7eadd8ba21">983</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtNy0xLTEtNjgzODI_9b4a915f-a9f0-4248-ab4a-5c434ae1ba56">1,115</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtOS0xLTEtNjgzODI_12e65125-f95e-4cc5-924b-857d3a1c1403">2,070</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtMTEtMS0xLTY4Mzgy_ee51c699-4ce3-43f0-a7c7-f0065383f7b8">903</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtMTMtMS0xLTY4Mzgy_07138a44-b759-4938-8499-747a759f8d36">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTEyNw_b7877dbb-f7ed-400a-9f0b-50347f01d559" continuedAt="ic3117034435f427e93c9461db1aaa510" escape="true">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2022 is as follows:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><ix:continuation id="ic3117034435f427e93c9461db1aaa510"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"></td><td style="width:72.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfMS0xLTEtMS02ODM4Mg_97a9d7cc-5a46-4ccf-87b2-611530ac9d8b">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfMi0xLTEtMS02ODM4Mg_97bef4bc-d350-4c47-b906-b04d2c95a26e">105</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfMy0xLTEtMS02ODM4Mg_3df29c97-4159-4580-950b-818a7c9644b7">102</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNC0xLTEtMS02ODM4Mg_78b1236e-d5a4-47dc-b246-f5f487da0c3e">100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNS0xLTEtMS02ODM4Mg_6220597e-e12e-4197-8783-36c1fa8f0918">95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNi0xLTEtMS02ODM4Mg_507245b9-c1a0-454c-9214-373628969b8b">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNy0xLTEtMS02ODM4Mg_bf76466c-e650-4139-9147-aa869d9e2770">366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfOC0xLTEtMS02ODM4Mg_a7049001-875d-48f4-b9d5-b58e017ad325">879</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RleHRyZWdpb246MTZmNDhlOWZlZDE1NDE4YjgzZjc2MWM1MTIwYTAyY2ZfMzMzNw_39d08351-df88-4c67-9858-7e1018dc0511" continuedAt="i91fb4ff51d604030af1cf20daed20fd9" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i91fb4ff51d604030af1cf20daed20fd9" continuedAt="i9131d7d9012f427c803d72051f704485"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RleHRyZWdpb246MTZmNDhlOWZlZDE1NDE4YjgzZjc2MWM1MTIwYTAyY2ZfMzM0MQ_a87900bd-c681-48a2-911d-a458d9fd8989" continuedAt="i6fe56b5b23404a59a4284441af291982" escape="true">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6fe56b5b23404a59a4284441af291982" continuedAt="i3380faef18cc40618dad5a92b6663ce3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9131d7d9012f427c803d72051f704485" continuedAt="id615ff7c699a41f1b8dc6ad851b16d6c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3380faef18cc40618dad5a92b6663ce3">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RleHRyZWdpb246MTZmNDhlOWZlZDE1NDE4YjgzZjc2MWM1MTIwYTAyY2ZfMzMzNQ_9628f7af-c465-4c8a-8c5e-5f8558a0186a" continuedAt="ia2226b15109a4dd88f8d834ddf493a38" escape="true">As of September&#160;30, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div><ix:continuation id="ia2226b15109a4dd88f8d834ddf493a38"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c1dcdf5ded4bc5be532f869db993b6_I20220930" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RhYmxlOjI0MTM5YWVhYWM5YjRjYmFiZmU2NzkwZTY5MzdlNWQ5L3RhYmxlcmFuZ2U6MjQxMzlhZWFhYzliNGNiYWJmZTY3OTBlNjkzN2U1ZDlfMi01LTEtMS02ODM4Mg_947dbeb0-9009-4d3c-9c8b-4de3c9f2ff00">29</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8892d167ced44fed893e191b22d3989c_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RhYmxlOjI0MTM5YWVhYWM5YjRjYmFiZmU2NzkwZTY5MzdlNWQ5L3RhYmxlcmFuZ2U6MjQxMzlhZWFhYzliNGNiYWJmZTY3OTBlNjkzN2U1ZDlfMi05LTEtMS02ODM4Mg_487c4ca1-5ea3-42ca-ac21-80f8a264456e">38</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both September&#160;30, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="id615ff7c699a41f1b8dc6ad851b16d6c" continuedAt="ie466ef180a72419e9c956c481f379770">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie466ef180a72419e9c956c481f379770">A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</ix:continuation>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMzgxMQ_83b210ca-f3f5-4ce5-b1f1-610133b4e349" continuedAt="i81235c34b0e84b30954aaeab0ac50bda" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="i81235c34b0e84b30954aaeab0ac50bda" continuedAt="ibfe7de327a124690bebe5d165decbb35"><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2022 and 2021, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the first three quarters of 2022, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1102df7028da465093e08195001df34c_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTEyMQ_30b21e40-e699-489d-978e-06f2fca02f8d"><ix:nonFraction unitRef="usdPerShare" contextRef="i29663b176c084c83ba8d49b48433f6a7_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTEyMQ_4e62fcd0-c684-4edb-b8c4-9b4d15264e1a"><ix:nonFraction unitRef="usdPerShare" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTEyMQ_5f34ef54-2fad-4cd9-8387-99a7bf156e77">0.66</ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_10abde4e-c924-41fe-af45-c3c35c72236c"><ix:nonFraction unitRef="usdPerShare" contextRef="if16effd867954c738404b7b96d2e8eae_D20211001-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_32705575-917f-439f-bd33-1f5198ea2c5c"><ix:nonFraction unitRef="usdPerShare" contextRef="i67d9eea602464d4fab91b47e890a65ff_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_d4d75a05-1386-4ae6-b008-4fb7a8b02826"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb3a7eac45ff47d6b334f694b10c9c80_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_dfcc52be-16ff-47f4-b705-b987aa7b5cdd">0.62</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ibfe7de327a124690bebe5d165decbb35"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2022, the Company's Board of Directors increased the size of its share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="i973ec05c00df4ad6a2a4472b1d8d2332_D20220201-20220201" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTQxMg_db8c068b-d673-4053-a757-aed7c784a536">1</ix:nonFraction>&#160;billion. As of September&#160;30, 2022, $<ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTQyNg_9abbac54-a1db-43bc-a684-9cf7a231289e">746</ix:nonFraction>&#160;million remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTY1NQ_81ef4097-9b35-446c-aabe-e72b48d04ad7">7.1</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTY4OQ_6600cd6c-6d12-47f6-bd72-f82d27596223">950</ix:nonFraction>&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTc0OA_c04dd649-2e7e-4b29-8e48-a2709c1453da">12.5</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930" decimals="-8" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTc4Mg_2f67dddc-bfea-4fa5-858c-2871b5e3bc00">1.6</ix:nonFraction> billion, including <ix:nonFraction unitRef="shares" contextRef="i0af15cd6ca4d4d5a9a34b91873ffc960_D20210101-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTc5Ng_50f43e9e-9fcf-4908-aa54-d05147f7f667">9.1</ix:nonFraction>&#160;million shares repurchased under accelerated share repurchase agreements ("ASRs") as follows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase its common stock as part of its share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock, less a fixed discount, during the repurchase period, which ended during the fourth quarter of 2021. For the nine months ended September&#160;30, 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i7c0f85b320f34c5db62f1f89cba5a333_D20210401-20210430" decimals="-6" name="dgx:AcceleratedShareRepurchasesPayment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjM5Nw_582200ec-d461-46e6-bc20-ab7f6296634b">1.5</ix:nonFraction>&#160;billion to the financial institutions and initially received <ix:nonFraction unitRef="shares" contextRef="i0af15cd6ca4d4d5a9a34b91873ffc960_D20210101-20210930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjQ0Mw_50f43e9e-9fcf-4908-aa54-d05147f7f667">9.1</ix:nonFraction>&#160;million shares of its common stock for a value of $<ix:nonFraction unitRef="usd" contextRef="i1fa78c23eb41439b8bceb72de57816d2_D20210101-20210930" decimals="-8" name="dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjUyNA_d5f552d4-404f-4039-a474-190e357d3c03">1.2</ix:nonFraction>&#160;billion, which represented <ix:nonFraction unitRef="number" contextRef="i1fa78c23eb41439b8bceb72de57816d2_D20210101-20210930" decimals="2" name="dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjU0Ng_956c0057-1737-44f9-89a8-b2c965f610cd">80</ix:nonFraction>% of the total value of shares to be repurchased under the ASRs based on the stock price at inception of the ASRs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022 and 2021, the Company reissued <ix:nonFraction unitRef="shares" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjcxNg_214a8f8e-1dd9-42f4-b3e3-d9280746ce70">1.6</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfNTQ5NzU1ODE3NzY3_94ba7aaf-0db2-46ae-a5b6-2b1206b10f2d">1.7</ix:nonFraction> million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock Retirement &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended September&#160;30, 2021, the Company retired <ix:nonFraction unitRef="shares" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfNTQ5NzU1ODE4MjA1_52601e17-fd4a-4ca2-b295-0657bec8e104">55</ix:nonFraction>&#160;million shares of treasury stock. In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i109ee53a89994956b1b78b0354ad068a_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMzA4Nw_2fd2bf05-f18e-410e-a16f-c846231a02c8">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of September&#160;30, 2022 and December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  For further details regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_58"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RleHRyZWdpb246MTgxZGIwZGI5ZDY2NDdiYjhkZWE5Y2JjYTI0OTFmMmVfNDE1_34dcf5d8-3c29-4083-8870-46d3f883a90c" continuedAt="iecfaeb7c7fa1426a97be1155cc485779" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iecfaeb7c7fa1426a97be1155cc485779"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RleHRyZWdpb246MTgxZGIwZGI5ZDY2NDdiYjhkZWE5Y2JjYTI0OTFmMmVfNDI0_71f95f10-f6a1-486a-8d7a-e2173f005678" continuedAt="ie88a864beced4bada67fe13699c2534d" escape="true">Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2022 and 2021 was as follows:</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie88a864beced4bada67fe13699c2534d" continuedAt="i863dd4b5cd12487691abc19aa07337c3"> </ix:continuation></span></div><div style="margin-top:5pt"><ix:continuation id="i863dd4b5cd12487691abc19aa07337c3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi0xLTEtMS02ODM4Mg_7a5926d5-60cc-4498-8c02-49ee3a822fc8">81</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi0zLTEtMS02ODM4Mg_05763185-fee4-4a4f-b309-fed8df2a0eff">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi01LTEtMS02ODM4Mg_80af1dc8-e858-4fc8-88d9-cba78b39ad46">240</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi03LTEtMS02ODM4Mg_5c698d8f-218b-4f8a-a559-25bb3e537fc7">225</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy0xLTEtMS02ODM4Mg_eef4ee17-d683-4022-8fda-6d75db956051">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy0zLTEtMS02ODM4Mg_6cb276b3-85a4-40f1-9acf-8810276b7469">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy01LTEtMS02ODM4Mg_680e0a6f-8742-47d9-a1c4-7885bdb704d8">81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy03LTEtMS02ODM4Mg_7452c21f-c1b7-4e4c-8ebe-c5d3527cdade">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC0xLTEtMS02ODM4Mg_0a7f0d1e-b306-4a2f-93ea-81976401f598">108</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC0zLTEtMS02ODM4Mg_f079f2f9-e182-4785-93aa-85d7fa0ef8ed">101</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC01LTEtMS02ODM4Mg_585935d7-0875-4522-bc20-acc2dcb1dd86">321</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC03LTEtMS02ODM4Mg_d06dbb8b-3a69-403f-8d87-cad7df3551b2">302</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi0xLTEtMS02ODM4Mg_82f21e54-a964-424e-b177-bf85151814b3">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi0zLTEtMS02ODM4Mg_f5f0d26e-158c-4784-a24a-f798c6875eaf">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi01LTEtMS02ODM4Mg_9f7cbd3a-e374-4048-a4be-285b24389d5e">112</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi03LTEtMS02ODM4Mg_bedc7518-cb69-4fbf-ab9c-1c17fe6447ef">114</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy0xLTEtMS02ODM4Mg_625ae616-51ab-4df2-a2cd-2524773d4226">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy0zLTEtMS02ODM4Mg_19d8916e-2db3-4e75-9041-8cbe0b807218">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy01LTEtMS02ODM4Mg_1f88ea9c-f458-465e-a240-e0bd6e29f8da">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy03LTEtMS02ODM4Mg_e41e0cc2-f25d-4315-80bb-77290b907ff9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC0xLTEtMS02ODM4Mg_7aa3214a-83bd-467d-a752-225cdbcaf9d8">33</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC0zLTEtMS02ODM4Mg_9223dceb-b351-4898-9ec5-344818ba47e4">38</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC01LTEtMS02ODM4Mg_a05ca972-0452-4cab-a24a-bdd63668770e">106</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC03LTEtMS02ODM4Mg_ef1c4209-3d52-4fc9-9212-aa84ba0f687e">114</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtMS0xLTEtNjgzODI_03b749e0-fe09-42e0-888c-ca5ac2da6b64">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtMy0xLTEtNjgzODI_56fdfc99-28b1-422a-b0b4-1bab7bdc2857">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtNS0xLTEtNjgzODI_0275dbad-bf2b-4e9a-9282-b35179a79884">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtNy0xLTEtNjgzODI_44cc28b1-8fdf-47da-8145-5146749954af">111</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtMS0xLTEtNjgzODI_bb70a9b8-a783-4c47-ba82-256e803ed0bc">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtMy0xLTEtNjgzODI_7b98c482-e3da-45c0-a2b0-99e387e434a2">187</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtNS0xLTEtNjgzODI_4c8613a7-4bb4-4a39-8bca-3493ce531635">187</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtNy0xLTEtNjgzODI_8a635181-da4e-4bb4-903b-32d8925e4992">522</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtMS0xLTEtNjgzODI_4898eec5-1ee5-459e-811b-a95e4f63c0f6">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtMy0xLTEtNjgzODI_c00605a9-37dc-436f-bb61-5ee4166d9106">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtNS0xLTEtNjgzODI_d6880963-fe07-40ce-a3d0-4f49e4657948">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtNy0xLTEtNjgzODI_6fd67760-8ad1-4bdd-b4e9-de1e4190ca9b">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtMS0xLTEtNjgzODI_1481d2dc-1b09-411e-8c4c-f227861f9025">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtMy0xLTEtNjgzODI_4d82eec7-9ac0-4628-8a56-49b10ae4d797">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtNS0xLTEtNjgzODI_f26e6def-a98c-49e4-a63a-2a9d0b1b725a">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtNy0xLTEtNjgzODI_e8755d13-73c9-48d6-8430-2c90c86931d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtMS0xLTEtNjgzODI_5a5086e1-c208-423b-a5b6-4d584edecf75">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtMy0xLTEtNjgzODI_757af959-019a-40dd-a915-afae43b7408b">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtNS0xLTEtNjgzODI_e88d7064-f626-4cb1-9715-d8d04eff6064">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtNy0xLTEtNjgzODI_da8b2f77-e272-4fbc-a79a-7601bdd2f99e">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtMS0xLTEtNjgzODI_bbbbd84e-189a-4316-97a6-41dfeb0cced6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtMy0xLTEtNjgzODI_0ed7e36a-5b3f-44a4-af7c-fb37fb7f09c4">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtNS0xLTEtNjgzODI_7d219304-6908-4695-b268-4b7a8aade43c">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtNy0xLTEtNjgzODI_4a6acb80-3e25-4e7c-bb72-fb0c77a1ebc2">254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:LiabilitiesAssumed1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktMS0xLTEtNjgzODI_0b73d643-402b-4221-99d3-cb0c7e51da76">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:LiabilitiesAssumed1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktMy0xLTEtNjgzODI_a7b42530-036d-4ea5-8c01-3fcd5b203897">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktNS0xLTEtNjgzODI_4e57d6cd-9e96-4c63-9410-ec307377be11">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktNy0xLTEtNjgzODI_25588c0d-c02f-4082-a317-aef0ba51f783">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtMS0xLTEtNjgzODI_440908d2-dd5d-44a3-b10e-31b21d077331">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtMy0xLTEtNjgzODI_0a4f7d08-e53c-4ad4-81e4-d6d898a30fbd">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtNS0xLTEtNjgzODI_114de2c4-ba55-4f58-9b0a-a9eb2dd84301">128</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtNy0xLTEtNjgzODI_552b0cde-40de-4913-98a6-2a3031bba1f7">251</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtMS0xLTEtNjgzODI_eb570fbc-b3b9-446c-b5d9-02749cb3782e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtMy0xLTEtNjgzODI_479270f6-eb5f-477c-8a04-e23c258fed34">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtNS0xLTEtNjgzODI_126c128f-78a0-4d9f-80da-0c718ff705b0">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtNy0xLTEtNjgzODI_32d63a26-4e8b-433a-837f-a4098c247555">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItMS0xLTEtNjgzODI_a6dccc9e-d712-4169-a957-b20eac7b5d9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItMy0xLTEtNjgzODI_e585b5b3-a081-45cf-b056-a63af26ece9b">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItNS0xLTEtNjgzODI_431cb5f1-fd04-4122-a52b-57bb7f6d877a">110</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItNy0xLTEtNjgzODI_31b34d62-d9fc-46eb-8653-e3ae90517b75">251</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtMS0xLTEtNjgzODI_46d8b55c-5291-4771-8dd3-095f39f325dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtMy0xLTEtNjgzODI_afa07ba0-39d4-4929-b9cc-ccb2563f9365">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtNS0xLTEtNjgzODI_95316f80-1ca5-44ca-9bf1-8d2a62eeda52">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtNy0xLTEtNjgzODI_07e16212-ffff-40df-8e34-d4fc36810b44">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtMS0xLTEtNjgzODI_bb42f230-c76f-480e-824a-d8c99f6b7828">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtMy0xLTEtNjgzODI_2ca725de-db22-4702-bf9a-cafea22bf246">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtNS0xLTEtNjgzODI_27ae9dbf-5169-494a-9f07-1c0348c1b4b5">106</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtNy0xLTEtNjgzODI_c8d2f481-2252-4e26-9219-41956f9f7334">251</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtMS0xLTEtNjgzODI_6bcee9a9-acf1-437e-a2b9-257c447ee1d3">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtMy0xLTEtNjgzODI_924a8ed0-9710-4fc2-b094-1d8d769df1b6">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtNS0xLTEtNjgzODI_d2d162ce-009f-468f-8c4a-501e7dbd3a67">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtNy0xLTEtNjgzODI_59c75e9a-d0e4-41a0-bede-5bf3d3eb62cc">115</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2022, the Company amended a real estate lease and, based on the updated terms, the classification of the lease changed from a finance lease to an operating lease. As a result, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i191fbddd79df46e9b0198928feb36a29_I20220930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RleHRyZWdpb246MTgxZGIwZGI5ZDY2NDdiYjhkZWE5Y2JjYTI0OTFmMmVfMzY4_ab41dd01-5aee-4ba2-84b6-4bbbfc981a05">31</ix:nonFraction>&#160;million operating lease right-of-use asset.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_61"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTE0OTc_8164391b-347a-48d2-8b7c-291bcb7a3b5d" continuedAt="i200632c5d9e74f7299f3a2b2364cb901" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i200632c5d9e74f7299f3a2b2364cb901" continuedAt="icb320375844a4d568f3152ba5017ad28"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i6f0c266cfabc4117a5db448c8bd6d03f_I20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTEx_857b6fcf-9c62-474a-b7ea-fc9f2a048206">100</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i8b2ee25f2ed8463cb9acb8e346af111a_I20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTI0_a11e985d-6732-455b-8549-0bfe8b105213">600</ix:nonFraction>&#160;million secured receivables credit facility and $<ix:nonFraction unitRef="usd" contextRef="ia1a4fda1687b418eb6a88b57bee7ee91_I20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTY3_b4803782-3d7b-4773-9d5c-fd93c766009c">150</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i71bd2faa4dcb410aac7083d1314895b2_I20220930" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTgw_2217652b-2033-4dc1-bfa9-09895bc99f01">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 15.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $<ix:nonFraction unitRef="usd" contextRef="i8b2ee25f2ed8463cb9acb8e346af111a_I20220930" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfNTE0_2840aba6-59d6-42b2-98f5-fa94d5a75de6">70</ix:nonFraction> million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2022, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="i2429a6bcd9bd4c65a106279746ec156f_I20201031" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTg1OA_5d795f4e-9cbf-4b0e-a3f9-958f380d892c">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="i2429a6bcd9bd4c65a106279746ec156f_I20201031" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMjQwNg_ef845bda-469a-4cd7-9507-0b12b3b245b8">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="icb320375844a4d568f3152ba5017ad28" continuedAt="i1bd2d8d5a82c429586c8d4dd1adf9fab"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  Discovery is proceeding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the Company has been notified that numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  </span></div><div><span><br/></span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ReproSource Fertility Diagnostics, Inc.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#8220;ReproSource&#8221;), a subsidiary of the Company, is subject to <ix:nonFraction unitRef="claim" contextRef="ib3f4b1ab656b429792e65b699bbd3194_I20220930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfNDkzNw_34c84fd2-91f6-4aea-8ad6-8b12ab9abb25">two</ix:nonFraction> putative class action lawsuits in the U.S. District Court for Massachusetts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bickham v. ReproSource Fertility Diagnostics, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#8217; private information. ReproSource has moved to dismiss both complaints.  In addition, the Company had been notified that the Office of Civil Rights of the U.S. Department of Health and Human Services (&#8220;OCR&#8221;) and three state governmental authorities were investigating or otherwise seeking information and/or documents related to the incident.  The OCR and one state investigation have been closed, and the other state investigations are inactive.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of September&#160;30, 2022, the Company does not believe that material losses related to legal matters are probable.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i1bd2d8d5a82c429586c8d4dd1adf9fab"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="ibad21a9259c74090ab33049d5d123cd2_I20220930" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfODQwNQ_0b12dad3-2a2c-4483-8bba-04bb6e3354f3">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i049e3ca5238248948e41058b0359b2cc_I20211231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfODQxMg_930ade11-8756-4ed6-b643-ff3e6968a056">4</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;The Company is subject to a series of individual claims brought by persons in Ireland related to allegations stemming from pap smear screening services performed by the Company.  In general, claimants have alleged that the results of certain pap smear screening tests performed by the Company and other providers, pursuant to a program coordinated by the Irish government, were incorrect for individuals who were later diagnosed with cervical cancer.  The Irish government and an independent scoping inquiry commissioned by the Irish government found that the Company&#8217;s performance of its screening services for the Irish cervical cancer screening program were in accordance with both Ireland&#8217;s requirements and international standards.  The Company has settled claims made by certain individuals, is a party in multiple lawsuits and may be served as a party in additional lawsuits.  The Company does not believe that the resolution of existing or future claims will have a material adverse effect on its financial position or liquidity, but the ultimate outcomes of these claims are unpredictable and subject to significant uncertainties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTA2NjU_88774796-19aa-4f7b-8879-4e040bed97a8">162</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTA2NzI_3c1b6515-fa2b-46b6-92c3-0ffb346c4acc">159</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;While the basis for claims reserves is actuarially determined losses based upon the Company's historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although the Company believes that its present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that the Company may incur liabilities in excess of its recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material impact on the Company&#8217;s results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.</span></div></ix:continuation><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfMjQwOQ_1bac2924-c771-41a1-ab82-7c23fc6a62e3" continuedAt="i17956e89ba3f469eb84e25d1405d2e4b" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i17956e89ba3f469eb84e25d1405d2e4b" continuedAt="i4f6d56f2d7204cf2bb199b9d358a2d33"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, and ACOs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i6780bd5df0e2405c8a5497be06f79406_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfODA3_3b7b5a7e-f459-4fc8-8f40-b94115283395"><ix:nonFraction unitRef="number" contextRef="i778d30c2a5f04d5bbd79b50d49dff45b_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfODA3_9897c76b-cb90-4fc8-9ca7-0a5322db0d1a">95</ix:nonFraction></ix:nonFraction>% of net revenues in 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2022, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfMjQxMw_5ccbd409-76ea-4b64-852e-a40aec1963bf" continuedAt="if241f9903baf4dfab9bbe8e666d42d6b" escape="true">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i4f6d56f2d7204cf2bb199b9d358a2d33"><ix:continuation id="if241f9903baf4dfab9bbe8e666d42d6b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35233092ea214d52af667521fd4f34ba_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy0xLTEtMS02ODM4Mg_afc52c15-845f-490d-8ffc-b68fb5bc8ee1">2,419</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy0zLTEtMS02ODM4Mg_eec19ff4-4b28-4ee3-8a59-24377c4ce2ad">2,703</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy01LTEtMS02ODM4Mg_41f7c35b-8477-4d38-b8c7-99d01eddd9c4">7,344</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy03LTEtMS02ODM4Mg_31d755ff-e35f-4335-8103-315c9f1ddf75">7,820</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2022fe35c0ed49ce8cbcf4e5663b9586_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC0xLTEtMS02ODM4Mg_98737cfd-4af0-4243-84fe-8462f94f9486">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f82d92935446eda7827eecbc1d0446_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC0zLTEtMS02ODM4Mg_d1d96944-8213-4fbd-9a8c-2f8c550b0b44">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dd75de4a9a04a92817af7be460230d6_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC01LTEtMS02ODM4Mg_2039b1d9-a368-46b3-8e3b-34575fe840ba">206</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54292d821ae48a68d7b57aa83ce30d5_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC03LTEtMS02ODM4Mg_8df6cf44-8824-4532-9080-3c4497679ca7">224</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS0xLTEtMS02ODM4Mg_6d18262b-f012-4920-bdb7-08019c3e7f90">2,486</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS0zLTEtMS02ODM4Mg_801c2c89-a122-4cd6-ba5a-951e8ffd1cd2">2,774</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS01LTEtMS02ODM4Mg_6a3529ef-b84e-4df4-960d-6fe65e5a6f0b">7,550</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS03LTEtMS02ODM4Mg_fa23fde1-7f55-4812-8841-bc66cf170400">8,044</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35233092ea214d52af667521fd4f34ba_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC0xLTEtMS02ODM4Mg_1fdfb0de-0955-43e3-b925-462469604e5e">441</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC0zLTEtMS02ODM4Mg_f36a1a4d-01f3-477c-81d7-5f8ba06cb29f">713</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC01LTEtMS02ODM4Mg_c7e378ce-f306-4aba-aee5-c01d0ff61b93">1,445</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC03LTEtMS02ODM4Mg_f5557a5c-056c-4240-a5ff-0d70a72fd6a2">2,026</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2022fe35c0ed49ce8cbcf4e5663b9586_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS0xLTEtMS02ODM4Mg_03860901-92f1-4bd2-81be-693cb376ba22">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f82d92935446eda7827eecbc1d0446_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS0zLTEtMS02ODM4Mg_88ccb905-f82b-4f03-89bc-756ca7058e96">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dd75de4a9a04a92817af7be460230d6_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS01LTEtMS02ODM4Mg_bf46e8c0-8ccb-4edb-b17f-9e98ec19125d">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54292d821ae48a68d7b57aa83ce30d5_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS03LTEtMS02ODM4Mg_a12b35f5-07db-4ad6-98e1-38665c39b00b">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e38360cd91846de82063fcaaf58e127_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtMS0xLTEtNjgzODI_0e329d57-1d1e-4f58-acad-6825729058e1">52</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedba8be9e6d9474cbeea5e69c3817a44_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtMy0xLTEtNjgzODI_38600909-22d5-406b-b7b4-bffdf389bbff">69</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2213ad4f9e044d1f9f73b935280a85d0_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtNS0xLTEtNjgzODI_33feedd6-5a97-45d2-b2c2-6d956a0ec07a">168</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05844d0d291141408b4c5e911aa1a773_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtNy0xLTEtNjgzODI_4adb8445-dcf0-41a1-8854-8d89f15e11dc">207</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtMS0xLTEtNjgzODI_f68f6c40-4f9c-4099-aaf8-774831641ebe">392</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtMy0xLTEtNjgzODI_a37dc0ed-b73e-486e-b55a-3618892eb66d">652</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtNS0xLTEtNjgzODI_47436938-b389-43bc-86e7-f1e3fb35e374">1,293</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtNy0xLTEtNjgzODI_f13e0ac9-eef1-4579-bc82-36ffac3e1eb4">1,845</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating (expense) income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItMS0xLTEtNjgzODI_88080f73-0777-44dd-9e01-2eb2dd483743">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItMy0xLTEtNjgzODI_51f3a2ed-df02-4898-8961-1b2170f7a375">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItNS0xLTEtNjgzODI_4c7e7711-f6d0-46d6-b9e0-460e9d74a940">167</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItNy0xLTEtNjgzODI_6a516a5c-7282-42fa-889f-df4c91f6705a">252</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtMS0xLTEtNjgzODI_65ddfe60-a419-46c0-8b62-c6d24f5024a7">351</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtMy0xLTEtNjgzODI_32918cb4-da4d-43f7-bfdf-47037ef6132c">654</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtNS0xLTEtNjgzODI_32dc352d-ccdb-433e-bb21-8bf22ebd449c">1,126</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtNy0xLTEtNjgzODI_99a4bfd9-da23-474d-a508-fd5ae04d899a">2,097</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtMS0xLTEtNjgzODI_151987d9-ecc8-4563-a6a2-76c814f46a34">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtMy0xLTEtNjgzODI_9e76fd08-9f6f-4115-8202-a2fa10e4fece">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtNS0xLTEtNjgzODI_ab827632-f527-41b4-ac80-1d39be642727">268</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtNy0xLTEtNjgzODI_6680b582-d998-4251-b199-733ff2eb2dcd">483</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtMS0xLTEtNjgzODI_0c8925c5-7333-467e-952b-a62c47feca2c">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtMy0xLTEtNjgzODI_e2c0aa41-f9f9-4c9a-bbce-e8f546c47117">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtNS0xLTEtNjgzODI_cfbd7f53-7950-4ec3-93c8-e6cec3b60275">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtNy0xLTEtNjgzODI_e7a97980-092c-41b4-8123-ecdce68b9aaa">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtMS0xLTEtNjgzODI_7e2749fd-c906-44b7-9045-683f14963fab">276</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtMy0xLTEtNjgzODI_48491f4a-1e1c-4f0c-b3bf-a6d99a443b9e">527</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtNS0xLTEtNjgzODI_61431ae7-0fde-4acf-ac90-c0f9b29996b7">899</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtNy0xLTEtNjgzODI_5084862b-0006-4aa8-9a45-2a0524b8c18e">1,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktMS0xLTEtNjgzODI_5c515df2-d40b-40ca-b776-2121828d00ca">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktMy0xLTEtNjgzODI_97549feb-1b39-40e1-a781-c6820d95f740">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktNS0xLTEtNjgzODI_12d66b37-92e7-4365-8110-154c29fae806">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktNy0xLTEtNjgzODI_01c5b90e-4a28-4d85-a446-bc805819e641">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtMS0xLTEtNjgzODI_750f8746-396d-44d7-a064-34b8c1293e17">256</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtMy0xLTEtNjgzODI_e586363c-46e9-475e-b01f-b94161abfc0e">505</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtNS0xLTEtNjgzODI_bc876f59-ada6-40b2-9f27-50b29033e5c5">845</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtNy0xLTEtNjgzODI_7f2148d1-1c24-4280-af40-d1c4dfe3f735">1,605</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfMjQyMg_ac4e16ff-9473-4ecc-9697-e4a232950da2" continuedAt="i5b8ebdac869a4a04b1c19ac3e893115f" escape="true">Net revenues by major service were as follows:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i5b8ebdac869a4a04b1c19ac3e893115f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fc81340b331406aaaa1e47f50446a3a_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy0xLTEtMS02ODM4Mg_a291ea36-c433-4db9-89e8-9e5934a3da4e">1,119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2262f05753a4ec9afdc14f6b0ffdd09_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy0zLTEtMS02ODM4Mg_969b5619-7755-4051-8d24-8287714d269e">1,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba791edd92545c5a2aef512c9a4b212_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy01LTEtMS02ODM4Mg_bc507ca3-e065-41ea-ad6f-08f5ec0f2c52">3,283</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3982f629690f495cbf0e0ba3db8ad100_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy03LTEtMS02ODM4Mg_7a7cf7de-8491-4d02-813a-d10b196310d5">3,392</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2ec2a973ec44539d673cf6d99f87ec_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC0xLTEtMS02ODM4Mg_9e2384d5-6609-4dc7-b2e2-23fc1b2730ab">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa3c11aef7e473182161c33c456b37b_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC0zLTEtMS02ODM4Mg_15989171-094e-4c1a-b3f7-1395952ea7ba">709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeb59228d7c345f18c522deada6d4507_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC01LTEtMS02ODM4Mg_efd9adfb-8bf5-4532-a75f-12cf8a5e995b">1,270</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3b88fd5ccc4285a63afa1e6f852f11_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC03LTEtMS02ODM4Mg_77c20633-141b-4f13-b0cf-725429ca5fd7">2,048</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i882d231dd7374595abf2c323937f41ba_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS0xLTEtMS02ODM4Mg_987e48c5-1788-4b11-a738-4f979714ca48">835</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33932a80efde433c898a298b0df7e2c0_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS0zLTEtMS02ODM4Mg_092d4da4-0be6-4e10-9fed-0e45c294d75a">646</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4b2c0774334fd9bff7edabc3b2f8d4_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS01LTEtMS02ODM4Mg_8dabda31-6f4f-49cd-988e-60d8835f8b2a">2,361</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id771340b26ba466d84857e28e997aad7_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS03LTEtMS02ODM4Mg_8f9d5846-c7ba-45d3-9fcd-bb7b91f10ab4">1,972</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5981a21f65c64729863e38afe9d108b6_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi0xLTEtMS02ODM4Mg_33f8a70f-f271-4bfe-a6ee-0429ea83812f">149</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d569efaaa7146efa0ff3406897b8dbc_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi0zLTEtMS02ODM4Mg_c582df19-f0a8-4955-96f3-accc82e7c2c7">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9489e8daf9452f86f8ce2d6e8b66d4_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi01LTEtMS02ODM4Mg_7e6313d9-2f76-4c8f-8b6a-c0d01586b099">430</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c6fc5be8aa4490a60a9c8eb3f467ff_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi03LTEtMS02ODM4Mg_8cb2c6b1-7145-4bb6-88a6-22b922bef9f9">408</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b74cfcfe6b74088a041cf19f39f8bfd_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy0xLTEtMS02ODM4Mg_a7f917c9-0a0b-4c82-86f3-84c09ac4fd75">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac9122b4d044d2aac6ae108cb25b79d_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy0zLTEtMS02ODM4Mg_a0a1d20f-d666-4554-ba18-bfbc5b38bd1c">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a4fa9bc40c5420697f812025c278d5f_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy01LTEtMS02ODM4Mg_e05c783d-2cbe-46ee-8cfa-3423251d757f">206</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2463ba51e264dbbb561f3ebd2a7ae68_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy03LTEtMS02ODM4Mg_3018cda7-e343-4f69-9dab-236ca7238935">224</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC0xLTEtMS02ODM4Mg_6b963640-1b64-4596-ab38-f00fe408a2bd">2,486</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC0zLTEtMS02ODM4Mg_6af83162-66fa-4b8b-ae0e-b0598a6bcfe0">2,774</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC01LTEtMS02ODM4Mg_fb4b14db-850d-4ff9-b716-2d9ec7c73f64">7,550</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC03LTEtMS02ODM4Mg_8d6fb942-39e3-47a5-a5e7-0be6b2fa0889">8,044</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfMTYwNw_0a028e8a-f61e-4a69-9788-0ad9e75a71b7" continuedAt="icaaf87429557463c99ff75c380ceac54" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icaaf87429557463c99ff75c380ceac54" continuedAt="i1aeffcab49d34764a54d5856b6da8faf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over <ix:nonFraction unitRef="number" contextRef="i6780bd5df0e2405c8a5497be06f79406_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_0f14eacf-e8e1-4c59-9b28-78e16dba5b07"><ix:nonFraction unitRef="number" contextRef="i778d30c2a5f04d5bbd79b50d49dff45b_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_a6da3724-1d21-4b4b-a9df-a643c59fd9fe"><ix:nonFraction unitRef="number" contextRef="id4bb02bf9fa849cb99832a402efd5409_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_d74171ff-15d5-425a-9faf-ddd0ebd8e053"><ix:nonFraction unitRef="number" contextRef="icafe184efc93430796a2beab39669d01_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_f21178b8-4211-491e-9ba0-6c59e65641c8">95</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total net revenues for the three and nine months ended September&#160;30, 2022 and 2021 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i1aeffcab49d34764a54d5856b6da8faf" continuedAt="iebc94be3d7034ed8b42265f29e8a6bf9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue and Net Accounts Receivable by Customer Type</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfMTYwNA_b15a7aa1-efe7-49da-aac3-45040b85c62f" continuedAt="ia956bc8ca9fe45ae9c12cc7d4914f72c" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><ix:continuation id="ia956bc8ca9fe45ae9c12cc7d4914f72c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:57.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.770%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i229509c7231549db925bf29fdce1531d_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy0xLTEtMS02ODM4Mg_54c8845a-cda4-4abf-9f43-eebfb04ec637">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff5758981e1444b4b9fd02f8aa63d7bf_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy0zLTEtMS02ODM4Mg_1ca30e8f-f169-48bd-9dcc-e450d213dac5">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice963a3c871a4964b7fada36abe521f5_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy01LTEtMS02ODM4Mg_6777704c-8c23-434f-9cde-f011e3200504">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe66bde611c3455b968735afb276accc_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy03LTEtMS02ODM4Mg_be2130bf-1359-4308-b1c0-dd1a0bf44fae">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb2da7bb5bdf450d94c7cb844900e0b1_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC0xLTEtMS02ODM4Mg_63aeb50a-b28a-483a-9ac8-947663ff1aa6">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9ec7b61dbc848dc972c1fd56b0ab080_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC0zLTEtMS02ODM4Mg_eb7bb871-9ac5-4da4-b080-a4c4902e741b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iedddff22ba5b4fb0a008f2787a6212e5_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC01LTEtMS02ODM4Mg_28dfe9b4-bf7d-46ac-9fd9-8b6ee41014e4">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee7efe5928604ef39c7c110d8e85cdaa_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC03LTEtMS02ODM4Mg_bc3e67fe-ead4-4f69-82b3-ca5551463e63">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0dee333059084814b53e9d3f76a165f5_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS0xLTEtMS02ODM4Mg_b0cde1f9-2da4-42f5-b4a9-642fd7e6db12">42</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8f803ca658f4d9ca283e32e2641679d_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS0zLTEtMS02ODM4Mg_c5c386ba-9827-47d7-92a3-40af37e268f7">43</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0abea2ff94d74055876d608a5384541f_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS01LTEtMS02ODM4Mg_25994741-52f1-4f07-9c59-cab5db672cea">42</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c844b73612e4d969c32144072e69482_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS03LTEtMS02ODM4Mg_1c77a672-f4ae-40a5-92f7-a04205dc27f8">42</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70b790ee8c6b4795a8b810a63f6d3fbf_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi0xLTEtMS02ODM4Mg_631becbb-89d8-4854-af43-9a2eb01c9da5">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icfc6ae7ce5004bf1a030a03d500851b6_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi0zLTEtMS02ODM4Mg_f538b8e0-6a42-4a61-9fb0-8d0785703178">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie972687548c145bea8a73606c134780f_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi01LTEtMS02ODM4Mg_a881ddfb-fd2f-42da-b62d-31fe7ee9bfb5">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic36a1aa9ec14411bbb9b140920cd721e_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi03LTEtMS02ODM4Mg_89eaecaa-e1ae-4e7a-be90-27b5a22df402">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb786a9417bf40a9a53c78abcd60b86a_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy0xLTEtMS02ODM4Mg_fb37a8e2-e913-42a9-82cd-1c13304362d5">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5ab3f4c5668458b9be3e667d579e95d_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy0zLTEtMS02ODM4Mg_f3871121-1c88-4542-af88-43202154d01f">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a3b7e0a1ab747b4a88ba384b9c6f5e3_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy01LTEtMS02ODM4Mg_d3cca410-1591-4002-a948-2714e15ecb68">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if614926c685244ce8994f73e3407170e_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy03LTEtMS02ODM4Mg_db3f681d-c0bc-4eea-a77c-2a3a3fc1b3f1">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40c24d1fe9e0422f98322342e1b600dc_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC0xLTEtMS02ODM4Mg_7c4742e5-c477-4938-8fa9-b985661a30f9">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80681a5902484c9794b52f9ce9a0fe75_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC0zLTEtMS02ODM4Mg_7e25b426-0904-4d23-a4f6-b992225ba952">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36f1feca4ebc4193a027d4329c6dbdb5_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC01LTEtMS02ODM4Mg_c7fec2b3-ce02-474a-9475-cbc24c3a2662">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2ee8ab6bcc5441f948edbcabba5af31_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC03LTEtMS02ODM4Mg_c5f3eb26-1e33-45e2-ba01-84f6cc84ffad">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35233092ea214d52af667521fd4f34ba_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS0xLTEtMS02ODM4Mg_c2a7dc42-a013-4f48-983b-e78eda19000a">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS0zLTEtMS02ODM4Mg_ce790de4-a791-4789-aa4e-abb9a12ca037">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS01LTEtMS02ODM4Mg_6fe64b3e-4013-4402-8c15-1a2be9f2555c">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS03LTEtMS02ODM4Mg_c7c9857f-1cd8-49e2-8777-ec5ea987714d">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2443278408344ab88c125996c678332_D20220701-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtMS0xLTEtNjgzODI_5bfe9895-e93f-41d6-9111-c8825376b1de">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5550fc4948864d109a0e41c607884cf3_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtMy0xLTEtNjgzODI_e41f0312-8ad3-42a1-91b0-e53b4d8d7706">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f4871ad170844a7986509f75afcd399_D20220101-20220930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtNS0xLTEtNjgzODI_de00dca0-d0fd-4ae9-8427-3c50788dccde">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ea4dfa98d0b49eeaaccda4c4ae455f7_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtNy0xLTEtNjgzODI_004b2e16-b388-4611-83bc-ce46cbdffcc6">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtMS0xLTEtNjgzODI_627397fc-80e3-4e4f-bd47-b4554722d2b4">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtMy0xLTEtNjgzODI_acf751e2-158a-4796-89a9-588b29b5650f">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtNS0xLTEtNjgzODI_fde95081-75dc-42e6-9a0d-aac199e1a366">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtNy0xLTEtNjgzODI_e2b107d9-e4cb-414e-8dab-eac88e166bfc">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfMTYxMw_4bede27e-f4b7-428b-99a5-8f733cefe398" continuedAt="i0e9be171f93443ce878b30dd4d0f182e" escape="true">The approximate percentage of net accounts receivable by type of customer was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:5pt;text-align:center"><ix:continuation id="iebc94be3d7034ed8b42265f29e8a6bf9"><ix:continuation id="i0e9be171f93443ce878b30dd4d0f182e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice796a3655d941feb767f6c8fe65158b_I20220930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMi0xLTEtMS02ODM4Mg_61a0f0ba-5445-4eea-a704-9508ff6e1a64">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e911465833a4a6798f86e6b37692664_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMi0zLTEtMS02ODM4Mg_e9148dea-6a1d-4e62-a0e2-10f77862dbff">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95ec2390c17341c28ef60e2177b55f77_I20220930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMy0xLTEtMS02ODM4Mg_30184065-f60a-4886-bf85-d63a5f226421">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56774b5505024ca583c3885fc53e3512_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMy0zLTEtMS02ODM4Mg_b488e089-9412-4dc0-9091-fe965f169f4b">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e9c25981e2a4d4bac14a20a91cdad7f_I20220930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNC0xLTEtMS02ODM4Mg_fd9a16cd-4d3f-46a0-afcc-01b591c15d26">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ba474b936bc4d4ab84b4dc85c5d37f6_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNC0zLTEtMS02ODM4Mg_b19cbb98-3627-4234-bc6a-56f6c9da7d58">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56d1825da4ab49a8b78821022de2b6e8_I20220930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNS0xLTEtMS02ODM4Mg_0d8c9d61-12d5-4d1c-837c-3b7b36ebb22c">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9190b150986345cd97cfc2aebc94c2c3_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNS0zLTEtMS02ODM4Mg_cce9705d-111f-466a-abb0-aebbb7d62797">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cef2104bcc84b258c94c1efe866d9b3_I20220930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNi0xLTEtMS02ODM4Mg_6f461d92-afd4-4aea-b9e3-01520ca6cb79">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i913e83ce0c8349688375d506afd9d9ea_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNi0zLTEtMS02ODM4Mg_0fb55dce-4f82-479d-8a72-b7f1c8c05fbb">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib54a2680ca68495bb80170fdfa0a42bd_I20220930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNy0xLTEtMS02ODM4Mg_f62e9d49-8461-4c5d-9917-7d55e7f3ab98">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50a1c819b1b44a4aa7ad7742dca1f94f_I20211231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNy0zLTEtMS02ODM4Mg_eb2bedb1-31be-4899-af0f-0fcc062238f3">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib247069292a644faa219725ce24814d2_I20220930" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfOC0xLTEtMS02ODM4Mg_5b9a0d6e-e4ab-47c7-b4fc-a8d8bcaf7b5c">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0339863356d84ed3995b604e24b5634d_I20211231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfOC0zLTEtMS02ODM4Mg_9cc68e10-c37d-4f3b-8c3c-674093030fb4">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfMTAwMw_aade7aac-425e-4f65-8947-5c5cf5a0a369" continuedAt="ib33f973559e34650821d747c6a7d78f8" escape="true">TAXES ON INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ib33f973559e34650821d747c6a7d78f8" continuedAt="i01428ca252c044b2a8c61f4e533d77f4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022 and 2021, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNTk1_74feac62-f48d-48af-b31d-a23acf972eb8">23.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNjAy_ad8a286f-7e1e-411c-a0d8-48cddc251f87">23.1</ix:nonFraction>%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, <ix:nonFraction unitRef="number" contextRef="i33d1ee32d81244fcbd386f76884c5ada_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNzI5_e72fd4d6-ee7c-4d59-a5fa-2e76a130d2c8">17.6</ix:nonFraction>%, on the gain on the sale of the Company's <ix:nonFraction unitRef="number" contextRef="i08caf8d530cf43008af3a0306e3e477c_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNzc0_33f5175d-7a84-4283-971f-2d2c48fa5c4e">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5).  In </span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i01428ca252c044b2a8c61f4e533d77f4">addition, the effective income tax rate benefited from $<ix:nonFraction unitRef="usd" contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfODg1_59761e71-8195-4405-ad69-d51bfab826c2">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNTQ5NzU1ODE1NjA4_43636ac9-6f35-450d-b5de-8411723920c7">15</ix:nonFraction> million of excess tax benefits associated with stock-based compensation arrangements for the nine months ended September&#160;30, 2022 and 2021, respectively.</ix:continuation></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_1108"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV80OTQ3ODAyMzMyMTcw_caeecb82-874b-4679-8e26-4654e2e003b4" continuedAt="ida56b55046364ab1a4a0be36be0aeee6" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ida56b55046364ab1a4a0be36be0aeee6">&#160;&#160;&#160;&#160;During October 2022, the Company amended its $<ix:nonFraction unitRef="usd" contextRef="id12e6b7fc3d84f40ab1168ad2af450f4_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8zMjk4NTM0ODg3MDU1_acd418d0-543d-4dec-a1d8-db794190a0f2">600</ix:nonFraction>&#160;million secured receivables credit facility in order to extend the maturity dates for each underlying commitment by <ix:nonNumeric contextRef="ie53b722a57ce4b9daa9771d76111e184_D20221001-20221021" name="dgx:DebtInstrumentExtensionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8zMjk4NTM0ODg5NDg3_e4ea0347-6229-4018-9eda-2ff85a51f4cd">one year</ix:nonNumeric> while decreasing the aggregate borrowing capacity under the secured receivables credit facility to $<ix:nonFraction unitRef="usd" contextRef="ib0810507aff24122a43695ca80ce0367_I20221021" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc2NjYy_9caa5331-1c00-4e21-8d54-5cf623ff54b6">525</ix:nonFraction>&#160;million.  Under the amended secured receivables credit facility, the Company can borrow against a $<ix:nonFraction unitRef="usd" contextRef="ife2cffd951d24830bd6a215df4ae3b0b_I20221021" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc4NzE0_3ce435ac-788e-400c-b36f-d52cc5046fa4">425</ix:nonFraction>&#160;million loan commitment, half of which matures in October 2023 and half of which matures in October 2024.  Additionally, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="i9cee0dfd60be4a578a2484c1cd2ed559_I20221021" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8zMjk4NTM0ODg3NDc4_93400d3f-1824-41bf-8aaf-5d7047f20544">100</ix:nonFraction>&#160;million of letters of credit through October 2024.  Borrowings under the secured receivables credit facility are collateralized by certain domestic receivables.  Prior to the amendment, interest on borrowings under the secured receivables credit facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread.  Subsequent to the amendment, interest on borrowings under the facility will be based on either commercial paper rates for highly-rated issuers or the Term Secured Overnight Financing Rate, plus a spread of <ix:nonFraction unitRef="number" contextRef="i2cc95a9c78fc4bcb85da10d7ada37895_D20221001-20221021" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc4ODI1_29969679-e45d-4b3b-8468-2f3f5517346a">0.725</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i04cac7194168497fb90bd4b4e067a6cc_D20221001-20221021" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc4ODE4_508670f4-7048-4085-9441-1ed1d0b8d83d">0.80</ix:nonFraction>%.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers and accountable care organizations ("ACOs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition. Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s).  Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e., unit price), test mix, payer mix, and the number of tests per requisition. Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix.  Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third Quarter Highlights</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:60.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,486</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,774</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base business revenues (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,170</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,065</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$316</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$709</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,419</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,703</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.1)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.4)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$67</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$256</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$505</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.02</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$502</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$561</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Excludes COVID-19 testing.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts that the COVID-19 pandemic had on our DIS revenues, including requisition volume and revenue per requisition are discussed further below under "Impact of COVID-19" and "Results of Operations".</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further discussion of the year-over-year changes for the three months ended September&#160;30, 2022 compared to the three months ended September&#160;30, 2021, see "Results of Operations" below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID - 19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a novel strain of coronavirus (COVID-19) continues to impact the economy of the United States and other countries around the world, we are committed to being a part of the coordinated public and private sector response to this unprecedented challenge. We have made substantial investments to expand and maintain the amount of COVID-19 testing available to the country. We have been effectively managing challenges in the global supply chain; and, at this point, we have sufficient supplies to conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Due to the COVID-19 pandemic, we have experienced significant volatility, including periods of material decline compared to prior year periods in testing volume in our base business (which excludes COVID-19 testing) and periods of significant demand for COVID-19 testing services, with demand generally fluctuating in line with changes in the prevalence of the virus and related variants.  Additionally, compared to historical levels, our revenue per requisition has been positively impacted by COVID-19 molecular testing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of Pack Health, LLC ("Pack Health")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 1, 2022, we completed the acquisition of Pack Health, a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $123&#160;million, net of $4&#160;million cash acquired, which consisted of cash consideration of $105&#160;million and contingent consideration initially estimated at $18&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Notes 4 and 6 to the interim unaudited consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Invigorate Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to achieve savings and productivity improvements of approximately 3% of our costs, which we believe will help offset pressures from the current inflationary environment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization and automation; and optimization initiatives in our lab network and patient service center network.  We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, we incurred $32&#160;million of pre-tax charges under our Invigorate program primarily consisting of systems conversion and integration costs, all of which resulted in cash expenditures. Additional restructuring charges may be incurred in future periods as we identify additional opportunities to achieve further savings and productivity improvements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There have been no significant changes to our critical accounting policies from those disclosed in our 2021 Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of new accounting standards, if any, is discussed in Note 2 to the interim unaudited consolidated financial statements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impact of recent accounting pronouncements not yet effective on our consolidated financial statements, if any, is also discussed in Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables set forth certain results of operations data for the periods presented:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(476)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,094&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,199&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating (expense) income, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(419)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(49.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(760)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share attributable to Quest Diagnostics' common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.85)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.36)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not Meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended September&#160;30, 2022 were affected by certain items that on a net basis decreased diluted earnings per share by $0.19 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $27 million recorded in amortization of intangible assets or $0.17 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $13 million ($6 million in cost of services and $7 million in selling, general and administrative expenses), or $0.08 per diluted share, primarily associated with workforce reductions, systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $2 million in other (expense) income, net or $0.01 per diluted share, representing net losses associated with changes in the carrying value of our strategic investments; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $9 million ($2 million of charges in cost of services, and $5 million of charges in selling, general and administrative expenses offset by $16 million of gains in other operating income, net), or $0.06 per diluted share, primarily representing a $10 million gain from a payroll tax credit under the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") associated with the retention of employees and a $7 million gain associated with the decrease in the fair value of the contingent consideration accrual associated with previous acquisitions, partially offset by $5 million of costs associated with donations, contributions and other financial support through Quest for Health Equity (our initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities); and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $1 million, or $0.01 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the nine months ended September&#160;30, 2022 were affected by certain items that on a net basis decreased diluted earnings per share by $0.89 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $81 million recorded in amortization of intangible assets or $0.50 per diluted share; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $39&#160;million ($30 million in other (expense) income, net and $9 million in equity in earnings of equity method investees, net of taxes), or $0.24 per diluted share, representing net losses associated with changes in the carrying value of our strategic investments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $37 million ($13 million in cost of services and $24 million in selling, general and administrative expenses), or $0.23 per diluted share, primarily associated with workforce reductions, systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net pre-tax charges of $1 million ($2 million of charges in cost of services, and $9 million of charges in selling, general and administrative expenses largely offset by $10 million of gains in other operating income, net), or $0.00 per diluted share, primarily representing $9 million of costs associated with donations, contributions and other financial support through Quest for Health Equity offset by a $10 million gain from a payroll tax credit under the CARES Act associated with the retention of employees; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $10 million, or $0.08 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2022, diluted earnings per share benefited from the impact of share repurchases, including under accelerated share repurchase agreements ("ASRs") entered into in April 2021 to repurchase $1.5 billion of our common stock, on our weighted average shares outstanding as compared to the prior year periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended September&#160;30, 2021 were affected by certain items that on a net basis increased diluted earnings per share by $0.06 as follows:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $45&#160;million (a $42&#160;million gain recorded in other (expense) income, net and a $3 million gain recorded in equity in earnings of equity method investees, net of taxes), or $0.26 per diluted share, primarily due to gains associated with changes in the carrying value of our strategic investments; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $6 million, or $0.04 per diluted share, recorded in income tax expense; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $25 million, or $0.15 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $13 million ($7 million in cost of services and $6&#160;million in selling, general and administrative expenses), or $0.08 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $4&#160;million in selling, general and administrative expenses, or $0.01 per diluted share, primarily due to costs associated with donations, contributions and other financial support through Quest for Health Equity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the nine months ended September&#160;30, 2021 were affected by certain items that on a net basis increased diluted earnings per share by $1.50 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain recorded in other (expense) income, net of $314 million, or $2.00 per diluted share, on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions"), our clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), our joint venture partner (see Note 5 to the interim unaudited consolidated financial statements);</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $37&#160;million (a $42&#160;million gain recorded in other (expense) income, net, partially offset by $5 million of net charges recorded in equity in earnings of equity method investees), or $0.22 per diluted share, primarily due to gains associated with changes in the carrying value of our strategic investments, partially offset by a non-cash impairment charge to the carrying value of an equity method investment; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $15 million, or $0.11 per diluted share, recorded in income tax expense; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $79 million ($77 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes) or $0.46 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $51 million ($26 million in cost of services and $25 million in selling, general and administrative expenses), or $0.30 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $9&#160;million in selling, general and administrative expenses, or $0.04 per diluted share, primarily due to costs associated with donations, contributions and other financial support through Quest for Health Equity; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $4 million in cost of services, or $0.03 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including incremental costs incurred to protect the health and safety of our employees and customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the three months ended September&#160;30, 2022 decreased by 10.4% compared to the prior year period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the three months ended September&#160;30, 2022 decreased by 10.5% compared to the prior year period.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The decrease in revenue compared to the prior year period was driven by a decrease in COVID-19 testing, partially offset by growth in the base business (which excludes COVID-19 testing) and, to a lesser extent, the impact of recent acquisitions.  For the three months ended September&#160;30, 2022, recent acquisitions contributed approximately 0.5% to DIS revenues.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume decreased by 6.2% compared to the prior year period driven by a decrease in COVID-19 testing, partially offset by growth in the base business and the impact of recent acquisitions, which contributed approximately 0.2% to DIS volume.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition decreased by 5.1% compared to prior year period driven in large part by the decrease in COVID-19 molecular testing, and unit price pressure of approximately 0.5%, partially offset by favorable test mix.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 5.4% compared to the prior year period.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) was up 1.6% compared to the prior year period.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition in the base business increased by 3.3% compared to the prior year period primarily due to favorable test mix.</span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DS revenues for the three months ended September&#160;30, 2022 decreased by 5.9% compared to the prior year period primarily due to lower revenues associated with our risk assessment services offered to the life insurance industry.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the nine months ended September&#160;30, 2022 decreased by 6.1% compared to the prior year period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the nine months ended September&#160;30, 2022 decreased by 6.1% compared to the prior year period.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The decrease in revenue compared to the prior year period was driven by a decrease in COVID-19 testing, partially offset by growth in the base business and the impact of recent acquisitions.  For the nine months ended September&#160;30, 2022, recent acquisitions contributed approximately 0.9% to DIS revenues.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume decreased by 2.2% compared to the prior year period driven by a decrease in COVID-19 testing, partially offset by growth in the base business and the impact of recent acquisitions, which contributed approximately 0.8% to DIS volume.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition decreased by 4.3% compared to the prior year period driven in large part by the decrease in COVID-19 molecular testing and unit price pressure of approximately 0.5%, partially offset by favorable test mix. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 5.2% compared to the prior year period.  </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) was up 3.1% compared to the prior year period.      </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition in the base business increased by 1.7% compared to the prior year period primarily due to favorable test mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DS revenues for the nine months ended September&#160;30, 2022 decreased by 7.9% compared to the prior year period primarily due to lower revenues associated with our risk assessment services offered to the life insurance industry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2022, cost of services decreased by $52 million compared to the prior year period.  The decrease was primarily driven by lower expense associated with reduced COVID-19 testing volumes, and $20 million of expense in the prior year period associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19.  These decreases were partially offset by higher compensation and benefits costs (primarily related to wage increases).</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, cost of services increased by $14 million compared to the prior year period.  The increase was primarily driven by higher compensation and benefits costs (primarily related to wage increases), and additional costs associated with our acquisitions.  These increases were partially offset by lower supplies expense associated with reduced COVID-19 testing volumes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consist principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support as well as administrative facility costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $37 million for the three months ended September&#160;30, 2022, compared to the prior year period primarily due to additional costs associated with investments in our strategic growth initiatives and higher compensation and benefits costs (including headcount and wage increases).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $48 million for the nine months ended September&#160;30, 2022, compared to the prior year period, primarily driven by additional costs associated with investments in our strategic growth initiatives and higher compensation and benefits costs (including headcount and wage increases), partially offset by $42 million of lower costs associated with changes in the value of our deferred compensation obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in the value of our deferred compensation obligations is largely offset by changes in the value of the associated investments, which are recorded in other (expense) income, net.  For further details regarding our deferred compensation plans, see Note 17 to the audited consolidated financial statements included in our 2021 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Amortization Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2022, amortization expense increased by $2&#160;million and $4&#160;million, respectively, compared to the prior year periods as a result of recent acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Operating Income, Net</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other operating income, net includes miscellaneous income and expense items and other charges related to operating activities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and nine months ended September&#160;30, 2022, other operating income, net includes a $10&#160;million gain from a payroll tax credit under the CARES Act associated with the retention of employees.  The three months ended September&#160;30, 2022 also includes a gain associated with the decrease in the fair value of the contingent consideration accrual associated with previous acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2022, interest expense, net decreased by $5&#160;million and $8&#160;million, respectively, compared to the prior year periods due to increased interest income resulting from the impact of rising interest rates on our cash and cash equivalents. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other (Expense) Income, Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other (expense) income, net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2022, other (expense) income, net included $6&#160;million of losses associated with investments in our deferred compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2021, other (expense) income, net included $42 million of gains associated with changes in the carrying value of our strategic investments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, other (expense) income, net included $31&#160;million of losses associated with investments in our deferred compensation plans and $30&#160;million of losses associated with changes in the carrying value of our strategic investments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, other (expense) income, net primarily included a $314&#160;million pre-tax gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner (see Note 5 to the interim unaudited consolidated financial statements) and $42 million of gains associated with changes in the carrying value of our strategic investments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Income Tax Expense </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the three months ended September&#160;30, 2022 and 2021 was $81 million and $153 million, respectively.  The decrease in income tax expense for the three months ended September&#160;30, 2022 compared to the prior year period was primarily driven by a decrease in income before income taxes and equity in earnings of equity method investees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the nine months ended September&#160;30, 2022 and 2021 was $268 million and $483 million, respectively.  The decrease in income tax expense for the nine months ended September&#160;30, 2022 compared to the prior year period was primarily driven by a decrease in income before income taxes and equity in earnings of equity method investees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022 and 2021, the effective income tax rate was 23.8% and 23.1%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions. In addition, the effective income tax rate benefited from $10 million and $15 million of excess tax benefits associated with stock-based compensation arrangements for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes decreased for the three months ended September&#160;30, 2022 by $20 million compared to the prior year period primarily due to lower demand for COVID-19 testing services at our diagnostic information services joint venture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes decreased for the nine months ended September&#160;30, 2022 by $12 million compared to the prior year period primarily due to $14&#160;million of lower equity earnings in the current year period associated with changes in the carrying value of strategic investments of an equity method investee and lower demand for COVID-19 testing services at our diagnostic information services joint venture, partially offset by a non-cash impairment to the carrying value of an equity method investment of $8&#160;million in the prior year period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2022 and December&#160;31, 2021, the fair value of our debt was estimated at approximately $3.6 billion and $4.4 billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of September&#160;30, 2022 and December&#160;31, 2021, the estimated fair value (was less than) exceeded the carrying value of the debt by $(354)&#160;million and $403&#160;million, respectively.  A hypothetical 10% increase in interest rates (representing 52 basis points as of September&#160;30, 2022 and 23 basis points as of December&#160;31, 2021) would potentially reduce the estimated fair value of our debt by approximately $124&#160;million and $89&#160;million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates.  As of September 30, 2022, interest on our secured receivables credit facility is based on either commercial paper rates for highly rated issuers, or London Interbank Offered Rate ("LIBOR"), plus a spread.  As of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings. As such, our borrowing cost under this credit arrangement is subject to fluctuations in interest rates and changes in our public debt ratings.  As of September&#160;30, 2022, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.725% to 0.80%; and for our senior unsecured revolving credit facility, LIBOR plus 1.00%.  As of September&#160;30, 2022, there were no borrowings outstanding under either our $600&#160;million secured receivables credit facility or our $750&#160;million senior unsecured revolving credit facility.  During October 2022, we amended the secured receivables credit facility and, subsequent to the amendment, borrowing rates are based on commercial paper rates for highly rated issuers, or the Term Secured Overnight Financing Rate ("Term SOFR"), plus a spread of 0.725% to 0.80%.   In conjunction with the amendment we decreased the aggregate borrowing capacity to $525&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change our annual interest expense. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt, see Note 15 to the interim unaudited consolidated financial statements and Note 13 to the audited consolidated financial statements included in our 2021 Annual Report on Form 10-K.  For details regarding our financial instruments and hedging activities, see Note 8 to the interim unaudited consolidated financial statements and Note 15 to the audited consolidated financial statements included in our 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in our consolidated balance sheet with changes in fair value recorded in current earnings in our consolidated statement of operations.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  We regularly evaluate equity investments that do not have readily determinable fair values to determine if there are any indicators that the investments are impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $4&#160;million as of September&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  As of September&#160;30, 2022, a 10% change in the fair values of our equity investments with readily determinable fair values would have impacted our consolidated income before income taxes and equity in earnings of equity method investees by $1&#160;million.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified, as our ability to realize returns on investments depends on, among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our September&#160;30, 2022 financial statements, we considered whether the carrying values of our investments were impaired and concluded that no such impairment existed. </span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(368)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(617)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,187)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,171)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments with original maturities, at the time of acquisition, of three months or less.  Cash and cash equivalents as of September&#160;30, 2022 totaled $700 million, compared to $872 million as of December&#160;31, 2021. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2022, approximately 5% of our $700 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the nine months ended September&#160;30, 2022 and 2021 was $1,384 million and $1,752 million, respectively.  The $368 million decrease in net cash provided by operating activities for the nine months ended September&#160;30, 2022, compared to the prior year period was primarily a result of:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower operating income in 2022 as compared to 2021; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher payments associated with an additional payroll cycle in 2022 as compared to 2021; partially offset by </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $335 million decrease in income tax payments in 2022 as compared to 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding, a measure of billing and collection efficiency, was 47 days as of September&#160;30, 2022, 48 days as of December&#160;31, 2021 and 47 days as of September&#160;30, 2021.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash (used in) provided by investing activities for the nine months ended September&#160;30, 2022 and 2021 was $(369) million and $248 million, respectively.  This $617 million change in net cash (used in) provided by investing activities for the nine months ended September&#160;30, 2022, compared to the prior year period was primarily a result of $755 million of net cash proceeds received in 2021 from the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, partially offset by a $145 million decrease in net cash paid for business acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the nine months ended September&#160;30, 2022 and 2021 was $1,187 million and $2,171 million, respectively.  This $984 million decrease in net cash used in financing activities for the nine months ended September&#160;30, 2022, compared to the prior year period was primarily a result of a $963 million decrease in repurchases of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During both the nine months ended September&#160;30, 2022 and 2021, there were no borrowings or repayments under our secured receivables credit facility or senior unsecured revolving credit facility.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the three quarters of 2022, our Board of Directors declared a quarterly cash dividend of $0.66 per common share. During each of the four quarters of 2021, our Board of Directors declared a quarterly cash dividend of $0.62 per common share. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2022, our Board of Directors increased the size of our share repurchase program by $1&#160;billion.  As of September&#160;30, 2022, $746 million remained available under our share repurchase authorization. The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, we repurchased 7.1 million shares of our common stock for $950 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, we repurchased 12.5 million shares of our common stock for $1.6 billion, including 9.1&#160;million shares repurchased under ASRs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our share repurchases, see Note 9 to the interim unaudited consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of a diagnostic information services joint venture and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is less than 5% of our consolidated income before income taxes and equity in earnings of equity method investees.  We have no material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our September&#160;30, 2022 financial statements, we considered whether the carrying values of our equity method investments were impaired and concluded that no such impairment existed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $400&#160;million during 2022 for capital expenditures, to support and grow our existing operations, principally related to investments in information technology, laboratory equipment and facilities, including laboratory automations and footprint optimization; and in our advanced diagnostics and consumer growth strategies.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2022, we had $1.3 billion of borrowing capacity available under our existing credit facilities, including $530&#160;million available under our secured receivables credit facility and $750 million available under our senior unsecured revolving credit facility.  There were no borrowings under these credit facilities as of September&#160;30, 2022. In support of our risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2022.  During October 2022, we amended our secured receivables credit facility and decreased the aggregate borrowing capacity under the secured receivables credit facility to $525&#160;million.  The amended secured receivables credit facility includes a $425&#160;million loan commitment, half of which matures in October 2023 and half of which matures in October 2024.  Additionally, the amended secured receivables credit facility includes a $100&#160;million letter of credit facility which matures in October 2024.  The senior unsecured revolving credit facility matures in November 2026. For further details regarding our credit facilities, see Note 13 to the audited consolidated financial statements in our 2021 Annual Report on Form 10-K and Note 15 to the interim unaudited consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness.  As of September&#160;30, 2022, we were in compliance with all such applicable financial covenants.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have assessed the impact of the cessation of LIBOR and have identified and evaluated financial instruments and other contracts that refer to LIBOR. Our underlying exposure to LIBOR includes our senior unsecured revolving credit facility (see discussion above) under which we had no outstanding borrowings as of September&#160;30, 2022.  During October 2022, we amended our secured receivables credit facility and, subsequent to the amendment, borrowing rates are based on commercial paper rates for highly rated issuers, or the Term SOFR, plus a spread of 0.725% to 0.80%.  We expect to be able to transition all LIBOR based instruments and contracts to an alternative reference rate on or before the cessation of LIBOR and we do not believe that the cessation of LIBOR, or its replacement with an alternative reference rate or rates, will have a material impact on us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities for the foreseeable future.  However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_85"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements.  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221;  These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements.  Risks and uncertainties that may affect our future results include, but are not limited to, impacts of the COVID-19 pandemic and measures taken in response, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in our most recently filed Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; &#8220;Cautionary Factors that May Affect Future Results&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of those reports.</span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the third quarter of 2022, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_94"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART II - OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 11 to the interim unaudited consolidated financial statements for information regarding the status of legal proceedings involving the Company.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_100"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the third quarter of 2022.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.186%"><tr><td style="width:1.0%"></td><td style="width:45.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2022 &#8211; July 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115,906&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2022 &#8211; August 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235,212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235,212&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949,174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2022 &#8211; September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,908&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,084,614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,084,614&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745,908&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">In February 2022, our Board of Directors increased the size of our share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="i973ec05c00df4ad6a2a4472b1d8d2332_D20220201-20220201" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMDAvZnJhZzpkNDYzNjI0NzczMGU0ODFiYTZkOThkMTVlMjY4ZGVlZC90ZXh0cmVnaW9uOmQ0NjM2MjQ3NzMwZTQ4MWJhNmQ5OGQxNWUyNjhkZWVkXzMyOQ_db8c068b-d673-4053-a757-aed7c784a536">1</ix:nonFraction>&#160;billion.  Since the share repurchase program&#8217;s inception in May 2003, our Board of Directors has authorized $12&#160;billion of share repurchases of our common stock through September&#160;30, 2022.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company&#8217;s Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted stock units and performance share units.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Exhibits </span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibits:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302022ex31.htm">Restated Certificate of Incorporation</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302022ex101.htm">Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan as amended July 25, 2022</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302022ex22.htm">Subsidiary Guarantors of Securities</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302022ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302022ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302022ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302022ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document  - dgx-20220930.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20220930_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20220930_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20220930_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20220930_pre.xml</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9396b6ccfb5c492fae93ffab319e2ada_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;21, 2022 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.087%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sam Samad</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sam Samad</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div id="i9396b6ccfb5c492fae93ffab319e2ada_109"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>dgx09302022ex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib89f77242a1a4b45a9e426de224191d4_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 3.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTATED CERTIFICATE OF INCORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUEST DIAGNOSTICS INCORPORATED</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The present name of the corporation is Quest Diagnostics Incorporated.  The corporation was incorporated under the name &#8220;Corning Lab Services Inc.&#8221; by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on December 12, 1990.  This Restated Certificate of Incorporation of the corporation only restates and integrates and does not further amend the provisions of the corporation&#8217;s Certificate of Incorporation, as heretofore amended or supplemented, and there is no discrepancy between the provisions of the Certificate of Incorporation, as heretofore amended or supplemented, and the provisions of this Restated Certificate of Incorporation.  This Restated Certificate of Incorporation was duly adopted in accordance with the provisions of Section 245 of the General Corporation Law of the State of Delaware.  The Certificate of Incorporation of the corporation, as heretofore amended or supplemented, is hereby integrated and restated to read in its entirety as follows&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Name. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The name of the Corporation is Quest Diagnostics Incorporated. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The address of the Corporation&#8217;s registered office in the State of Delaware is 251 Little Falls Drive, City of Wilmington, 19808, County of New Castle. The name of the Registered Agent at such address is Corporation Service Company. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Corporate Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The purpose of the Corporation is (i) to own and operate medical, clinical, industrial and research laboratories, and (ii) to research, manufacture, design, construct, use, buy, sell, lease, hire and deal in and with articles and property of all kinds, to render services of all kinds, and (iii) generally to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The total number of shares which the Corporation may henceforth have is 610,000,000, of which 10,000,000 shares are to have a par value of $1.00 each and 600,000,000 shares are to have a par value of $0.01 each, which shares shall be classified as follows&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10,000,000 shares, of the par value of $1.00 each, are to be Series Preferred Stock&#59; and </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">600,000,000 shares, of the par value of $0.01 each, are to be Common Stock. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The relative voting, dividend, liquidation and other rights, preferences and limitations of the shares of each class are as follows&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I. &#160;&#160;&#160;&#160;The Preferred Stock may be issued from time to time in one or more series, each such series to have the number of shares and designation, and the shares of each such series to have such relative rights, preferences or limitations, as the Board of Directors, subject to the limitations prescribed by law or provided herein, may from time to time fix, before issuance, by filing an appropriate certificate (&#8220;Certificate of Designation&#8221;) with the Secretary of State pursuant to the General Corporation Law of the State of Delaware. The authority of the Board of Directors with respect to each series shall include, but not be limited to, the fixing of the following&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;The number of shares to constitute the series and the distinctive designation thereof&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) &#160;&#160;&#160;&#160;The dividend rate on the shares of the series&#59; whether dividends shall be cumulative, and, if so, from what date or dates&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) &#160;&#160;&#160;&#160;Whether or not the shares of the series shall be redeemable and, if redeemable, the terms upon which the shares of the series may be redeemed and the premium, if any, over and above the par value thereof and any dividends accrued thereon which the share of the series shall be entitled to receive upon the redemption thereof&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) &#160;&#160;&#160;&#160;Whether or not the shares of the series shall be subject to the operation of a retirement or sinking fund to be applied to the purchase or redemption of such shares for retirement and, if such retirement or sinking fund be established, the annual amount thereof and the terms and provisions relative to the operation thereof&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) &#160;&#160;&#160;&#160;Whether or not the shares of the series shall be convertible into shares of any class or classes of stock of the Corporation, with or without par value, or of any other series of the same class and, if convertible, the conversion price or prices or the rate at which such conversion may be made and the method, if any, of adjusting the same&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f) &#160;&#160;&#160;&#160;The rights of the shares of the series in the event of voluntary or involuntary liquidation, dissolution or winding-up of the Corporation&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) &#160;&#160;&#160;&#160;The restrictions, if any, on the payment of dividends upon, and the making of the distributions to any class of stock ranking junior to the shares of the series, and the restrictions, if any, on the purchase or redemption of the shares of any such junior class&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h) &#160;&#160;&#160;&#160;Whether the series shall have voting rights, in addition to the voting rights provided by law, and, if so, the terms of such voting rights&#59; and </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;Any other relative rights, preferences and limitations of the series. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">II. &#160;&#160;&#160;&#160;Holders of shares of Preferred Stock shall be entitled to receive, when and as declared by the Board of Directors, out of funds legally available for the payment of dividends, dividends at the rates fixed by the Board of Directors for the respective series, before any dividends shall be declared and paid, or set apart for payment, on any other class of stock of the Corporation ranking junior to the Preferred Stock either as to dividends or assets, with respect to the same dividend period.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">III. &#160;&#160;&#160;&#160;Whenever, at any time, dividends on the then outstanding Preferred Stock as may be required by the terms of the certificate creating the series representing the shares outstanding shall have been paid or declared and set apart for payment on the then outstanding Preferred Stock and after complying with all the provisions with respect to any retirement or sinking fund or funds for any series of Preferred Stock, the Board of Directors may, subject to the provisions of any certificate creating any series of Preferred Stock with respect to the payment of dividends on any other class or classes of stock, declare and pay dividends on the Common Stock, and the Preferred Stock shall not be entitled to share therein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IV. &#160;&#160;&#160;&#160;Upon any liquidation, dissolution or winding-up of the Corporation, after payment if any is required, shall have been made in full to the Preferred Stock as provided in any certificate creating any series thereof, but not prior thereto, the Common Stock shall, subject to the respective terms and provisions, if any, of any such certificate, be entitled to receive any and all assets remaining to be paid or distributed, and the Preferred Stock shall not be entitled to share therein. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">V. &#160;&#160;&#160;&#160;No holder of Common Stock or any series of Preferred Stock shall, as such holder, have any preemptive or preferential right of subscription to any stock of any class of the Corporation or to any obligations convertible into any such stock or to any right of subscription to, or to any warrant or option for, the purchase of any stock, other than such, if any, as the Board of Directors of the Corporation in its discretion may determine from time to time. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">VI. &#160;&#160;&#160;&#160;The holders of the Common Stock shall have the right to vote on all questions to the exclusion of all other classes of stock, except as by law expressly provided or as otherwise expressly provided with respect to the holders of any other class or classes of stock. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;The business and affairs of the Corporation shall be managed by a Board of Directors consisting of not less than three nor more than twelve persons. The exact number of directors within the minimum and maximum limitations specified in the preceding sentence shall be fixed from time to time by the Board of Directors pursuant to a resolution adopted by the affirmative vote of a majority of the entire Board of Directors&#59; and such exact number shall be six unless otherwise determined by a resolution so adopted by a majority of the entire Board of Directors. As used in this Certificate of Incorporation, the term &#8220;entire Board of Directors&#8221; means the total authorized number of directors which the Corporation would have if there were no vacancies. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of the Distribution Date (as defined in the Transaction Agreement dated as of November 22, 1996 among Corning Incorporated, Corning Life Sciences Inc., the Corporation, Covance and Corning Clinical Laboratories Inc. (Michigan) (the &#8220;Distribution Date&#8221;), the directors shall be divided into three classes, as nearly equal in number as possible, with the term of office of the first class to expire at the 1998 Annual Meeting of Stockholders, the term of office of the second class to expire at the 1999 Annual Meeting of Stockholders, and the terms of office of the third class to expire at the 2000 Annual Meeting of Stockholders. Commencing with the 1998 Annual Meeting of Stockholders, directors elected to succeed those directors whose terms have thereupon expired shall be elected for a term of office to expire at the third succeeding Annual Meeting of Stockholders after their election. Notwithstanding the foregoing, at the 2014 Annual Meeting of Stockholders of the Corporation, the successors of the directors whose terms expire at that meeting shall be elected for a term expiring at the 2015 Annual Meeting of Stockholders of the Corporation&#59; at the 2015 Annual Meeting of Stockholders of the Corporation, the successors of the directors whose terms expire at that meeting shall be elected for a term expiring at the 2016 Annual Meeting of Stockholders of the Corporation&#59; and at each annual meeting of stockholders of the Corporation thereafter, the directors shall be elected for terms expiring at the next succeeding annual meeting of stockholders of the Corporation, with each director to hold office until his or her successor shall have been duly elected and qualified. Commencing with the 2016 Annual Meeting of Stockholders of the Corporation, the classification of the Board of Directors shall cease. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) &#160;&#160;&#160;&#160;Subject to the rights of the holders of any series of Preferred Stock or any other class of capital stock of the Corporation (other than the Common Stock) then outstanding, vacancies on the Board of Directors resulting from a newly created directorship, death, resignation, retirement, disqualification, removal from office or other cause shall be filled only by the affirmative vote of a majority of the remaining directors of the entire Board of Directors then in office, although less than a quorum, or by the sole remaining director. Any director so elected shall hold office until the next Annual Meeting of Stockholders of the Corporation (or, if so elected prior to the 2016 Annual Meeting of Stockholders of the Corporation, until the next election of the class for which such directors shall have been chosen) and until his successor is elected and qualified. No decrease in the number of directors shall shorten the term of any incumbent director. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) &#160;&#160;&#160;&#160;Whenever the holders of any one or more series of Preferred Stock issued by the Corporation shall have the right, voting separately by series, to elect directors at an annual or special meeting of stockholders, the election, term of office, filling of vacancies and other features of such directorships shall be governed by this Paragraph 5 unless expressly otherwise provided by the resolution or resolutions providing for the creation of such series. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) &#160;&#160;&#160;&#160;Until the 2016 Annual Meeting of Stockholders, subject to the rights of the holders of any series of Preferred Stock or any other class of capital stock of the Corporation (other than the Common Stock) then outstanding, any director, or the entire Board of Directors, may be removed by the stockholders from office at any time prior to the expiration of his term of office, but only for cause, and only by the affirmative vote of the holders of record of outstanding shares representing a majority of the voting power of all of the outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) &#160;&#160;&#160;&#160;Notwithstanding any other provision of this Certificate of Incorporation and subject to the other provisions of this Paragraph 5, the Board of Directors shall determine the rules and procedures that shall affect the Directors&#8217; power to manage and direct the business and affairs of the Corporation. Without limiting the foregoing, the Board of Directors shall designate and empower committees of the Board of Directors, shall elect and empower the officers of the Corporation, may appoint and empower other officers and agents of the Corporation, and shall determine the time and place of, and the notice requirements for, Board meetings, as well as quorum and voting requirements for, and the manner of taking, Board actions. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Reserved.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Special Stockholder Meetings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as otherwise required by law, special meetings of the stockholders shall be called only by (a) the Board of Directors or (b) the Secretary, but only upon the written request of a stockholder or group of stockholders of record of the Corporation who own, as of the Stockholder Meeting Request Record Date (as defined below), at least fifteen percent (15%) in the aggregate of the Common Stock issued, outstanding and entitled to vote, who have owned that amount in a net long position continuously for at least one year, and who have complied in full with all of the requirements set forth in this Paragraph 7 and the Amended and Restated By-Laws of the Corporation (as amended and&#47;or restated from time to time, the &#8220;Bylaws&#8221;) (such request, a &#34;Stockholder Meeting Request&#34;). The record date for determining stockholders entitled to make a Stockholder Meeting Request shall be requested pursuant to a notice given in writing by a stockholder of record by delivery to the Secretary at the corporation&#8217;s principal executive offices (which notice shall comply in all respects with this Paragraph 7 and the Bylaws) and fixed by the Board of Directors as set forth in the Bylaws (the &#8220;Stockholder Meeting Request Record Date&#8221;). Any disposition by a requesting party (as defined below) after the date of the Stockholder Meeting Request or after a request to fix a Stockholder Meeting Request Record Date, as the case may be, of any shares of Common Stock (or, in the case of a stockholder making a Stockholder Meeting Request or a request to fix a Stockholder Meeting Request Record Date on behalf of the beneficial owner of shares, any disposition by such beneficial owner of beneficial ownership of such shares) shall be deemed a revocation of the Stockholder Meeting Request and any request to fix a Stockholder Meeting Request Record Date, as the case may be, with respect to such shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the purposes of this Paragraph 7, &#8220;net long position&#8221; shall be determined with respect to each stockholder making a Stockholder Meeting Request and each beneficial owner, if any, who is directing such stockholder to act on such owner&#8217;s behalf (each stockholder and owner, a &#8220;requesting party&#8221;) in accordance with the definition thereof set forth in Rule 14e-4 under the Securities Exchange Act of 1934, as amended from time to time (the &#8220;Exchange Act&#8221;), provided that (x) for purposes of such definition, in determining such requesting party&#8217;s &#8220;short position,&#8221; the reference in Rule 14e-4 to &#8220;the date that a tender offer is first publicly announced or otherwise made known by the bidder to holders of the security to be acquired&#8221; shall be deemed to be the Stockholder Meeting Request Record Date, and the reference to the &#8220;highest tender offer price or stated amount of the consideration offered for the subject security&#8221; shall be deemed to refer to the closing sales price of the Common Stock on the New York Stock Exchange (or such other securities exchange designated by the Board of Directors if the Common Stock is not listed for trading on the New York Stock Exchange) on such Stockholder Meeting Request </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Record Date (or, if such date is not a trading day, the next succeeding trading day) and (y) the net long position of such requesting party shall be reduced by the number of shares as to which the Board of Directors determines that such requesting party does not, or will not, have the right to vote or direct the vote as of the Stockholder Meeting Request Record Date or as of the record date for determining stockholders entitled to vote at the special meeting to be called pursuant to the Stockholder Meeting Request, or as to which the Board of Directors determines that such requesting party has entered into any derivative or other agreement, arrangement or understanding that hedges or transfers, in whole or in part, directly or indirectly, any of the economic consequences of ownership of such shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Whenever this Paragraph 7 or Paragraph 8 of this Certificate of Incorporation or any provision of the Bylaws requires one or more persons (including a record or beneficial owner of capital stock of the Corporation) to give or deliver any notice, request, consent (including any Consent (as defined below)), revocation, or any other documents or materials (the &#8220;Documents&#8221;) to the Corporation or any of its officers, directors, employees or agents, unless the Corporation consents or requests otherwise, such Documents shall be in writing and shall be delivered exclusively by hand (including, without limitation, overnight courier service) or by certified or registered mail, return receipt requested, and not by electronic transmission or any other means. The Corporation shall not be required to accept delivery of any Document given by a stockholder or beneficial owner of capital stock of the Corporation pursuant to Paragraph 7 or Paragraph 8 or any provision of the Bylaws that is not (x) in written form and (y) delivered in accordance with the immediately preceding sentence. For the avoidance of doubt, with respect to any Document given by any such stockholder or beneficial owner to the Corporation pursuant to this Paragraph 7 or Paragraph 8 of this Certificate of Incorporation or any provision of the Bylaws, the Corporation expressly opts out of Section 116 of the General Corporation Law of the State of Delaware to the fullest extent permitted by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Action by Written Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Any action that is required or permitted to be taken by stockholders at any annual or special meeting of stockholders may be taken without a meeting and without a vote if a Consent or Consents setting forth the action so taken shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the Corporation in the manner required by Section 228 of the General Corporation Law of the State of Delaware and this Certificate of Incorporation (each such consent, a &#8221;Consent&#8221;)&#59; provided, however, that no such action of stockholders in  lieu of a meeting may be taken or authorized except in accordance with this Certificate of Incorporation, the Bylaws, and applicable law. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;In order for stockholders to authorize or take corporate action by consent in lieu of a meeting, a stockholder of record seeking to have stockholders authorize or take such action (a &#8220;Written Consent Requesting Stockholder&#8221;) shall deliver to the Secretary of the Corporation at its principal executive offices a written request containing the information required by this Paragraph 8 and the Bylaws (such request, a &#8220;Written Consent Request&#8221;). Stockholders shall not be entitled to authorize or take corporate action in lieu of a meeting unless the Corporation shall have first received Written Consent Requests from a stockholder or group of stockholders of record of the Corporation who own, as of the close of business on the date the first Written Consent Request is delivered to the Corporation (the &#8220;Written Consent Request Record Date&#8221;), at least fifteen percent (15%) in the aggregate of Common Stock issued, outstanding and entitled to vote and who have owned that position in a net long position continuously for at least one year (the &#8220;Requisite Percent&#8221;) in accordance with this Paragraph 8 and all other conditions and requirements under this Paragraph 8 and the Bylaws shall have been fully satisfied or complied with. For purposes of this Paragraph 8, &#8220;net long position&#8221; shall be determined with respect to each Written Consent Requesting Stockholder (and each beneficial owner, if any, who is directing such stockholder to act on such owner&#8217;s behalf in accordance with the definition thereof set forth in Rule 14e-4 under the Exchange Act&#59; provided that (x) for purposes of such definition, in determining such Written Consent Requesting Stockholder&#8217;s (or beneficial owner&#8217;s) &#8220;short position,&#8221; the reference in Rule 14e-4 to &#8220;the date that a tender offer is first publicly announced or otherwise made known by the bidder to holders of the security to be </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">acquired&#8221; shall be deemed to be the Written Consent Request Record Date, and the reference to the &#8220;highest tender offer price or stated amount of the consideration offered for the subject security&#8221; shall be deemed to refer to the closing sales price of the Common Stock on the New York Stock Exchange (or such other securities exchange designated by the Board of Directors if the Common Stock is not listed for trading on the New York Stock Exchange) on such Written Consent Request Record Date (or, if such date is not a trading day, the next succeeding trading day) and (y) the net long position of such Written Consent Requesting Stockholder (or such beneficial owner) shall be reduced by the number of shares as to which the Board of Directors determines that such Written Consent Requesting Stockholder (or such beneficial owner) does not, or will not, have the right to vote or direct the vote as of the Written Consent Request Record Date or the Written Consent Record Date (as defined below), or as to which the Board of Directors determines that such Written Consent Requesting Stockholder (or such beneficial owner) has entered into any derivative or other agreement, arrangement or understanding that hedges or transfers, in whole or in part, directly or indirectly, any of the economic consequences of ownership of such shares. Following the date on which the Corporation shall have received Written Consent Request(s) representing the Requisite Percent in accordance herewith (the &#8220;Written Consent Request Effective Time&#8221;), the Board of Directors shall, by the later of (i) twenty (20) days after the Written Consent Request Effective Time and (ii) five (5) days after</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">delivery to the Corporation by any Written Consent Requesting Stockholder of any information requested by the Corporation to determine the validity of such Written Consent Request(s) (the later of the dates in the immediately preceding clauses (i) and (ii), the &#8220;Determination Outside Date&#8221;), determine the validity of such Written Consent Request(s) (including whether such Written Consent Requests were delivered in accordance with this Certificate of Incorporation and whether the proposed action is a proper matter for stockholder action under this Certificate of Incorporation) and, if appropriate, adopt a resolution fixing the record date for determining stockholders entitled to consent to the action(s) set forth in such Written Consent Request(s) (the &#8220;Written Consent Record Date&#8221;) (unless the Board of Directors shall have previously fixed such a Written Consent Record Date). The Written Consent Record Date shall be no more than ten (10) days after the date upon which the resolution fixing such record date is adopted by the Board of Directors and shall not precede the date upon which such resolution is adopted. If the Board of Directors determines that Written Consent Requests from Written Consent Requesting Stockholders representing the Requisite Percent have been validly delivered in accordance with this Certificate of Incorporation and relate to an action that may be effected by consent in lieu of a meeting pursuant to this Certificate of Incorporation, or if no such determination shall have been made by the Determination Outside Date, and in either event no Written Consent Record Date has been fixed by the Board of Directors, the Written Consent Record Date shall be the first date following the Determination Outside Date on which a signed Consent relating to the action taken or proposed to be taken by consent of stockholders in lieu of a meeting pursuant to the Written Consent Request is delivered to the Corporation in accordance with paragraph (g) of this Paragraph 8 and applicable law. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) &#160;&#160;&#160;&#160;Each Written Consent Requesting Stockholder shall include with his, her or its Written Consent Request written evidence reasonably satisfactory to the Corporation of his, her or its ownership of shares of Common Stock as of the Written Consent Request Record Date and continuous net long position as required by paragraph (b) of this Paragraph 8 (provided, however, that if any Written Consent Requesting Stockholder is not the beneficial owner of the shares as to which any Written Consent Request is made, then such Written Consent Request must also include documentary evidence reasonably satisfactory to the Corporation as to such ownership by the beneficial owner on whose behalf such request is made). Each Written Consent Requesting Stockholder (or the beneficial owner, if any, on whose behalf a Written Consent Request is made) must include with his, her or its Written Consent Request an agreement by such Written Consent Requesting Stockholder (or the beneficial owner, if any, on whose behalf a Written Consent Request is made) to solicit Consents in accordance with paragraph (e) of this Paragraph 8&#59; provided that an agreement by one such Written Consent Requesting Stockholder (or beneficial owner) shall be deemed to constitute such agreement on the part of all such Written Consent Requesting Stockholders. Each Written Consent Request must describe the action proposed to be taken by consent of stockholders in lieu of a meeting and contain all such information and representations, to the extent applicable, with respect to each Written Consent Requesting Stockholder (and each beneficial owner, if any, on whose behalf a Written Consent Request is made) and the proposed action of stockholders by consent in lieu of a meeting as </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">would be required by the Bylaws to present any item of business (other than the election of directors) before a meeting of stockholders, as applicable, including, without limitation, a detailed summary of the proposed action to be taken (including the text of any resolutions to be adopted by written consent of stockholders and, if any resolution proposes to amend the Bylaws, the exact language of any such proposed amendment). The Corporation may require each Written Consent Requesting Stockholder to furnish such other information as may be requested by the Corporation to determine the validity of any Written Consent Request and whether any proposed action set forth in the Written Consent Request may be effected by consent of stockholders in lieu of a meeting under paragraph (d) of this Paragraph 8. In connection with an action or actions proposed to be taken by consent of stockholders in lieu of a meeting in accordance with this Paragraph 8 and applicable law, each Written Consent Requesting Stockholder shall further update and supplement the information previously provided to the Corporation in connection therewith so that it is true and correct (i) as of the Written Consent Record Date and (ii) as of each tenth day thereafter until the earlier of the date each action is duly adopted and the Consent Termination Date (as defined below), with such updated or supplemental information being delivered to the Secretary of the Corporation at its principal executive office in the manner required in this Paragraph 8 within five (5) business days after the date as of which the information is required to be updated or supplemented. Any Written Consent Requesting Stockholder may revoke his, her or its Written Consent Request at any time by written revocation delivered to the Secretary of the Corporation at the Corporation&#8217;s principal executive offices. Any disposition by a Written Consent Requesting Stockholder of any shares of capital stock of the Corporation entitled to consent to the action to which a Written Consent Request relates (or, in the case of a Written Consent Requesting Stockholder that has submitted a Written Consent Request on behalf of the beneficial owner of shares, a disposition by such beneficial owner of beneficial ownership of such shares) after the date of the Written Consent Request shall be deemed a revocation of his, her or its Written Consent Request with respect to such shares. If, at any time after the Written Consent Request Effective Time and before the Written Consent Certification Date (as defined below), the Written Consent Request(s) represent in the aggregate less than the Requisite Percent due to any revocation of a Written Consent Request or any deemed revocation of shares of Common Stock with respect to any such request, no Written Consent Record Date shall be fixed (and any Written Consent Record Date theretofore fixed shall be cancelled), and no action by consent of stockholders in lieu of a meeting as provided in such Written Consent Request(s) shall be taken pursuant thereto. In determining whether Written Consent Request(s) have been delivered by Written Consent Requesting Stockholders representing in the aggregate the Requisite Percent in accordance with this Paragraph 8, multiple Written Consent Requests delivered to the Secretary will be considered together only if each such Written Consent Request (x) identifies substantially the same purpose or purposes of the action proposed to be taken by consent of stockholders and substantially the same matters proposed to be taken by written consent of stockholders, as determined by the Board of Directors (which, if such purpose is the removal of one or more directors, will mean that each Written Consent Request includes an identical list of directors proposed to be removed by the action by consent of stockholders in lieu of a meeting that is the subject of the request), and (y) has been dated and delivered to the Secretary as provided herein on the Written Consent Request Record Date or within thirty (30) days thereafter.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) &#160;&#160;&#160;&#160;Stockholders shall not be entitled to act by consent in lieu of a meeting if (i) the action relates to an item of business that is not a proper subject for stockholder action under applicable law, (ii) the Written Consent Request Effective Time occurs during the period commencing one hundred twenty (120) days prior to the first anniversary of the annual meeting of stockholders for the immediately preceding annual meeting and ending on the thirtieth (30th) calendar day after the first anniversary of the date of the immediately preceding annual meeting, (iii) an identical or substantially similar item (as determined by the Board of Directors, a &#8220;Similar Item&#8221;) was presented at any meeting of stockholders of the Corporation held not more than twelve (12) months before the Written Consent Request Record Date in respect of any Written Consent Request (provided that, for purposes of this clause (iii), an election of directors at any such meeting shall not be deemed to be a Similar Item with respect to any proposal to remove one or more directors), (iv) the action relates to a removal of directors occurring at any time within 90 days after any meeting of stockholders for the election of directors, (v) a Similar Item is included in the Corporation&#8217;s notice as an item of business to be brought before a meeting of stockholders that has been called by the Written Consent Request Record Date in respect of a </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Written Consent Request but has not yet been held or that is called for a date within ninety (90) days after the Written Consent Request Effective Time, (vi) the Board of Directors calls an annual or special meeting of stockholders for purposes of presenting a Similar Item or solicits action by written consent of stockholders of a Similar Item pursuant to paragraph (i) of this Paragraph 8 or (vii) the Written Consent Request(s) otherwise giving rise to a Written Consent Request Effective Time were made in a manner that either did not comply with this Certificate of Incorporation, the Bylaws or involved a violation of Regulation 14A under the Exchange Act or other applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) &#160;&#160;&#160;&#160;Stockholders of the Corporation may take action by consent in lieu of a meeting only if consents are solicited by (i) the Board of Directors or (ii) the Written Consent Requesting Stockholder or group (or the beneficial owner(s), if any, on whose behalf any such Written Consent Requesting Stockholder is acting) seeking to take action by written consent of stockholders in accordance with this Paragraph 8, Regulation 14A of the Exchange Act (without reliance upon any exemption in Regulation 14A, including the exemption contained in clause (iv) of Rule 14a-1(l)(2) or Rule 14a-2(b) thereunder) (or any subsequent provisions replacing such act or regulations) and any other applicable law, from all holders of shares of capital stock of the Corporation entitled to give consent the proposed action. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f) &#160;&#160;&#160;&#160;No Consent shall be effective to take the corporate action referred to therein unless such Consent is dated and delivered to the Corporation in accordance with this Paragraph 8 and applicable law and, within sixty (60) days after the first date on which a Consent is validly delivered in the manner required by paragraph (g) of this Paragraph 8 and applicable law (and in any event not later than one hundred and twenty (120) days after the Written Consent Record Date), Consents signed by a sufficient number of stockholders to take such action are so delivered to the Corporation. A Consent shall not be valid if it purports to provide (or if the person signing such Consent provides, through instructions to an agent or otherwise) that it will be effective at a future time or at a time determined upon the happening of an event.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) &#160;&#160;&#160;&#160;No Consents may be delivered to the Corporation until (i) sixty (60) days after the Written Consent Request Effective Time, or (ii) such later date as may be determined in good faith by the Board of Directors, which determination shall be conclusive and binding, in the event it concludes, consistent with its fiduciary duties, that additional time is required for stockholders to make an informed decision in connection with such Consent. Consents must be delivered to the Secretary at the principal executive offices of the Corporation. In the event of the receipt by the Corporation of one or more Consents, the Secretary of the Corporation, or such other officer of the Corporation as the Board of Directors may designate, shall provide for the safe-keeping of such Consents and any related revocations and shall promptly conduct such ministerial review of the sufficiency of all Consents and any related revocations and of the validity of the action to be taken by consent of stockholders in lieu of a meeting as the Secretary of the Corporation or such other officer deems necessary or appropriate to determine whether the stockholders of a number of shares of capital stock having the requisite voting power to authorize or take the action specified in Consents have given consent. The Board of Directors may appoint an independent person to serve as inspector (&#8220;Inspector&#8221;) to conduct the ministerial review referenced in the immediately preceding sentence, and such Inspector shall provide a report with respect to such review to the Corporation promptly upon the completion thereof. Subject to paragraph (h) of this Paragraph 8, if, after completion of the review required by this paragraph (g), the Secretary of the Corporation or such other officer as the Board of Directors shall have designated shall determine that the action purported to have been taken is duly authorized by the Consents, the Secretary or such other officer shall certify that fact on the records of the Corporation kept for the purpose of recording the proceedings of meetings of stockholders and the Consents shall be filed in such records. No action by consent of stockholders in lieu of a meeting shall be effective until such date as the Secretary or such other officer certifies to the Corporation that the Consents delivered to the Corporation in accordance with this paragraph (g) represent at least the minimum number of votes that would be necessary to take the corporate action at a meeting at which all shares entitled to vote thereon were present and voted, in accordance with the General Corporation Law, the Certificate of Incorporation and the Bylaws (the &#8220;Written Consent Certification Date&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h) &#160;&#160;&#160;&#160;If the Board of Directors shall determine, which determination shall be conclusive and binding, that any Written Consent Request or any proposed action by consent of stockholders in lieu of a meeting was not properly made or effected in accordance with this Certificate of Incorporation, the Bylaws or applicable law, including, without limitation, due to the fact that one or more Written Consent Requests or Consents were not delivered in compliance with the provisions of this Certificate of Incorporation, the Bylaws or applicable law regulating action by consent of stockholders in lieu of a meeting, then the Board of Directors shall not be required to fix a Written Consent Record Date and any such purported action by consent of stockholders in lieu of a meeting shall be null and void to the fullest extent permitted by applicable law. Nothing contained in this Paragraph 8 shall in any way be construed to suggest or imply that the Board of Directors of the Corporation or any stockholder shall not be entitled to contest the validity of any Consent or related revocations, whether before or after such certification by the Secretary of the Corporation, such other officer of the Corporation as the Board of Directors may designate or the Inspectors, as the case may be, or to take any other action (including, without limitation, the commencement or prosecution of any action, suit or proceeding, or the defense of any litigation, with respect thereto, and the seeking of a declaratory judgment, injunctive relief or other remedy at law or in equity).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;Notwithstanding anything to the contrary set forth above, (x) none of the foregoing provisions of this Paragraph 8 or any related provisions of the Bylaws shall apply to any solicitation of stockholder action by written consent by or at the direction of the Board of Directors and (y) the Board of Directors shall be entitled to solicit action by consent of stockholders in lieu of a meeting in accordance with applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Bylaws. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Board of Directors shall have the right to make, alter or repeal the Bylaws of the Corporation, subject to the right of the stockholders of the Corporation to alter or repeal any Bylaw made by the Board of Directors. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The election of directors of the Corporation need not be by written ballot, unless the Bylaws of the Corporation otherwise provide. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Indemnification. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;No director of the Corporation shall have any personal liability to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, provided that this provision shall not eliminate or limit the liability of a director (i) for any breach of the director&#8217;s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the General Corporation Law of the State of Delaware, or (iv) for any transaction from which the director derived an improper personal benefit. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) &#160;&#160;&#160;&#160;Each person who was or is made a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a &#8220;proceeding&#8221;), by reason of the fact that he or she is or was a director or officer of the Corporation or is or was serving at the request of the Corporation as a director or officer of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether the basis of such proceeding is alleged action either in an official capacity as a director or officer or in any other capacity while serving as a director or officer, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the General Corporation Law of the State of Delaware, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than said law permitted the Corporation to provide prior to such amendment), against all expenses, liability and loss (including attorneys&#8217; fees, judgments, fines, excise taxes pursuant to the Employee Retirement Income Security Act of 1974, as amended, or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of his or her heirs, executors and administrators&#59; provided, however, that the Corporation shall indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">was authorized by the Board of Directors of the Corporation. The right to be indemnified conferred in this Paragraph 11 shall be a contract right and shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition&#59; provided, however, that the payment of such expenses incurred by the director or officer in his or her capacity as a director or officer (and not in any other capacity in which service was or is to be rendered by such person while a director or officer, including, without limitation, service to an employee benefit plan), in advance of the final disposition of proceeding, shall be made only upon delivery to the Corporation of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified under this Paragraph or otherwise. The Corporation may also provide indemnification to employees and agents of the Corporation with the same scope and effect as the foregoing indemnification of directors and officers. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) &#160;&#160;&#160;&#160;The indemnification provided by this Paragraph 11 shall not limit or exclude any rights, indemnities or limitations of liability to which any person may be entitled, whether as a matter of law, under the By-Laws of the Corporation, by agreement, vote of the stockholders or disinterested directors of the Corporation or otherwise. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) &#160;&#160;&#160;&#160;If a claim under paragraph (b) of this Paragraph 11 is not paid in full by the Corporation within sixty (60) days after a written claim has been received by the Corporation, the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been tendered to the Corporation) that the claimant has not met the standards of conduct which make it permissible under the General Corporation Law of the State of Delaware for the Corporation to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its Board, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard or conduct set forth in the General Corporation Law of the State of Delaware, nor an actual determination by the Corporation (including its Board, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard of conduct, shall create a presumption that the claimant has not met the applicable standard of conduct. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) &#160;&#160;&#160;&#160;The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the corporation or another corporation, partnership, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the General Corporation Law of the State of Delaware. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amendment or Repeal.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to any other vote required by law or this Certificate of Incorporation (including any Certificate of Designation relating to a series of Preferred Stock), the affirmative vote of the holders of record of outstanding shares of capital stock of the Corporation representing at least a majority of the voting power of all the outstanding shares of capital stock of the Corporation shall be required to amend, alter or repeal, or adopt any provision of this Restated Certificate of Incorporation.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, Quest Diagnostics Incorporated has caused this Restated Certificate of Incorporation to be executed by its duly authorized officer on this 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of August, 2022.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;QUEST DIAGNOSTICS INCORPORATED</font></div><div style="margin-top:12pt;padding-left:216pt"><font><br></font></div><div style="margin-top:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>        William J. O&#8217;Shaughnessy, Jr.<br>        Secretary</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>dgx09302022ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_1"></div><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT 10.1</font></div><div style="margin-bottom:0.08pt;padding-right:36pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">AMENDED AND RESTATED QUEST DIAGNOSTICS INCORPORATED</font></div><div style="margin-top:12pt;padding-left:54pt;padding-right:54pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXECUTIVE OFFICER SEVERANCE PLAN</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The purpose of the Quest Diagnostics Incorporated Executive Officer Severance Plan (together with the attached schedules, appendices and exhibits, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is to secure the continued services of the executive officers of the Company and provide these executives with certain termination benefits in the event of a Qualifying Termination (as defined in Section&#160;2) and to ensure their continued dedication to their duties in the event of any threat or occurrence of a Change in Control of the Company (as defined in Section&#160;2).</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As used in this Plan, the following terms shall have the respective meanings set forth below&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Annual Performance Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the annual cash bonus awarded under the Company&#8217;s applicable incentive plans, as in effect from time to time (as of the date of adoption of this Plan the &#8220;Bonus&#8221; within the meaning of Section&#160;5(a) of the Company&#8217;s Senior Management Incentive Plan, effective as of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">May&#160;13, 2003 and under the Company&#8217;s Management Incentive Plan such plans referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Company Incentive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Participant&#8217;s annual rate of base salary as in effect on the Date of Termination,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Base Salary for the Termination Period shall mean the Participant&#8217;s highest annual rate of base salary during the twelve-month period immediately prior to the Participant&#8217;s Date of Termination.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Directors of the Company and, after a Change in Control, the &#8220;board of directors&#8221; of the surviving corporation. References herein to the Board include any committee or person to whom the Board has designated its authority.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Bonus Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Participant&#8217;s target Annual Performance Bonus for the fiscal year in which the Participant&#8217;s Date of Termination occurs,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if the Participant&#8217;s Qualifying Termination is on account of Good Reason pursuant to a reduction in a Participant&#8217;s compensation or compensation opportunity under Section&#160;2(k)(ii), &#8220;Bonus Amount&#8221; shall be the Participant&#8217;s target Annual Performance Bonus for the prior fiscal year if higher.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i)&#160;the willful and continued failure of the Participant to perform substantially his duties with the Company (other than any such failure resulting from the Participant&#8217;s incapacity due to physical or mental illness or any such failure subsequent to the Participant being delivered a notice of termination without Cause by the Company or delivering a notice of termination for Good Reason to the Company) after a written demand for substantial performance is delivered to the Participant by or on behalf of the Board which specifically identifies the manner in which the Board believes that the Participant has not substantially performed his duties, (ii)&#160;the willful engaging by the Participant in illegal conduct or gross misconduct which is demonstrably and materially injurious to the Company or its affiliates, (iii)&#160;the engaging by the Participant in conduct or misconduct that materially harms the reputation or financial position of the Company, (iv)&#160;the Participant (x)&#160;obstructs or impedes, (y)&#160;endeavors to influence, obstruct or impede or (z)&#160;fails to materially cooperate with, an Investigation, (v)&#160;the commission of a felony by the Participant or (vi)&#160;the Participant is found liable in any Securities and Exchange Commission or other civil or criminal securities law action.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this paragraph&#160;(e), no act or failure to act by the Participant shall be considered &#8220;willful&#8221; unless done or omitted to be done by the Participant in bad faith and without reasonable belief that the Participant&#8217;s action or omission was in the best interests of the Company or its affiliates. Any act, or failure to act, in accordance with authority duly given by the Board, based upon the advice of counsel for the Company (including counsel employed by the Company) shall be conclusively presumed to be done, or omitted to be done, by the Participant in good faith and in the best interests of the Company.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A Participant who is designated on Schedule&#160;A (and, after a Change in Control, a Participant who is designated on Schedule&#160;B) shall not be considered to have been terminated for Cause unless and until the Company has delivered to the Participant a copy of a resolution duly adopted by </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">three-quarters (3&#47;4) of the entire Board (excluding the Participant from both the numerator and denominator if the Participant is a Board member) at a meeting of the Board called and held for such purpose (after reasonable notice to the Participant and an opportunity for the Participant, together with counsel, to be heard before the Board), finding that in the good faith opinion of the Board an event set forth in clauses&#160;(i), (ii), (iii), (iv), (v), or (vi) has occurred and specifying the particulars thereof in detail.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anything herein to the contrary notwithstanding, if, following a termination of the Participant&#8217;s employment by the Company for Cause based upon the conviction of the Participant for a felony, such conviction is overturned in a final determination on appeal, the Participant shall be entitled to the payments and the economic equivalent of the benefits the Participant would have received if his employment had been terminated by the Company without Cause.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any one of the following events&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">any person is or becomes a &#8220;beneficial owner&#8221; (as defined in Rule&#160;13d 3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 40% of the total voting power of the Company&#8217;s then outstanding securities generally eligible to vote for the election of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Company Voting Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that any of the following acquisitions shall not be deemed to be a Change in Control&#58; (1)&#160;by the Company or any subsidiary or affiliate, (2)&#160;by any employee benefit plan (or related trust) sponsored or maintained by the Company or any subsidiary or affiliate, (3)&#160;by any underwriter temporarily holding securities pursuant to an offering of such securities, or (4)&#160;pursuant to a Non-Qualifying Transaction (as defined in paragraph&#160;(ii))&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company or any of its subsidiaries or affiliates that requires the approval of the Company&#8217;s stockholders whether for such transaction or the issuance of securities in the transaction (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Business Combination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), unless immediately following such Business Combination&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">more than 50% of the total voting power of (x)&#160;the corporation resulting from such Business Combination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Surviving Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or (y)&#160;if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of 95% of the voting securities eligible to elect directors of the Surviving Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Parent Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the holders thereof immediately prior to the Business Combination,</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">no person (other than any employee benefit plan (or any related trust) sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial owner, directly or indirectly, of securities of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) representing 40% of the total voting power of the securities then outstanding generally eligible to vote for the election of directors of the Parent Corporation (or the Surviving Corporation), and</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) following the consummation of the Business Combination were Incumbent Directors at the time of the Board&#8217;s approval of the execution of the initial agreement providing for such Business Combination&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above </font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall be deemed to be a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Non-Qualifying Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">individuals who, on the effective date of this Plan, constitute the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Incumbent Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the effective date of this Plan, whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent director&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board shall be deemed to be an Incumbent Director&#59; or</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">the shareholders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Company approve a plan of complete liquidation or dissolution of the Company or the consummation of a sale of all or substantially all of the Company&#8217;s assets to an entity that is not an affiliate of the Company (other than pursuant to a Non-Qualifying Transaction).</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, a Change in Control of the Company shall not be deemed to occur solely because any person acquires beneficial ownership of more than 40% of Company Voting Securities as a result of the acquisition of Company Voting Securities by the Company which reduces the number of Company Voting Securities outstanding&#59; provided, that if after such acquisition by the Company such person becomes the beneficial owner of additional Company Voting Securities that increases the percentage of outstanding Company Voting Securities beneficially owned by such person, a Change in Control of the Company shall then occur.</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Quest Diagnostics Incorporated, a Delaware corporation.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i)&#160;the effective date on which the Participant&#8217;s employment by the Company terminates as specified in a prior written notice by the Company or the Participant, as the case may be, to the other, delivered pursuant to Section&#160;12 or (ii)&#160;if the Participant&#8217;s employment by the Company terminates by reason of death, the date of death of the Participant.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the same meaning ascribed to that term in Section&#160;22(e)(3) of the Internal Revenue Code of 1986, as amended.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Equity Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all equity-based compensation (including stock options, stock appreciation rights, restricted stock and performance shares) awarded under the Company&#8217;s incentive plan(s), as in effect from time to time (as of the date of adoption of this Plan the Amended and Restated Employee Long-Term Incentive Plan).</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence of one or more of the following circumstances, without the Participant&#8217;s express written consent, and which circumstance(s) are not remedied by the Company within thirty (30) days of receipt of a written notice from the Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">describing in reasonable detail the Good Reason event that has occurred (which notice must be provided within ninety (90) days of the Participant&#8217;s obtaining knowledge of the event)&#58;</font></div><div style="margin-bottom:0.08pt;padding-right:36pt"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(i)&#160;&#160;&#160;&#160;(A)&#160;any material change in the duties, responsibilities or status (including reporting</font></div><div style="padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">responsibilities) of the Participant that is inconsistent in any material and adverse respect with the Participant&#8217;s position(s), duties, responsibilities or authority with the Company immediately prior to such Change in Control (including any material and adverse diminution of such duties or responsibilities)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Good Reason shall not be deemed to occur upon a change in duties, responsibilities (other than reporting responsibilities) or status that is solely and directly a result of the Company no longer being a publicly traded entity and does not involve any other event set forth in this Section&#160;2(k) or (B)&#160;a material and adverse change in the Participant&#8217;s titles or offices (including, if applicable, membership on the Board) with the Company as in effect immediately prior to such Change in Control&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;a material reduction by the Company in the Participant&#8217;s aggregate rate of annual base salary, Annual Performance Bonus opportunity and Equity Incentive Compensation target opportunity (including any material and adverse change in the formula for such targets) as in effect immediately prior to such Change in Control&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;the Company&#8217;s requiring the Participant to be based at any office or location more than fifty (50) miles from the office where the Participant is located at the time of the Change in Control and as a result causing the Participant&#8217;s commute from his residence at the time of the Change in Control to the new location to increase by more than fifty (50) miles&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;the failure of the Company to continue in effect any employee benefit plan, compensation plan, welfare benefit plan or fringe benefit plan in which the Participant is participating immediately prior to such Change in Control or the taking of any action by the Company, in each case which would materially adversely affect the Participant, unless the Participant is permitted to participate in other plans providing the Participant with materially equivalent benefits in the aggregate (at materially equivalent or lower cost with respect to welfare benefit plans)&#59; or</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;the failure of the Company to obtain the assumption of the Company&#8217;s obligations hereunder from any successor as contemplated in Section&#160;11(b).</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, an isolated, insubstantial and inadvertent action taken in good faith and which is remedied by the Company within thirty (30) days after receipt of notice thereof given by the Participant shall not constitute Good Reason. The Participant&#8217;s right to terminate employment for Good Reason shall not be affected by the Participant&#8217;s incapacities due to mental or physical illness and the Participant&#8217;s continued employment shall not constitute consent to, or a waiver of rights with respect to, any event or condition constituting Good Reason. The Participant may terminate his employment for a &#8220;Good Reason&#8221; event that is not reasonably remedied by the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Participant shall have delivered a notice of termination within ninety (90) days after delivery of the notice describing the Good Reason event giving rise to such termination.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Investigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an investigation authorized by the Board, a self-regulatory organization empowered with self-regulatory responsibilities under federal or state laws or a governmental department or agency.</font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an executive officer of the Company selected, from time to time, by the Board for participation in this Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">who is designated on Schedule&#160;A or B at the applicable time but only if such executive has completed at least one year of continuous employment with the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company and its Subsidiaries at the applicable time (unless such one year employment requirement has been waived in writing by the Board).</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Potential Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the execution or entering into of any agreement by the Company the consummation of which can be expected to be a Change in Control.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a termination of the Participant&#8217;s employment with the Company that occurs on or after January&#160;1, 2008 (i)&#160;prior to a Change in Control, by the Company other than for Cause and (ii)&#160;after a Change in Control, by the Company other than for Cause or by the Participant for Good Reason. Termination of the Participant&#8217;s employment on account of death, Disability or Retirement shall not be treated as a Qualifying Termination. Notwithstanding the preceding sentence, the death of the Participant after notice of termination for Good Reason or without Cause has been validly provided shall be deemed to be a Qualifying Termination.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Participant&#8217;s voluntary termination of employment on or after he or she attains age&#160;60 with five (5) years of service.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(q)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any corporation or other entity in which the Company has a direct or indirect ownership interest of 50% or more of the total combined voting power of the then outstanding securities or interests of such corporation or other entity entitled to vote generally in the election of directors (or members of any similar governing body) or in which the Company has the right to receive 50% or more of the distribution of profits or 50% of the assets or liquidation or dissolution.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(r)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Termination Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the period of time beginning with a Change in Control and ending two (2) years following such Change in Control. Notwithstanding anything in this Plan to the contrary, if (i)&#160;the Participant&#8217;s employment is terminated prior to a Change in Control for reasons that would have constituted a Qualifying Termination if they had occurred following a Change in Control&#59; (ii)&#160;the Participant reasonably demonstrates that such termination (or Good Reason event) was at the request of a third party who had indicated an intention or taken steps reasonably calculated to effect a Change in Control&#59; and (iii)&#160;a Change in Control involving such third party (or a party competing with such third party to effectuate a Change in Control) does occur within six (6) months from the date of such termination, then for purposes of this Plan, the date immediately prior to the date of such termination of employment or event constituting Good Reason shall be treated as a Change in Control. For purposes of determining the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">timing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of payments and benefits to the Participant under Section&#160;5, the date of the actual Change in Control shall be treated as the Participant&#8217;s Date of Termination under Section&#160;2(h), and for purposes of determining the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of payments and benefits owed to the Participant under Section&#160;5, the date the Participant&#8217;s employment is actually terminated shall be treated as the Participant&#8217;s Date of Termination under Section&#160;2(h).</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (a)&#160;&#160;The Board shall determine in its sole discretion which executives of the Company shall be Participants in this Plan and whether a Participant shall be designated on Schedule&#160;A or B.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board may, in its sole discretion, remove any executive from Schedule&#160;A and add such executive to Schedule&#160;B but may not remove any executive from participation in this Plan entirely&#59; provided, that a Participant who is designated on Schedule&#160;A as of immediately prior to a Change in Control may not be removed from such Schedule without his or her prior written consent within the two year period following a Change in Control.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board may delegate its authority to determine which senior executives of the Company shall be Participants in this Plan, to designate the Participants on Schedule&#160;A or B and to remove a Participant from Schedule&#160;A to the Compensation Committee (or any successor committee) of the Board.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:108pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;text-decoration:underline">Payments Upon Termination of Employment Prior to a Change in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%;text-decoration:underline">Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. If the</font></div><div style="margin-bottom:0.08pt;padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">employment of the Participant is terminated pursuant to a Qualifying Termination, then, subject to the &#160;&#160;&#160;&#160;Participant&#8217;s execution of a Separation Agreement and Release in the form attached to this Plan as Exhibit&#160;A (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Separation Agreement and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8221;) which shall be provided to the Participant no later than two (2) days after the Date of Termination and must be executed by the Participant, become effective and not be revoked by the Participant by the fifty-fifth (55</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">) day following the Date of Termination, the Company shall provide to the Participant&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;A cash payment equal to the Participant&#8217;s Base Salary multiplied by either (i)&#160;2.00 for a Participant designated on Schedule&#160;A or (ii)&#160;1.00 for a Participant designated on Schedule&#160;B&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;A cash payment equal to the Bonus Amount times (i)&#160;2.00 for a Participant designated on Schedule&#160;A or (ii)&#160;1.00 for a Participant designated on Schedule&#160;B&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;For eighteen (18) months for a Participant designated on Schedule&#160;A or (ii)&#160;twelve (12) months for a Participant designated on Schedule&#160;B, following the Date of Termination, group medical and life insurance coverage to the Participant (and his eligible dependents), under the terms prevailing at the time immediately preceding the Date of Termination&#59; the Company shall continue to provide such coverage on the same terms as provided by the Company to similarly situated executives&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Company shall cease to provide such coverage if the Participant obtains alternate employment and is eligible for substantially comparable group medical or life insurance coverage with such employer&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Participant shall notify the Company within 10&#160;days of securing such alternate employment&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that in the event of the disability of the Participant, group medical coverage shall continue for a longer period consistent with the Consolidated Omnibus Budget Reconciliation Act of 1986 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the extent that any plan does not permit continuation of the Participant&#8217;s or his eligible dependents&#8217; participation throughout such period, the Company shall pay the Participant an amount, on an after-tax basis, equal to the Company&#8217;s cost of providing such benefits&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;For one (1) year following the Date of Termination, the Participant will be entitled to receive executive outplacement assistance from Lee Hecht Harrison or an equivalent career placement firm at the Company&#8217;s expense and in accordance with the Company&#8217;s policies for similarly situated executives&#59; and</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;A cash payment equal to any matching contributions made by the Company on behalf of the Participant to the Company&#8217;s 401(k) plan and the Company&#8217;s Supplemental Deferred Compensation Plan during the year preceding the Date of Termination.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The cash payments specified in paragraphs (a), (b), (c) and (e) of this Section&#160;4 shall be paid no later than the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day (or the next following business day if the sixtieth day is not a business day) following the Date of Termination, but may be made earlier provided that the Separation Agreement has been executed by the Participant and the revocation period thereunder has lapsed. Each such cash payment shall be deemed to be a separate payment for purposes of Section&#160;409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Payments Upon Termination of Employment After a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If during the Termination Period the employment of the Participant is terminated pursuant to a Qualifying Termination, then, subject to the Participant&#8217;s execution of a Separation Agreement and Release which shall be provided to the Participant no later than two (2) days after the Date of Termination and must be </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">5</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">executed by the Participant, become effective and not be revoked by the Participant by the fifty-fifth (55</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day following the Date of Termination, the Company shall provide to the Participant&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;A cash payment equal to the result of multiplying the sum of the Participant&#8217;s Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Participant&#8217;s Bonus Amount by (i)&#160;either 3.00 for a Participant designated on Schedule&#160;A or (ii)&#160;2.00 for a Participant designated on Schedule&#160;B&#59; and</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;A cash payment equal to the Participant&#8217;s target Annual Performance Bonus for the fiscal year in which the Participant&#8217;s Date of Termination occurs, multiplied by a fraction the numerator of which shall be the number of days the Participant was employed by the Company during the fiscal year in which the Date of Termination occurred and the denominator of which is 365&#59;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The benefits and payments specified in paragraphs (c), (d) and (e) of Section&#160;4.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;The provisions of Appendix A shall apply if a Participant listed on Schedule A or Schedule B is subject to the Excise Tax, as defined in Appendix A.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The cash payments specified in paragraphs (a), (b) and (c) of this Section&#160;5 shall be paid no later than the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day (or the next following business day if the sixtieth day is not a business day) following the Date of Termination, but may be made earlier provided that the Separation Agreement has been executed by the Participant and the revocation period thereunder has lapsed. Each such cash payment shall be deemed to be a separate payment for purposes of Section&#160;409A of the Code.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Key Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. It is the intent of the Company that no payments or benefits provided under this Plan shall be considered &#8220;non-qualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code and the Plan shall be interpreted accordingly. If and to the extent that any payment or benefit is determined by the Company (a)&#160;to constitute &#8220;non-qualified deferred compensation&#8221; subject to Section&#160;409A of the Code, (b)&#160;such payment or benefit is provided to a Participant who is a &#8220;specified employee&#8221; (within the meaning of Section&#160;409A of the Code and as determined pursuant to procedures established by the Company) and (c)&#160;such payment or benefit must be delayed for six months from the Participant&#8217;s Date of Termination (or an earlier date) in order to comply with Section&#160;409A(a)(2)(B)(i) of the Code and not cause the Participant to incur any additional tax under Section&#160;409A of the Code, then the Company will delay making any such payment or providing such benefit until the expiration of such six month period. The Company shall set aside those payments that would have been made but for payment delay required by the preceding sentence in a trust that is in compliance with Rev. Proc. 92&#8209;64 which may, but need not be, the trust established under the Company&#8217;s Supplemental Deferred Compensation Plan&#59; provided, however, that no payment will be made to the Rabbi Trust if it would be contrary to law or cause the Participant to incur additional tax under Section 409A.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Participant&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant agrees that&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Without the consent of the Company, the Participant will not terminate employment with the Company without giving 30&#160;days prior notice to the Company, and during such 30&#8209;day period the Participant will assist the Company, as and to the extent reasonably requested by the Company, to effect an orderly transition of the Participant&#8217;s duties and responsibilities with the Company.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;In the event that the Participant has received any benefits from the Company under Section&#160;4 of this Agreement, then, during the period of 36&#160;months following the Date of Termination, the Participant, upon request by the Company&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Will consult with one or more of the executive officers concerning the business and affairs of the Company for not to exceed four hours in any month at times and places selected by the Participant as being convenient to him or her, all without compensation other than what is provided for in Section&#160;4 of this Agreement&#59; and</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;Will testify as a witness on behalf of the Company in any legal proceedings involving the Company which arise out of events or circumstances that occurred or existed prior to the Date of Termination (except for any such proceedings relating to this Plan), without compensation other than what is provided for in Section&#160;4 of this Agreement&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that all out-of-pocket expenses incurred by the Participant in connection with serving as a witness shall be paid by the Company.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant shall not be required to perform the Participant&#8217;s obligations under this Section&#160;7 if and so long as the Company is in default with respect to performance of any of its obligations under this Agreement.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may withhold from all payments due to the Participant (or his beneficiary or estate)&#160;hereunder all taxes which, by applicable federal, state, local or other law, the Company is required to withhold therefrom.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Reimbursement of Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Following a Change in Control, if any contest or dispute shall arise under this Plan involving termination of a Participant&#8217;s employment with the Company or involving the failure or refusal of the Company to perform fully in accordance with the terms hereof, the Company shall reimburse the Participant on a current basis for all reasonable legal fees and related expenses, if any, incurred by the Participant in connection with such contest or dispute (regardless of the result thereof), together with interest in an amount equal to the prime rate as reported in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, but in no event higher than the maximum legal rate permissible under applicable law, such interest to accrue thirty (30) days from the date the Company receives the Participant&#8217;s statement for such fees and expenses through the date of payment thereof, regardless of whether or not the Participant&#8217;s claim is upheld by a court of competent jurisdiction or an arbitration panel&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Participant shall be required to repay immediately any such amounts to the Company to the extent that a court or an arbitration panel issues a final and non-appealable order setting forth the determination that the position taken by the Participant was frivolous or advanced by the Participant in bad faith.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">No Guarantee of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Plan shall be deemed to entitle the Participant to continued employment with the Company or its Subsidiaries.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Successors&#59; Binding Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (a)&#160;&#160;This Plan shall not be terminated by any Business Combination. In the event of any Business Combination, the provisions of this Plan shall be binding upon the Surviving Corporation, and such Surviving Corporation shall be treated as the Company hereunder.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;The Company agrees that in connection with any Business Combination, it will cause any successor entity to the Company unconditionally to assume all of the obligations of the Company hereunder. Failure of the Company to obtain such assumption prior to the effectiveness of any such Business Combination that constitutes a Change in Control, shall be a breach of this Plan and shall constitute Good Reason hereunder and shall entitle the Participant to compensation and other benefits from the Company in the same amount and on the same terms as the Participant would be entitled hereunder if the Participant&#8217;s employment were terminated following a Change in Control by reason of a Qualifying Termination. For purposes of implementing the foregoing, the date on which any such Business Combination becomes effective shall be deemed the date Good Reason occurs, and shall be the Date of Termination if requested by a Participant.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The benefits provided under this Plan shall inure to the benefit of and be enforceable by the Participant&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Participant shall die while any amounts would be payable to the Participant hereunder had the Participant continued to live, all such amounts, unless otherwise provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">herein, shall be paid in accordance with the terms of this Plan to such person or persons appointed in writing by the Participant to receive such amounts or, if no person is so appointed, to the Participant&#8217;s estate.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (a)&#160;&#160;For purposes of this Plan, all notices and other communications required or permitted hereunder shall be in writing and shall be deemed to have been duly given when delivered or five (5) days after deposit in the United States mail, certified and return receipt requested, postage prepaid, addressed as follows&#58;</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Participant&#58; the address listed as the Participant&#8217;s address in the Company&#8217;s personnel files.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Company&#58;</font></div><div style="margin-bottom:0.08pt;padding-right:36pt"><font><br></font></div><div style="padding-left:108pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Quest Diagnostics Incorporated</font></div><div style="padding-left:108pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1290 Wall Street West</font></div><div style="padding-left:108pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lyndhurst, NJ 07071</font></div><div style="padding-left:108pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58; General Counsel</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">7</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;A written notice of the Participant&#8217;s Date of Termination by the Company or the Participant, as the case may be, to the other, shall (i)&#160;indicate the specific termination provision in this Plan relied upon, (ii)&#160;to the extent applicable, set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Participant&#8217;s employment under the provision so indicated and (iii)&#160;specify the date of termination, which date shall be not less than fifteen (15) nor more than sixty (60) days after the giving of such notice&#59; provided, however, that the Company may in its sole discretion accelerate such date to an earlier date or, alternatively, place the Participant on paid leave during such period. The failure by the Participant or the Company to set forth in such notice any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Participant or the Company hereunder or preclude the Participant or the Company from asserting such fact or circumstance in enforcing the Participant&#8217;s or the Company&#8217;s rights hereunder.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Full Settlement&#59; Resolution of Disputes and Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (a)&#160;&#160;The Company&#8217;s obligation to make any payments provided for in this Plan and otherwise to perform its obligations hereunder shall be in lieu and in full settlement of all other severance payments to the Participant under any other severance or employment agreement between the Participant and the Company, and any severance plan of the Company. In no event shall the Participant be obligated to seek other employment or take other action by way of mitigation of the amounts payable to the Participant under any of the provisions of this Plan and, except as provided in the Separation Agreement and Release, such amounts shall not be reduced whether or not the Participant obtains other employment.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Any dispute or controversy arising under or in connection with this Plan shall be settled exclusively by arbitration in New Jersey by three arbitrators in accordance with the commercial arbitration rules of the American Arbitration Association (&#8220;AAA&#8221;) then in effect. One arbitrator shall be selected by the Company, the other by the Participant and the third jointly by these arbitrators (or if they are unable to agree within thirty (30) days of the commencement of arbitration the third arbitrator will be appointed by the AAA). Judgment may be entered on the arbitrators&#8217; award in any court having jurisdiction. In the event of any such dispute or controversy arising during a Termination Period, the Company shall bear all costs and expenses arising in connection with any arbitration proceeding on the same terms as set forth in Section&#160;9 of this Plan.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Employment with Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Employment with the Company for purposes of this Plan shall include employment with any Subsidiary.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The respective obligations and benefits afforded to the Company and the Participant as provided in Sections 4 (to the extent that payments or benefits are owed as a result of a termination of employment that occurs during the term of this Plan) 5, 6, 8(c) and 10 shall survive the termination of this Plan.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">GOVERNING LAW&#59; VALIDITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. THE INTERPRETATION, CONSTRUCTION AND PERFORMANCE OF THIS PLAN SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW JERSEY, WITHOUT REGARD TO THE PRINCIPLE OF CONFLICTS OF LAWS, AND APPLICABLE FEDERAL LAWS. THE INVALIDITY OR UNENFORCEABILITY OF ANY PROVISION OF THIS PLAN SHALL NOT AFFECT THE VALIDITY OR ENFORCEABILITY OF ANY OTHER PROVISION OF THIS PLAN, WHICH OTHER PROVISIONS SHALL REMAIN IN FULL FORCE AND EFFECT.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Board may amend or terminate the Plan at any time&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (i)&#160;Sections 3(b), 4(a) and 4(b) may not be amended in a manner which is materially adverse to any Participant then listed on Schedule&#160;A or B without such Participant's written consent, (ii)&#160;during the period commencing on a Change in Control and ending on the second anniversary of the Change in Control, the Plan (including, for the avoidance of doubt, any Schedules, Appendices and Exhibits) may not be amended or terminated by the Board in any manner which is materially adverse to any Participant then listed on Schedule&#160;A or B without such Participant's written consent and (iii)&#160;any termination or amendments to the Plan (including, for the avoidance of doubt, any Schedules, Appendices and Exhibits) that are materially adverse to the interests of any Participant then listed on Schedule&#160;A or B, and that occur during the period of time beginning on a date three (3) months prior to a Potential Change </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">8</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in Control and ending on the termination of the agreement that constituted the Potential Change in Control, shall be void unless consented to in writing by the affected Participant.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Interpretation and Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan shall be administered by the Board. The Board may delegate any of its powers under the Plan to the Compensation Committee of the Board (or any successor committee). With respect to those Participants who are not subject to Section&#160;16 of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Committee may delegate any of its powers under the Plan to the Chief Executive Officer of the Company. The Board, the Compensation Committee (or any successor committee) and the Chief Executive Officer (to the extent of the powers delegated to him) shall have the authority in its sole and absolute discretion to&#58; (i)&#160;exercise all of the powers granted to it under this Plan&#59; (ii)&#160;construe, interpret and implement this Plan&#59; (iii)&#160;prescribe, amend and rescind rules and regulations relating to this Plan, including rules and regulations governing its own operations&#59; (iv)&#160;make all determinations necessary or advisable in administering this Plan&#59; (v)&#160;correct any defect, supply any omission and reconcile any inconsistency in this Plan&#59; and (vi)&#160;amend this Plan to reflect changes in or interpretations of applicable law, rules or regulations. The determination of the Board on all matters relating to the Plan and any amounts payable thereunder shall be final, binding and conclusive on all parties&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that following a Change in Control, notwithstanding anything in this Plan to the contrary, any court, tribunal or arbitration panel that adjudicates any dispute, controversy or claim arising between a Participant and the Company, or any of their delegates or successors, in respect of a Participant&#8217;s Qualifying Termination, will apply a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">de</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">novo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">standard of review to any determinations made by such person and such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">de</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">novo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">standard shall apply notwithstanding the grant of full discretion hereunder to any such person or characterization of any such decision by such person as final, binding or conclusive on any party.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Claims and Appeals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Participants may submit claims for benefits by giving notice to the Company pursuant to Section&#160;12 of this Plan. If a Participant believes that he or she has not received coverage or benefits to which he or she is entitled under the Plan, the Participant may notify the Board in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">writing of a claim for coverage or benefits. If the claim for coverage or benefits is denied in whole or in part, the Board shall notify the applicant in writing of such denial within thirty (30) days (which may be extended to sixty (60) days under special circumstances), with such notice setting forth&#58; (i)&#160;the specific reasons for the denial&#59; (ii)&#160;the Plan provisions upon which the denial is based&#59; (iii)&#160;any additional material or information necessary for the applicant to perfect his or her claim&#59; and (iv)&#160;the procedures for requesting a review of the denial. Upon a denial of a claim by the Board, the Participant may&#58; (i)&#160;request a review of the denial by the Board or, where review authority has been so delegated, by such other person or entity as may be designated by the Board for this purpose&#59; (ii)&#160;review any Policy documents relevant to his or her claim&#59; and (iii)&#160;submit issues and comments to the Board or its delegate that are relevant to the review. Any request for review must be made in writing and received by the Board or its delegate within sixty (60) days of the date the applicant received notice of the initial denial, unless special circumstances require an extension of time for processing. The Board or its delegate will make a written ruling on the applicant&#8217;s request for review setting forth the reasons for the decision and the Plan provisions upon which the denial, if appropriate, is based. This written ruling shall be made within thirty (30) days of the date the Board or its delegate receives the applicant&#8217;s request for review unless special circumstances require an extension of time for processing, in which case a decision will be rendered as soon as possible, but not later than sixty (60) days after receipt of the request for review. All extensions of time permitted by this Section&#160;16 will be permitted at the sole discretion of the Board or its delegate. If the Board does not provide the Participant with written notice of the denial of his or her appeal, the Participant&#8217;s claim shall be deemed denied.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Type of Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Plan is intended to be, and shall be interpreted as an unfunded employee welfare plan under Section&#160;3(1) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and Section&#160;2520.104&#8209;24 of the Department of Labor Regulations, maintained primarily for the purpose of providing employee welfare benefits, to the extent that it provides welfare benefits, and under Sections 201, 301 and 401 of ERISA, as a plan that is unfunded and maintained primarily for the purpose of providing deferred compensation, to the extent that it provides such compensation, in each case for a select group of management or highly compensated employees.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">No Duplication of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except as otherwise expressly provided pursuant to this Plan, this Plan shall be construed and administered in a manner which avoids duplication of compensation and benefits which may be provided under any other plan, program, policy, or other arrangement. In the event a Participant is covered by any other plan, program, policy, individually negotiated agreement or other arrangement, in effect as of his or her Date of Termination, that may duplicate the payments provided in Sections 4 or 5, as applicable, the Company is specifically empowered to reduce or eliminate the duplicative benefits provided for under the Plan. In taking such action, the </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:72pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company will be guided by the principles that (1)&#160;such a Participant will otherwise be treated, for the purpose of the Sections specified above, no more or no less favorably than are other Participants who are not covered by such other plan, program, policy, individually negotiated agreement or other arrangement and (2)&#160;the provisions of such other plan, program, policy, individually negotiated agreement or other arrangement (including, but not limited to, a special individual pension, a special deferral account and&#47;or a special equity based grant) which are not duplicative of the payments provided in Sections 4 or 5, as applicable, will not be considered in determining elimination and&#47;or reductions in Plan benefits.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Nonassignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Benefits under the Plan may not be assigned by the Participant. The terms and conditions of the Plan shall be binding on the successors and assigns of the Company.</font></div><div style="padding-left:72pt;padding-right:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan, as amended and restated, shall be effective as of May&#160;10, 2012.</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">10</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_4"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule A</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stephen H. Rusckowski&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chairman, Chief Executive Officer and President</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Michael E. Prevoznik&#160;&#160;&#160;&#160;Senior Vice President and General Counsel</font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sch. A-1</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_7"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule B</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">James E. Davis&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CEO-Elect</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sam A. Samad&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Executive President and Chief Financial Officer</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:72pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Catherine T. Doherty&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Senior Vice President, Regional Businesses</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Sch. B-1</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_10"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Appendix A</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Cutback to 280G Safe Harbor Cap in Certain Circumstances -</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Schedule A and Schedule B Participants</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) Anything in this Plan to the contrary notwithstanding, in the event it shall be determined that (i) any payment, award, benefit or distribution (or any acceleration of any payment, award, benefit or distribution) by the Company (or any of its affiliated entities) or any entity which effectuates a Change in Control (or any of its affiliated entities) to or for the benefit of the Participant (whether pursuant to the terms of this Plan or otherwise) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) would be subject to the excise tax imposed by Section&#160;4999 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (such excise tax, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and (ii) the reduction of the amounts payable to the Participant under this Plan to the maximum amount that could be paid to the Participant without giving rise to the Excise Tax (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Safe Harbor Cap</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) would provide the Participant with a greater after-tax amount than if such amounts were not reduced, then the amounts payable to the Participant under this Plan shall be reduced (but not below zero) to the Safe Harbor Cap. The reduction of the Payments, if applicable, shall be made by reducing the payments and benefits under the following sections of this Plan in the following order&#58; (i) Section 5(a), (ii) Section 5(b) and (iii) Section 5(c) (in the order set forth in such Section 5(c)). For purposes of reducing the Payments to the Safe Harbor Cap, only amounts payable under this Plan (and no other Payments) shall be reduced. If the reduction of the amounts payable hereunder would not result in a greater after tax result to the Participant, no amounts payable under this Plan shall be reduced pursuant to this provision.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) All determinations required to be made under this Appendix&#160;A shall be made by a public accounting firm that is retained by the Company as of the date immediately prior to the Change in Control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Accounting Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) which shall provide detailed supporting calculations both to the Company and the Participant within fifteen (15) business days of the receipt of notice from the Company or the Participant that there has been a Payment, or such earlier time as is requested by the Company (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Determination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). For the avoidance of doubt, the Accounting Firm may use the Option Redetermination Amount (as defined in paragraph (c), below) in determining the reduction of the Payments to the Safe Harbor Cap. Notwithstanding the foregoing, in the event (i)&#160;the Board shall determine prior to the Change in Control that the Accounting Firm is precluded from performing such services under applicable auditor independence rules or (ii)&#160;the Audit Committee of the Board determines that it does not want the Accounting Firm to perform such services because of auditor independence concerns or (iii)&#160;the Accounting Firm is serving as accountant or auditor for the person(s) effecting the Change in Control, the Board shall appoint another nationally recognized public accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by the Company, and the Company shall enter into any agreement reasonably requested by the Accounting Firm in connection with the performance of the services hereunder. If the Accounting Firm determines that no Excise Tax is payable by a Participant, it shall furnish the Participant with a written opinion to such effect, and to the effect that failure to report the Excise Tax, if any, on the Participant&#8217;s applicable federal income tax return will not result in the imposition of a negligence or similar penalty. In the event the Accounting Firm determines that the Payments shall be reduced to the Safe Harbor Cap, it shall furnish the Participant with a written opinion to such effect. The Determination by the Accounting Firm shall be binding upon the Company and the Participant.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) As a result of the uncertainty in the application of Section&#160;4999 of the Code at the time of the Determination, it is possible that Payments will have been made to, or provided for the benefit of, a Participant by the Company, which are in excess of the limitations provided in Paragraph (a) (hereinafter referred to as an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Overpayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), such Overpayment shall be deemed for all purposes to be a loan to the Participant made on the date the Participant received the Overpayment and the Participant shall repay the Overpayment to the Company on demand, together with interest on the Overpayment at the applicable federal rate (as defined in Section 1274(d) of the Code) from the date of the Participant&#8217;s receipt of such Overpayment until the date of such repayment. As a result of the uncertainty in the application of Section 4999 of the Code at the time of the Determination, it is possible that Payments which will not have been made by the Company should have been made to a Participant (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Underpayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), consistent with the calculations required to be made under this Appendix A. In the event that it is determined (i) by the Accounting Firm, the Company (which shall include the position taken by the Company, or together with its consolidated group, on its federal income tax return) or the IRS or (ii) pursuant to a determination by a court, that an Underpayment has occurred, the Company shall pay an amount equal to such Underpayment to the Participant within ten (10) days of such determination together with interest on such amount at the applicable federal rate from the date such amount would have been paid to the Participant until the date of payment. The Participant shall cooperate, to the extent his or her expenses are reimbursed by the Company, with any reasonable requests by the Company in connection with any contests or disputes with the IRS in connection with the Excise Tax. Notwithstanding the foregoing, in the event that amounts payable under this Plan were</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">App. A-1</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_13"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduced pursuant to Paragraph (a) and the value of stock options is subsequently redetermined by the Accounting Firm within the context of Treasury Regulation &#167;1.280G-1 Q&#47;A 33 that reduces the value of the Payments attributable to such options (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Option Redetermination Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Company shall pay to the Participant (on the first business day of the calendar year following the year the Option Redetermination is made) any cash payments payable under this Plan that were not previously paid solely as a result of Paragraph&#160;(a) up to the Safe Harbor Cap, plus interest from the date such amount would have been paid to the participant until the date of payment at the 3&#160;month Treasury Bill rate.</font></div><div style="padding-right:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">App. A-2</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_16"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit A</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FORM OF SEPARATION AGREEMENT AND RELEASE</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(HEREIN &#8220;AGREEMENT&#8221;)</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Quest Diagnostics Incorporated (the &#8220;Company&#8221;) and _______________ (&#8220;Executive&#8221;) agree as follows&#58;</font></div><div style="margin-top:12pt;padding-left:144pt;padding-right:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">Executive&#8217;s employment with the Company will terminate effective</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;Date&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;Executive agrees to make himself reasonably available to the Company to respond to requests by the Company for information concerning litigation, regulatory inquiry or investigation, involving facts or events relating to the Company that may be within his knowledge. Executive will cooperate fully with the Company in connection with any and all future litigation or regulatory proceedings brought by or against the Company to the extent the Company reasonably deems Executive&#8217;s cooperation necessary. Executive will be entitled to reimbursement of reasonable out-of-pocket expenses (not including counsel fees) incurred in connection with fulfilling his obligations under this Section&#160;2.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;In consideration of Executive&#8217;s undertakings herein, the Company will pay an amount equal to $____________ in accordance with Section&#160;4 of the Company&#8217;s Executive Severance Plan (the &#8220;Severance Plan&#8221;), less required deductions (including, but not limited to, federal, state and local tax withholdings) as separation&#47;severance pay (the &#8220;Severance Payment&#8221;). The Severance Payment will be paid in accordance with the Severance Plan. Payment of the Severance Payment is contingent upon the execution of this Agreement by Executive and Executive&#8217;s compliance with all terms and conditions of this Agreement and the Severance Plan. Executive agrees that if this Agreement does not become effective, the Company shall not be required to make any further payments to Executive pursuant to this Agreement or the Severance Plan and shall be entitled to recover all payments already made by it (including interest thereon).</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;Executive understands and agrees that any amounts that Executive owes the Company, including any salary or other overpayments related to Executive&#8217;s employment with the Company, will be offset and deducted from Executive&#8217;s final paycheck from the Company. Executive specifically authorizes the Company to offset and deduct any such amounts from his final paycheck. Executive agrees and acknowledges that, to the extent the amount of Executive&#8217;s final paycheck is not sufficient to repay the full amount that Executive owes to the Company, if any, the full remaining amount owed to the Company, if any, will be offset and deducted from the amount of the Severance Payment. Executive specifically authorizes the Company to offset and deduct any such amounts from his Severance Payment.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;Executive agrees that, after payment of Executive&#8217;s final paycheck on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;Date&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and the Severance Payment, Executive will have received all compensation and benefits that are due and owing to Executive by the Company, including but not limited to salary, vacation pay, bonus, commissions and incentive&#47;override compensation but excluding any benefits or services provided pursuant to Sections 4(e) and 4(f) of the Severance Plan.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;Executive represents that he has returned to the Company all property or information, including, without limitation, all reports, files, memos, plans, lists, or other records (whether electronically stored or not) belonging to the Company or its affiliates, including copies, extracts or other documents derived from such property or information. Executive will immediately forfeit all rights and benefits under this Agreement and the Severance Plan, including, without limitation, the right to receive any Severance Payment if Executive, directly or indirectly, at any time (i)&#160;discloses to any third party or entity any trade secrets or other proprietary or confidential information pertaining to the Company or any of its affiliates or uses such secrets or information without the prior written consent of the General Counsel of the Company or (ii)&#160;takes any actions or makes or publishes any statements, written or oral, or instigates, assists or participates in the making or publication of any such statements which libel, slander or disparage the Company or any of its past or present directors, officers or employees.</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EX. A-1</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_19"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing in this Agreement shall prevent or prohibit Executive or the Company from responding to an order, subpoena, other legal process or regulatory inquiry directed to them or from providing information to or making a filing with a governmental or regulatory body. Executive agrees that upon learning of any order, subpoena or other legal process seeking information that would otherwise be prohibited from disclosure under this Agreement, he will promptly notify the Company, in writing, directed to the Company&#8217;s General Counsel. In the event disclosure is so required, Executive agrees not to oppose any action by the Company to seek or obtain a protective order or other appropriate remedy.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;Executive agrees that Executive&#8217;s Employment and Confidentiality Agreement (the &#8220;Employment and Confidentiality Agreement&#8221;) shall continue to be in full force and effect, including but not limited to all non-competition and non-solicitation provisions contained therein.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;Executive hereby represents that he has not filed any action, complaint, charge, grievance or arbitration against the Company or any of its affiliates in connection with any matters relating, directly or indirectly, to his employment, and covenants and agrees not to file any such action, complaint or arbitration or commence any other judicial or arbitral proceedings against the Company or any of its affiliates with respect to events occurring prior to the termination of his employment with the Company or any affiliates thereof.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;Effective on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;Date&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Company will cease all health benefit coverage and other benefit coverage for Executive.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">GENERAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- Effective as of the Effective Date, and in return for the consideration set forth above, Executive agrees not to sue or file any action, claim, or lawsuit against the Company, agrees not to pursue, seek to recover or recover any alleged damages, seek to obtain or obtain any other form of relief or remedy with respect to, and cause the dismissal or withdrawal of, any lawsuit, action, claim, or charge against the Company, and Executive agrees to waive all claims and release and forever discharge the Company, its officers, directors, subsidiaries, affiliates, parents, attorneys, shareholders and employees from any claims, demands, actions, causes of action or liabilities for compensatory damages or any other relief or remedy, and obligations of any kind or nature whatsoever, based on any matter, cause or thing, relating in any way, directly or indirectly, to his employment, from the beginning of time through the Effective Date of this Agreement, whether known or unknown, fixed or contingent, liquidated or unliquidated, and whether arising from tort, statute, or contract, including, but not limited to, any claims arising under or pursuant to the California Fair Employment and Housing Act, Title&#160;VII of the Civil Rights Act of 1964, the Civil Rights Act of 1871, the Civil Rights Act of 1991, the Americans with Disabilities Act, the Rehabilitation Act, the Family and Medical Leave Act of 1993, the Occupational Safety &#38; Health Act, the Employee Retirement Income Security Act of 1974, the Older Workers Benefit Protection Act of 1990, the Worker Adjustment and Retraining Notification Act, the Fair Labor Standards Act, the Age Discrimination in Employment Act of 1967 (&#8220;ADEA&#8221;), New York State Labor Law, New York State Human Rights Law, New York Human Rights Law, and any other state, federal, city, county or local statute, rule, regulation, ordinance or order, or the national or local law of any foreign country, any claim for future consideration for employment with the Company, any claims for attorneys&#8217; fees and costs and any employment rights or entitlement law, and any claims for wrongful discharge, intentional infliction of emotional distress, defamation, libel or slander, payment of wages, outrageous behavior, breach of contract or any duty allegedly owed to Executive, discrimination based upon race, color, ethnicity, sex, age, national origin, religion, disability, sexual orientation, or another unlawful criterion or circumstance, and any other theory of recovery. It is the intention of the parties to make this release as broad and as general as the law permits.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive acknowledges that he is aware of, has read, has had explained to him by his attorneys, understands and expressly waives any and all rights he has or may have under Section&#160;1542 of the California Civil Code, which provides as follows&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;padding-right:58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him must have materially</font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">affected his or her settlement with the debtor.&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">   Include bracketed language for California employees.</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EX. A-2</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_22"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-top:12pt;padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;Executive acknowledges that he may later discover facts different from or in addition to those which he knows or believes to be true now, and he agrees that, in such event, this Agreement shall nevertheless remain effective in all respects, notwithstanding such different or additional facts or the discovery of those facts.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.&#160;&#160;&#160;&#160;This Agreement may not be introduced in any legal or administrative proceeding, or other similar forum, except one concerning a breach of this Agreement or the Severance Plan.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;Executive acknowledges that Executive has made an independent investigation of the facts, and does not rely on any statement or representation of the Company in entering into this Agreement, other than those set forth herein.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.&#160;&#160;&#160;&#160;Executive agrees that, without limiting the Company&#8217;s remedies, should he commence, continue, join in, or in any other manner attempt to assert any claim released in connection herewith, or otherwise violate in a material fashion any of the terms of this Agreement, the Company shall not be required to make any further payments to the Executive pursuant to this Agreement or the Severance Plan and shall be entitled to recover all payments already made by it (including interest thereon), in addition to all damages, attorneys&#8217; fees and costs the Company incurs in connection with Executive&#8217;s breach of this Agreement. Executive further agrees that the Company shall be entitled to the repayments and recovery of damages described above without waiver of or prejudice to the release granted by him in connection with this Agreement, and that his violation or breach of any provision of this Agreement shall forever release and discharge the Company from the performance of its obligations arising from the Agreement.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;Executive has been advised and acknowledges that he has been given forty-five (45) days to sign this Agreement, he has seven (7) days following his signing of this Agreement to revoke and cancel the terms and conditions contained herein, and the terms and conditions of this Agreement shall not become effective or enforceable until the revocation period has expired (the &#8220;Effective Date&#8221;).</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.&#160;&#160;&#160;&#160;Executive acknowledges that Executive has been advised hereby to consult with, and has consulted with, an attorney of his choice prior to signing this Agreement.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.&#160;&#160;&#160;&#160;Executive acknowledges that Executive has fully read this Agreement, understands the contents of this Agreement, and agrees to its terms and conditions of his own free will, knowingly and voluntarily, and without any duress or coercion.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.&#160;&#160;&#160;&#160;Executive understands that this Agreement includes a final general release, and that Executive can make no further claims against the Company or the persons listed in Section&#160;10 of this Agreement relating in any way, directly or indirectly, to his employment. Executive also understands that this Agreement precludes Executive from recovering any damages or other relief as a result of any lawsuit, grievance, charge or claim brought on Executive&#8217;s behalf against the Company or the persons listed in Section&#160;10 of this Agreement.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.&#160;&#160;&#160;&#160;Executive acknowledges that Executive is receiving adequate consideration (that is in addition to what Executive is otherwise entitled to) for signing this Agreement.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.&#160;&#160;&#160;&#160;This Agreement and the Severance Plan constitute the complete understanding between Executive and the Company regarding the subject matter hereof and thereof. No other promises or agreements regarding the subject matter hereof and thereof will be binding unless signed by Executive and the Company.</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EX. A-3</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i8f15fdf2e5f14c8f87f0d691604fb45c_25"></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.&#160;&#160;&#160;&#160;Executive and the Company agree that all notices or other communications required or permitted to be given under the terms of this Agreement shall be given in accordance with Section&#160;9 of the Severance Plan.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.&#160;&#160;&#160;&#160;Executive and the Company agree that any disputes relating to any matters covered under the terms of this Agreement shall be resolved in accordance with Section&#160;10 of the Severance Plan.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.&#160;&#160;&#160;&#160;By entering into this Agreement, the Company does not admit and specifically denies any liability, wrongdoing or violation of any law, statute, regulation or policy, and it is expressly understood and agreed that this Agreement is being entered into solely for the purpose of amicably resolving all matters of any kind whatsoever between Executive and the Company.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24.&#160;&#160;&#160;&#160;In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, the remaining provisions or portions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by law.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25.&#160;&#160;&#160;&#160;The respective rights and obligations of the parties hereunder shall survive any termination of this Agreement to the extent necessary for the intended preservation of such rights and obligations.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26.&#160;&#160;&#160;&#160;Unless expressly specified elsewhere in this Agreement, this Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of New York without reference to the principles of conflict of law.</font></div><div style="padding-left:36pt;padding-right:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27.&#160;&#160;&#160;&#160;This Agreement may be executed in one or more counterparts.</font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Executive</font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;</font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font><br></font></div><div style="padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date&#58;&#160;&#160;&#160;&#160;</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:36pt;padding-right:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EX. A-4</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>4
<FILENAME>dgx09302022ex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i32a614335d3e439985786f0c630acd45_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit 22</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Subsidiary Guarantors of Securities</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of October&#160;21, 2022, the following subsidiaries of Quest Diagnostics Incorporated provided, subject to the terms of such senior notes, unconditional and irrevocable guarantees to the senior notes listed below that were issued by Quest Diagnostics Incorporated pursuant to an offering registered under the Securities Act of 1933, as amended&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:27.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Securities</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuer</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsidiary Guarantor</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Organization</font></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="29" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.95% Senior Notes due 2037</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.75% Senior Notes due 2040</font></div></td><td colspan="3" rowspan="29" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">American Medical Laboratories, Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Consolidated Labs, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Hospital Services Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Kentucky, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kentucky</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath New York, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Texas, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Athena Diagnostics, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Pathology Services, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oklahoma</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pennsylvania</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide of NJ, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New Jersey</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kailash B. Sharma, M.D., Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Missouri</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne of Ohio, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ocmulgee Medical Pathology Association, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Clinical Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Holdings Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nevada</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Investments LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Connecticut</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illinois</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Massachusetts</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Virginia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics of Pennsylvania Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Specialty Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unilab Corporation</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>dgx09302022ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i030833b9727749278987fe5677b5c3f6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen H. Rusckowski, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;21, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.134%"><tr><td style="width:1.0%"></td><td style="width:11.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>dgx09302022ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i03cf9870d0de49c9970c3b63024973b4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sam Samad, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;21, 2022 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.140%"><tr><td style="width:1.0%"></td><td style="width:14.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sam Samad</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sam Samad</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>dgx09302022ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i540ca65db6e6444da285bb55efed6b73_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended September&#160;30, 2022 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 21, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>dgx09302022ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ice466d87736d419bbf24d74fb56ef8e0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended September&#160;30, 2022 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 21, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sam Samad</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sam Samad</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>dgx-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18deedef-37c4-4d4c-a3c0-638e0a05a492,g:42e53fcd-5b3b-4fb8-92f9-d69b94944099-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>2104103 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>2107104 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITION" roleURI="http://questdiagnostics.com/role/DISPOSITION">
        <link:definition>2109105 - Disclosure - DISPOSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2111106 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2117107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2121108 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2124109 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA">
        <link:definition>2126110 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2130111 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>2132112 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION">
        <link:definition>2135113 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOME" roleURI="http://questdiagnostics.com/role/TAXESONINCOME">
        <link:definition>2138114 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTS">
        <link:definition>2140115 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables">
        <link:definition>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2318303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2322304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables">
        <link:definition>2327305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2333306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables">
        <link:definition>2336307 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails">
        <link:definition>2406401 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITIONDetails" roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails">
        <link:definition>2410403 - Disclosure - DISPOSITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails">
        <link:definition>2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2415406 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails">
        <link:definition>2416407 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSGoodwillDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
        <link:definition>2419408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSSchedulesDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
        <link:definition>2420409 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>2423410 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
        <link:definition>2425411 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails">
        <link:definition>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
        <link:definition>2429413 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2431414 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>2434415 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2437416 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMEDetails" roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails">
        <link:definition>2439417 - Disclosure - TAXES ON INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>2441418 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PackHealthLLCMember" abstract="true" name="PackHealthLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataLineItems" abstract="true" name="SupplementalCashFlowAndOtherDataLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" abstract="true" name="ExcludesgeneralandprofessionalliabilityclaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchasesPayment" abstract="false" name="AcceleratedShareRepurchasesPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchaseAgreementsMember" abstract="true" name="AcceleratedShareRepurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAmountAuthorized" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DataSecurityIncidentMember" abstract="true" name="DataSecurityIncidentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember" abstract="true" name="CommercialPaperAndTermSecuredOvernightFinancingRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" abstract="false" name="EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_Mergerconsiderationpaidpayablenet" abstract="false" name="Mergerconsiderationpaidpayablenet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DescriptionOfBusinessAbstract" abstract="true" name="DescriptionOfBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AmendedRealEstateLeaseMember" abstract="true" name="AmendedRealEstateLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" abstract="false" name="EquityMethodInvestmentOwnershipPercentDisposedOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" abstract="true" name="MeasurementInputComparableCompanyRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" abstract="false" name="ScheduleOfRevenuesByMajorServiceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_TotalAmortizingIntangibleAssetsMember" abstract="true" name="TotalAmortizingIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ForeignCurrencyTranslationMember" abstract="true" name="ForeignCurrencyTranslationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_PatientsMember" abstract="true" name="PatientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_LabtechDiagnosticsLLCMember" abstract="true" name="LabtechDiagnosticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_A401kPlanLawsuitMember" abstract="true" name="A401kPlanLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" abstract="true" name="PackHealthLLCAndLabtechDiagnosticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TreasuryStockPurchasedbutNotyetPaid" abstract="false" name="TreasuryStockPurchasedbutNotyetPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LoanCommitmentMember" abstract="true" name="LoanCommitmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" abstract="false" name="ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TriggeringEventDomain" abstract="true" name="TriggeringEventDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataTable" abstract="true" name="SupplementalCashFlowAndOtherDataTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_InventoryPurchaseAccountingAdjustments" abstract="false" name="InventoryPurchaseAccountingAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" abstract="false" name="PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_Q2SolutionsMember" abstract="true" name="Q2SolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" abstract="false" name="ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_RoutineClinicalTestingAndOtherServicesMember" abstract="true" name="RoutineClinicalTestingAndOtherServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" abstract="false" name="ProceedsFromSaleOfEquityMethodInvestmentsGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TriggeringEventAxis" abstract="true" name="TriggeringEventAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_GainLossOnDispositionOfJointVenture" abstract="false" name="GainLossOnDispositionOfJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>dgx-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18deedef-37c4-4d4c-a3c0-638e0a05a492,g:42e53fcd-5b3b-4fb8-92f9-d69b94944099-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f1d8358e-216c-448b-ae10-09f8a247628c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7820e121-5ba6-47dd-9eaf-1521c10bb368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f1d8358e-216c-448b-ae10-09f8a247628c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7820e121-5ba6-47dd-9eaf-1521c10bb368" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3d73ed7e-7f7e-43da-add5-9d6f475f7469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f1d8358e-216c-448b-ae10-09f8a247628c" xlink:to="loc_us-gaap_OperatingIncomeLoss_3d73ed7e-7f7e-43da-add5-9d6f475f7469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1225f253-9600-4a31-940e-02447cd2c005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_da7e48ba-552d-4e99-ad17-c21293aa3521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1225f253-9600-4a31-940e-02447cd2c005" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_da7e48ba-552d-4e99-ad17-c21293aa3521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_10805db3-cc89-4909-bbd3-c8c6fdad8465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1225f253-9600-4a31-940e-02447cd2c005" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_10805db3-cc89-4909-bbd3-c8c6fdad8465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_667363ae-c6ed-4faa-8c6d-5044a770d892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16c7a0eb-1738-4dc1-8134-6a52ef04d50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_667363ae-c6ed-4faa-8c6d-5044a770d892" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_16c7a0eb-1738-4dc1-8134-6a52ef04d50c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_806ed207-0009-47bb-8401-e9e148750eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_667363ae-c6ed-4faa-8c6d-5044a770d892" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_806ed207-0009-47bb-8401-e9e148750eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e7999442-9f4c-4fa5-b20e-01c412b42b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_667363ae-c6ed-4faa-8c6d-5044a770d892" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e7999442-9f4c-4fa5-b20e-01c412b42b39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b15340c1-96ee-4b00-986c-565678f77348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f2b6f221-8f61-48dd-be09-fd43febb3fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b15340c1-96ee-4b00-986c-565678f77348" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f2b6f221-8f61-48dd-be09-fd43febb3fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_297795f3-9cf7-4e20-8f23-777f562f981a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b15340c1-96ee-4b00-986c-565678f77348" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_297795f3-9cf7-4e20-8f23-777f562f981a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_29e197ff-c03d-45c0-97dc-be01dd7f6c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b15340c1-96ee-4b00-986c-565678f77348" xlink:to="loc_us-gaap_CostOfRevenue_29e197ff-c03d-45c0-97dc-be01dd7f6c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b4520540-179f-43bf-83f9-707bd37819a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_b15340c1-96ee-4b00-986c-565678f77348" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b4520540-179f-43bf-83f9-707bd37819a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_703e61e0-f67b-4926-bf76-b7bb54eb68e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f77be4eb-0471-484b-8c77-95bf3a636b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_703e61e0-f67b-4926-bf76-b7bb54eb68e9" xlink:to="loc_us-gaap_ProfitLoss_f77be4eb-0471-484b-8c77-95bf3a636b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c8ba70fa-1931-4499-ab8d-2bc00fbf8f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_703e61e0-f67b-4926-bf76-b7bb54eb68e9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c8ba70fa-1931-4499-ab8d-2bc00fbf8f04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1e4ca4f2-de0c-4af1-b402-83814d924f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_38a0a124-e9b4-4c18-bd81-09f15cb0e13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1e4ca4f2-de0c-4af1-b402-83814d924f99" xlink:to="loc_us-gaap_CostsAndExpenses_38a0a124-e9b4-4c18-bd81-09f15cb0e13f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_daccadbd-2f02-49be-9c74-1111c2fa76c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1e4ca4f2-de0c-4af1-b402-83814d924f99" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_daccadbd-2f02-49be-9c74-1111c2fa76c7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_37017683-7b93-4fad-a7e1-ca5d90054cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_aee6c4d7-62ee-4c3d-bb64-e65e16aa10b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_37017683-7b93-4fad-a7e1-ca5d90054cb9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_aee6c4d7-62ee-4c3d-bb64-e65e16aa10b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1825c58f-cc9e-49fa-94ee-6e4bf987e66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_37017683-7b93-4fad-a7e1-ca5d90054cb9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1825c58f-cc9e-49fa-94ee-6e4bf987e66a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a3ba1863-e326-4381-8556-6b4d663f385c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e25d8ab5-4129-4985-bb5e-7478c907747c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a3ba1863-e326-4381-8556-6b4d663f385c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e25d8ab5-4129-4985-bb5e-7478c907747c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_746979da-bb79-4153-9178-0ec16568f502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a3ba1863-e326-4381-8556-6b4d663f385c" xlink:to="loc_us-gaap_ProfitLoss_746979da-bb79-4153-9178-0ec16568f502" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3482e774-84d2-4228-8a59-ab0e1b7a2f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ec5e7d82-8265-409d-bfb3-915676bce715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3482e774-84d2-4228-8a59-ab0e1b7a2f19" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ec5e7d82-8265-409d-bfb3-915676bce715" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_baf3c2c9-bac8-4c85-be27-0506c23feccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3482e774-84d2-4228-8a59-ab0e1b7a2f19" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_baf3c2c9-bac8-4c85-be27-0506c23feccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2fadb932-a6b8-4f46-8061-4153424da2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3482e774-84d2-4228-8a59-ab0e1b7a2f19" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2fadb932-a6b8-4f46-8061-4153424da2f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f9f7e39c-a152-4368-8130-a9e8b200377a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c6d86ae7-c124-41b4-95d9-96b7188079fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f9f7e39c-a152-4368-8130-a9e8b200377a" xlink:to="loc_us-gaap_StockholdersEquity_c6d86ae7-c124-41b4-95d9-96b7188079fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3ae82b10-e44a-4abb-b348-6a093b5a05b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f9f7e39c-a152-4368-8130-a9e8b200377a" xlink:to="loc_us-gaap_MinorityInterest_3ae82b10-e44a-4abb-b348-6a093b5a05b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b43b9d44-8960-45c2-97be-7d628f145ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_43cf6af0-8677-49f8-9eed-6b589fd4f50b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b43b9d44-8960-45c2-97be-7d628f145ac1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_43cf6af0-8677-49f8-9eed-6b589fd4f50b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_57c3a92d-4efd-4056-b50e-2882c321a4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b43b9d44-8960-45c2-97be-7d628f145ac1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_57c3a92d-4efd-4056-b50e-2882c321a4e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6c426182-d2e5-49d3-a8f3-8a10e9980859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b43b9d44-8960-45c2-97be-7d628f145ac1" xlink:to="loc_us-gaap_InventoryNet_6c426182-d2e5-49d3-a8f3-8a10e9980859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8eef4dc1-1b60-4776-92f3-7f35d1d96b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b43b9d44-8960-45c2-97be-7d628f145ac1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8eef4dc1-1b60-4776-92f3-7f35d1d96b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0de76726-5517-4d42-b384-032a0a41c38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:to="loc_us-gaap_AssetsCurrent_0de76726-5517-4d42-b384-032a0a41c38d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da163dd7-6ea9-4bc2-afeb-6a35827ca20c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da163dd7-6ea9-4bc2-afeb-6a35827ca20c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1a42371b-7667-4ac7-acb5-a70054c25377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1a42371b-7667-4ac7-acb5-a70054c25377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8a75fcff-fb0d-4e0e-b007-f5279e330e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:to="loc_us-gaap_Goodwill_8a75fcff-fb0d-4e0e-b007-f5279e330e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9d117db5-cdfb-43ac-819e-9edeff9cefa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9d117db5-cdfb-43ac-819e-9edeff9cefa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_49f86b77-e371-46f3-a6cd-461a945620f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:to="loc_us-gaap_EquityMethodInvestments_49f86b77-e371-46f3-a6cd-461a945620f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e189dbc2-ff9f-459c-aa96-6526d81a169c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3d4c8cde-a33f-432c-8512-babdd8d4e60d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e189dbc2-ff9f-459c-aa96-6526d81a169c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a0e9aed1-8417-42f4-948e-bfa533bfa983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5177343a-4ec4-4801-93f9-58c5fc403c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0e9aed1-8417-42f4-948e-bfa533bfa983" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5177343a-4ec4-4801-93f9-58c5fc403c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7f0688b5-428b-478a-8092-ce8fa231a391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0e9aed1-8417-42f4-948e-bfa533bfa983" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7f0688b5-428b-478a-8092-ce8fa231a391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7c69e419-6fff-4e45-ab68-b2ec63875ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a0e9aed1-8417-42f4-948e-bfa533bfa983" xlink:to="loc_us-gaap_LongTermDebtCurrent_7c69e419-6fff-4e45-ab68-b2ec63875ef3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_11668c1b-34c8-4546-81f5-32ddc6d750b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:to="loc_us-gaap_LiabilitiesCurrent_11668c1b-34c8-4546-81f5-32ddc6d750b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_634d058c-35e9-4c9c-925c-081e4c24fe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_634d058c-35e9-4c9c-925c-081e4c24fe5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_06a561fd-520e-42cb-99b6-858f754c9795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_06a561fd-520e-42cb-99b6-858f754c9795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cadb5c2-5269-4b53-b6cd-b8238c0022f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9cadb5c2-5269-4b53-b6cd-b8238c0022f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b30a1b8c-530c-4ebf-bef0-25261eb8f569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b30a1b8c-530c-4ebf-bef0-25261eb8f569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4a80fba2-2341-4ae7-87f0-db7f50d8f79b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4a80fba2-2341-4ae7-87f0-db7f50d8f79b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3b83c3b3-0cbb-4494-b50e-fc2ec16c4b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d638016e-9a36-437b-9add-430872470282" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3b83c3b3-0cbb-4494-b50e-fc2ec16c4b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9ffd6a1c-0d10-4cf8-b963-af1adffccdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_096f9590-5c42-4bde-a3f0-51635bb2aaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9ffd6a1c-0d10-4cf8-b963-af1adffccdb3" xlink:to="loc_us-gaap_CommonStockValue_096f9590-5c42-4bde-a3f0-51635bb2aaf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_91ebc5ad-9cb9-490b-b567-1b7b7151cb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9ffd6a1c-0d10-4cf8-b963-af1adffccdb3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_91ebc5ad-9cb9-490b-b567-1b7b7151cb56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_443ac759-4969-4e46-abc1-b8a956e67c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9ffd6a1c-0d10-4cf8-b963-af1adffccdb3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_443ac759-4969-4e46-abc1-b8a956e67c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_86608a18-a11f-4f0c-a9c4-5ee3c469a3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9ffd6a1c-0d10-4cf8-b963-af1adffccdb3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_86608a18-a11f-4f0c-a9c4-5ee3c469a3bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_0fd21df3-38cf-4186-b0e4-c8041edee315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9ffd6a1c-0d10-4cf8-b963-af1adffccdb3" xlink:to="loc_us-gaap_TreasuryStockValue_0fd21df3-38cf-4186-b0e4-c8041edee315" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41cf8f6a-6976-4578-9d0d-90e8f3dbf1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4231411b-42bc-4379-9a64-ef1d86c2e575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41cf8f6a-6976-4578-9d0d-90e8f3dbf1fb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4231411b-42bc-4379-9a64-ef1d86c2e575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_9b6070f1-d507-4487-9557-619be0cf8073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41cf8f6a-6976-4578-9d0d-90e8f3dbf1fb" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_9b6070f1-d507-4487-9557-619be0cf8073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_20a1c7e2-8977-417f-9168-ef90ee570f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41cf8f6a-6976-4578-9d0d-90e8f3dbf1fb" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_20a1c7e2-8977-417f-9168-ef90ee570f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1d9c821c-f121-4823-9bb1-be2f200a275e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41cf8f6a-6976-4578-9d0d-90e8f3dbf1fb" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1d9c821c-f121-4823-9bb1-be2f200a275e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4a5efe70-13db-44f7-bb43-9483753cfe65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_610f48be-4be4-4d65-ac3d-0df46d06aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4a5efe70-13db-44f7-bb43-9483753cfe65" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_610f48be-4be4-4d65-ac3d-0df46d06aa35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1afcd04a-c437-4119-88e5-8db08bc74dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4a5efe70-13db-44f7-bb43-9483753cfe65" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1afcd04a-c437-4119-88e5-8db08bc74dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0bf73bb7-07e2-4827-8c3d-d3676209e088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4a5efe70-13db-44f7-bb43-9483753cfe65" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0bf73bb7-07e2-4827-8c3d-d3676209e088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_ba7c04c1-7c5d-4bab-8ce3-385a4c3c6830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:to="loc_us-gaap_RepaymentsOfDebt_ba7c04c1-7c5d-4bab-8ce3-385a4c3c6830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b274f7cf-5d5b-46fa-b545-d3fb33c529d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b274f7cf-5d5b-46fa-b545-d3fb33c529d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_4f24ecf3-a883-4adf-93f1-a52b1c6b8cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_4f24ecf3-a883-4adf-93f1-a52b1c6b8cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_39959a9f-ef51-4d96-928e-6f55487cae7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_39959a9f-ef51-4d96-928e-6f55487cae7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_0eea53f9-f194-4bcc-ae3d-e3a37e83d9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_0eea53f9-f194-4bcc-ae3d-e3a37e83d9c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_a72b414f-eeb6-469a-9bb5-cb41689c5227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_a72b414f-eeb6-469a-9bb5-cb41689c5227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_15f8290f-4a04-46bd-bad1-8bb8436f1a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f4290fa-e990-411e-9279-6f5cd7d74935" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_15f8290f-4a04-46bd-bad1-8bb8436f1a90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_296995dd-2d75-4ecc-8a5c-d0c22aafe9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_ProfitLoss_296995dd-2d75-4ecc-8a5c-d0c22aafe9d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_678f91d9-a41d-4475-82df-b03b08c49fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_678f91d9-a41d-4475-82df-b03b08c49fac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_e32abfa6-c7f9-43aa-9817-1443c465164e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_e32abfa6-c7f9-43aa-9817-1443c465164e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_82e4c73d-89a3-4141-b258-61d2950e6066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_82e4c73d-89a3-4141-b258-61d2950e6066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_74869ccb-c599-4b9b-b408-41b49c68a822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_ShareBasedCompensation_74869ccb-c599-4b9b-b408-41b49c68a822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture_555f5e7a-c479-4f24-8435-f4810dcec3f3" xlink:href="dgx-20220930.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_dgx_GainLossOnDispositionOfJointVenture_555f5e7a-c479-4f24-8435-f4810dcec3f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_3ad7d5dc-717b-4c4a-b5e8-0592ba6a9fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_3ad7d5dc-717b-4c4a-b5e8-0592ba6a9fbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1e57449-1f35-4f55-b914-c6fe8fed6ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1e57449-1f35-4f55-b914-c6fe8fed6ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_75d828cf-01c3-4692-8018-f86a9c680491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_75d828cf-01c3-4692-8018-f86a9c680491" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f6a5d590-1f89-4fb8-b6b9-d3a214b72ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f6a5d590-1f89-4fb8-b6b9-d3a214b72ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6d555106-bb1b-4ead-94cf-28233206b247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904c361d-adb9-4944-89d7-3fd51e19e69a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6d555106-bb1b-4ead-94cf-28233206b247" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ed1e5e34-2b83-4091-9af5-a4e05d107fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aa04d005-6b5e-4a95-895d-1cae14c575f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ed1e5e34-2b83-4091-9af5-a4e05d107fe2" xlink:to="loc_us-gaap_NetIncomeLoss_aa04d005-6b5e-4a95-895d-1cae14c575f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_84473ce8-a78c-48a7-8c71-7aba052bf9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ed1e5e34-2b83-4091-9af5-a4e05d107fe2" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_84473ce8-a78c-48a7-8c71-7aba052bf9e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2e071313-9d1f-4253-a6ba-3a4edc22d90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_47164852-acf0-48c1-ba41-9acb503a4a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2e071313-9d1f-4253-a6ba-3a4edc22d90c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_47164852-acf0-48c1-ba41-9acb503a4a88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6ba72f46-6281-44bb-b684-17eb5b4e7ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2e071313-9d1f-4253-a6ba-3a4edc22d90c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6ba72f46-6281-44bb-b684-17eb5b4e7ea1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_51d9478b-de48-4788-951e-f79a70f9056d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_edcb0ba3-5630-4463-9c32-4c4a47d6e699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_51d9478b-de48-4788-951e-f79a70f9056d" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_edcb0ba3-5630-4463-9c32-4c4a47d6e699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_61d34adb-d0ec-43f9-9605-6ad9c3031242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_51d9478b-de48-4788-951e-f79a70f9056d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_61d34adb-d0ec-43f9-9605-6ad9c3031242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d9998fc5-4a6d-48a5-a525-5e32ebb8ec46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_65f372fe-ea8b-412b-8774-79c95841c031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d9998fc5-4a6d-48a5-a525-5e32ebb8ec46" xlink:to="loc_us-gaap_TradingSecurities_65f372fe-ea8b-412b-8774-79c95841c031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_5b688a7e-20b3-4523-9ef6-574de6a21882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d9998fc5-4a6d-48a5-a525-5e32ebb8ec46" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_5b688a7e-20b3-4523-9ef6-574de6a21882" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_274191f2-58a0-4df9-b69c-83deb13b451f" xlink:href="dgx-20220930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d9998fc5-4a6d-48a5-a525-5e32ebb8ec46" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_274191f2-58a0-4df9-b69c-83deb13b451f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d3e26ad1-f04e-4709-a13c-5cf0fb195b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d9998fc5-4a6d-48a5-a525-5e32ebb8ec46" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d3e26ad1-f04e-4709-a13c-5cf0fb195b4f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5543b50f-058e-4735-a366-2597cfe09f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5543b50f-058e-4735-a366-2597cfe09f36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a573d099-8fd3-46a3-bcae-107186e03bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_a573d099-8fd3-46a3-bcae-107186e03bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_98cd7768-63b7-451c-9064-9542283c14e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_98cd7768-63b7-451c-9064-9542283c14e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0d52e571-c109-48b3-978f-d1e9d8351888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0d52e571-c109-48b3-978f-d1e9d8351888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c477a8e6-ba91-4929-bac4-5e8a446d02bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c477a8e6-ba91-4929-bac4-5e8a446d02bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8b5c2528-730b-4005-8a98-6c0666b3453e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8b5c2528-730b-4005-8a98-6c0666b3453e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_dbbbf011-c180-47fa-b2db-710a9f797fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_333346c3-554a-4839-94f8-28fbb46ac0e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_dbbbf011-c180-47fa-b2db-710a9f797fc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_62a7661e-93a8-46c5-baec-0eec05e6102e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a87ecfb7-0dab-4c88-9e99-646e2ad746df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_62a7661e-93a8-46c5-baec-0eec05e6102e" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a87ecfb7-0dab-4c88-9e99-646e2ad746df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b888fee1-165a-4f84-bae4-be6fe7dc1d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_62a7661e-93a8-46c5-baec-0eec05e6102e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b888fee1-165a-4f84-bae4-be6fe7dc1d78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_218a07c5-301d-464b-ab71-a9dda913c9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a30d7199-d788-497b-a02c-d05e7aa4d2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_218a07c5-301d-464b-ab71-a9dda913c9a8" xlink:to="loc_us-gaap_Depreciation_a30d7199-d788-497b-a02c-d05e7aa4d2d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6e64dea2-0aa9-4abc-ade3-13a787017691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_218a07c5-301d-464b-ab71-a9dda913c9a8" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6e64dea2-0aa9-4abc-ade3-13a787017691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_f0d8466f-8f78-4061-b05e-8ce3d94c618c" xlink:href="dgx-20220930.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_b31fc380-8bb3-4c80-9745-3e7ce92641a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_f0d8466f-8f78-4061-b05e-8ce3d94c618c" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_b31fc380-8bb3-4c80-9745-3e7ce92641a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_e3a4a0e8-4ee5-4887-9df9-dbf794804be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_f0d8466f-8f78-4061-b05e-8ce3d94c618c" xlink:to="loc_us-gaap_LiabilitiesAssumed1_e3a4a0e8-4ee5-4887-9df9-dbf794804be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_e49a5e6f-6d44-4baa-a5b1-770ea74e23d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4bd6b266-ec39-4ea9-9c84-3eb31ac268f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_e49a5e6f-6d44-4baa-a5b1-770ea74e23d2" xlink:to="loc_us-gaap_InterestExpense_4bd6b266-ec39-4ea9-9c84-3eb31ac268f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_70666187-be70-4a3b-9994-33c3b96857db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_e49a5e6f-6d44-4baa-a5b1-770ea74e23d2" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_70666187-be70-4a3b-9994-33c3b96857db" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>dgx-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18deedef-37c4-4d4c-a3c0-638e0a05a492,g:42e53fcd-5b3b-4fb8-92f9-d69b94944099-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i57a0a9f2d8924feabed1b1eeb591fc26_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_28a8cb02-7c4d-40c0-a2f7-0c6363982dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_28a8cb02-7c4d-40c0-a2f7-0c6363982dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3598261-77f0-4b91-97bb-4b925623d828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3598261-77f0-4b91-97bb-4b925623d828" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_c3a4fe34-10c9-4272-ba5b-fb875682c73b" xlink:href="dgx-20220930.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_c3a4fe34-10c9-4272-ba5b-fb875682c73b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ec20409-2e71-4b3d-8eae-8fe9189f902f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ec20409-2e71-4b3d-8eae-8fe9189f902f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_11a20673-1aef-4f7a-a941-894d1b94725f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_DividendsCommonStockCash_11a20673-1aef-4f7a-a941-894d1b94725f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cee941f7-82ab-467b-875a-8d517531dfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cee941f7-82ab-467b-875a-8d517531dfd0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_f70f64d1-de88-4a05-9215-c9126eedd457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_f70f64d1-de88-4a05-9215-c9126eedd457" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d9eb1e9a-c8f7-4b0d-824d-0a652b6d46ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d9eb1e9a-c8f7-4b0d-824d-0a652b6d46ab" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f93af4c0-c80a-47f4-ae6d-34d103c0e8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f93af4c0-c80a-47f4-ae6d-34d103c0e8f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_473f0dea-abca-4bad-98ca-0b5aea1f6b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_473f0dea-abca-4bad-98ca-0b5aea1f6b12" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8c573193-65c2-4cd1-90f6-5b86f5015ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8c573193-65c2-4cd1-90f6-5b86f5015ad3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_ab5f5857-f9ae-4f10-b6cd-6e8265f2491a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_ab5f5857-f9ae-4f10-b6cd-6e8265f2491a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ffff65ad-0402-41d3-8918-001943b82dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ffff65ad-0402-41d3-8918-001943b82dd8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ef08800a-cc6a-45d9-ada3-4b174c137165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ef08800a-cc6a-45d9-ada3-4b174c137165" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_76406555-c54e-454f-aa1e-bbb8c522fe25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_76406555-c54e-454f-aa1e-bbb8c522fe25" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d62cc3c5-e18a-4083-9157-255b2835f703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_940875a3-be67-49df-b2a0-d3c64467c73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_80adcaa2-afa5-47a4-9ed4-a56de43654b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_80adcaa2-afa5-47a4-9ed4-a56de43654b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_48ed7a54-1512-4e8e-a156-644a7ad89804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_48ed7a54-1512-4e8e-a156-644a7ad89804" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_619d122f-8e5f-4e42-b04d-bd43efef05c2" xlink:href="dgx-20220930.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_619d122f-8e5f-4e42-b04d-bd43efef05c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_66bac114-52e1-4c5b-b35a-24e86e35717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_781d7974-7961-43e7-aa3c-4802aa2cc594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:to="loc_us-gaap_StatementTable_781d7974-7961-43e7-aa3c-4802aa2cc594" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2fa27ba1-829c-4b75-afc6-6f52e09dcf84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_781d7974-7961-43e7-aa3c-4802aa2cc594" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2fa27ba1-829c-4b75-afc6-6f52e09dcf84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2fa27ba1-829c-4b75-afc6-6f52e09dcf84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2fa27ba1-829c-4b75-afc6-6f52e09dcf84" xlink:to="loc_us-gaap_EquityComponentDomain_2fa27ba1-829c-4b75-afc6-6f52e09dcf84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2fa27ba1-829c-4b75-afc6-6f52e09dcf84" xlink:to="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a2941db8-08c8-49ec-a174-46d760f06e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_CommonStockMember_a2941db8-08c8-49ec-a174-46d760f06e1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f5ad0865-a5d5-4eb9-9fe6-b51de78444d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f5ad0865-a5d5-4eb9-9fe6-b51de78444d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3fd662be-921a-430f-b8af-967bb9f2689d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_RetainedEarningsMember_3fd662be-921a-430f-b8af-967bb9f2689d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fbb2c8d-49d6-45d2-8275-e0951a67dacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fbb2c8d-49d6-45d2-8275-e0951a67dacc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_93bf91f0-5f56-483a-83c4-7c41f3f12142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_TreasuryStockMember_93bf91f0-5f56-483a-83c4-7c41f3f12142" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5a8799cd-a966-4bc6-9354-79f1d19854e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5a8799cd-a966-4bc6-9354-79f1d19854e6" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="id7fb74e784cb4fdab90f893b786a961a_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_24af9dde-2b76-4f17-9d23-16e97539fc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_24af9dde-2b76-4f17-9d23-16e97539fc39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_963d0e92-c62e-4dad-9b88-a0dafca72406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_963d0e92-c62e-4dad-9b88-a0dafca72406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b370cc9d-e245-4407-a94e-3c64791d7965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b370cc9d-e245-4407-a94e-3c64791d7965" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_15aa6c9e-f664-4c24-8dbe-a1916557570f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_15aa6c9e-f664-4c24-8dbe-a1916557570f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ee13810f-ff2a-4129-becb-19beafea9bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_Goodwill_ee13810f-ff2a-4129-becb-19beafea9bfa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_bb000c56-283d-418f-a59e-5956d125a17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_bb000c56-283d-418f-a59e-5956d125a17d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dcf058c2-76ae-4a18-a8b0-d7c311a22e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dcf058c2-76ae-4a18-a8b0-d7c311a22e62" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_82fa3990-8cf6-4070-bd8c-d3bd53e769b8" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_82fa3990-8cf6-4070-bd8c-d3bd53e769b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_5bf3a287-4e17-4f00-809f-5cdda81cd3fb" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_5bf3a287-4e17-4f00-809f-5cdda81cd3fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_bd122474-28f7-4a74-86cb-88ddf493facf" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_bd122474-28f7-4a74-86cb-88ddf493facf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ea9206fc-734f-41db-90b8-628dc222d388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ea9206fc-734f-41db-90b8-628dc222d388" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a91dad4e-070e-4d26-85db-697fbb24b2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a91dad4e-070e-4d26-85db-697fbb24b2b9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_c9218727-2195-4cfb-b647-ec5bc881f126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_c9218727-2195-4cfb-b647-ec5bc881f126" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InventoryPurchaseAccountingAdjustments_cf6dbefb-ecbf-496a-8c33-ae2798e76dfc" xlink:href="dgx-20220930.xsd#dgx_InventoryPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_InventoryPurchaseAccountingAdjustments_cf6dbefb-ecbf-496a-8c33-ae2798e76dfc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_313bc778-ab98-4820-8121-a23f79939a66" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_313bc778-ab98-4820-8121-a23f79939a66" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5576a91f-b87f-41d9-bb4b-e2146f5cd40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5576a91f-b87f-41d9-bb4b-e2146f5cd40b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5576a91f-b87f-41d9-bb4b-e2146f5cd40b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5576a91f-b87f-41d9-bb4b-e2146f5cd40b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5576a91f-b87f-41d9-bb4b-e2146f5cd40b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5576a91f-b87f-41d9-bb4b-e2146f5cd40b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember_11ce88d1-b941-4b59-baee-bde6ac53d75b" xlink:href="dgx-20220930.xsd#dgx_PackHealthLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:to="loc_dgx_PackHealthLLCMember_11ce88d1-b941-4b59-baee-bde6ac53d75b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_e593ee8d-44c2-4772-865b-a97c76dd3b03" xlink:href="dgx-20220930.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_e593ee8d-44c2-4772-865b-a97c76dd3b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07c6818b-3fe4-463a-962d-eda591cebcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07c6818b-3fe4-463a-962d-eda591cebcba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_07c6818b-3fe4-463a-962d-eda591cebcba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07c6818b-3fe4-463a-962d-eda591cebcba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_07c6818b-3fe4-463a-962d-eda591cebcba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ec4c80-e347-4378-abc3-242258e7f719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07c6818b-3fe4-463a-962d-eda591cebcba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ec4c80-e347-4378-abc3-242258e7f719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9002798f-0796-4c93-8121-b537673c892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ec4c80-e347-4378-abc3-242258e7f719" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9002798f-0796-4c93-8121-b537673c892d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#DISPOSITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended" id="ia4f9c647fea046b280ce80a24d421231_DISPOSITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_29b06659-7e62-4f3c-8fde-57bcd1a85d7b" xlink:href="dgx-20220930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_29b06659-7e62-4f3c-8fde-57bcd1a85d7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_d9aa6767-b5d4-4c77-9d4d-73572479f77a" xlink:href="dgx-20220930.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_d9aa6767-b5d4-4c77-9d4d-73572479f77a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_364774cd-de8c-49b2-84af-87fc44893bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_364774cd-de8c-49b2-84af-87fc44893bb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b58583d0-9e67-490e-ad26-494ee5bc705f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b58583d0-9e67-490e-ad26-494ee5bc705f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d8774b7-59f2-4ca3-bfc0-3027a89e125a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d8774b7-59f2-4ca3-bfc0-3027a89e125a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ab969367-0188-4914-91c0-3aeff409501f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ab969367-0188-4914-91c0-3aeff409501f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8f0b5a43-0da3-4204-93a7-43cf4b6a2bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8f0b5a43-0da3-4204-93a7-43cf4b6a2bdd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8ff06b7-04ee-44a4-a5c0-9d254ad26df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8ff06b7-04ee-44a4-a5c0-9d254ad26df8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_00f9474c-e9f8-4caa-9e6f-07d105521504" xlink:href="dgx-20220930.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8ff06b7-04ee-44a4-a5c0-9d254ad26df8" xlink:to="loc_dgx_Q2SolutionsMember_00f9474c-e9f8-4caa-9e6f-07d105521504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_325ba4a8-8ce0-43f0-969b-c2b848ea1201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_325ba4a8-8ce0-43f0-969b-c2b848ea1201" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_325ba4a8-8ce0-43f0-969b-c2b848ea1201_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_325ba4a8-8ce0-43f0-969b-c2b848ea1201" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_325ba4a8-8ce0-43f0-969b-c2b848ea1201_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_dddf3340-5b50-4971-a37d-031a1f9fafba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_325ba4a8-8ce0-43f0-969b-c2b848ea1201" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_dddf3340-5b50-4971-a37d-031a1f9fafba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e984af5c-bd1f-4181-932b-41c67538f2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_dddf3340-5b50-4971-a37d-031a1f9fafba" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e984af5c-bd1f-4181-932b-41c67538f2fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_91eea82d-f2da-4ff0-8ff5-620d7efa6acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_91eea82d-f2da-4ff0-8ff5-620d7efa6acf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_91eea82d-f2da-4ff0-8ff5-620d7efa6acf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_91eea82d-f2da-4ff0-8ff5-620d7efa6acf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_91eea82d-f2da-4ff0-8ff5-620d7efa6acf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ec331269-4cdb-4628-80f3-c1991ff62105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_91eea82d-f2da-4ff0-8ff5-620d7efa6acf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ec331269-4cdb-4628-80f3-c1991ff62105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_5305caf9-c276-4dd8-8f2e-fb6afb278598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec331269-4cdb-4628-80f3-c1991ff62105" xlink:to="loc_us-gaap_OtherIncomeMember_5305caf9-c276-4dd8-8f2e-fb6afb278598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66e63e83-85d6-4610-90d5-49f5a4ca929d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66e63e83-85d6-4610-90d5-49f5a4ca929d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66e63e83-85d6-4610-90d5-49f5a4ca929d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66e63e83-85d6-4610-90d5-49f5a4ca929d" xlink:to="loc_us-gaap_EquityComponentDomain_66e63e83-85d6-4610-90d5-49f5a4ca929d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cc73f045-a119-45b5-a96e-f37a4f552492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66e63e83-85d6-4610-90d5-49f5a4ca929d" xlink:to="loc_us-gaap_EquityComponentDomain_cc73f045-a119-45b5-a96e-f37a4f552492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_6a6ed23f-9e2c-4e0d-8c24-e2369732bba0" xlink:href="dgx-20220930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cc73f045-a119-45b5-a96e-f37a4f552492" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_6a6ed23f-9e2c-4e0d-8c24-e2369732bba0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i87cc7881c7234eafbe28e0ea112757d3_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_405744e2-ce4e-4db0-b7f3-4381f2b8a5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_TradingSecurities_405744e2-ce4e-4db0-b7f3-4381f2b8a5c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_12b89482-2a51-49ac-a89c-770289792ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_12b89482-2a51-49ac-a89c-770289792ae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_17a504a0-0b35-4360-a8c1-80f85175162b" xlink:href="dgx-20220930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_17a504a0-0b35-4360-a8c1-80f85175162b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a0ca4ea-092c-4351-81eb-ffe322572437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a0ca4ea-092c-4351-81eb-ffe322572437" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_84b6069d-dbc2-4afb-b996-35982a9b615e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_84b6069d-dbc2-4afb-b996-35982a9b615e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ef60219b-0f81-4d56-8e48-85c7545fcc25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ef60219b-0f81-4d56-8e48-85c7545fcc25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ad42d1f5-48ac-4464-83bc-dfbd00180813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ad42d1f5-48ac-4464-83bc-dfbd00180813" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ec6e6b73-a116-4072-bd0e-96ceed5122a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ec6e6b73-a116-4072-bd0e-96ceed5122a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_3c196166-05ef-4a93-b1ab-d8415d360ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_3c196166-05ef-4a93-b1ab-d8415d360ff9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eca353dd-393c-47ba-892c-fc01e916cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eca353dd-393c-47ba-892c-fc01e916cc12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_eca353dd-393c-47ba-892c-fc01e916cc12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eca353dd-393c-47ba-892c-fc01e916cc12" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_eca353dd-393c-47ba-892c-fc01e916cc12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_45eeb142-f769-4e42-ab8e-d391da30e470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eca353dd-393c-47ba-892c-fc01e916cc12" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_45eeb142-f769-4e42-ab8e-d391da30e470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_96c2c6d4-0e4c-42cf-9625-d1cdcb6cd11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_45eeb142-f769-4e42-ab8e-d391da30e470" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_96c2c6d4-0e4c-42cf-9625-d1cdcb6cd11e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4ed227b-314d-4efc-b0d3-3f88a472897a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4ed227b-314d-4efc-b0d3-3f88a472897a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e4ed227b-314d-4efc-b0d3-3f88a472897a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4ed227b-314d-4efc-b0d3-3f88a472897a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e4ed227b-314d-4efc-b0d3-3f88a472897a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4ed227b-314d-4efc-b0d3-3f88a472897a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a679d41a-f522-4e6e-852d-3940360ea253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a679d41a-f522-4e6e-852d-3940360ea253" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_19e2a65f-86cc-41ee-b1fa-e4df3280d16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_19e2a65f-86cc-41ee-b1fa-e4df3280d16c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a3f516f9-652f-4c82-9b24-f59eceff5a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a3f516f9-652f-4c82-9b24-f59eceff5a4c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="extended" id="i3f4bf7eab3d4460b8e816f0661fb92b9_FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d153bcf7-1af0-4181-afaf-20b67b19c722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d153bcf7-1af0-4181-afaf-20b67b19c722" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1d607088-d6bf-48b2-8d3a-158def32fa20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1d607088-d6bf-48b2-8d3a-158def32fa20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_332e6c8a-1bbd-4c67-8d50-9867ea3410ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_332e6c8a-1bbd-4c67-8d50-9867ea3410ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_73e578ff-03d1-463f-9939-2697657772b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_73e578ff-03d1-463f-9939-2697657772b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e578ff-03d1-463f-9939-2697657772b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_73e578ff-03d1-463f-9939-2697657772b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e578ff-03d1-463f-9939-2697657772b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e570f0-d278-4bfe-b355-b2d684efac80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_73e578ff-03d1-463f-9939-2697657772b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e570f0-d278-4bfe-b355-b2d684efac80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_97a5c8ef-5397-4a34-aeee-7bb86fa9f2b0" xlink:href="dgx-20220930.xsd#dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e570f0-d278-4bfe-b355-b2d684efac80" xlink:to="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_97a5c8ef-5397-4a34-aeee-7bb86fa9f2b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a81ca484-3781-4464-acb8-5c0dd4828c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a81ca484-3781-4464-acb8-5c0dd4828c17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a81ca484-3781-4464-acb8-5c0dd4828c17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a81ca484-3781-4464-acb8-5c0dd4828c17" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a81ca484-3781-4464-acb8-5c0dd4828c17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a81ca484-3781-4464-acb8-5c0dd4828c17" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_fdef5913-d72e-4461-b7f3-ca6878961063" xlink:href="dgx-20220930.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:to="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_fdef5913-d72e-4461-b7f3-ca6878961063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_59c44b51-bb83-4988-b6d6-1118579ee6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_59c44b51-bb83-4988-b6d6-1118579ee6d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ddb931f6-b374-4082-a295-fbb708aecc09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_srt_RangeAxis_ddb931f6-b374-4082-a295-fbb708aecc09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ddb931f6-b374-4082-a295-fbb708aecc09_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ddb931f6-b374-4082-a295-fbb708aecc09" xlink:to="loc_srt_RangeMember_ddb931f6-b374-4082-a295-fbb708aecc09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ddb931f6-b374-4082-a295-fbb708aecc09" xlink:to="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_41c7c430-a924-4fad-8ae9-392a9fa2cd5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:to="loc_srt_MinimumMember_41c7c430-a924-4fad-8ae9-392a9fa2cd5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_03455625-fb98-44ee-af62-3efdb41954a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:to="loc_srt_MaximumMember_03455625-fb98-44ee-af62-3efdb41954a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_60ff7673-b1de-4843-a74d-0aa78ac54805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_60ff7673-b1de-4843-a74d-0aa78ac54805" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_60ff7673-b1de-4843-a74d-0aa78ac54805_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_60ff7673-b1de-4843-a74d-0aa78ac54805" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_60ff7673-b1de-4843-a74d-0aa78ac54805_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ae48dbf9-f4df-4a2e-907c-4c17c582a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_60ff7673-b1de-4843-a74d-0aa78ac54805" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ae48dbf9-f4df-4a2e-907c-4c17c582a7e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_f1b2d4ba-1f81-4c4d-b349-9e55c92d4b24" xlink:href="dgx-20220930.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ae48dbf9-f4df-4a2e-907c-4c17c582a7e0" xlink:to="loc_dgx_ContingentConsiderationMember_f1b2d4ba-1f81-4c4d-b349-9e55c92d4b24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_71b3d6d2-a451-4416-b4fc-bf12c17457ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_71b3d6d2-a451-4416-b4fc-bf12c17457ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_71b3d6d2-a451-4416-b4fc-bf12c17457ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_71b3d6d2-a451-4416-b4fc-bf12c17457ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_71b3d6d2-a451-4416-b4fc-bf12c17457ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd4d18b-a11c-4bae-98e4-f75df508a3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_71b3d6d2-a451-4416-b4fc-bf12c17457ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd4d18b-a11c-4bae-98e4-f75df508a3ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_01898a2b-4315-4e5e-91a1-23f2c4e6a56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd4d18b-a11c-4bae-98e4-f75df508a3ff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_01898a2b-4315-4e5e-91a1-23f2c4e6a56f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i0ff41ab6e248433d9015ca9f1522b495_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a9565a9-679e-4f30-acda-85ab920d83f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daee7b4c-bbf3-4939-b8e1-6fb4b299e0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a9565a9-679e-4f30-acda-85ab920d83f5" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daee7b4c-bbf3-4939-b8e1-6fb4b299e0ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_542239d6-77ab-4dfc-beac-ff9f861ce764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a9565a9-679e-4f30-acda-85ab920d83f5" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_542239d6-77ab-4dfc-beac-ff9f861ce764" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_00524155-454c-4a48-a085-ef50c3c9cb6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_542239d6-77ab-4dfc-beac-ff9f861ce764" xlink:to="loc_srt_OwnershipAxis_00524155-454c-4a48-a085-ef50c3c9cb6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_00524155-454c-4a48-a085-ef50c3c9cb6e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_00524155-454c-4a48-a085-ef50c3c9cb6e" xlink:to="loc_srt_OwnershipDomain_00524155-454c-4a48-a085-ef50c3c9cb6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ca7f5569-515f-4a18-a450-c3c12375ed6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_00524155-454c-4a48-a085-ef50c3c9cb6e" xlink:to="loc_srt_OwnershipDomain_ca7f5569-515f-4a18-a450-c3c12375ed6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_8e747b4f-77c7-4569-8d21-4ff859a44960" xlink:href="dgx-20220930.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ca7f5569-515f-4a18-a450-c3c12375ed6a" xlink:to="loc_dgx_UMassJointVentureMember_8e747b4f-77c7-4569-8d21-4ff859a44960" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="extended" id="if7b782797708458da6fa9ec1c2a81769_FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_93a6a3be-7e2b-415b-8951-ddc7fa71cbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_93a6a3be-7e2b-415b-8951-ddc7fa71cbcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_012678dc-72b8-47ee-8d1b-b0146495fa02" xlink:href="dgx-20220930.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_012678dc-72b8-47ee-8d1b-b0146495fa02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_eee4a414-2ad2-4891-aa1e-f73e0fc8fece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_eee4a414-2ad2-4891-aa1e-f73e0fc8fece" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d27391c3-bc66-4a9a-8ccb-b94230cc9b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d27391c3-bc66-4a9a-8ccb-b94230cc9b25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_22e4cf6e-5a7e-45dd-812d-426b3883104a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_570d3060-406f-4ac1-84f8-ad23f5849cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_570d3060-406f-4ac1-84f8-ad23f5849cda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_570d3060-406f-4ac1-84f8-ad23f5849cda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_570d3060-406f-4ac1-84f8-ad23f5849cda" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_570d3060-406f-4ac1-84f8-ad23f5849cda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67355514-72a0-4ffe-a3cc-01adc1bc95ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_570d3060-406f-4ac1-84f8-ad23f5849cda" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67355514-72a0-4ffe-a3cc-01adc1bc95ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_981e386f-ae4f-4258-b08b-1c344284b279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67355514-72a0-4ffe-a3cc-01adc1bc95ba" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_981e386f-ae4f-4258-b08b-1c344284b279" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9657d59c-db1c-4b86-99df-ffd11452f403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9657d59c-db1c-4b86-99df-ffd11452f403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_3a8890a5-080f-4489-adf8-171ed7920bfb" xlink:href="dgx-20220930.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9657d59c-db1c-4b86-99df-ffd11452f403" xlink:to="loc_dgx_ContingentConsiderationMember_3a8890a5-080f-4489-adf8-171ed7920bfb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended" id="i95943e48a2534837846444c6d1bec861_GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:href="dgx-20220930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eef7e5aa-f5c5-4c75-bb6d-44e492c14048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eef7e5aa-f5c5-4c75-bb6d-44e492c14048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b9f69ae5-4d9a-4774-a67b-2839ada7acdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b9f69ae5-4d9a-4774-a67b-2839ada7acdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_565343bc-8a5c-4473-8dba-81aaf92ba4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_565343bc-8a5c-4473-8dba-81aaf92ba4bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c4b64fae-3422-4bda-ab7c-a2c6fcbca035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c4b64fae-3422-4bda-ab7c-a2c6fcbca035" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3bac3ae5-8ab3-4c14-a63a-d5db91475f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3bac3ae5-8ab3-4c14-a63a-d5db91475f08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_09d80aab-1772-4d11-86dc-c3e30980a348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_09d80aab-1772-4d11-86dc-c3e30980a348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ea1cc41c-d8d7-4fed-b46c-13c19ee7185c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ea1cc41c-d8d7-4fed-b46c-13c19ee7185c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e58407c6-fa32-419b-96ac-b130cc27d806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e58407c6-fa32-419b-96ac-b130cc27d806" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8f41b50a-d462-4f9c-a8b3-04e00b958a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8f41b50a-d462-4f9c-a8b3-04e00b958a71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_34bb9420-5aa7-43e3-9e40-e7b9e693f74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_34bb9420-5aa7-43e3-9e40-e7b9e693f74a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5845a13b-f56b-40f4-a950-18dc9d6b5a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5845a13b-f56b-40f4-a950-18dc9d6b5a65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b20ee06f-aae9-4987-8ab8-2f0ee5a780b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b20ee06f-aae9-4987-8ab8-2f0ee5a780b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3c0c603-f181-4762-b45d-234c829acd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3c0c603-f181-4762-b45d-234c829acd36" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:href="dgx-20220930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8395ac9b-1f10-4430-bfca-f5ffb563b209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8395ac9b-1f10-4430-bfca-f5ffb563b209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8395ac9b-1f10-4430-bfca-f5ffb563b209_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8395ac9b-1f10-4430-bfca-f5ffb563b209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8395ac9b-1f10-4430-bfca-f5ffb563b209_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8395ac9b-1f10-4430-bfca-f5ffb563b209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bfec5567-6a2a-4358-b585-7bf81ef27c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bfec5567-6a2a-4358-b585-7bf81ef27c0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_6171cbbe-2b5d-4e20-937e-f64418ee0b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_6171cbbe-2b5d-4e20-937e-f64418ee0b69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_a987cf62-369d-4b50-aced-b90888937866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_a987cf62-369d-4b50-aced-b90888937866" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f1d55c5a-7ad0-486f-a023-3b97c8b29332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f1d55c5a-7ad0-486f-a023-3b97c8b29332" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_33526994-943f-42e2-a4fe-8299f5f0a8a7" xlink:href="dgx-20220930.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_33526994-943f-42e2-a4fe-8299f5f0a8a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7d88daf1-908a-409e-a74e-b06f2077a199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7d88daf1-908a-409e-a74e-b06f2077a199" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d88daf1-908a-409e-a74e-b06f2077a199_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7d88daf1-908a-409e-a74e-b06f2077a199" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d88daf1-908a-409e-a74e-b06f2077a199_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7d88daf1-908a-409e-a74e-b06f2077a199" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e007a8e1-af7b-4221-9107-dedfc8b68135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:to="loc_us-gaap_TradeNamesMember_e007a8e1-af7b-4221-9107-dedfc8b68135" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_b2ce32bf-ee83-43eb-a2f2-8f23d53b4681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_b2ce32bf-ee83-43eb-a2f2-8f23d53b4681" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="ifee1806954734f39a5a2cd72b9dd1787_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c192d43f-f2ed-4a87-95f6-d83a18c290f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3b19b273-d46b-4528-931f-d362bfbbf038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c192d43f-f2ed-4a87-95f6-d83a18c290f0" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3b19b273-d46b-4528-931f-d362bfbbf038" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_c192d43f-f2ed-4a87-95f6-d83a18c290f0" xlink:to="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_abe8e895-8635-40aa-a977-21968ab88d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_abe8e895-8635-40aa-a977-21968ab88d9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_abe8e895-8635-40aa-a977-21968ab88d9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_abe8e895-8635-40aa-a977-21968ab88d9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_abe8e895-8635-40aa-a977-21968ab88d9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f9f0b6fe-3514-4fa2-a0b8-2ba41165dfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_abe8e895-8635-40aa-a977-21968ab88d9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f9f0b6fe-3514-4fa2-a0b8-2ba41165dfa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_c287e7e7-cdd9-4d2c-914b-40d2c79a5298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9f0b6fe-3514-4fa2-a0b8-2ba41165dfa9" xlink:to="loc_us-gaap_LongTermDebtMember_c287e7e7-cdd9-4d2c-914b-40d2c79a5298" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d111f346-db8e-4794-93b0-dff75d9ae85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d111f346-db8e-4794-93b0-dff75d9ae85d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d111f346-db8e-4794-93b0-dff75d9ae85d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d111f346-db8e-4794-93b0-dff75d9ae85d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d111f346-db8e-4794-93b0-dff75d9ae85d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_830baa59-39da-48bc-9526-a094a6de0382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d111f346-db8e-4794-93b0-dff75d9ae85d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_830baa59-39da-48bc-9526-a094a6de0382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_fe9a413f-45e7-447c-bda7-bf5922061e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_830baa59-39da-48bc-9526-a094a6de0382" xlink:to="loc_us-gaap_FairValueHedgingMember_fe9a413f-45e7-447c-bda7-bf5922061e63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended" id="i2c12fc8213bc45bdb4f1bb0ccf9a431c_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:href="dgx-20220930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c2cec77e-4716-47e0-ae61-8de30b2f44f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c2cec77e-4716-47e0-ae61-8de30b2f44f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_eec6298a-f22b-40ec-a880-6015c3608d9d" xlink:href="dgx-20220930.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_eec6298a-f22b-40ec-a880-6015c3608d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_349f856f-ad9a-461d-9ae5-89f4566a3aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_349f856f-ad9a-461d-9ae5-89f4566a3aad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_4d352036-c026-47f2-ab87-d4133105939c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_4d352036-c026-47f2-ab87-d4133105939c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9abd6fa4-3890-41a6-b64f-671249b244e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9abd6fa4-3890-41a6-b64f-671249b244e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment_1fadc79d-cb46-48bc-848a-f0b2ccbd5a4d" xlink:href="dgx-20220930.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_AcceleratedShareRepurchasesPayment_1fadc79d-cb46-48bc-848a-f0b2ccbd5a4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_54628781-d1e5-4c92-9e9f-89288bcdba8c" xlink:href="dgx-20220930.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_54628781-d1e5-4c92-9e9f-89288bcdba8c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_388300a3-62d9-40be-a1d9-0ebc53e86b13" xlink:href="dgx-20220930.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_388300a3-62d9-40be-a1d9-0ebc53e86b13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a3e670fd-1636-4082-9890-64bbc23e6584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a3e670fd-1636-4082-9890-64bbc23e6584" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_5c539b46-cf98-49e6-b3c4-424ff26f70b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_5c539b46-cf98-49e6-b3c4-424ff26f70b2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a35a961c-5792-47a4-8355-994bd6aa26a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a35a961c-5792-47a4-8355-994bd6aa26a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:href="dgx-20220930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d3567cb1-7bf5-4a60-8148-c32a14af5314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d3567cb1-7bf5-4a60-8148-c32a14af5314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d3567cb1-7bf5-4a60-8148-c32a14af5314_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3567cb1-7bf5-4a60-8148-c32a14af5314" xlink:to="loc_us-gaap_EquityComponentDomain_d3567cb1-7bf5-4a60-8148-c32a14af5314_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3567cb1-7bf5-4a60-8148-c32a14af5314" xlink:to="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1cf8dd6d-31b7-4550-8978-c54a2ea40ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:to="loc_us-gaap_TreasuryStockMember_1cf8dd6d-31b7-4550-8978-c54a2ea40ab9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_56a75be8-4cdf-473a-a2a9-9d93455fabbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_56a75be8-4cdf-473a-a2a9-9d93455fabbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a215c4be-3550-421c-b75d-db0484e13386" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:to="loc_srt_OwnershipAxis_a215c4be-3550-421c-b75d-db0484e13386" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a215c4be-3550-421c-b75d-db0484e13386_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_a215c4be-3550-421c-b75d-db0484e13386" xlink:to="loc_srt_OwnershipDomain_a215c4be-3550-421c-b75d-db0484e13386_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5fd0ed3d-8a69-4133-82a8-83363f5c1c15" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_a215c4be-3550-421c-b75d-db0484e13386" xlink:to="loc_srt_OwnershipDomain_5fd0ed3d-8a69-4133-82a8-83363f5c1c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_49ae542a-89b8-456b-85e3-23d62b2ac430" xlink:href="dgx-20220930.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_5fd0ed3d-8a69-4133-82a8-83363f5c1c15" xlink:to="loc_dgx_UMassJointVentureMember_49ae542a-89b8-456b-85e3-23d62b2ac430" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_ade612a5-b4e8-4fac-8516-646e02f13857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_ade612a5-b4e8-4fac-8516-646e02f13857" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_ade612a5-b4e8-4fac-8516-646e02f13857_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_ade612a5-b4e8-4fac-8516-646e02f13857" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_ade612a5-b4e8-4fac-8516-646e02f13857_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_5d35d3d2-23bf-4448-ab17-a8207a2772f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_ade612a5-b4e8-4fac-8516-646e02f13857" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_5d35d3d2-23bf-4448-ab17-a8207a2772f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_98ff700c-9a0c-4ba2-aa2b-c97bd6cb9cbd" xlink:href="dgx-20220930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_5d35d3d2-23bf-4448-ab17-a8207a2772f9" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_98ff700c-9a0c-4ba2-aa2b-c97bd6cb9cbd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended" id="i3434b46212634ab48db0beaf03d3a433_SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_888f2658-52a3-4778-b97d-c4fe1a53461d" xlink:href="dgx-20220930.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f3ca6202-238d-425d-bef7-d800d315e5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_888f2658-52a3-4778-b97d-c4fe1a53461d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f3ca6202-238d-425d-bef7-d800d315e5e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_cb3e6794-3761-4295-aec1-c0e6180946a6" xlink:href="dgx-20220930.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_888f2658-52a3-4778-b97d-c4fe1a53461d" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_cb3e6794-3761-4295-aec1-c0e6180946a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventAxis_25376875-c86d-4273-847c-5e0a06cf9db3" xlink:href="dgx-20220930.xsd#dgx_TriggeringEventAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_cb3e6794-3761-4295-aec1-c0e6180946a6" xlink:to="loc_dgx_TriggeringEventAxis_25376875-c86d-4273-847c-5e0a06cf9db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain_25376875-c86d-4273-847c-5e0a06cf9db3_default" xlink:href="dgx-20220930.xsd#dgx_TriggeringEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dgx_TriggeringEventAxis_25376875-c86d-4273-847c-5e0a06cf9db3" xlink:to="loc_dgx_TriggeringEventDomain_25376875-c86d-4273-847c-5e0a06cf9db3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain_8c6b7f56-f8de-4788-b98b-ad523df2f603" xlink:href="dgx-20220930.xsd#dgx_TriggeringEventDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dgx_TriggeringEventAxis_25376875-c86d-4273-847c-5e0a06cf9db3" xlink:to="loc_dgx_TriggeringEventDomain_8c6b7f56-f8de-4788-b98b-ad523df2f603" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmendedRealEstateLeaseMember_1cf1499c-8401-4e99-a442-4557b15229a7" xlink:href="dgx-20220930.xsd#dgx_AmendedRealEstateLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_TriggeringEventDomain_8c6b7f56-f8de-4788-b98b-ad523df2f603" xlink:to="loc_dgx_AmendedRealEstateLeaseMember_1cf1499c-8401-4e99-a442-4557b15229a7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ie0d5eed8fde543a6949e031b4718785d_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_3c2b82e5-9979-4c1b-962d-d049a2626070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_3c2b82e5-9979-4c1b-962d-d049a2626070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_4112fc74-3264-4c2b-b910-c4f00b00a6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:to="loc_us-gaap_LitigationReserve_4112fc74-3264-4c2b-b910-c4f00b00a6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:to="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_95fbccb3-79b2-4287-90f3-ea4008aa224c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:to="loc_srt_LitigationCaseAxis_95fbccb3-79b2-4287-90f3-ea4008aa224c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_95fbccb3-79b2-4287-90f3-ea4008aa224c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_95fbccb3-79b2-4287-90f3-ea4008aa224c" xlink:to="loc_srt_LitigationCaseTypeDomain_95fbccb3-79b2-4287-90f3-ea4008aa224c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_95fbccb3-79b2-4287-90f3-ea4008aa224c" xlink:to="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_A401kPlanLawsuitMember_e076fcf6-8203-4c2a-9f16-548897d72f8d" xlink:href="dgx-20220930.xsd#dgx_A401kPlanLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:to="loc_dgx_A401kPlanLawsuitMember_e076fcf6-8203-4c2a-9f16-548897d72f8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DataSecurityIncidentMember_02964858-02e8-4ef7-be7a-5061017fd9a9" xlink:href="dgx-20220930.xsd#dgx_DataSecurityIncidentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:to="loc_dgx_DataSecurityIncidentMember_02964858-02e8-4ef7-be7a-5061017fd9a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c3f17fcc-fe57-48ea-9776-3c6be8bceac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:to="loc_us-gaap_LitigationStatusAxis_c3f17fcc-fe57-48ea-9776-3c6be8bceac9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c3f17fcc-fe57-48ea-9776-3c6be8bceac9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_c3f17fcc-fe57-48ea-9776-3c6be8bceac9" xlink:to="loc_us-gaap_LitigationStatusDomain_c3f17fcc-fe57-48ea-9776-3c6be8bceac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ea2f6b8f-13ed-4d47-a836-1ce0ccdad3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_c3f17fcc-fe57-48ea-9776-3c6be8bceac9" xlink:to="loc_us-gaap_LitigationStatusDomain_ea2f6b8f-13ed-4d47-a836-1ce0ccdad3b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_2d02721e-2c97-46b9-9f0c-11e5b48f2721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_ea2f6b8f-13ed-4d47-a836-1ce0ccdad3b7" xlink:to="loc_us-gaap_PendingLitigationMember_2d02721e-2c97-46b9-9f0c-11e5b48f2721" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1932904f-d151-4cd1-84ae-faf88adde9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1932904f-d151-4cd1-84ae-faf88adde9d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1932904f-d151-4cd1-84ae-faf88adde9d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1932904f-d151-4cd1-84ae-faf88adde9d9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1932904f-d151-4cd1-84ae-faf88adde9d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c4fe588-698c-4dab-863e-3693689780a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1932904f-d151-4cd1-84ae-faf88adde9d9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c4fe588-698c-4dab-863e-3693689780a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5be7953a-1578-4eb8-8872-cbff7683964e" xlink:href="dgx-20220930.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c4fe588-698c-4dab-863e-3693689780a4" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5be7953a-1578-4eb8-8872-cbff7683964e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fe766ea7-a33c-4342-a110-8d87037cf19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fe766ea7-a33c-4342-a110-8d87037cf19c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_267a2dfa-8612-43ab-a44a-9c859e9e1d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_267a2dfa-8612-43ab-a44a-9c859e9e1d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:to="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cb686de6-1b74-4c76-a831-13d28e22aba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cb686de6-1b74-4c76-a831-13d28e22aba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cb686de6-1b74-4c76-a831-13d28e22aba8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb686de6-1b74-4c76-a831-13d28e22aba8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cb686de6-1b74-4c76-a831-13d28e22aba8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb686de6-1b74-4c76-a831-13d28e22aba8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_99df59a1-77d9-40aa-8ed5-78a38b06b77f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:to="loc_us-gaap_SecuredDebtMember_99df59a1-77d9-40aa-8ed5-78a38b06b77f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_4027d6b3-395c-462f-bf0f-48f8bcc851e2" xlink:href="dgx-20220930.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_4027d6b3-395c-462f-bf0f-48f8bcc851e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1471a9a9-0e98-43b5-8d7d-eba28309f065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:to="loc_us-gaap_CreditFacilityAxis_1471a9a9-0e98-43b5-8d7d-eba28309f065" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1471a9a9-0e98-43b5-8d7d-eba28309f065_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1471a9a9-0e98-43b5-8d7d-eba28309f065" xlink:to="loc_us-gaap_CreditFacilityDomain_1471a9a9-0e98-43b5-8d7d-eba28309f065_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_84dada86-8f22-4372-9d0f-7ecaa1430b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1471a9a9-0e98-43b5-8d7d-eba28309f065" xlink:to="loc_us-gaap_CreditFacilityDomain_84dada86-8f22-4372-9d0f-7ecaa1430b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d3967d63-18d3-4698-9a45-9042443e67c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_84dada86-8f22-4372-9d0f-7ecaa1430b61" xlink:to="loc_us-gaap_LetterOfCreditMember_d3967d63-18d3-4698-9a45-9042443e67c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="if1f717f33ad74222afff04a1030e4adf_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_d11b56d0-a58c-4be7-8e9b-c683a46571ec" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_dgx_PercentageofNetRevenues_d11b56d0-a58c-4be7-8e9b-c683a46571ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0c811e5-fe2f-46f8-8c5e-ebd5c5ff6b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0c811e5-fe2f-46f8-8c5e-ebd5c5ff6b3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_487b82de-4407-4316-bc18-a475c27f6825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_OperatingIncomeLoss_487b82de-4407-4316-bc18-a475c27f6825" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_082d4507-b2d8-47b9-9738-a2bb670f29df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_082d4507-b2d8-47b9-9738-a2bb670f29df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9b321a1-b6b6-452b-8c56-84cac9d20ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9b321a1-b6b6-452b-8c56-84cac9d20ad5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_73a0c548-e0f0-4aa7-9f56-b4f4eeca23e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_73a0c548-e0f0-4aa7-9f56-b4f4eeca23e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a42f499f-fb6c-41f2-a60d-8b7b076e3d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a42f499f-fb6c-41f2-a60d-8b7b076e3d48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_50d6b7be-d262-41b8-96bc-69014f220308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_ProfitLoss_50d6b7be-d262-41b8-96bc-69014f220308" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8886652e-9537-4bc8-99c8-352dd9e08d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8886652e-9537-4bc8-99c8-352dd9e08d64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4dd431ab-8977-4a09-bf8e-af49a92c3b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_NetIncomeLoss_4dd431ab-8977-4a09-bf8e-af49a92c3b3c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_75be6552-509f-4581-a40d-eedb258c3a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_75be6552-509f-4581-a40d-eedb258c3a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_75be6552-509f-4581-a40d-eedb258c3a58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_75be6552-509f-4581-a40d-eedb258c3a58" xlink:to="loc_us-gaap_SegmentDomain_75be6552-509f-4581-a40d-eedb258c3a58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_75be6552-509f-4581-a40d-eedb258c3a58" xlink:to="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_6b2271c1-39e3-4fe7-bedc-d889afc6a985" xlink:href="dgx-20220930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_6b2271c1-39e3-4fe7-bedc-d889afc6a985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d6149674-00fc-468c-80f5-4899d5e327bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d6149674-00fc-468c-80f5-4899d5e327bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_2ea32467-d09c-4f37-8f95-8c7326e9580e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:to="loc_us-gaap_CorporateMember_2ea32467-d09c-4f37-8f95-8c7326e9580e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:to="loc_srt_RangeAxis_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58" xlink:to="loc_srt_RangeMember_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b8fe667f-ef76-4093-ab12-9aa333a095a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58" xlink:to="loc_srt_RangeMember_b8fe667f-ef76-4093-ab12-9aa333a095a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e64206c0-2051-45bd-9f89-562c8bf62d6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b8fe667f-ef76-4093-ab12-9aa333a095a7" xlink:to="loc_srt_MinimumMember_e64206c0-2051-45bd-9f89-562c8bf62d6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b555a75f-9ccb-4500-8d19-44f262df7f57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:to="loc_srt_ProductOrServiceAxis_b555a75f-9ccb-4500-8d19-44f262df7f57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b555a75f-9ccb-4500-8d19-44f262df7f57_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b555a75f-9ccb-4500-8d19-44f262df7f57" xlink:to="loc_srt_ProductsAndServicesDomain_b555a75f-9ccb-4500-8d19-44f262df7f57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b555a75f-9ccb-4500-8d19-44f262df7f57" xlink:to="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_cb65b6e0-19a1-429c-8bad-6a824487414c" xlink:href="dgx-20220930.xsd#dgx_RoutineClinicalTestingAndOtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_cb65b6e0-19a1-429c-8bad-6a824487414c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_5b8a4bdc-3df2-4c3c-9198-edd18865b2b6" xlink:href="dgx-20220930.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_COVID19TestingServicesMember_5b8a4bdc-3df2-4c3c-9198-edd18865b2b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_95ec4f03-f520-4cd2-911d-462afeba9614" xlink:href="dgx-20220930.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_95ec4f03-f520-4cd2-911d-462afeba9614" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_b8009e1b-bb37-4add-9f6e-d9c8033d57a8" xlink:href="dgx-20220930.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_b8009e1b-bb37-4add-9f6e-d9c8033d57a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_ed8b13bc-1cf3-4588-86e9-adbef374a6c7" xlink:href="dgx-20220930.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_AllotherservicesMember_ed8b13bc-1cf3-4588-86e9-adbef374a6c7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="i1528307498d54b99a86635ecd5362e7e_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_5939a909-68a4-4ff1-b2fb-88651423ace1" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:to="loc_dgx_PercentageofNetRevenues_5939a909-68a4-4ff1-b2fb-88651423ace1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_8b22db56-f5e4-4be9-bef5-2d389a9d9882" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_8b22db56-f5e4-4be9-bef5-2d389a9d9882" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2f3e89a8-759f-4d14-af3f-b90541a17885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2f3e89a8-759f-4d14-af3f-b90541a17885" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2f3e89a8-759f-4d14-af3f-b90541a17885_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2f3e89a8-759f-4d14-af3f-b90541a17885" xlink:to="loc_us-gaap_SegmentDomain_2f3e89a8-759f-4d14-af3f-b90541a17885_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2f3e89a8-759f-4d14-af3f-b90541a17885" xlink:to="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_e8a02909-7fb4-4ab7-9185-e90d5676d46b" xlink:href="dgx-20220930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_e8a02909-7fb4-4ab7-9185-e90d5676d46b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_8f7366f4-07a8-4dc1-bc90-a03ae11c92e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_8f7366f4-07a8-4dc1-bc90-a03ae11c92e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_srt_RangeAxis_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3" xlink:to="loc_srt_RangeMember_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6596604-6112-4830-97b5-b41f17965d6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3" xlink:to="loc_srt_RangeMember_b6596604-6112-4830-97b5-b41f17965d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ada18da-b1db-4ee8-99f6-379e35d6e531" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6596604-6112-4830-97b5-b41f17965d6d" xlink:to="loc_srt_MinimumMember_6ada18da-b1db-4ee8-99f6-379e35d6e531" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_067dc89d-52a1-490f-9b3c-31c7889538cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_us-gaap_SubsegmentsAxis_067dc89d-52a1-490f-9b3c-31c7889538cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_067dc89d-52a1-490f-9b3c-31c7889538cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_067dc89d-52a1-490f-9b3c-31c7889538cb" xlink:to="loc_us-gaap_SubsegmentsDomain_067dc89d-52a1-490f-9b3c-31c7889538cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_067dc89d-52a1-490f-9b3c-31c7889538cb" xlink:to="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_a56bfe13-b19f-4c4f-a017-806d91a83fd6" xlink:href="dgx-20220930.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_HealthcareInsurersMember_a56bfe13-b19f-4c4f-a017-806d91a83fd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_908bee7d-d264-4bc5-b7ec-12aa0e093d29" xlink:href="dgx-20220930.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_GovernmentPayersMember_908bee7d-d264-4bc5-b7ec-12aa0e093d29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_50de0ef6-5021-4d0a-b67d-97acc4d72e6d" xlink:href="dgx-20220930.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_ClientPayersMember_50de0ef6-5021-4d0a-b67d-97acc4d72e6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_a86fb6d4-14dd-4e4c-823b-cc43a3fbbab5" xlink:href="dgx-20220930.xsd#dgx_PatientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_PatientsMember_a86fb6d4-14dd-4e4c-823b-cc43a3fbbab5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_caa95640-5fa1-4737-abc4-f364e173b22a" xlink:href="dgx-20220930.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_DSBusinessesMember_caa95640-5fa1-4737-abc4-f364e173b22a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4fbe6b54-4636-46f7-948f-7009976933a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_srt_ProductOrServiceAxis_4fbe6b54-4636-46f7-948f-7009976933a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4fbe6b54-4636-46f7-948f-7009976933a5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4fbe6b54-4636-46f7-948f-7009976933a5" xlink:to="loc_srt_ProductsAndServicesDomain_4fbe6b54-4636-46f7-948f-7009976933a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4fbe6b54-4636-46f7-948f-7009976933a5" xlink:to="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_2c14f72c-6a96-48ca-b8c8-0d283b436399" xlink:href="dgx-20220930.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:to="loc_dgx_FeeforserviceMember_2c14f72c-6a96-48ca-b8c8-0d283b436399" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_ac19ab40-340e-4167-9268-d599188f3baa" xlink:href="dgx-20220930.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:to="loc_dgx_CapitatedMember_ac19ab40-340e-4167-9268-d599188f3baa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#TAXESONINCOMEDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended" id="i441adb8dd207418fbc7454aa7a730d35_TAXESONINCOMEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_54525227-2925-4cca-9c4e-208f232f1701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_54525227-2925-4cca-9c4e-208f232f1701" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_b2e5d55b-35ff-47b6-a4a8-39220b6f2a1d" xlink:href="dgx-20220930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_b2e5d55b-35ff-47b6-a4a8-39220b6f2a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_c708de87-753c-473b-842b-2f97a3ffd0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_c708de87-753c-473b-842b-2f97a3ffd0e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d4905e01-327a-4483-b9b4-8d2bc21467c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d4905e01-327a-4483-b9b4-8d2bc21467c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d4905e01-327a-4483-b9b4-8d2bc21467c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d4905e01-327a-4483-b9b4-8d2bc21467c4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d4905e01-327a-4483-b9b4-8d2bc21467c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d3b08c9b-7434-420a-bb56-392e34f4bccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d4905e01-327a-4483-b9b4-8d2bc21467c4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d3b08c9b-7434-420a-bb56-392e34f4bccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4acea291-bf9e-47c8-9e8c-b1cb632d680a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d3b08c9b-7434-420a-bb56-392e34f4bccc" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4acea291-bf9e-47c8-9e8c-b1cb632d680a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1fcc35aa-2b8e-428e-bca9-d20e4746efe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1fcc35aa-2b8e-428e-bca9-d20e4746efe3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1fcc35aa-2b8e-428e-bca9-d20e4746efe3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1fcc35aa-2b8e-428e-bca9-d20e4746efe3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1fcc35aa-2b8e-428e-bca9-d20e4746efe3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f9a523d-a24f-457e-9c58-0a6c1e73cd58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1fcc35aa-2b8e-428e-bca9-d20e4746efe3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f9a523d-a24f-457e-9c58-0a6c1e73cd58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_6c3960e5-92f8-46cd-8345-1e6af8e15a9b" xlink:href="dgx-20220930.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f9a523d-a24f-457e-9c58-0a6c1e73cd58" xlink:to="loc_dgx_Q2SolutionsMember_6c3960e5-92f8-46cd-8345-1e6af8e15a9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="i3d7a921b077b4aac95b9d5257711ffc7_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3cee085-eca5-44d0-8cdc-7fcb7e7d394a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3cee085-eca5-44d0-8cdc-7fcb7e7d394a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod_c8d95093-6caf-43b4-8daa-601760fbe6f1" xlink:href="dgx-20220930.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:to="loc_dgx_DebtInstrumentExtensionPeriod_c8d95093-6caf-43b4-8daa-601760fbe6f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_654d93f4-6694-4c5a-9485-274b67c784af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_654d93f4-6694-4c5a-9485-274b67c784af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:to="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2006f304-4258-49b4-9fc2-36cb7ae7708e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2006f304-4258-49b4-9fc2-36cb7ae7708e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2006f304-4258-49b4-9fc2-36cb7ae7708e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2006f304-4258-49b4-9fc2-36cb7ae7708e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2006f304-4258-49b4-9fc2-36cb7ae7708e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6a9bad08-6b9c-4974-9cdc-490c62881ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2006f304-4258-49b4-9fc2-36cb7ae7708e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6a9bad08-6b9c-4974-9cdc-490c62881ad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_495694c2-1cff-4784-a87b-54d51e1963f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6a9bad08-6b9c-4974-9cdc-490c62881ad1" xlink:to="loc_us-gaap_SubsequentEventMember_495694c2-1cff-4784-a87b-54d51e1963f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c0e4804b-958f-4e9a-b355-ffca9d229092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c0e4804b-958f-4e9a-b355-ffca9d229092" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c0e4804b-958f-4e9a-b355-ffca9d229092_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c0e4804b-958f-4e9a-b355-ffca9d229092" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c0e4804b-958f-4e9a-b355-ffca9d229092_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_00029723-3eed-43fc-b365-51945c7354c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c0e4804b-958f-4e9a-b355-ffca9d229092" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_00029723-3eed-43fc-b365-51945c7354c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_7e6c9071-09ef-492c-af3b-7b5f7ec45bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_00029723-3eed-43fc-b365-51945c7354c9" xlink:to="loc_us-gaap_SecuredDebtMember_7e6c9071-09ef-492c-af3b-7b5f7ec45bff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ed0eea81-8ccf-434b-8f83-a7fa15d2436c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_CreditFacilityAxis_ed0eea81-8ccf-434b-8f83-a7fa15d2436c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ed0eea81-8ccf-434b-8f83-a7fa15d2436c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ed0eea81-8ccf-434b-8f83-a7fa15d2436c" xlink:to="loc_us-gaap_CreditFacilityDomain_ed0eea81-8ccf-434b-8f83-a7fa15d2436c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ed0eea81-8ccf-434b-8f83-a7fa15d2436c" xlink:to="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMember_b7311348-29ab-4a12-ba34-f4638eb987ca" xlink:href="dgx-20220930.xsd#dgx_LoanCommitmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:to="loc_dgx_LoanCommitmentMember_b7311348-29ab-4a12-ba34-f4638eb987ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_8b0ddfc7-5eee-486e-ae97-5a4c64968b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:to="loc_us-gaap_LetterOfCreditMember_8b0ddfc7-5eee-486e-ae97-5a4c64968b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_917bbf0a-6174-4b23-b768-26cd22483db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_VariableRateAxis_917bbf0a-6174-4b23-b768-26cd22483db9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_917bbf0a-6174-4b23-b768-26cd22483db9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_917bbf0a-6174-4b23-b768-26cd22483db9" xlink:to="loc_us-gaap_VariableRateDomain_917bbf0a-6174-4b23-b768-26cd22483db9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_452694e0-f855-40dc-9af1-64a7ae9ad503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_917bbf0a-6174-4b23-b768-26cd22483db9" xlink:to="loc_us-gaap_VariableRateDomain_452694e0-f855-40dc-9af1-64a7ae9ad503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember_70118e01-0906-4dcb-bdde-517ab8ec6e81" xlink:href="dgx-20220930.xsd#dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_452694e0-f855-40dc-9af1-64a7ae9ad503" xlink:to="loc_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember_70118e01-0906-4dcb-bdde-517ab8ec6e81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_535560d6-8c0f-4acf-a90e-664a1845f8c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_srt_RangeAxis_535560d6-8c0f-4acf-a90e-664a1845f8c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_535560d6-8c0f-4acf-a90e-664a1845f8c7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_535560d6-8c0f-4acf-a90e-664a1845f8c7" xlink:to="loc_srt_RangeMember_535560d6-8c0f-4acf-a90e-664a1845f8c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_535560d6-8c0f-4acf-a90e-664a1845f8c7" xlink:to="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ab22014-3526-483d-ae59-498319782da1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:to="loc_srt_MinimumMember_0ab22014-3526-483d-ae59-498319782da1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_79e5cf08-d22b-464f-a642-b561ca694978" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:to="loc_srt_MaximumMember_79e5cf08-d22b-464f-a642-b561ca694978" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>dgx-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18deedef-37c4-4d4c-a3c0-638e0a05a492,g:42e53fcd-5b3b-4fb8-92f9-d69b94944099-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f478ab8e-e9d6-4ef6-b87e-544d46d5f53c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b94fd2d1-5957-4744-9803-4629d5d4cde2_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0db8f617-474c-48e4-bad1-25470aa68006_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_6a9190e4-3cb0-4bb1-b77f-89fece83b27b_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_34b1f935-4bc3-4b55-963f-6d130e39650d_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_a61466a7-6311-4f07-be59-52d82fc932b5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action lawsuits</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_415655ae-be50-4d2d-b4e6-f0f47025e1a4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_ccd50182-74cc-4389-955f-e6838893571f_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5727c6cb-84ba-4709-9c2c-7ba25fa1d7ab_terseLabel_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_label_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_documentation_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:href="dgx-20220930.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:to="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_4523def2-f147-4c56-a018-a96c95b1daa9_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20220930.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_730e81a3-ca86-4c1f-9a03-298d6f8d01cd_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_4296e044-9e8d-491f-8203-7f0fabb296eb_terseLabel_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period</link:label>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Extension Period</link:label>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod" xlink:href="dgx-20220930.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DebtInstrumentExtensionPeriod" xlink:to="lab_dgx_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_9b471942-a168-4844-b046-7b65ec4f2fb0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_65df228f-dc47-4e12-95f4-9a7a1cb9360f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_46f89f18-4b8c-4e03-8240-00b6f59aa2b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_0b324b55-39dc-499d-a536-1571a205127c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_26a5dc5a-41df-478d-aa7c-adb320ca14e4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5e959238-7ea2-47f3-a9e5-d0368db19b3e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2fc165a2-d90c-4341-9f6b-3d43884c1d69_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) decrease in investments and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_b3960117-65e7-4732-9a75-65058b8e37dc_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_799d74b8-8be1-4dfc-b5e2-58a38b6ae326_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f0249ce1-949d-4dba-af62-1a83f24d7a7b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9942012a-3e7e-4ebd-b202-bf7f495df547_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_59552ff1-8418-4588-98c7-38848274350c_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20220930.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_c0484431-6efd-4d96-9554-0a2107deeb7d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_409351d2-db67-4935-a668-08bf437c4ab3_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20220930.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_69161cd1-9cc1-421d-8d54-2906bc2d8182_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_5235557e-2709-4e5d-8f63-476376659b7e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_b554c3a6-1cde-4040-9bca-7defb99e8339_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_6c953680-0680-4c4e-9fba-850171fcb5f8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_2fd0cb5c-b228-453a-8f79-8a6144214a74_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_3198e0b1-9252-4188-9b40-21a38b54688f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_02feb867-be85-4ee6-a8aa-6cf58da3fc9c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ea94069a-1339-4777-a8fb-9fa9e056d165_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_e2956954-0c6f-466e-9056-ba95296a494c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0d20e159-70a6-44f8-af6f-2918389a00e6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_89ce8e5c-4070-4eb3-88b4-aca280f4a797_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_ba285ef0-38ef-4840-adec-35a9cb109a6c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DataSecurityIncidentMember_1b098b0c-d19a-43ff-b79f-df1104b44e1a_terseLabel_en-US" xlink:label="lab_dgx_DataSecurityIncidentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Security Incident</link:label>
    <link:label id="lab_dgx_DataSecurityIncidentMember_label_en-US" xlink:label="lab_dgx_DataSecurityIncidentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Security Incident [Member]</link:label>
    <link:label id="lab_dgx_DataSecurityIncidentMember_documentation_en-US" xlink:label="lab_dgx_DataSecurityIncidentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Security Incident</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DataSecurityIncidentMember" xlink:href="dgx-20220930.xsd#dgx_DataSecurityIncidentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DataSecurityIncidentMember" xlink:to="lab_dgx_DataSecurityIncidentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_cdb7e29a-b869-4bfd-81f9-08f50bd65213_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_36f1af5b-66d7-4e17-9ead-14588abe58c9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_66bec7cf-e8dd-4230-babd-897ff1dbeedb_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_1a4cac4a-d185-43d7-a044-d8b6ea4dc898_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_47df7ee8-a637-4b71-9e81-4df5a6fc5149_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_7d46cba0-e602-42ed-af37-54d9ab22159e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PackHealthLLCMember_7b7e7a4e-e3d5-473e-9dad-8d702a8575d8_terseLabel_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC</link:label>
    <link:label id="lab_dgx_PackHealthLLCMember_label_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC [Member]</link:label>
    <link:label id="lab_dgx_PackHealthLLCMember_documentation_en-US" xlink:label="lab_dgx_PackHealthLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember" xlink:href="dgx-20220930.xsd#dgx_PackHealthLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PackHealthLLCMember" xlink:to="lab_dgx_PackHealthLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_08c88aa9-7bb8-408d-b076-50cc5f76fcfe_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2d899102-96c0-4fe3-b8ae-2cc205dac00d_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_12fffabb-f7d8-4973-9802-9f53e08bde88_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_6080015e-7cc4-4326-9ad3-fd93bc51a85e_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_aeaffb60-1eb9-4345-ab5c-5be9171c22c9_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_d4f2cdb3-33ca-42bc-90aa-30bd4f8f9cac_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20220930.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bc13cbc1-18a2-4c82-a60c-63ed9e60a1c3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_865578b8-efd9-4d11-afdf-10a26d39b77c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f4e2a648-2dda-4b77-96ec-173ac98f9365_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d77d049-4ad6-449e-af51-9959e632a858_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_def8541f-8977-46c5-866c-51c21eb6579a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_7ba0f963-91f7-46eb-b7fe-357c09b4a45a_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3f77df7e-95a3-4fa3-832b-f55560f9c263_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_d3a8d5b5-9dbf-4aee-ab4e-cafe8fde8e7d_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1b100347-405f-414d-82cb-eee34dd5fe75_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4eb53e63-a42f-4e95-8e55-68f7b94baa46_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_5921a699-ddff-47ef-bda9-8487bc3e0238_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:href="dgx-20220930.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_490df471-e8fe-45f9-996a-73271c661a94_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_fafee1e5-3c4e-4a0e-b8d8-0a30812929a4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, purchase adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70ba3bfa-67f0-461e-a442-1f5341a57950_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c3dd1016-10d5-449f-bbb2-03e0c6040ba3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f76fca6b-4287-4fa3-94c8-9cc1af908641_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_c3147280-8940-47ab-888c-798128ffdc1d_terseLabel_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comparable Company Revenue Volatility</link:label>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_label_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Comparable Company Revenue Volatility [Member]</link:label>
    <link:label id="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_documentation_en-US" xlink:label="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Comparable Company Revenue Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:href="dgx-20220930.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:to="lab_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c1e7f388-33cd-4607-a003-e6a2e0b1c70e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0f6c6da3-f7fa-45d0-afc7-3e4eeb3e3a8c_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8442a681-ad19-4918-a4b6-d9ec16b587b8_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_81d40c6f-ca8e-4970-8723-37b438973775_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_8f1d738e-9b6c-4097-9a54-4927d96c309c_terseLabel_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of ownership interest sold</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_label_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_documentation_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:href="dgx-20220930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:to="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9f6f2d12-1eda-4328-8bad-7107163b59ee_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_800c4017-9223-4f1f-a20f-5ce11f1b5964_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_cb55f7a9-8dd4-4e39-a556-7f7cc67cbf1d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating income:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_59807194-c040-42ef-a167-82a83c805410_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_e422bd60-e543-4f7f-8486-06621684a1fd_terseLabel_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration payable</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_label_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_documentation_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:href="dgx-20220930.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:to="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b3109eee-d09f-4ce8-98e5-b4b02ca7fb69_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_2cbfc3fb-3b97-4585-bdfe-27ed0a0aa2db_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_caac0875-0131-4e3a-b515-619ce64d40ae_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20220930.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_12210271-ca04-4e98-bfe7-32dc9b1ce247_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Q2SolutionsMember_cd00648b-131d-4fd7-8e31-868d83e74fd0_terseLabel_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_label_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions [Member]</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_documentation_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember" xlink:href="dgx-20220930.xsd#dgx_Q2SolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Q2SolutionsMember" xlink:to="lab_dgx_Q2SolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_adb538a1-816f-4c16-bc70-310d84a9fabd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3a259d8d-dcf3-4c90-97f7-9d6bc0b8ee4c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_adcd50ff-b3bd-4c0c-89c7-080794d8af04_terseLabel_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_label_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_documentation_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:href="dgx-20220930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:to="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_e55156fc-73bb-4c83-927a-aa42f1222363_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to the estimated contingent consideration liability</link:label>
    <link:label id="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill and Intangible Assets</link:label>
    <link:label id="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill, Intangible Assets and Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:to="lab_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_27a48a7b-c3f9-4f50-ac9a-2884000fe07c_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_baae9370-6d1d-46cb-89f3-296ac04c9a9c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_c2cc37d2-2d42-4904-b268-b2e1e5506614_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20220930.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9da1c8fa-afb8-4013-9dd2-e52cf77d6e83_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2506a387-7d18-4034-a1c6-dff9bf50bdd2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_7fbcadb3-cb76-4de1-a51e-6fe38276a6d3_terseLabel_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase, percent of total value to be repurchased</link:label>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_label_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</link:label>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_documentation_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:href="dgx-20220930.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:to="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientsMember_beca4190-2b11-4a20-9870-1128db11d6cf_terseLabel_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients (including coinsurance and deductible responsibilities)</link:label>
    <link:label id="lab_dgx_PatientsMember_label_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:label id="lab_dgx_PatientsMember_documentation_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember" xlink:href="dgx-20220930.xsd#dgx_PatientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientsMember" xlink:to="lab_dgx_PatientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_a66ac7a8-c2f9-47df-b6f4-96c1e98bb256_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c3dc0d12-8c3b-42a8-86b4-1d228a27f43e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_7ab1ecb7-4045-4e62-bc0c-ea261fa75353_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c5092331-7d66-4ff4-bd2c-e4385ae1a16f_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_0d640964-157d-426a-9da7-1c9bd2c58891_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_beeeacb4-98bc-42d5-b4f4-94153360cd59_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ea458fc6-31ce-4aea-b210-322ea10a7b55_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_81c788e8-cb0f-4a8d-9802-c8446eab5ba0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_164b32bf-b0f3-4659-83b6-b647de9b307c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_cfc3535f-f43c-4851-9cdb-0fb34cff64d6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_996b2716-596f-4dc7-9f48-6a37d2bb2764_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_0963ba45-a2cb-425a-b307-91c59de7b681_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_de81fca0-6de5-4db1-9fed-16b847ce2a30_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20220930.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_db1fa7b5-0835-4464-b864-20b0e93961e2_terseLabel_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_label_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_documentation_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract" xlink:href="dgx-20220930.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DescriptionOfBusinessAbstract" xlink:to="lab_dgx_DescriptionOfBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9aba6c98-5f68-4a1d-a1ef-358fc38e07ab_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_8fc9ed49-1e12-457d-b6d3-d21d1e310156_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_0d9df3bb-14e2-44c7-84bd-78ea2ead1d0b_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_eab2d76d-0542-4314-bb51-c85792f8cf78_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related intangibles</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_6c802a37-0033-4a12-8e29-65978ec7f26a_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20220930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3ce8112d-2226-4fe9-852e-29fb3bae3b2b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_779df062-0755-41a4-915a-17e9955b3fe8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_171b420a-3d9c-4272-88ba-8e15c53883a1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d94a536b-ab56-41b0-95d2-7d0fc02591db_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6491fb76-9452-43b8-99e2-c6775434d0f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_d6571404-a089-44e6-b6c3-55e83568dd9c_terseLabel_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with purchases of treasury stock</link:label>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_label_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchased but Not yet Paid</link:label>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_documentation_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchased but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:href="dgx-20220930.xsd#dgx_TreasuryStockPurchasedbutNotyetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:to="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_5bcddb98-e7bb-4adc-81f3-d750da3abd20_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_11a6e6a8-892a-4337-8eab-4ead3115b59e_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="dgx-20220930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_b418fd19-0cc8-438e-893e-971dfb50ecab_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_66f08e45-c213-4019-8c8e-846682ae48e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9c792223-e9bf-4b78-96f4-ea02ad1697c0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_906b5651-3257-4285-b029-39e04967ed16_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06f85452-cd54-46a2-b0ec-bcbb5e7eecbc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_87446397-5180-4464-b46a-b1bbc44aa8bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_b509edf9-3565-4e40-860f-ab56c6e1f516_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_e25bfa89-2357-45bb-8b4c-2f1a32778523_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_d24ec067-651c-42d1-a178-4c4b00f41a9f_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:href="dgx-20220930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8366058c-aaf1-43c6-99d6-3b6152bcc020_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_42c0dd41-7053-48ed-94dc-591559cce501_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_6ea59f8c-6895-49be-b5a3-34a20160d7a5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, purchase adjustments</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_5a5377c0-9eac-424d-b1fb-f353ed8f8020_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_05573364-a992-4633-a7b9-cb10e9e70f62_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_806d878f-5577-44b7-b497-d190f335eb09_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f0172ec3-84d6-4b5f-b0e2-c8c8e3a689b1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_60fc5048-e243-4ee9-84e5-cc4fc81f9bf4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_b9d8badb-0723-453e-987e-7cab240bedca_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20220930.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_8922b11c-6522-4ee5-8ea6-9157a3afe3ba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fab90488-7942-4d9d-b71a-47fd713740b8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_0886960d-ea01-4a9a-9763-0e050c059244_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_9b5c6297-fe63-4c39-a28e-071438a99e5f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_8c24ce91-440d-44bd-9552-0777400890d2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8a974bf6-ce89-421d-91b5-ee54f8464985_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_58266680-cd1e-41cc-814b-07f18818f9dd_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, September 30, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_ed585547-f153-456c-9df5-9c7f2995f1c9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d51ef1bb-8ba2-4f28-8e54-e4f5d5c08d56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred gain on cash flow hedges, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39b8c9d7-6256-46b1-9a73-b2dd265b7edb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_947d8c65-9775-4ce6-9eae-8597e92a9c97_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAXES ON INCOME</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_52272a0a-8090-412b-93de-6263bab81b13_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fe58847b-4a7a-4ecc-88a3-d8ec64ef3b36_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c3200392-ff31-4f28-9ea1-7cf928d60f77_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_07167d6e-bc19-495b-9e42-5afa3badeed0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_ca67d4ba-8e6b-4637-a5ed-f17038c25b54_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_ffed5a5d-2379-4f18-bf9a-242a5ce56abe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_bc607e92-ec98-4e68-b519-4e2ea9dd27d3_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContingentConsiderationMember_49376f45-c4e9-4734-b83e-d5bd391ac2ac_terseLabel_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_label_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember" xlink:href="dgx-20220930.xsd#dgx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContingentConsiderationMember" xlink:to="lab_dgx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_96c5042e-bdb1-483d-af07-66a96275806b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fa0a8b56-38e4-432b-a620-18d05e5d7c7c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f61d5a59-ccb6-47f1-9736-e423ce498f22_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f2fa3664-8091-4df6-82c2-0fc6d759c449_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_67153225-bc25-44ff-9090-347f67a1a3d6_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ae69989f-c8bc-41e3-b4b9-80b56e9004e1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ae853fbf-4927-49d8-a61d-47adab8a08a7_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_185a9794-499b-4e9a-9aac-4253d2721673_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4fdfe6e7-f120-473b-b446-5257c5232b43_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_212712dc-f89a-4cda-a5c0-b90234f7ef33_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_2190a4c6-baf3-4679-b9e8-bb96ea76b566_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0f95fdaa-ce28-4918-aa29-24bcdea4e8ba_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a3918374-95af-4f60-859c-b5e5381d4a1b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_a67808ec-92bd-4654-be06-71856877339f_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_ff81ac25-21bc-4df7-8618-f3d8697930f9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_91665283-a6d3-4cfa-ad7b-dd7d957a979c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9c19df8d-f05d-45f1-8d97-a2f180e6a2c7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_375baacf-2f44-4170-a3a5-db724b8166ee_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_53988d85-b627-41d9-97fa-4d05f5dda038_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_29854453-3361-4593-a2d3-e8b16e51e57c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_244c9ec3-0085-4c9c-b27a-bba07006e098_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_b7686d2d-bbdc-44bd-b5ac-777a521c546b_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investment, before tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_384a0c92-ea0e-4b52-9083-4202fa7d1784_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_7b1b8ee5-323a-4244-90f4-8339e6115d3f_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_04a008fd-fcf0-4660-8696-159a0e4a9b29_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_feb92327-c3e5-44a7-838f-4802db9aeeec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b8971f18-2c43-4e57-ab65-f062bc46d638_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_0a59e481-a5aa-4af9-a841-2abcf13e87e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_6775db93-3905-4943-b28d-347dce25ea3d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock- shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_7f56253c-6604-4ecd-b7bc-0c0747867e01_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20220930.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e7df31ef-264f-4dec-8da3-7d2988d369cd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30831dfd-a478-4fc6-bcf2-93688e58b7c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bc10a071-00a4-42f9-b46e-1a630c90d873_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $29 and $31 as of September&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_31bd5916-8099-457b-be12-e9cba4444a1b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_eca3bacc-dd38-464a-9a4c-b235ae0a77bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_4fa2682d-2b6c-48d0-b6c1-dee42fdffb68_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_fc45c1b5-c65a-4799-a44e-75391435f59e_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:href="dgx-20220930.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_95854c70-de70-40fb-9e88-706b3b3916d5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_26e25eba-e229-491a-95b8-a8d2b2bc1f71_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_16a69a2e-b714-458a-9eeb-a07f7a956b23_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_47a05064-fed5-49b5-8458-0cb1719cc065_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_49a92b80-a062-4133-b07a-b29edbc8a4ab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_793f8823-d862-41b6-ace7-8cb21bf1cf95_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating (expense) income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_273b39d3-6173-4ddd-bd95-ceefb078116d_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating (expense) income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_6d9cc699-7cae-49be-b823-68d28bfed583_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_76381eb8-b1b1-4042-809e-a882e5761f81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_InventoryPurchaseAccountingAdjustments_adf7028c-ebd5-41dc-a074-60dd53a7d764_terseLabel_en-US" xlink:label="lab_dgx_InventoryPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, purchase adjustments</link:label>
    <link:label id="lab_dgx_InventoryPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_dgx_InventoryPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Purchase Accounting Adjustments</link:label>
    <link:label id="lab_dgx_InventoryPurchaseAccountingAdjustments_documentation_en-US" xlink:label="lab_dgx_InventoryPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InventoryPurchaseAccountingAdjustments" xlink:href="dgx-20220930.xsd#dgx_InventoryPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_InventoryPurchaseAccountingAdjustments" xlink:to="lab_dgx_InventoryPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_bec4ceff-b70d-4a0d-b0d8-d4328cb29310_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_b27df2f0-d457-4953-a950-194c8370e7b3_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20220930.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_fe567661-e6be-49bd-8640-e23c0d360721_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_fbdd8f15-afc3-411e-a823-bcbce60d7128_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1e488340-bcc8-444b-9eb8-ae82465d99a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33927b31-6e82-4576-bab9-6b745ad6a733_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1484d94a-fad7-47e8-8b15-f22137d43c27_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1993f35d-2a96-49d9-8d7b-2e1836054721_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_12170784-d9df-446f-8a99-db1da72e9ad1_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:href="dgx-20220930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_bedde60c-3d25-4563-a57a-10ea6d0f8d91_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f3567f90-8f21-4724-95e2-5e2976ccd252_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_A401kPlanLawsuitMember_782fd9d1-a29b-4946-acbc-fd144787791c_terseLabel_en-US" xlink:label="lab_dgx_A401kPlanLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan Lawsuit</link:label>
    <link:label id="lab_dgx_A401kPlanLawsuitMember_label_en-US" xlink:label="lab_dgx_A401kPlanLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan Lawsuit [Member]</link:label>
    <link:label id="lab_dgx_A401kPlanLawsuitMember_documentation_en-US" xlink:label="lab_dgx_A401kPlanLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_A401kPlanLawsuitMember" xlink:href="dgx-20220930.xsd#dgx_A401kPlanLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_A401kPlanLawsuitMember" xlink:to="lab_dgx_A401kPlanLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c9d658c6-11d2-445e-9e98-65ac2ffcb90b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards to be Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_46c4c583-6d73-4361-81a5-9174357c72a6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_214cdab2-b6f1-4317-a7c0-6161d82ebec1_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20220930.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LoanCommitmentMember_df722c25-5b50-44d8-9b2e-d8823dde8928_terseLabel_en-US" xlink:label="lab_dgx_LoanCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Commitment</link:label>
    <link:label id="lab_dgx_LoanCommitmentMember_label_en-US" xlink:label="lab_dgx_LoanCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Commitment [Member]</link:label>
    <link:label id="lab_dgx_LoanCommitmentMember_documentation_en-US" xlink:label="lab_dgx_LoanCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMember" xlink:href="dgx-20220930.xsd#dgx_LoanCommitmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LoanCommitmentMember" xlink:to="lab_dgx_LoanCommitmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_476627b0-653f-4c50-be96-ca739af7bec5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9f12093d-c94c-4f9f-aaf7-80bdb9fdb0ef_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_1daa4f81-aaed-4b10-8c75-1d91cfdcddcd_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c51d067a-8694-4784-b76c-0d8aabf8e5e2_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_65781f2a-cf23-4aad-baf6-e5bf0851ef72_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_7dca9730-3cd7-443f-a8a1-567a8942e89e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_0f6924a6-dc63-428d-8bf3-6e72c509c744_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e054f392-5eee-4663-bf23-eb1744fa69ae_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c1f4c468-1906-4214-bf73-e5866880dba8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_30e771f4-0903-4de2-b800-5f1306857095_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_5fe48bfe-5ed2-45a8-80c2-cad12778eb65_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4ac4474a-99b8-46cb-ba3d-9a21351064e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7021d81d-551e-4860-ad65-d126c027d220_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_f754c8b1-209f-4a15-bd8e-0131471e01b8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_5c4d6bd6-9473-46ab-ba93-cceb248381dd_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_920c54df-3656-4de3-8e8b-7c5fedfe83b7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_28ddf838-533a-4426-8571-39490ebcc977_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposition of joint venture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_908092d1-a420-4197-aabc-963a71387a8e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd7521bd-e925-451e-955b-a28c5c4aa690_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e4b7e9a6-9a99-4cce-9feb-a0aae1b817c6_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_e9d840aa-f68d-4698-87f7-a4354c2a6288_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_748f9db1-d240-424d-9485-c27b065f031f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1fbb5366-aa83-430b-bf74-4c200417562b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_32e06127-4b87-4169-91f2-06d6ebc8f803_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both September&#160;30, 2022 and December&#160;31, 2021; 162 shares issued as of both September&#160;30, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_420a04ea-fb3a-4d72-bbe2-10af4df8d39c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_3f57b5ba-04d5-4eac-94d5-6003cbe60557_terseLabel_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:href="dgx-20220930.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:to="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_262fae58-116d-4bee-8efc-150c4d9fbe7b_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_527ac2b5-24e8-4ba9-9279-6b9fe81da8f6_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d098e8bf-4a74-4a04-8f4e-d1e5fc6e1523_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_bccf49f6-c1b2-4f1e-8372-09ce6ec510c3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9bc84ef9-1084-4958-9ee9-7fe0fd8a4ca0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44b626fd-2cd3-41b0-bedf-bd7e77743227_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_edcf3351-1034-4efc-a5e9-1bb774396d9f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4eb0665a-1b5c-4899-b47d-63fd0e7d9fe8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d58030b8-8d92-46ff-9719-76313d9efba6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_927e9856-fac3-40cd-949c-f74ad0f1bbe2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_41c6d25a-f907-4606-82e6-2c6127278c36_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5a200688-95ec-4c53-a2e5-8770629f58d4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_edf2f886-b75b-43b7-a4b8-1b4a694dbd6a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_857d969a-cfd7-400d-9e27-335091736cf9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7599f0fa-0f8a-409c-b64d-bc0d4a23ff1f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_ce90c534-5d65-41b4-82b0-bbad188724ce_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_01cb20c2-0b03-435c-a0e4-9eb3ca43a718_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c0ad6b71-47f6-455e-8a0c-d1d5adb102d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8735a20d-e2ba-4e26-acdb-61749748b838_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c92572e1-dfdf-4084-84bf-7d04064a6ddd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_ef3c5275-af75-4386-89f7-9947ff19dd39_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aa3e9d71-456c-46c9-b3d8-40187b80403d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_71988670-9b6a-4487-b191-cc3bd2af85f5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6e85dc1d-378d-4285-ae79-80ffce9b41a0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_20f83370-299e-4c14-9963-30be96dad0eb_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_f5260178-7ded-468b-ad7e-18567ada824b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_75645628-e657-426a-aa57-64c867b6858f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Reporting Information by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_7fa0dcee-f18a-4c5f-9ce9-0160112638a7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2bbd05b2-ee32-47a2-ade2-080ed327df5c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_40889f54-a249-4e99-94eb-78062af498e8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_8046cab2-f69c-4ad5-a0cb-1e551ca4b16a_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_08a90095-210b-4453-975b-f914d0e1cdff_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7f4e7b4c-7d6e-429c-869c-4c11aefa1d84_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_d8cdbca3-6d2e-42ba-97bc-5bbc37e3c808_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_ad9783dc-403b-4c5e-994d-00c5d2af7952_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_add2ef72-edd8-444e-a3fa-80234ab923af_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7b7abe9e-cd71-462d-89c8-8ccfd03cfce1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_78457185-11d4-4146-9b2c-a491f3404054_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5643635a-605a-4118-843e-4da1f077abe3_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_474af435-4e85-4768-ab4c-181cd360c916_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_b95fee41-bb58-471e-8f9b-7d51283743fe_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_6504fc01-a9c0-4b6a-b07b-7ee9ff6edbca_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20220930.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8cb7163c-79bb-4a9a-88fb-afcc65118b27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0b54d3ea-a4a4-424e-91a1-76189a77a984_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value adjustments included in earnings - realized/unrealized</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e490ee9d-9aca-4937-be02-50e7cd22d786_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value adjustments included in earnings - realized/unrealized</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_7c3347d7-ff4d-4421-84ca-6c94c3c45425_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 48 and 43 shares as of September&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_30a2ebae-37e0-42ec-b9a6-9c2b400ce73e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7b709081-22ba-46a1-940c-4879691dcf37_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contingent consideration payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_42b1247c-f967-4f42-9723-1733b49a3243_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_76cbce07-d85a-480b-99bd-b0c91e4ac307_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f74d0d0d-518a-445a-9bf2-d53fb31a74a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d6a0339b-5e62-4fa1-9c69-fc5cc2403806_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TriggeringEventAxis_38645c09-fc02-4fd5-a2f5-0b41144330d5_terseLabel_en-US" xlink:label="lab_dgx_TriggeringEventAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Axis]</link:label>
    <link:label id="lab_dgx_TriggeringEventAxis_label_en-US" xlink:label="lab_dgx_TriggeringEventAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Axis]</link:label>
    <link:label id="lab_dgx_TriggeringEventAxis_documentation_en-US" xlink:label="lab_dgx_TriggeringEventAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventAxis" xlink:href="dgx-20220930.xsd#dgx_TriggeringEventAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TriggeringEventAxis" xlink:to="lab_dgx_TriggeringEventAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2964a8ec-e1af-47dc-b8c4-8d0a09e073bf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in available-for-sale debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_959e4136-0c9d-440e-b93c-fa48d7cee486_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_31d5c6b5-6149-47c0-9b44-eba126afa41c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_fc7d9cc4-b14a-438e-8596-16a0ba6d56ae_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_4f202fba-5bf8-402c-97dc-c8cdc13661e2_terseLabel_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from disposition of joint venture</link:label>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_label_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments, Gross</link:label>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_documentation_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:href="dgx-20220930.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:to="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5c6e452c-a9fa-4948-b6e8-6e8b170b8bc7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_07ab5e62-7ce0-44e8-9469-9d323e2a230f_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_05f0b8d6-2c66-4a30-8b0a-7254f5e31cb5_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20220930.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5dd1c766-899b-439f-afdf-12bff9af0834_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_f2916b21-293e-4776-b883-fc888650cd34_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:href="dgx-20220930.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:to="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b50fd454-e078-46b8-841b-e449574042f7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_99c8195d-9755-4348-823c-21dfbe174a07_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_64c02792-df17-45de-8432-468b2ef29dcf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_84eacb1e-79be-4fc0-a963-e428240b4b8a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_be741960-0d77-4c4b-a477-26857879bb15_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_27d20e31-0b36-4c1d-8ab4-09a51900442c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8e0131f8-820c-4228-84f0-7c6dd7c85a17_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_6b22ed68-3075-4028-b3a1-7a977d8991c7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_afe4ec04-a4c9-4686-b4d9-67410928a8b4_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TriggeringEventDomain_4b1a5ffd-3692-4d78-bed6-801455836064_terseLabel_en-US" xlink:label="lab_dgx_TriggeringEventDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Domain]</link:label>
    <link:label id="lab_dgx_TriggeringEventDomain_label_en-US" xlink:label="lab_dgx_TriggeringEventDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event [Domain]</link:label>
    <link:label id="lab_dgx_TriggeringEventDomain_documentation_en-US" xlink:label="lab_dgx_TriggeringEventDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Triggering Event</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain" xlink:href="dgx-20220930.xsd#dgx_TriggeringEventDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TriggeringEventDomain" xlink:to="lab_dgx_TriggeringEventDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_68d6f945-4b69-4f5c-b6b5-ac02962f86da_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_94dae773-4171-4137-b801-47b15e566799_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_93e81b0a-7bd6-45e3-a8b3-45ce8e3bcab8_terseLabel_en-US" xlink:label="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC and Labtech Diagnostics, LLC</link:label>
    <link:label id="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_label_en-US" xlink:label="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC and Labtech Diagnostics, LLC [Member]</link:label>
    <link:label id="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_documentation_en-US" xlink:label="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pack Health, LLC and Labtech Diagnostics, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:href="dgx-20220930.xsd#dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:to="lab_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_29e118e5-29c3-4372-8134-5b59d5061e8d_terseLabel_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpatentedTechnologyMember" xlink:to="lab_us-gaap_UnpatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_420bc739-a6bd-4aa8-ae72-422c9b27491b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_b155e956-6896-4da4-bbe1-d605edf64be1_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20220930.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a4bf18e2-789b-4d93-a6d6-7254d63ff838_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_14d67f46-862e-49e5-a508-e97bda6c7eef_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1ee5c9b7-e84a-4c63-8e00-6b825b0fdf80_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_8cad9ae9-770e-4860-b6b9-dcd5a0052754_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_94020f3e-acf3-47d8-ba8e-80b5308de730_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_727f9d2a-c808-4ccc-88a4-769db88f4a37_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7b5644a4-b7e6-470d-980c-fd391366a277_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineClinicalTestingAndOtherServicesMember_690263ff-8b37-4b2d-bfc5-225a60d1c7c3_terseLabel_en-US" xlink:label="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing and other services</link:label>
    <link:label id="lab_dgx_RoutineClinicalTestingAndOtherServicesMember_label_en-US" xlink:label="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing and other services [Member]</link:label>
    <link:label id="lab_dgx_RoutineClinicalTestingAndOtherServicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing and other services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:href="dgx-20220930.xsd#dgx_RoutineClinicalTestingAndOtherServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:to="lab_dgx_RoutineClinicalTestingAndOtherServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_665762a0-8ac0-47c4-912f-afbfdfcbac6d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_2f0239e5-6bf3-4628-afc8-68672a2f1c38_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a6ea25a4-7710-4bea-b6f0-07295fbbff43_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6f8bd78a-f506-4c51-aea2-56c9a419c1a1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6a6e35f6-a37a-46cb-9394-41903f4e2290_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_0efc51fa-883a-4d8f-8bb5-6b8cb6e8dacf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_260e80a8-329c-4ac6-9d0e-b3bf3b7eaeaf_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20220930.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_5c0a5056-c646-4f8f-bd33-d4ca40058cda_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:href="dgx-20220930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_6dc3460c-676e-4af0-8c18-ff992b360e44_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember_a59030e6-6e67-4d2d-9775-e771afeed8e2_terseLabel_en-US" xlink:label="lab_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper and Term Secured Overnight Financing Rate</link:label>
    <link:label id="lab_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember_label_en-US" xlink:label="lab_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper and Term Secured Overnight Financing Rate [Member]</link:label>
    <link:label id="lab_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember_documentation_en-US" xlink:label="lab_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper and Term Secured Overnight Financing Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember" xlink:href="dgx-20220930.xsd#dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember" xlink:to="lab_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_407e151e-d948-4a78-a3a1-6817726a0900_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_d5004b97-5aaa-42ed-bdcd-7c72db53b430_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e7fa2d87-cbb1-43a7-9474-616a11279e1d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ba40d964-bfcb-4dd0-b3e0-6733b62451d4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_81682d12-fb83-4dac-b3fb-c0d996df1929_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ecba4c2b-9e31-46ef-8cd8-95e188005bd8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b1ed3e04-5ee0-49f0-bd31-f81775bc1c3e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_b80618a2-0e5a-4577-bdd3-38a708a5e33b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c7ebbd60-f545-447e-948e-4e8ab9ff7330_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8c2c2847-6aa0-4ef4-bb02-ad521a9a81d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_0883de07-2332-467f-a280-67cf501d4c5d_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_280244dd-d873-407f-b551-4a57278272d0_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_84a1316a-179d-4668-88e5-b5cb5e98a04d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_67a6f124-5c5b-474b-9dcf-4ab10e87831e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_28ca5797-e681-454a-a7e8-3bf5b4bb0c94_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b93709fd-82a1-410d-9b5b-42013563b94b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2273256b-45a9-4775-97e6-beb831bb0a91_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_ee0e17ec-ad8e-491b-ba1e-fbfe5d679b4e_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_12b08085-00a9-4908-b3d4-4e00faa9584a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_ea26b79f-504b-4cdd-b9b6-49949323add4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b78fc1f-d560-424f-ace3-6a0cb07844de_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ae454929-ef49-40d9-8faf-0b8d794e18cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_5d330a92-91db-4f91-9657-3662cf507f87_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_e183bbf1-637b-4938-a2d3-9053c4e5451c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_74747f4c-390f-48d5-a951-74d7d2d90a29_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_a2b7339d-ddff-4253-b9c2-d41f8b2ea9fe_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_9cc327cc-9fda-4ee8-b9f3-c37ac2eaf940_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_df12e539-58d3-4c3e-abba-6570670986aa_terseLabel_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares to be received under accelerated share repurchase agreements at execution</link:label>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_label_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</link:label>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_documentation_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:href="dgx-20220930.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:to="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_0680ccb8-c737-4b7e-9cd3-db44a3a1b8ff_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate activities</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_3292bc38-a046-4c8f-89ca-cacbf5225911_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_a87442b7-47f5-44e0-87b7-44b7d8e13b7c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_90dabe2d-dc9e-4c4a-8ec7-1eacdab311de_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2fa95a54-6e89-4272-a3d2-295a76000554_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_bdffc2f5-64cb-401c-90e8-6fc3dd23def6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_bdc02bc9-1096-4183-8f53-8ff24b42b3d6_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20220930.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ae6bc30a-a82c-40f4-85ca-916c1d62e5db_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_0c30d927-d860-42d8-bde8-d15f855d8013_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_3a2cac73-ffd8-46dd-80fb-b69501415a34_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization remaining available</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_298b73d5-73a8-47c1-82c2-939ccacf2ac6_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_05e2d80b-fadf-4138-9fe1-a805c21b02cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AmendedRealEstateLeaseMember_4b931124-58ab-436c-b241-3dd362cd7050_terseLabel_en-US" xlink:label="lab_dgx_AmendedRealEstateLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Real Estate Lease</link:label>
    <link:label id="lab_dgx_AmendedRealEstateLeaseMember_label_en-US" xlink:label="lab_dgx_AmendedRealEstateLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Real Estate Lease [Member]</link:label>
    <link:label id="lab_dgx_AmendedRealEstateLeaseMember_documentation_en-US" xlink:label="lab_dgx_AmendedRealEstateLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Real Estate Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmendedRealEstateLeaseMember" xlink:href="dgx-20220930.xsd#dgx_AmendedRealEstateLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AmendedRealEstateLeaseMember" xlink:to="lab_dgx_AmendedRealEstateLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_803d78d1-82af-4e52-b985-cfad011c2b81_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9d5ee38-f4db-4cde-9cd7-93544ea0c74b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c3440051-2006-435a-8c6a-50c7596d3a22_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fe3fc293-bfda-44ab-8bf6-3cca7b6be4d0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_e77f4113-5965-4425-9ee7-09eb9a095003_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_290d48f0-6cfa-478e-9783-3704d701708d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_d5f1c425-c3f9-4c23-970f-5de93cb4f3dc_terseLabel_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, additions and issuances</link:label>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_label_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</link:label>
    <link:label id="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_documentation_en-US" xlink:label="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:href="dgx-20220930.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:to="lab_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_fb50afa9-9f05-4e95-bbc2-a22c55704d79_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ce746848-6465-4eb5-a841-d2b2589fc17d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9a86c87c-c3b8-4430-acc9-af2288bef83a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_1a78a161-c022-464d-b31a-988cca14dcbe_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_59570709-9b18-4fa3-b318-a06f89d430b0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0ca9ffe6-fec5-41a4-ac69-cc8e4f0913cb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_5345b4bc-6353-4e0c-b77b-e73d00ae7a7e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_c4093064-59af-4ee8-9c34-0dc8445525ca_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:href="dgx-20220930.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:to="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_0972371f-223f-4dc8-8e30-bf24ba23b1f6_netLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISPOSITION</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_5ce9432b-9c17-472d-aa73-b36fda111a94_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_a009182a-d322-4e03-95f8-1817c7b565e1_terseLabel_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC</link:label>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_label_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC [Member]</link:label>
    <link:label id="lab_dgx_LabtechDiagnosticsLLCMember_documentation_en-US" xlink:label="lab_dgx_LabtechDiagnosticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labtech Diagnostics, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember" xlink:href="dgx-20220930.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LabtechDiagnosticsLLCMember" xlink:to="lab_dgx_LabtechDiagnosticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1fc85815-0caf-430e-a809-9b77411403e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_a6a71815-3908-4820-ab3a-e4cd458d8fc9_terseLabel_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_label_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation [Member]</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_documentation_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember" xlink:href="dgx-20220930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ForeignCurrencyTranslationMember" xlink:to="lab_dgx_ForeignCurrencyTranslationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_8164adf7-8474-45bb-84aa-dcce7560e350_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_61d4c4fa-6ad0-4bb1-81b7-d77e5fa6bc15_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_af3989b6-9ac3-4f21-8fcd-deaf2ea32b53_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_27378686-55e1-4798-8b2c-284133e3eb5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_4b51fa23-df96-4f52-ad86-35f6b409266e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8a69a297-0410-4e7b-bd0f-ddaeba547e73_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_c0006820-af07-4a82-be54-160e83b81700_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_ab523e1e-bfc3-4688-a456-988a077cf402_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_45208b69-d5c3-46e0-ac78-d56459574029_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_361ba715-b0fc-4e16-bccc-d9f77089bf4d_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASRs</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements [Member]</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:href="dgx-20220930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:to="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_bad3ea35-a95d-4ee1-ad8c-f65906ace912_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b86597ce-cb89-4b02-b0d3-5f488897805c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_0f2fca9a-f1f4-4a63-b73d-94161830c022_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_01a1f493-14aa-46b2-82f8-3df51a3860c3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_63b897ac-38b3-4faf-a4b5-934ad5614995_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_53883f30-ffc3-4f21-903d-45e8878ae1d9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_5fb23a78-6c9f-48ca-a0b7-27dd7d794d15_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_0a3b8fa5-be09-4bb8-8281-574ed23612af_negatedLabel_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposition of joint venture</link:label>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_label_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Joint Venture</link:label>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_documentation_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture" xlink:href="dgx-20220930.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GainLossOnDispositionOfJointVenture" xlink:to="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0e588a19-269b-40a6-8644-1f68641b4b36_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesPayment_6134a329-6a00-4182-827f-559dd74312fb_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases, payment</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesPayment_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Payment</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesPayment_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment" xlink:href="dgx-20220930.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchasesPayment" xlink:to="lab_dgx_AcceleratedShareRepurchasesPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_c13121c8-a421-4ae5-8727-09d5718d47c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_dace0f58-28e0-406a-aba9-0b171d7d7ede_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Other</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1283045f-c2c9-4215-afa2-8a39c1be2c4d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b82fdc9d-a3fe-459d-9ceb-ed470a3d571d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_5a89893b-95db-4e3d-b0c8-9c8e913dd7bf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_24b9ba4f-a199-4bc7-a085-0dfb6cbc97a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef84cae7-c76e-4145-b7d4-0d7c213ab2f0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b8b055ec-92dd-4ecc-ad6b-0b972c38e2f2_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_39d6f399-787a-4b48-b291-6c1f4e2a62fa_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_d099063e-d97d-43e2-b3fb-6a42a1fa5d77_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_64b96977-8fc0-4ba3-93d6-e8adb8fd84d6_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_6839039e-fcf2-4905-8cb1-158356eb1367_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b17d237e-6adc-4083-8057-69c461af154c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6b51c2a3-eb98-4d07-aa91-3dc8961c63ea_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d8837591-c494-46c1-8b9d-73a42e6a3f8c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_aa9ea76d-c494-41f4-8d28-d56d54fd348a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2c04cc30-96ea-4f33-bb14-73093a41ed47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_253b7301-0430-4435-8161-8199f4f15970_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:href="dgx-20220930.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d4177a2a-b203-49a4-8372-b0fbc73f4d3c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_275f8f5f-6d8b-4ccb-b632-3ba43cf55362_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_41b42b9c-3832-409c-ab42-86df4a827371_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f2c6b1de-e9ce-4c08-95de-d652b7ec8e69_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_deab2ac0-f1ea-4407-abd9-4ca5a1b48084_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_7f84c12f-1cef-4c14-8b17-34e94e9f6279_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_fc4264e0-3a5a-4475-b6cb-cf93f72289b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_3ce9f1b1-6d25-48f2-8ec4-2eab4ba7f293_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7e73caa2-cc40-4f8b-9bf5-188e8ef2ff8a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fc707c8b-d7ea-46f2-94d1-9ddaf2958d9b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f4bdaa3a-f7ee-4e81-8ac1-93676f38e754_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3e2efd79-a6f2-476b-a395-95a8a5c9d338_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>dgx-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18deedef-37c4-4d4c-a3c0-638e0a05a492,g:42e53fcd-5b3b-4fb8-92f9-d69b94944099-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cdf0bd40-cbe3-4841-b0a3-80f62d623dc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_DocumentType_cdf0bd40-cbe3-4841-b0a3-80f62d623dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_f06983c2-ae87-4bcf-905e-637d003d8a4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_DocumentQuarterlyReport_f06983c2-ae87-4bcf-905e-637d003d8a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4d5bad02-a2c4-4a95-b205-8ebafb68fbdc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_DocumentPeriodEndDate_4d5bad02-a2c4-4a95-b205-8ebafb68fbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c6cf1433-f115-4fa5-8d5b-67c87fe032db" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_DocumentTransitionReport_c6cf1433-f115-4fa5-8d5b-67c87fe032db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bd845af6-c166-4e59-a0ea-5549f01b7da7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityFileNumber_bd845af6-c166-4e59-a0ea-5549f01b7da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0b2ae669-db25-4042-bc62-abb5169af1ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityRegistrantName_0b2ae669-db25-4042-bc62-abb5169af1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0e0c2808-135b-4252-b465-d9c09928ce98" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityCentralIndexKey_0e0c2808-135b-4252-b465-d9c09928ce98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9fd78513-6576-406d-9572-1f41bc932f32" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_CurrentFiscalYearEndDate_9fd78513-6576-406d-9572-1f41bc932f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_66212ed9-9ec0-4ed7-b30b-96a0ef79518c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_DocumentFiscalYearFocus_66212ed9-9ec0-4ed7-b30b-96a0ef79518c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_282b01c4-732f-45c1-b5c4-fdfe4866f537" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_282b01c4-732f-45c1-b5c4-fdfe4866f537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5d1cf886-d842-419b-a8a2-3f2a3867f637" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_AmendmentFlag_5d1cf886-d842-419b-a8a2-3f2a3867f637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6d3db1ea-1879-451b-959f-2e81e7d70e9b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6d3db1ea-1879-451b-959f-2e81e7d70e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_28540cb7-4c9d-46be-b36d-0c858574466f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityTaxIdentificationNumber_28540cb7-4c9d-46be-b36d-0c858574466f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5535fb42-c8d1-41a4-914c-5e23d61989d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityAddressAddressLine1_5535fb42-c8d1-41a4-914c-5e23d61989d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_76f6e9d1-e2d6-4951-859a-8f2176a23b62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityAddressCityOrTown_76f6e9d1-e2d6-4951-859a-8f2176a23b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_130ae38e-0eb8-495e-980d-e2955cdacec1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityAddressStateOrProvince_130ae38e-0eb8-495e-980d-e2955cdacec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ec87af7c-687d-47ce-b910-c0a2ea2d5dbb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityAddressPostalZipCode_ec87af7c-687d-47ce-b910-c0a2ea2d5dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b34947a7-5534-4d89-8598-b10cc5dad2bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_CityAreaCode_b34947a7-5534-4d89-8598-b10cc5dad2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_54b62bd2-79aa-4cab-bd84-abecfe680efa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_LocalPhoneNumber_54b62bd2-79aa-4cab-bd84-abecfe680efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4df3dd7f-725d-43e4-848e-40cb30c3a007" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_Security12bTitle_4df3dd7f-725d-43e4-848e-40cb30c3a007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5c948398-c083-4b6f-8f6c-5b850dee9343" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_TradingSymbol_5c948398-c083-4b6f-8f6c-5b850dee9343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_788a6492-4726-45e9-8ba6-16455aee0101" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_SecurityExchangeName_788a6492-4726-45e9-8ba6-16455aee0101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2e7cd952-a374-4e1d-acdf-2d415e08cf02" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityCurrentReportingStatus_2e7cd952-a374-4e1d-acdf-2d415e08cf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_49798bbf-5b09-4044-b480-30f5ec71f621" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityInteractiveDataCurrent_49798bbf-5b09-4044-b480-30f5ec71f621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_07d75c12-2a31-4144-a63a-362fb0f21543" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityFilerCategory_07d75c12-2a31-4144-a63a-362fb0f21543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_fddcee42-5eaa-4887-b6a5-496b0676953e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntitySmallBusiness_fddcee42-5eaa-4887-b6a5-496b0676953e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7a8bcc14-f1d2-4340-94ac-d3fef22129b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityEmergingGrowthCompany_7a8bcc14-f1d2-4340-94ac-d3fef22129b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_54772b9b-6535-466c-96ec-08226ffbd314" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityShellCompany_54772b9b-6535-466c-96ec-08226ffbd314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f049e667-b974-4b93-b4e1-8f47c96d8388" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200744b9-0af2-43f5-8f10-00629ef555e0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f049e667-b974-4b93-b4e1-8f47c96d8388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b5a40638-8614-495d-baec-79a3f67c4fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b5a40638-8614-495d-baec-79a3f67c4fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_7e41b66f-ea98-4969-a9d8-4bc977e9a064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_CostOfRevenueAbstract_7e41b66f-ea98-4969-a9d8-4bc977e9a064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_cfe76ec9-19ae-4cd1-938c-574792896b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7e41b66f-ea98-4969-a9d8-4bc977e9a064" xlink:to="loc_us-gaap_CostOfRevenue_cfe76ec9-19ae-4cd1-938c-574792896b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cba424c9-b46d-4576-9f89-fa43bff87270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7e41b66f-ea98-4969-a9d8-4bc977e9a064" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cba424c9-b46d-4576-9f89-fa43bff87270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cb0b3b38-f556-4d93-ba64-11c7430003c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7e41b66f-ea98-4969-a9d8-4bc977e9a064" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cb0b3b38-f556-4d93-ba64-11c7430003c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_5f55dcb4-ec6f-40ab-bb16-e0dca9dcde2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7e41b66f-ea98-4969-a9d8-4bc977e9a064" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_5f55dcb4-ec6f-40ab-bb16-e0dca9dcde2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_31714257-1b21-46c8-83be-f36dc42c4a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_CostsAndExpenses_31714257-1b21-46c8-83be-f36dc42c4a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4476b9cb-532f-4116-87d5-f5fd5f05fc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_OperatingIncomeLoss_4476b9cb-532f-4116-87d5-f5fd5f05fc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_034ebcff-6ff9-4da1-b780-62491c975f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_034ebcff-6ff9-4da1-b780-62491c975f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ea56382d-022d-4867-a9c4-21b4ff8a941c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_034ebcff-6ff9-4da1-b780-62491c975f79" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ea56382d-022d-4867-a9c4-21b4ff8a941c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ae3d52a8-2457-4ff1-89b3-8ba57654ebb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_034ebcff-6ff9-4da1-b780-62491c975f79" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ae3d52a8-2457-4ff1-89b3-8ba57654ebb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9f0c6a6e-5edc-4a79-8d11-5d338d5af3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_034ebcff-6ff9-4da1-b780-62491c975f79" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9f0c6a6e-5edc-4a79-8d11-5d338d5af3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ef432f26-a92d-4ddb-a249-4ecd6a00bbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ef432f26-a92d-4ddb-a249-4ecd6a00bbbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b930d04d-8992-40aa-9c43-a52a456ef65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b930d04d-8992-40aa-9c43-a52a456ef65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c4d2eb15-6c00-4013-a37d-acca3ea48f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c4d2eb15-6c00-4013-a37d-acca3ea48f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eae33373-62ab-471c-9cc2-5d26d0bcde80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_ProfitLoss_eae33373-62ab-471c-9cc2-5d26d0bcde80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c9c2c58c-a742-4911-95a8-455fe49f1cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c9c2c58c-a742-4911-95a8-455fe49f1cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d8894098-9dee-4a3b-923d-bbdc47b97724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_NetIncomeLoss_d8894098-9dee-4a3b-923d-bbdc47b97724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1e2288ff-397c-4786-881c-c547931fd908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_56318182-63f1-459c-ba79-b808610a3b01" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1e2288ff-397c-4786-881c-c547931fd908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2a268c5c-e5a6-4818-ae80-738d5db9c18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e2288ff-397c-4786-881c-c547931fd908" xlink:to="loc_us-gaap_EarningsPerShareBasic_2a268c5c-e5a6-4818-ae80-738d5db9c18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_44a7dd6e-dcc0-4325-a4e3-45411219f0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e2288ff-397c-4786-881c-c547931fd908" xlink:to="loc_us-gaap_EarningsPerShareDiluted_44a7dd6e-dcc0-4325-a4e3-45411219f0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_92b0d444-65cb-412c-abbe-127c97016efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e2288ff-397c-4786-881c-c547931fd908" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_92b0d444-65cb-412c-abbe-127c97016efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf2dce70-3524-4803-81ef-719976b76b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1e2288ff-397c-4786-881c-c547931fd908" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bf2dce70-3524-4803-81ef-719976b76b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0e11b5c3-c1cb-4a9b-9602-4b7fc83153b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bce9a78f-cf2a-4832-9283-b0ac7e39b0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0e11b5c3-c1cb-4a9b-9602-4b7fc83153b7" xlink:to="loc_us-gaap_ProfitLoss_bce9a78f-cf2a-4832-9283-b0ac7e39b0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_804d2d25-7fe3-4f7b-8f51-f8659d5fe1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0e11b5c3-c1cb-4a9b-9602-4b7fc83153b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_804d2d25-7fe3-4f7b-8f51-f8659d5fe1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_411c26fa-cffe-4751-83bf-920e65e16578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_804d2d25-7fe3-4f7b-8f51-f8659d5fe1b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_411c26fa-cffe-4751-83bf-920e65e16578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a5636e14-aaf0-4cee-a841-a0e9c6433bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_804d2d25-7fe3-4f7b-8f51-f8659d5fe1b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a5636e14-aaf0-4cee-a841-a0e9c6433bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ac58a893-ccda-45bf-b5c4-53581713c2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_804d2d25-7fe3-4f7b-8f51-f8659d5fe1b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ac58a893-ccda-45bf-b5c4-53581713c2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a8d299b4-ac9c-4944-a09b-232ca0480d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_804d2d25-7fe3-4f7b-8f51-f8659d5fe1b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a8d299b4-ac9c-4944-a09b-232ca0480d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9cec6d84-3285-44ba-a6ec-2119dd43fcef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0e11b5c3-c1cb-4a9b-9602-4b7fc83153b7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9cec6d84-3285-44ba-a6ec-2119dd43fcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a6ea3a1b-4543-4503-9880-fb9eb19f07cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0e11b5c3-c1cb-4a9b-9602-4b7fc83153b7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a6ea3a1b-4543-4503-9880-fb9eb19f07cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_66d7ecd9-f555-4e1d-aed6-2138e1654e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0e11b5c3-c1cb-4a9b-9602-4b7fc83153b7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_66d7ecd9-f555-4e1d-aed6-2138e1654e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_33acb153-b1b1-48a2-90a2-55654cd1b11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33acb153-b1b1-48a2-90a2-55654cd1b11d" xlink:to="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fc487d41-8ace-4578-b620-77c95b4dfc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fc487d41-8ace-4578-b620-77c95b4dfc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a55820f4-80bb-4093-9dc1-c2d272a5dd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a55820f4-80bb-4093-9dc1-c2d272a5dd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cf7d4ccc-66ce-4108-bfc5-c29d24683e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_InventoryNet_cf7d4ccc-66ce-4108-bfc5-c29d24683e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_67cadc4a-b6af-49e4-a4fe-5019718c9683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_67cadc4a-b6af-49e4-a4fe-5019718c9683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d05f67d2-ef49-417d-b8f9-8cccd18abd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_AssetsCurrent_d05f67d2-ef49-417d-b8f9-8cccd18abd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_785d5eab-b28f-4a11-bd6a-5a7b180c6da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_785d5eab-b28f-4a11-bd6a-5a7b180c6da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d70f6163-05ba-4184-8965-ae33d9d8812d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d70f6163-05ba-4184-8965-ae33d9d8812d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0f7680a-f143-4e42-a3d7-4d6d8fc55082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_Goodwill_c0f7680a-f143-4e42-a3d7-4d6d8fc55082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2fa6b22d-fb09-486b-9dfa-e74ca769f4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2fa6b22d-fb09-486b-9dfa-e74ca769f4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_9c99a41c-e905-4efa-9e30-88bd6fa4b084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_EquityMethodInvestments_9c99a41c-e905-4efa-9e30-88bd6fa4b084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e8bb9fb2-38b4-4cb4-8622-b12aef821487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e8bb9fb2-38b4-4cb4-8622-b12aef821487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6126a56e-2c0b-4cf6-b739-236343768265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3a95919d-c004-4b33-a2ed-35dffbb2e83b" xlink:to="loc_us-gaap_Assets_6126a56e-2c0b-4cf6-b739-236343768265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_33acb153-b1b1-48a2-90a2-55654cd1b11d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_09e9338d-5415-440a-a9f8-d6754f12ef31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_09e9338d-5415-440a-a9f8-d6754f12ef31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d046ba30-e773-45ea-85aa-c5ec5bd98d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_LongTermDebtCurrent_d046ba30-e773-45ea-85aa-c5ec5bd98d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a1a86850-9d27-45e2-8adc-fa9cb584be7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a1a86850-9d27-45e2-8adc-fa9cb584be7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cce71e6f-ee99-490b-b498-d51d1d252a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_LiabilitiesCurrent_cce71e6f-ee99-490b-b498-d51d1d252a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0c48be35-edd2-4d7f-b1c9-d251fbc3e573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0c48be35-edd2-4d7f-b1c9-d251fbc3e573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_11be76b4-2624-4956-971f-e98afafa1de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_11be76b4-2624-4956-971f-e98afafa1de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_39a09cdc-72ab-466b-b13f-8583f93c4eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_39a09cdc-72ab-466b-b13f-8583f93c4eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d63651cc-2d4d-4c97-b7bb-22a88697259b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d63651cc-2d4d-4c97-b7bb-22a88697259b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3e442e34-d5cc-480a-ab04-50fbda6e781c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3e442e34-d5cc-480a-ab04-50fbda6e781c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4f8f812d-bf12-4008-afbc-5e83fbe58793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4f8f812d-bf12-4008-afbc-5e83fbe58793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4f8f812d-bf12-4008-afbc-5e83fbe58793" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_50908357-7ae2-47fe-aa22-36ad40c40a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:to="loc_us-gaap_CommonStockValue_50908357-7ae2-47fe-aa22-36ad40c40a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0bd06cdf-07de-4d5d-801a-526b3db4db78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0bd06cdf-07de-4d5d-801a-526b3db4db78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3076eeaa-9991-46ec-80e2-9a8f59a7f6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3076eeaa-9991-46ec-80e2-9a8f59a7f6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7df816c7-6502-4fcc-9cc8-aa1cfed7c241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7df816c7-6502-4fcc-9cc8-aa1cfed7c241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_33647d14-4766-43ac-9ee3-f90753f1b602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:to="loc_us-gaap_TreasuryStockValue_33647d14-4766-43ac-9ee3-f90753f1b602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd64dbeb-27bf-49e9-9c5d-1014c4ad2f70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2d30a079-4f5c-4624-b8d5-9b01afb9492d" xlink:to="loc_us-gaap_StockholdersEquity_cd64dbeb-27bf-49e9-9c5d-1014c4ad2f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_6fe88400-ce14-437e-87b5-df8165ead2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4f8f812d-bf12-4008-afbc-5e83fbe58793" xlink:to="loc_us-gaap_MinorityInterest_6fe88400-ce14-437e-87b5-df8165ead2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8064f243-1b34-4ee7-9106-f47c72bec80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4f8f812d-bf12-4008-afbc-5e83fbe58793" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8064f243-1b34-4ee7-9106-f47c72bec80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_720a6d28-9a87-4c21-b005-861a64f81972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f54aaa4-2b88-42e0-a15a-5a62551410ba" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_720a6d28-9a87-4c21-b005-861a64f81972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b58903a0-9a90-4574-b08d-1c6e10328dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b7a3634e-76d4-4b63-9bc2-b21a189a7944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b58903a0-9a90-4574-b08d-1c6e10328dc3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b7a3634e-76d4-4b63-9bc2-b21a189a7944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_309f70d1-8a7f-4555-aaa7-1236a57d93f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b58903a0-9a90-4574-b08d-1c6e10328dc3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_309f70d1-8a7f-4555-aaa7-1236a57d93f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_89a9f86d-1691-49e7-a063-6d5300afd109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b58903a0-9a90-4574-b08d-1c6e10328dc3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_89a9f86d-1691-49e7-a063-6d5300afd109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7608e43b-e2d8-43fe-9bce-a4d5336bd897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b58903a0-9a90-4574-b08d-1c6e10328dc3" xlink:to="loc_us-gaap_CommonStockSharesIssued_7608e43b-e2d8-43fe-9bce-a4d5336bd897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_61c64069-286c-4af8-b645-61aab8275561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b58903a0-9a90-4574-b08d-1c6e10328dc3" xlink:to="loc_us-gaap_TreasuryStockShares_61c64069-286c-4af8-b645-61aab8275561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_39e99247-2e27-4d69-ae69-77f3050ff5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_39e99247-2e27-4d69-ae69-77f3050ff5dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_26fcac17-c6ea-4556-97a4-d92f032f1414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_26fcac17-c6ea-4556-97a4-d92f032f1414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d45748ae-b60f-4fc9-b3ba-11d4bec21174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_26fcac17-c6ea-4556-97a4-d92f032f1414" xlink:to="loc_us-gaap_ProfitLoss_d45748ae-b60f-4fc9-b3ba-11d4bec21174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_26fcac17-c6ea-4556-97a4-d92f032f1414" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8105ae3b-dce8-416a-a35e-351c4f0037af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8105ae3b-dce8-416a-a35e-351c4f0037af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_bc9ed5da-74ee-4fbf-81e4-f123e471afda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_bc9ed5da-74ee-4fbf-81e4-f123e471afda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6c9a5ef3-d9ce-4852-bbd5-91914d218fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6c9a5ef3-d9ce-4852-bbd5-91914d218fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_acfbb897-f9e9-4bdf-bc9f-a2869d487f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:to="loc_us-gaap_ShareBasedCompensation_acfbb897-f9e9-4bdf-bc9f-a2869d487f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture_54f81e0d-7c84-44af-b7a2-947543e23562" xlink:href="dgx-20220930.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:to="loc_dgx_GainLossOnDispositionOfJointVenture_54f81e0d-7c84-44af-b7a2-947543e23562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_517cf45c-1d77-4b7c-8f95-cd3434b99283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_73d1506e-af00-4dc4-9fd3-6dda3c6e5f09" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_517cf45c-1d77-4b7c-8f95-cd3434b99283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0813feb4-8071-4ea7-b80d-ef55c8104241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_26fcac17-c6ea-4556-97a4-d92f032f1414" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0813feb4-8071-4ea7-b80d-ef55c8104241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_db7a9025-39ff-4f2b-9cd0-9c1b5325e456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0813feb4-8071-4ea7-b80d-ef55c8104241" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_db7a9025-39ff-4f2b-9cd0-9c1b5325e456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4c53fb31-59fa-4f1b-9693-d9cf14734cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0813feb4-8071-4ea7-b80d-ef55c8104241" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4c53fb31-59fa-4f1b-9693-d9cf14734cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_4c0dbbc6-095f-4561-b2d3-294a58fa3afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0813feb4-8071-4ea7-b80d-ef55c8104241" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_4c0dbbc6-095f-4561-b2d3-294a58fa3afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1fb19294-a25a-476f-9b82-b681c2ab6a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0813feb4-8071-4ea7-b80d-ef55c8104241" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1fb19294-a25a-476f-9b82-b681c2ab6a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c87675e7-1e44-4734-9c82-b4cfe281893f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_26fcac17-c6ea-4556-97a4-d92f032f1414" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c87675e7-1e44-4734-9c82-b4cfe281893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a80d90f6-535f-4cfb-9acb-bc49a90538d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a80d90f6-535f-4cfb-9acb-bc49a90538d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5b9aa910-80d5-47a6-88cb-91bc19d53ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a80d90f6-535f-4cfb-9acb-bc49a90538d8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5b9aa910-80d5-47a6-88cb-91bc19d53ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2d7dfbb3-9c5f-4f61-a79e-9847d7eea339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a80d90f6-535f-4cfb-9acb-bc49a90538d8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2d7dfbb3-9c5f-4f61-a79e-9847d7eea339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_11b6936e-4439-4b6e-8ef4-87de05560806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a80d90f6-535f-4cfb-9acb-bc49a90538d8" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_11b6936e-4439-4b6e-8ef4-87de05560806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_27c9af14-abe2-4602-ba6a-7737ecc0e1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a80d90f6-535f-4cfb-9acb-bc49a90538d8" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_27c9af14-abe2-4602-ba6a-7737ecc0e1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b42c710f-be6e-4ea1-ba9b-b091cf734589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a80d90f6-535f-4cfb-9acb-bc49a90538d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b42c710f-be6e-4ea1-ba9b-b091cf734589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_73de6361-48e1-4f1f-8053-1f77841bec8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_RepaymentsOfDebt_73de6361-48e1-4f1f-8053-1f77841bec8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_76d1bb8c-c5fe-44bb-b262-843f6d1e69bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_76d1bb8c-c5fe-44bb-b262-843f6d1e69bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_033cb608-e946-4eac-9c9c-ae2c85593771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_033cb608-e946-4eac-9c9c-ae2c85593771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6973377c-cdbf-4876-823c-18c5a34152c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6973377c-cdbf-4876-823c-18c5a34152c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_b4c2661e-b6dd-4124-ab17-5fb79f2f0773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_b4c2661e-b6dd-4124-ab17-5fb79f2f0773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_d64720fd-70f1-49d2-900b-17b0263bace0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_d64720fd-70f1-49d2-900b-17b0263bace0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a840b33e-5878-4ee9-82a7-edaca95ea0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a840b33e-5878-4ee9-82a7-edaca95ea0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_613e3439-cdd5-4999-a8b4-d8757e5df75f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad605f89-2cde-4caf-aaf3-08cc177cdba8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_613e3439-cdd5-4999-a8b4-d8757e5df75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc0e8e51-a2cb-4cf6-accb-7fa1c8bf4631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc0e8e51-a2cb-4cf6-accb-7fa1c8bf4631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a2634dfa-1a21-4fff-b0c9-000c030e1e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a2634dfa-1a21-4fff-b0c9-000c030e1e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e8d71273-b818-4b76-9991-0a2fdfb0d231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_42ead0ac-f522-4a69-adcd-ab71ce5319ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e8d71273-b818-4b76-9991-0a2fdfb0d231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20220930.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c826206c-7d7a-4ecf-a1b5-3734d9fad232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_781d7974-7961-43e7-aa3c-4802aa2cc594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c826206c-7d7a-4ecf-a1b5-3734d9fad232" xlink:to="loc_us-gaap_StatementTable_781d7974-7961-43e7-aa3c-4802aa2cc594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2fa27ba1-829c-4b75-afc6-6f52e09dcf84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_781d7974-7961-43e7-aa3c-4802aa2cc594" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2fa27ba1-829c-4b75-afc6-6f52e09dcf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2fa27ba1-829c-4b75-afc6-6f52e09dcf84" xlink:to="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a2941db8-08c8-49ec-a174-46d760f06e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_CommonStockMember_a2941db8-08c8-49ec-a174-46d760f06e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f5ad0865-a5d5-4eb9-9fe6-b51de78444d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f5ad0865-a5d5-4eb9-9fe6-b51de78444d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3fd662be-921a-430f-b8af-967bb9f2689d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_RetainedEarningsMember_3fd662be-921a-430f-b8af-967bb9f2689d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fbb2c8d-49d6-45d2-8275-e0951a67dacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8fbb2c8d-49d6-45d2-8275-e0951a67dacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_93bf91f0-5f56-483a-83c4-7c41f3f12142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_TreasuryStockMember_93bf91f0-5f56-483a-83c4-7c41f3f12142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5a8799cd-a966-4bc6-9354-79f1d19854e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be0813cd-11e0-4e2b-8c39-19956b4deadb" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5a8799cd-a966-4bc6-9354-79f1d19854e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_781d7974-7961-43e7-aa3c-4802aa2cc594" xlink:to="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_28a8cb02-7c4d-40c0-a2f7-0c6363982dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_28a8cb02-7c4d-40c0-a2f7-0c6363982dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3598261-77f0-4b91-97bb-4b925623d828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c3598261-77f0-4b91-97bb-4b925623d828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_c3a4fe34-10c9-4272-ba5b-fb875682c73b" xlink:href="dgx-20220930.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_c3a4fe34-10c9-4272-ba5b-fb875682c73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ec20409-2e71-4b3d-8eae-8fe9189f902f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ec20409-2e71-4b3d-8eae-8fe9189f902f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_11a20673-1aef-4f7a-a941-894d1b94725f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_DividendsCommonStockCash_11a20673-1aef-4f7a-a941-894d1b94725f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cee941f7-82ab-467b-875a-8d517531dfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cee941f7-82ab-467b-875a-8d517531dfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_f70f64d1-de88-4a05-9215-c9126eedd457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_f70f64d1-de88-4a05-9215-c9126eedd457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d9eb1e9a-c8f7-4b0d-824d-0a652b6d46ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d9eb1e9a-c8f7-4b0d-824d-0a652b6d46ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f93af4c0-c80a-47f4-ae6d-34d103c0e8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f93af4c0-c80a-47f4-ae6d-34d103c0e8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_473f0dea-abca-4bad-98ca-0b5aea1f6b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_473f0dea-abca-4bad-98ca-0b5aea1f6b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8c573193-65c2-4cd1-90f6-5b86f5015ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8c573193-65c2-4cd1-90f6-5b86f5015ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_ab5f5857-f9ae-4f10-b6cd-6e8265f2491a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_ab5f5857-f9ae-4f10-b6cd-6e8265f2491a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ffff65ad-0402-41d3-8918-001943b82dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ffff65ad-0402-41d3-8918-001943b82dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ef08800a-cc6a-45d9-ada3-4b174c137165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ef08800a-cc6a-45d9-ada3-4b174c137165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_76406555-c54e-454f-aa1e-bbb8c522fe25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_76406555-c54e-454f-aa1e-bbb8c522fe25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d62cc3c5-e18a-4083-9157-255b2835f703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d62cc3c5-e18a-4083-9157-255b2835f703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_940875a3-be67-49df-b2a0-d3c64467c73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9968c394-6450-4ff1-93d0-5b1987e19dd7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_940875a3-be67-49df-b2a0-d3c64467c73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_46431c1f-0992-477c-a78b-0898def500ae" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_80adcaa2-afa5-47a4-9ed4-a56de43654b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_80adcaa2-afa5-47a4-9ed4-a56de43654b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_48ed7a54-1512-4e8e-a156-644a7ad89804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_48ed7a54-1512-4e8e-a156-644a7ad89804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_619d122f-8e5f-4e42-b04d-bd43efef05c2" xlink:href="dgx-20220930.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_619d122f-8e5f-4e42-b04d-bd43efef05c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_66bac114-52e1-4c5b-b35a-24e86e35717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_f7c4c987-fee0-4645-9bc3-b58d42e3cde8" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_66bac114-52e1-4c5b-b35a-24e86e35717a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20220930.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract_f8f27b84-7330-4ed2-80a3-67bb6490ba10" xlink:href="dgx-20220930.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_bd5f9d46-5bdc-4764-81e6-608be0aadc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_DescriptionOfBusinessAbstract_f8f27b84-7330-4ed2-80a3-67bb6490ba10" xlink:to="loc_us-gaap_NatureOfOperations_bd5f9d46-5bdc-4764-81e6-608be0aadc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e7abef18-5c3b-4f45-8cc6-38e82bd5bf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_46c96384-884b-4e44-a7b1-b1019cbee50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e7abef18-5c3b-4f45-8cc6-38e82bd5bf2c" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_46c96384-884b-4e44-a7b1-b1019cbee50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20220930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7ee91624-3fe5-4fe9-abfa-b87c1e0a1fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_40dd6e4b-aaa0-462b-bda0-9ab6557877e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7ee91624-3fe5-4fe9-abfa-b87c1e0a1fbe" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_40dd6e4b-aaa0-462b-bda0-9ab6557877e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20220930.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e78f469c-7746-46ee-8855-325737578204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_556eef6c-08cd-4957-8615-64813236fc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e78f469c-7746-46ee-8855-325737578204" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_556eef6c-08cd-4957-8615-64813236fc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITION" xlink:type="simple" xlink:href="dgx-20220930.xsd#DISPOSITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_016d3e12-3ccb-4684-b552-b094d68a1a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_37d36359-c5ef-4244-8fe5-1f63a5b2a5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_016d3e12-3ccb-4684-b552-b094d68a1a32" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_37d36359-c5ef-4244-8fe5-1f63a5b2a5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5f57515a-9203-4ff2-8517-d7cb72f30392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_29a2ef04-29e6-4a34-b436-5f32aefe4072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5f57515a-9203-4ff2-8517-d7cb72f30392" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_29a2ef04-29e6-4a34-b436-5f32aefe4072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20220930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_73edd631-b618-4ca2-8c7f-b0021f0fab1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f78595f2-bf65-4203-95e6-0ff05a1ada44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_73edd631-b618-4ca2-8c7f-b0021f0fab1e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f78595f2-bf65-4203-95e6-0ff05a1ada44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20220930.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_772be33b-748f-4f2f-bcf9-d36baa14caea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_eac0059f-16da-4bf1-8317-91c64ccfe7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_772be33b-748f-4f2f-bcf9-d36baa14caea" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_eac0059f-16da-4bf1-8317-91c64ccfe7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20220930.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_0d3186b6-8c4d-4db9-9874-583432796a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e76544b0-3404-4c61-8fba-e5cb4b6d8c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0d3186b6-8c4d-4db9-9874-583432796a42" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e76544b0-3404-4c61-8fba-e5cb4b6d8c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_fc0fde8a-19f3-4545-b722-d7a86c86fe91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_de91fb2e-6bc5-4069-9c42-68825eb65e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_fc0fde8a-19f3-4545-b722-d7a86c86fe91" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_de91fb2e-6bc5-4069-9c42-68825eb65e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20220930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3ad111c0-ddb5-40f3-897e-5119c89ea6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_96401134-e523-4100-a43e-a98f99d6aaae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3ad111c0-ddb5-40f3-897e-5119c89ea6d3" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_96401134-e523-4100-a43e-a98f99d6aaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20220930.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_da708b34-7d51-4956-ab0c-cc45352a0dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d7822b1a-0568-443f-80e2-c1b9778d2671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_da708b34-7d51-4956-ab0c-cc45352a0dd6" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d7822b1a-0568-443f-80e2-c1b9778d2671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20220930.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ca2dd07-6f72-4ca9-a2fa-6de2d67d7e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a541dde8-5fb1-460a-814e-28e9c5ade2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4ca2dd07-6f72-4ca9-a2fa-6de2d67d7e0f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a541dde8-5fb1-460a-814e-28e9c5ade2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20220930.xsd#TAXESONINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2a6aee2a-c4f0-4891-a5fb-b677dfdc62cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f0a1ab25-26f2-4c90-8ff2-df7ce013ddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2a6aee2a-c4f0-4891-a5fb-b677dfdc62cc" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f0a1ab25-26f2-4c90-8ff2-df7ce013ddb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_2452e4c8-6bd5-4329-8a02-d6f360f92f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_9bc7aba5-cbec-46ac-a8dd-e565cd046ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_2452e4c8-6bd5-4329-8a02-d6f360f92f98" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_9bc7aba5-cbec-46ac-a8dd-e565cd046ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c0694fae-bcca-4ac7-9214-704ca8808ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e3b69c46-bc92-44cd-ba71-47767d17dcad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0694fae-bcca-4ac7-9214-704ca8808ebc" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e3b69c46-bc92-44cd-ba71-47767d17dcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5c785d87-3258-4ad0-908c-5bf713b629d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0694fae-bcca-4ac7-9214-704ca8808ebc" xlink:to="loc_us-gaap_UseOfEstimates_5c785d87-3258-4ad0-908c-5bf713b629d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_af572019-6e91-479b-a4d1-15d49378e171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0694fae-bcca-4ac7-9214-704ca8808ebc" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_af572019-6e91-479b-a4d1-15d49378e171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_42d7b629-554e-42c4-b7f6-1fcfd4bfd34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0694fae-bcca-4ac7-9214-704ca8808ebc" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_42d7b629-554e-42c4-b7f6-1fcfd4bfd34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_573264ff-4866-4b11-b902-9e89d4211548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0694fae-bcca-4ac7-9214-704ca8808ebc" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_573264ff-4866-4b11-b902-9e89d4211548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20220930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c2538c96-79a6-43f6-8090-2c3eb2727183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4c165fcd-4c31-487b-9b92-08f02a9fed98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c2538c96-79a6-43f6-8090-2c3eb2727183" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4c165fcd-4c31-487b-9b92-08f02a9fed98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1d65015b-790d-496d-8401-21ab57fe98ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c2538c96-79a6-43f6-8090-2c3eb2727183" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1d65015b-790d-496d-8401-21ab57fe98ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_06defc82-5a1b-4ad4-b7c8-b56b85b766f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_61d4eb7d-6548-4f08-b13a-6672a74a6dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_06defc82-5a1b-4ad4-b7c8-b56b85b766f1" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_61d4eb7d-6548-4f08-b13a-6672a74a6dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_93d3be9b-c03f-4bdb-82a9-1064ec4da8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_06defc82-5a1b-4ad4-b7c8-b56b85b766f1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_93d3be9b-c03f-4bdb-82a9-1064ec4da8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3c976822-a2cd-4973-a8d5-0f3de70096e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_249ded52-f329-4b08-b995-32b5764a00b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3c976822-a2cd-4973-a8d5-0f3de70096e1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_249ded52-f329-4b08-b995-32b5764a00b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1eecf2b6-2095-403f-8586-367969de2d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3c976822-a2cd-4973-a8d5-0f3de70096e1" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1eecf2b6-2095-403f-8586-367969de2d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_59697164-24bb-4de6-bc80-8835533e18f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3c976822-a2cd-4973-a8d5-0f3de70096e1" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_59697164-24bb-4de6-bc80-8835533e18f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20220930.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e5202cc9-1032-4963-b36e-d617d1d91b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_9917aa39-c44d-4463-bf8a-ff571dabdf92" xlink:href="dgx-20220930.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e5202cc9-1032-4963-b36e-d617d1d91b3f" xlink:to="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_9917aa39-c44d-4463-bf8a-ff571dabdf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_288efa84-26d7-4374-a4bd-01347e3f6b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c6de5a62-fe93-4696-b162-a196b92973c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_288efa84-26d7-4374-a4bd-01347e3f6b8a" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c6de5a62-fe93-4696-b162-a196b92973c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20220930.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4e619426-4bb5-4bd4-87ba-825f355aeb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1241d999-0992-48a2-a861-c6c77707f872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4e619426-4bb5-4bd4-87ba-825f355aeb60" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1241d999-0992-48a2-a861-c6c77707f872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_fb6442a3-bac0-4584-8a58-bdf8eb8d2f8b" xlink:href="dgx-20220930.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4e619426-4bb5-4bd4-87ba-825f355aeb60" xlink:to="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_fb6442a3-bac0-4584-8a58-bdf8eb8d2f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20220930.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb7eb760-8de6-4501-89d5-b3723e05952f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1aa7d9bf-5d96-43b3-b79b-4578a6a458ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb7eb760-8de6-4501-89d5-b3723e05952f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1aa7d9bf-5d96-43b3-b79b-4578a6a458ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_c565337d-28db-4ee9-8127-6e12507bc21c" xlink:href="dgx-20220930.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb7eb760-8de6-4501-89d5-b3723e05952f" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_c565337d-28db-4ee9-8127-6e12507bc21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0ccf5e2a-a4a3-49e9-85b9-2bba63aff35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0ccf5e2a-a4a3-49e9-85b9-2bba63aff35b" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8aced189-c6ee-4c8f-b4ba-e47733e7436c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_NetIncomeLoss_8aced189-c6ee-4c8f-b4ba-e47733e7436c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_d1f20c9b-6d5c-4262-a924-dc2181912c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_d1f20c9b-6d5c-4262-a924-dc2181912c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_67cce932-5764-4980-9acc-ab4c126ddace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_67cce932-5764-4980-9acc-ab4c126ddace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ec68532e-dd91-4141-9498-92e709d83dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ec68532e-dd91-4141-9498-92e709d83dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5580638b-211a-4a07-879a-b9fcaaabccef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5580638b-211a-4a07-879a-b9fcaaabccef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5e517aae-d626-48d1-a84f-06cac2e63e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5e517aae-d626-48d1-a84f-06cac2e63e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f83a3199-936c-4cc2-aa29-cb8d1dbef4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_EarningsPerShareBasic_f83a3199-936c-4cc2-aa29-cb8d1dbef4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_83fd6d77-ceb0-463d-9a0e-536c7354e7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_fa728872-5701-41f2-bd33-f57f4a6f5315" xlink:to="loc_us-gaap_EarningsPerShareDiluted_83fd6d77-ceb0-463d-9a0e-536c7354e7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a02ba637-d66c-47ad-ab8d-951858a6a80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0ccf5e2a-a4a3-49e9-85b9-2bba63aff35b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a02ba637-d66c-47ad-ab8d-951858a6a80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a2d208a8-1bb0-4aa9-a18e-6c31669de338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a2d208a8-1bb0-4aa9-a18e-6c31669de338" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5576a91f-b87f-41d9-bb4b-e2146f5cd40b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5576a91f-b87f-41d9-bb4b-e2146f5cd40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5576a91f-b87f-41d9-bb4b-e2146f5cd40b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCMember_11ce88d1-b941-4b59-baee-bde6ac53d75b" xlink:href="dgx-20220930.xsd#dgx_PackHealthLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:to="loc_dgx_PackHealthLLCMember_11ce88d1-b941-4b59-baee-bde6ac53d75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LabtechDiagnosticsLLCMember_e593ee8d-44c2-4772-865b-a97c76dd3b03" xlink:href="dgx-20220930.xsd#dgx_LabtechDiagnosticsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_112f1661-f9b4-4cce-a2f0-8da418bcd992" xlink:to="loc_dgx_LabtechDiagnosticsLLCMember_e593ee8d-44c2-4772-865b-a97c76dd3b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07c6818b-3fe4-463a-962d-eda591cebcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07c6818b-3fe4-463a-962d-eda591cebcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ec4c80-e347-4378-abc3-242258e7f719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07c6818b-3fe4-463a-962d-eda591cebcba" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ec4c80-e347-4378-abc3-242258e7f719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9002798f-0796-4c93-8121-b537673c892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08ec4c80-e347-4378-abc3-242258e7f719" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9002798f-0796-4c93-8121-b537673c892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_81949848-ca6b-4941-9548-0841e4b8dc4a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_24af9dde-2b76-4f17-9d23-16e97539fc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_24af9dde-2b76-4f17-9d23-16e97539fc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_963d0e92-c62e-4dad-9b88-a0dafca72406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_963d0e92-c62e-4dad-9b88-a0dafca72406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b370cc9d-e245-4407-a94e-3c64791d7965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b370cc9d-e245-4407-a94e-3c64791d7965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_15aa6c9e-f664-4c24-8dbe-a1916557570f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_15aa6c9e-f664-4c24-8dbe-a1916557570f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ee13810f-ff2a-4129-becb-19beafea9bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_Goodwill_ee13810f-ff2a-4129-becb-19beafea9bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_bb000c56-283d-418f-a59e-5956d125a17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_bb000c56-283d-418f-a59e-5956d125a17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dcf058c2-76ae-4a18-a8b0-d7c311a22e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dcf058c2-76ae-4a18-a8b0-d7c311a22e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_82fa3990-8cf6-4070-bd8c-d3bd53e769b8" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_82fa3990-8cf6-4070-bd8c-d3bd53e769b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_5bf3a287-4e17-4f00-809f-5cdda81cd3fb" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_5bf3a287-4e17-4f00-809f-5cdda81cd3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_bd122474-28f7-4a74-86cb-88ddf493facf" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_bd122474-28f7-4a74-86cb-88ddf493facf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ea9206fc-734f-41db-90b8-628dc222d388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ea9206fc-734f-41db-90b8-628dc222d388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a91dad4e-070e-4d26-85db-697fbb24b2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a91dad4e-070e-4d26-85db-697fbb24b2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_c9218727-2195-4cfb-b647-ec5bc881f126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments_c9218727-2195-4cfb-b647-ec5bc881f126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InventoryPurchaseAccountingAdjustments_cf6dbefb-ecbf-496a-8c33-ae2798e76dfc" xlink:href="dgx-20220930.xsd#dgx_InventoryPurchaseAccountingAdjustments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_InventoryPurchaseAccountingAdjustments_cf6dbefb-ecbf-496a-8c33-ae2798e76dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_313bc778-ab98-4820-8121-a23f79939a66" xlink:href="dgx-20220930.xsd#dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_472e6544-b43d-4f28-ac22-edbb6852b0ee" xlink:to="loc_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets_313bc778-ab98-4820-8121-a23f79939a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#DISPOSITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_975f4d34-d8cf-4f58-b7f5-d3b1e9688cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_975f4d34-d8cf-4f58-b7f5-d3b1e9688cb6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8ff06b7-04ee-44a4-a5c0-9d254ad26df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2daa6ae2-abe3-40dc-8fee-6987dbf2f64e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8ff06b7-04ee-44a4-a5c0-9d254ad26df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_00f9474c-e9f8-4caa-9e6f-07d105521504" xlink:href="dgx-20220930.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8ff06b7-04ee-44a4-a5c0-9d254ad26df8" xlink:to="loc_dgx_Q2SolutionsMember_00f9474c-e9f8-4caa-9e6f-07d105521504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_325ba4a8-8ce0-43f0-969b-c2b848ea1201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_325ba4a8-8ce0-43f0-969b-c2b848ea1201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_dddf3340-5b50-4971-a37d-031a1f9fafba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_325ba4a8-8ce0-43f0-969b-c2b848ea1201" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_dddf3340-5b50-4971-a37d-031a1f9fafba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e984af5c-bd1f-4181-932b-41c67538f2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_dddf3340-5b50-4971-a37d-031a1f9fafba" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e984af5c-bd1f-4181-932b-41c67538f2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_91eea82d-f2da-4ff0-8ff5-620d7efa6acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_91eea82d-f2da-4ff0-8ff5-620d7efa6acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ec331269-4cdb-4628-80f3-c1991ff62105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_91eea82d-f2da-4ff0-8ff5-620d7efa6acf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ec331269-4cdb-4628-80f3-c1991ff62105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_5305caf9-c276-4dd8-8f2e-fb6afb278598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ec331269-4cdb-4628-80f3-c1991ff62105" xlink:to="loc_us-gaap_OtherIncomeMember_5305caf9-c276-4dd8-8f2e-fb6afb278598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66e63e83-85d6-4610-90d5-49f5a4ca929d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66e63e83-85d6-4610-90d5-49f5a4ca929d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cc73f045-a119-45b5-a96e-f37a4f552492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66e63e83-85d6-4610-90d5-49f5a4ca929d" xlink:to="loc_us-gaap_EquityComponentDomain_cc73f045-a119-45b5-a96e-f37a4f552492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_6a6ed23f-9e2c-4e0d-8c24-e2369732bba0" xlink:href="dgx-20220930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cc73f045-a119-45b5-a96e-f37a4f552492" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_6a6ed23f-9e2c-4e0d-8c24-e2369732bba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0a5d7e8a-56cc-4bf9-aac9-575345e26782" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_29b06659-7e62-4f3c-8fde-57bcd1a85d7b" xlink:href="dgx-20220930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_29b06659-7e62-4f3c-8fde-57bcd1a85d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_d9aa6767-b5d4-4c77-9d4d-73572479f77a" xlink:href="dgx-20220930.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_d9aa6767-b5d4-4c77-9d4d-73572479f77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_364774cd-de8c-49b2-84af-87fc44893bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_364774cd-de8c-49b2-84af-87fc44893bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b58583d0-9e67-490e-ad26-494ee5bc705f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b58583d0-9e67-490e-ad26-494ee5bc705f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d8774b7-59f2-4ca3-bfc0-3027a89e125a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d8774b7-59f2-4ca3-bfc0-3027a89e125a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ab969367-0188-4914-91c0-3aeff409501f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ab969367-0188-4914-91c0-3aeff409501f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8f0b5a43-0da3-4204-93a7-43cf4b6a2bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc41ed46-49f9-4684-a205-b81c229b595a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8f0b5a43-0da3-4204-93a7-43cf4b6a2bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_88ad467b-43f3-4724-9151-ac65990356ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_88ad467b-43f3-4724-9151-ac65990356ba" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eca353dd-393c-47ba-892c-fc01e916cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eca353dd-393c-47ba-892c-fc01e916cc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_45eeb142-f769-4e42-ab8e-d391da30e470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eca353dd-393c-47ba-892c-fc01e916cc12" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_45eeb142-f769-4e42-ab8e-d391da30e470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_96c2c6d4-0e4c-42cf-9625-d1cdcb6cd11e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_45eeb142-f769-4e42-ab8e-d391da30e470" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_96c2c6d4-0e4c-42cf-9625-d1cdcb6cd11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4ed227b-314d-4efc-b0d3-3f88a472897a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4ed227b-314d-4efc-b0d3-3f88a472897a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4ed227b-314d-4efc-b0d3-3f88a472897a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a679d41a-f522-4e6e-852d-3940360ea253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a679d41a-f522-4e6e-852d-3940360ea253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_19e2a65f-86cc-41ee-b1fa-e4df3280d16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_19e2a65f-86cc-41ee-b1fa-e4df3280d16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a3f516f9-652f-4c82-9b24-f59eceff5a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2caa732c-b1a1-47bf-8865-1918e8164676" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a3f516f9-652f-4c82-9b24-f59eceff5a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f1314dda-dce8-489c-9b58-7a61097d0d99" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_405744e2-ce4e-4db0-b7f3-4381f2b8a5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_TradingSecurities_405744e2-ce4e-4db0-b7f3-4381f2b8a5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_12b89482-2a51-49ac-a89c-770289792ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_12b89482-2a51-49ac-a89c-770289792ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_17a504a0-0b35-4360-a8c1-80f85175162b" xlink:href="dgx-20220930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_17a504a0-0b35-4360-a8c1-80f85175162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a0ca4ea-092c-4351-81eb-ffe322572437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1a0ca4ea-092c-4351-81eb-ffe322572437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_84b6069d-dbc2-4afb-b996-35982a9b615e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_84b6069d-dbc2-4afb-b996-35982a9b615e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ef60219b-0f81-4d56-8e48-85c7545fcc25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ef60219b-0f81-4d56-8e48-85c7545fcc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ad42d1f5-48ac-4464-83bc-dfbd00180813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ad42d1f5-48ac-4464-83bc-dfbd00180813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ec6e6b73-a116-4072-bd0e-96ceed5122a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ec6e6b73-a116-4072-bd0e-96ceed5122a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_3c196166-05ef-4a93-b1ab-d8415d360ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_91ec77f2-0b20-468c-97c4-d9c4616b2262" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_3c196166-05ef-4a93-b1ab-d8415d360ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7a68b0db-3d73-4a65-8f90-28852ee68ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7a68b0db-3d73-4a65-8f90-28852ee68ba1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_73e578ff-03d1-463f-9939-2697657772b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_73e578ff-03d1-463f-9939-2697657772b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e570f0-d278-4bfe-b355-b2d684efac80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_73e578ff-03d1-463f-9939-2697657772b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e570f0-d278-4bfe-b355-b2d684efac80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_97a5c8ef-5397-4a34-aeee-7bb86fa9f2b0" xlink:href="dgx-20220930.xsd#dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e570f0-d278-4bfe-b355-b2d684efac80" xlink:to="loc_dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember_97a5c8ef-5397-4a34-aeee-7bb86fa9f2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a81ca484-3781-4464-acb8-5c0dd4828c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a81ca484-3781-4464-acb8-5c0dd4828c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a81ca484-3781-4464-acb8-5c0dd4828c17" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_fdef5913-d72e-4461-b7f3-ca6878961063" xlink:href="dgx-20220930.xsd#dgx_MeasurementInputComparableCompanyRevenueVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:to="loc_dgx_MeasurementInputComparableCompanyRevenueVolatilityMember_fdef5913-d72e-4461-b7f3-ca6878961063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_59c44b51-bb83-4988-b6d6-1118579ee6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_5f02a0b3-6eb6-4293-a5b5-1f2b02a5fb80" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_59c44b51-bb83-4988-b6d6-1118579ee6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ddb931f6-b374-4082-a295-fbb708aecc09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_srt_RangeAxis_ddb931f6-b374-4082-a295-fbb708aecc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ddb931f6-b374-4082-a295-fbb708aecc09" xlink:to="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_41c7c430-a924-4fad-8ae9-392a9fa2cd5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:to="loc_srt_MinimumMember_41c7c430-a924-4fad-8ae9-392a9fa2cd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_03455625-fb98-44ee-af62-3efdb41954a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad250ff6-991e-4658-a690-b84ef8f46c37" xlink:to="loc_srt_MaximumMember_03455625-fb98-44ee-af62-3efdb41954a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_60ff7673-b1de-4843-a74d-0aa78ac54805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_60ff7673-b1de-4843-a74d-0aa78ac54805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ae48dbf9-f4df-4a2e-907c-4c17c582a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_60ff7673-b1de-4843-a74d-0aa78ac54805" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ae48dbf9-f4df-4a2e-907c-4c17c582a7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_f1b2d4ba-1f81-4c4d-b349-9e55c92d4b24" xlink:href="dgx-20220930.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ae48dbf9-f4df-4a2e-907c-4c17c582a7e0" xlink:to="loc_dgx_ContingentConsiderationMember_f1b2d4ba-1f81-4c4d-b349-9e55c92d4b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_71b3d6d2-a451-4416-b4fc-bf12c17457ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_71b3d6d2-a451-4416-b4fc-bf12c17457ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd4d18b-a11c-4bae-98e4-f75df508a3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_71b3d6d2-a451-4416-b4fc-bf12c17457ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd4d18b-a11c-4bae-98e4-f75df508a3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_01898a2b-4315-4e5e-91a1-23f2c4e6a56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8bd4d18b-a11c-4bae-98e4-f75df508a3ff" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_01898a2b-4315-4e5e-91a1-23f2c4e6a56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9af4ef67-c599-4644-a166-9e3d2485a5d1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d153bcf7-1af0-4181-afaf-20b67b19c722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_d153bcf7-1af0-4181-afaf-20b67b19c722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1d607088-d6bf-48b2-8d3a-158def32fa20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1d607088-d6bf-48b2-8d3a-158def32fa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_332e6c8a-1bbd-4c67-8d50-9867ea3410ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6b20e596-5415-4c04-a7f1-5d8cd1f0b5a5" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_332e6c8a-1bbd-4c67-8d50-9867ea3410ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a7963bd8-0923-47f5-a0e5-53327e30c823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_542239d6-77ab-4dfc-beac-ff9f861ce764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a7963bd8-0923-47f5-a0e5-53327e30c823" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_542239d6-77ab-4dfc-beac-ff9f861ce764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_00524155-454c-4a48-a085-ef50c3c9cb6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_542239d6-77ab-4dfc-beac-ff9f861ce764" xlink:to="loc_srt_OwnershipAxis_00524155-454c-4a48-a085-ef50c3c9cb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ca7f5569-515f-4a18-a450-c3c12375ed6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_00524155-454c-4a48-a085-ef50c3c9cb6e" xlink:to="loc_srt_OwnershipDomain_ca7f5569-515f-4a18-a450-c3c12375ed6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_8e747b4f-77c7-4569-8d21-4ff859a44960" xlink:href="dgx-20220930.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ca7f5569-515f-4a18-a450-c3c12375ed6a" xlink:to="loc_dgx_UMassJointVentureMember_8e747b4f-77c7-4569-8d21-4ff859a44960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a9565a9-679e-4f30-acda-85ab920d83f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_542239d6-77ab-4dfc-beac-ff9f861ce764" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a9565a9-679e-4f30-acda-85ab920d83f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daee7b4c-bbf3-4939-b8e1-6fb4b299e0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6a9565a9-679e-4f30-acda-85ab920d83f5" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daee7b4c-bbf3-4939-b8e1-6fb4b299e0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_196c95d6-0aef-43fb-8793-24deca4a74cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a7963bd8-0923-47f5-a0e5-53327e30c823" xlink:to="loc_us-gaap_DebtInstrumentFairValue_196c95d6-0aef-43fb-8793-24deca4a74cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_35b7a7ae-937b-4e2d-a4f7-cf859824fed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_35b7a7ae-937b-4e2d-a4f7-cf859824fed1" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_570d3060-406f-4ac1-84f8-ad23f5849cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_570d3060-406f-4ac1-84f8-ad23f5849cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67355514-72a0-4ffe-a3cc-01adc1bc95ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_570d3060-406f-4ac1-84f8-ad23f5849cda" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67355514-72a0-4ffe-a3cc-01adc1bc95ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_981e386f-ae4f-4258-b08b-1c344284b279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67355514-72a0-4ffe-a3cc-01adc1bc95ba" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_981e386f-ae4f-4258-b08b-1c344284b279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9657d59c-db1c-4b86-99df-ffd11452f403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_aaff6aa8-11bf-436f-95ff-7e1e70ef6f42" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9657d59c-db1c-4b86-99df-ffd11452f403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_3a8890a5-080f-4489-adf8-171ed7920bfb" xlink:href="dgx-20220930.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9657d59c-db1c-4b86-99df-ffd11452f403" xlink:to="loc_dgx_ContingentConsiderationMember_3a8890a5-080f-4489-adf8-171ed7920bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_6084e653-42ff-45d0-9b73-ef1f675fd9e2" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_93a6a3be-7e2b-415b-8951-ddc7fa71cbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_93a6a3be-7e2b-415b-8951-ddc7fa71cbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_012678dc-72b8-47ee-8d1b-b0146495fa02" xlink:href="dgx-20220930.xsd#dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances_012678dc-72b8-47ee-8d1b-b0146495fa02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_eee4a414-2ad2-4891-aa1e-f73e0fc8fece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_eee4a414-2ad2-4891-aa1e-f73e0fc8fece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d27391c3-bc66-4a9a-8ccb-b94230cc9b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d27391c3-bc66-4a9a-8ccb-b94230cc9b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_22e4cf6e-5a7e-45dd-812d-426b3883104a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_55ed80a6-2081-44ba-8dad-eb29b8501484" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_22e4cf6e-5a7e-45dd-812d-426b3883104a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1ad06455-3351-43a2-b5fb-38ec1c4c58ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_acda4334-a591-47eb-a60b-d8a3a23d930e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1ad06455-3351-43a2-b5fb-38ec1c4c58ab" xlink:to="loc_us-gaap_GoodwillRollForward_acda4334-a591-47eb-a60b-d8a3a23d930e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9993a37c-b407-4c46-81a2-7fa15fb24672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_acda4334-a591-47eb-a60b-d8a3a23d930e" xlink:to="loc_us-gaap_Goodwill_9993a37c-b407-4c46-81a2-7fa15fb24672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4560b253-9baf-4589-9ff1-a38c5475d44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_acda4334-a591-47eb-a60b-d8a3a23d930e" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4560b253-9baf-4589-9ff1-a38c5475d44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0f3ad7b1-43ee-4129-ada0-98e97205f225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_acda4334-a591-47eb-a60b-d8a3a23d930e" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0f3ad7b1-43ee-4129-ada0-98e97205f225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bf94e71e-4cd9-4d57-a32a-f411cc88b0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_acda4334-a591-47eb-a60b-d8a3a23d930e" xlink:to="loc_us-gaap_Goodwill_bf94e71e-4cd9-4d57-a32a-f411cc88b0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_adaf795a-fe10-4a53-86e3-6067f134e199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:href="dgx-20220930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_adaf795a-fe10-4a53-86e3-6067f134e199" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8395ac9b-1f10-4430-bfca-f5ffb563b209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8395ac9b-1f10-4430-bfca-f5ffb563b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8395ac9b-1f10-4430-bfca-f5ffb563b209" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bfec5567-6a2a-4358-b585-7bf81ef27c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bfec5567-6a2a-4358-b585-7bf81ef27c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_6171cbbe-2b5d-4e20-937e-f64418ee0b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_6171cbbe-2b5d-4e20-937e-f64418ee0b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_a987cf62-369d-4b50-aced-b90888937866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_a987cf62-369d-4b50-aced-b90888937866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f1d55c5a-7ad0-486f-a023-3b97c8b29332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f1d55c5a-7ad0-486f-a023-3b97c8b29332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_33526994-943f-42e2-a4fe-8299f5f0a8a7" xlink:href="dgx-20220930.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_10db37a6-843c-4a4e-8146-02727e70b25c" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_33526994-943f-42e2-a4fe-8299f5f0a8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7d88daf1-908a-409e-a74e-b06f2077a199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7d88daf1-908a-409e-a74e-b06f2077a199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7d88daf1-908a-409e-a74e-b06f2077a199" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e007a8e1-af7b-4221-9107-dedfc8b68135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:to="loc_us-gaap_TradeNamesMember_e007a8e1-af7b-4221-9107-dedfc8b68135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_b2ce32bf-ee83-43eb-a2f2-8f23d53b4681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f4472713-8999-4cfa-8386-36049ed32fa1" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_b2ce32bf-ee83-43eb-a2f2-8f23d53b4681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:href="dgx-20220930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_de9eb4b5-48a9-46fc-a7c8-68e3915ce5cb" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eef7e5aa-f5c5-4c75-bb6d-44e492c14048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eef7e5aa-f5c5-4c75-bb6d-44e492c14048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b9f69ae5-4d9a-4774-a67b-2839ada7acdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b9f69ae5-4d9a-4774-a67b-2839ada7acdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_565343bc-8a5c-4473-8dba-81aaf92ba4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_565343bc-8a5c-4473-8dba-81aaf92ba4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c4b64fae-3422-4bda-ab7c-a2c6fcbca035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c4b64fae-3422-4bda-ab7c-a2c6fcbca035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3bac3ae5-8ab3-4c14-a63a-d5db91475f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3bac3ae5-8ab3-4c14-a63a-d5db91475f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_4be7e59e-4c86-415e-9847-dc702f76a72d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_09d80aab-1772-4d11-86dc-c3e30980a348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_09d80aab-1772-4d11-86dc-c3e30980a348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ea1cc41c-d8d7-4fed-b46c-13c19ee7185c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ea1cc41c-d8d7-4fed-b46c-13c19ee7185c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e58407c6-fa32-419b-96ac-b130cc27d806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e58407c6-fa32-419b-96ac-b130cc27d806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8f41b50a-d462-4f9c-a8b3-04e00b958a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8f41b50a-d462-4f9c-a8b3-04e00b958a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_34bb9420-5aa7-43e3-9e40-e7b9e693f74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_34bb9420-5aa7-43e3-9e40-e7b9e693f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5845a13b-f56b-40f4-a950-18dc9d6b5a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5845a13b-f56b-40f4-a950-18dc9d6b5a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b20ee06f-aae9-4987-8ab8-2f0ee5a780b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b20ee06f-aae9-4987-8ab8-2f0ee5a780b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3c0c603-f181-4762-b45d-234c829acd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_a3a47184-53a5-4d90-9e96-063f53db6b83" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3c0c603-f181-4762-b45d-234c829acd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2d331c76-a79d-4fac-a1e1-9301dfd7d31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2d331c76-a79d-4fac-a1e1-9301dfd7d31e" xlink:to="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_abe8e895-8635-40aa-a977-21968ab88d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_abe8e895-8635-40aa-a977-21968ab88d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f9f0b6fe-3514-4fa2-a0b8-2ba41165dfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_abe8e895-8635-40aa-a977-21968ab88d9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f9f0b6fe-3514-4fa2-a0b8-2ba41165dfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_c287e7e7-cdd9-4d2c-914b-40d2c79a5298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9f0b6fe-3514-4fa2-a0b8-2ba41165dfa9" xlink:to="loc_us-gaap_LongTermDebtMember_c287e7e7-cdd9-4d2c-914b-40d2c79a5298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d111f346-db8e-4794-93b0-dff75d9ae85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d111f346-db8e-4794-93b0-dff75d9ae85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_830baa59-39da-48bc-9526-a094a6de0382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d111f346-db8e-4794-93b0-dff75d9ae85d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_830baa59-39da-48bc-9526-a094a6de0382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_fe9a413f-45e7-447c-bda7-bf5922061e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_830baa59-39da-48bc-9526-a094a6de0382" xlink:to="loc_us-gaap_FairValueHedgingMember_fe9a413f-45e7-447c-bda7-bf5922061e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c192d43f-f2ed-4a87-95f6-d83a18c290f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fad036af-fc23-467f-b33e-a8a20cf34aa1" xlink:to="loc_us-gaap_DerivativeLineItems_c192d43f-f2ed-4a87-95f6-d83a18c290f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3b19b273-d46b-4528-931f-d362bfbbf038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c192d43f-f2ed-4a87-95f6-d83a18c290f0" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3b19b273-d46b-4528-931f-d362bfbbf038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_42268b81-f3d5-4931-ba67-c792f6f3c5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:href="dgx-20220930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_42268b81-f3d5-4931-ba67-c792f6f3c5bc" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d3567cb1-7bf5-4a60-8148-c32a14af5314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d3567cb1-7bf5-4a60-8148-c32a14af5314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d3567cb1-7bf5-4a60-8148-c32a14af5314" xlink:to="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1cf8dd6d-31b7-4550-8978-c54a2ea40ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:to="loc_us-gaap_TreasuryStockMember_1cf8dd6d-31b7-4550-8978-c54a2ea40ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_56a75be8-4cdf-473a-a2a9-9d93455fabbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cb1d1d0a-2fad-4dea-b1cd-e4bd62d097ff" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_56a75be8-4cdf-473a-a2a9-9d93455fabbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a215c4be-3550-421c-b75d-db0484e13386" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:to="loc_srt_OwnershipAxis_a215c4be-3550-421c-b75d-db0484e13386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5fd0ed3d-8a69-4133-82a8-83363f5c1c15" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_a215c4be-3550-421c-b75d-db0484e13386" xlink:to="loc_srt_OwnershipDomain_5fd0ed3d-8a69-4133-82a8-83363f5c1c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_49ae542a-89b8-456b-85e3-23d62b2ac430" xlink:href="dgx-20220930.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_5fd0ed3d-8a69-4133-82a8-83363f5c1c15" xlink:to="loc_dgx_UMassJointVentureMember_49ae542a-89b8-456b-85e3-23d62b2ac430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_ade612a5-b4e8-4fac-8516-646e02f13857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_ade612a5-b4e8-4fac-8516-646e02f13857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_5d35d3d2-23bf-4448-ab17-a8207a2772f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_ade612a5-b4e8-4fac-8516-646e02f13857" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_5d35d3d2-23bf-4448-ab17-a8207a2772f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_98ff700c-9a0c-4ba2-aa2b-c97bd6cb9cbd" xlink:href="dgx-20220930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_5d35d3d2-23bf-4448-ab17-a8207a2772f9" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_98ff700c-9a0c-4ba2-aa2b-c97bd6cb9cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:href="dgx-20220930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_91a45a10-a39d-4dde-a3da-7ade86c583d8" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c2cec77e-4716-47e0-ae61-8de30b2f44f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c2cec77e-4716-47e0-ae61-8de30b2f44f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_eec6298a-f22b-40ec-a880-6015c3608d9d" xlink:href="dgx-20220930.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_eec6298a-f22b-40ec-a880-6015c3608d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_349f856f-ad9a-461d-9ae5-89f4566a3aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_349f856f-ad9a-461d-9ae5-89f4566a3aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_4d352036-c026-47f2-ab87-d4133105939c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_4d352036-c026-47f2-ab87-d4133105939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9abd6fa4-3890-41a6-b64f-671249b244e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_9abd6fa4-3890-41a6-b64f-671249b244e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesPayment_1fadc79d-cb46-48bc-848a-f0b2ccbd5a4d" xlink:href="dgx-20220930.xsd#dgx_AcceleratedShareRepurchasesPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_AcceleratedShareRepurchasesPayment_1fadc79d-cb46-48bc-848a-f0b2ccbd5a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_54628781-d1e5-4c92-9e9f-89288bcdba8c" xlink:href="dgx-20220930.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_54628781-d1e5-4c92-9e9f-89288bcdba8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_388300a3-62d9-40be-a1d9-0ebc53e86b13" xlink:href="dgx-20220930.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_388300a3-62d9-40be-a1d9-0ebc53e86b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a3e670fd-1636-4082-9890-64bbc23e6584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a3e670fd-1636-4082-9890-64bbc23e6584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_5c539b46-cf98-49e6-b3c4-424ff26f70b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_5c539b46-cf98-49e6-b3c4-424ff26f70b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a35a961c-5792-47a4-8355-994bd6aa26a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_0fc9fe1f-8acf-436f-aaa3-2f6dda88dbe1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_a35a961c-5792-47a4-8355-994bd6aa26a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_29884436-c717-42b8-ada3-9af5e8c692ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_Depreciation_29884436-c717-42b8-ada3-9af5e8c692ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_093c726f-e4aa-42c0-83f0-f93631a7362b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_093c726f-e4aa-42c0-83f0-f93631a7362b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c2b35b29-d544-429e-b097-9874ff8f9c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c2b35b29-d544-429e-b097-9874ff8f9c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b99c074c-bb7d-4697-9ff8-a6ada209b863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_InterestExpense_b99c074c-bb7d-4697-9ff8-a6ada209b863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_5874bbe9-4ce8-4936-a1fe-ec07fc91712f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_5874bbe9-4ce8-4936-a1fe-ec07fc91712f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_8371b10c-53bf-4a16-9de7-66e7bd93195a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_8371b10c-53bf-4a16-9de7-66e7bd93195a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b8ba2da4-e63e-4bf0-af45-adc8570d4d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_InterestPaidNet_b8ba2da4-e63e-4bf0-af45-adc8570d4d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_d46d3724-8e58-4827-80be-7055952c8fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_IncomeTaxesPaid_d46d3724-8e58-4827-80be-7055952c8fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1764a233-41ad-4310-9867-a0cee5f9b851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1764a233-41ad-4310-9867-a0cee5f9b851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockPurchasedbutNotyetPaid_6befc741-249c-4db2-a059-ce14ce164d54" xlink:href="dgx-20220930.xsd#dgx_TreasuryStockPurchasedbutNotyetPaid"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_dgx_TreasuryStockPurchasedbutNotyetPaid_6befc741-249c-4db2-a059-ce14ce164d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_89a9b022-7236-41b3-9baa-e64fd205c724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_89a9b022-7236-41b3-9baa-e64fd205c724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_4b833033-5b23-44aa-bb27-f8e593217e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_4b833033-5b23-44aa-bb27-f8e593217e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_da083772-8724-447f-83a5-c49d27c347ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_LiabilitiesAssumed1_da083772-8724-447f-83a5-c49d27c347ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_d797b27d-3916-4988-b297-ee53e3894f69" xlink:href="dgx-20220930.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_d797b27d-3916-4988-b297-ee53e3894f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet_0b43998e-a3bf-4fd7-863e-297e50ddf9d1" xlink:href="dgx-20220930.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_dgx_Mergerconsiderationpaidpayablenet_0b43998e-a3bf-4fd7-863e-297e50ddf9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_74f8d300-d88b-4eb1-8cf3-1a02e27504d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_74f8d300-d88b-4eb1-8cf3-1a02e27504d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_df0ccd87-75c7-4c8c-9c66-4198bebf36e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_df0ccd87-75c7-4c8c-9c66-4198bebf36e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_52c27d54-4186-40c6-a1c0-4f4a7c0d122c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_52c27d54-4186-40c6-a1c0-4f4a7c0d122c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_3d502761-4c45-447a-8517-d9da3b7f95b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9719c1ac-2636-45cc-94ca-14ff02adae58" xlink:to="loc_us-gaap_LeaseCostAbstract_3d502761-4c45-447a-8517-d9da3b7f95b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9e355e41-5824-479c-b7d5-21a59db91c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_3d502761-4c45-447a-8517-d9da3b7f95b6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9e355e41-5824-479c-b7d5-21a59db91c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_86cf1bcf-7900-47ed-bf4b-c674638efa22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_cb3e6794-3761-4295-aec1-c0e6180946a6" xlink:href="dgx-20220930.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_86cf1bcf-7900-47ed-bf4b-c674638efa22" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_cb3e6794-3761-4295-aec1-c0e6180946a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventAxis_25376875-c86d-4273-847c-5e0a06cf9db3" xlink:href="dgx-20220930.xsd#dgx_TriggeringEventAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_cb3e6794-3761-4295-aec1-c0e6180946a6" xlink:to="loc_dgx_TriggeringEventAxis_25376875-c86d-4273-847c-5e0a06cf9db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TriggeringEventDomain_8c6b7f56-f8de-4788-b98b-ad523df2f603" xlink:href="dgx-20220930.xsd#dgx_TriggeringEventDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_TriggeringEventAxis_25376875-c86d-4273-847c-5e0a06cf9db3" xlink:to="loc_dgx_TriggeringEventDomain_8c6b7f56-f8de-4788-b98b-ad523df2f603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmendedRealEstateLeaseMember_1cf1499c-8401-4e99-a442-4557b15229a7" xlink:href="dgx-20220930.xsd#dgx_AmendedRealEstateLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_TriggeringEventDomain_8c6b7f56-f8de-4788-b98b-ad523df2f603" xlink:to="loc_dgx_AmendedRealEstateLeaseMember_1cf1499c-8401-4e99-a442-4557b15229a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_888f2658-52a3-4778-b97d-c4fe1a53461d" xlink:href="dgx-20220930.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_cb3e6794-3761-4295-aec1-c0e6180946a6" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_888f2658-52a3-4778-b97d-c4fe1a53461d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f3ca6202-238d-425d-bef7-d800d315e5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_888f2658-52a3-4778-b97d-c4fe1a53461d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f3ca6202-238d-425d-bef7-d800d315e5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51da8279-04f0-4d5e-97b6-03988382ecbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51da8279-04f0-4d5e-97b6-03988382ecbf" xlink:to="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_95fbccb3-79b2-4287-90f3-ea4008aa224c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:to="loc_srt_LitigationCaseAxis_95fbccb3-79b2-4287-90f3-ea4008aa224c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_95fbccb3-79b2-4287-90f3-ea4008aa224c" xlink:to="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_A401kPlanLawsuitMember_e076fcf6-8203-4c2a-9f16-548897d72f8d" xlink:href="dgx-20220930.xsd#dgx_A401kPlanLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:to="loc_dgx_A401kPlanLawsuitMember_e076fcf6-8203-4c2a-9f16-548897d72f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DataSecurityIncidentMember_02964858-02e8-4ef7-be7a-5061017fd9a9" xlink:href="dgx-20220930.xsd#dgx_DataSecurityIncidentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_684e416c-0e18-455f-ba39-199accb3fb53" xlink:to="loc_dgx_DataSecurityIncidentMember_02964858-02e8-4ef7-be7a-5061017fd9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c3f17fcc-fe57-48ea-9776-3c6be8bceac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:to="loc_us-gaap_LitigationStatusAxis_c3f17fcc-fe57-48ea-9776-3c6be8bceac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ea2f6b8f-13ed-4d47-a836-1ce0ccdad3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_c3f17fcc-fe57-48ea-9776-3c6be8bceac9" xlink:to="loc_us-gaap_LitigationStatusDomain_ea2f6b8f-13ed-4d47-a836-1ce0ccdad3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_2d02721e-2c97-46b9-9f0c-11e5b48f2721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_ea2f6b8f-13ed-4d47-a836-1ce0ccdad3b7" xlink:to="loc_us-gaap_PendingLitigationMember_2d02721e-2c97-46b9-9f0c-11e5b48f2721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1932904f-d151-4cd1-84ae-faf88adde9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1932904f-d151-4cd1-84ae-faf88adde9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c4fe588-698c-4dab-863e-3693689780a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1932904f-d151-4cd1-84ae-faf88adde9d9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c4fe588-698c-4dab-863e-3693689780a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5be7953a-1578-4eb8-8872-cbff7683964e" xlink:href="dgx-20220930.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5c4fe588-698c-4dab-863e-3693689780a4" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5be7953a-1578-4eb8-8872-cbff7683964e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_54434a13-c0ef-4254-a9f9-550f374631cf" xlink:to="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_3c2b82e5-9979-4c1b-962d-d049a2626070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_3c2b82e5-9979-4c1b-962d-d049a2626070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_4112fc74-3264-4c2b-b910-c4f00b00a6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c31d2319-d2f6-43d0-935e-29c043235d00" xlink:to="loc_us-gaap_LitigationReserve_4112fc74-3264-4c2b-b910-c4f00b00a6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51da8279-04f0-4d5e-97b6-03988382ecbf" xlink:to="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cb686de6-1b74-4c76-a831-13d28e22aba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cb686de6-1b74-4c76-a831-13d28e22aba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb686de6-1b74-4c76-a831-13d28e22aba8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_99df59a1-77d9-40aa-8ed5-78a38b06b77f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:to="loc_us-gaap_SecuredDebtMember_99df59a1-77d9-40aa-8ed5-78a38b06b77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_4027d6b3-395c-462f-bf0f-48f8bcc851e2" xlink:href="dgx-20220930.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1b347508-60fd-47c5-bd25-77fc7cb0627f" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_4027d6b3-395c-462f-bf0f-48f8bcc851e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1471a9a9-0e98-43b5-8d7d-eba28309f065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:to="loc_us-gaap_CreditFacilityAxis_1471a9a9-0e98-43b5-8d7d-eba28309f065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_84dada86-8f22-4372-9d0f-7ecaa1430b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1471a9a9-0e98-43b5-8d7d-eba28309f065" xlink:to="loc_us-gaap_CreditFacilityDomain_84dada86-8f22-4372-9d0f-7ecaa1430b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d3967d63-18d3-4698-9a45-9042443e67c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_84dada86-8f22-4372-9d0f-7ecaa1430b61" xlink:to="loc_us-gaap_LetterOfCreditMember_d3967d63-18d3-4698-9a45-9042443e67c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ab26afc7-a484-4172-9c45-90e367f1fea3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fe766ea7-a33c-4342-a110-8d87037cf19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fe766ea7-a33c-4342-a110-8d87037cf19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_267a2dfa-8612-43ab-a44a-9c859e9e1d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_df4e1038-df92-4770-8160-539c54447da5" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_267a2dfa-8612-43ab-a44a-9c859e9e1d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ede0e4b2-373b-4cda-8389-aa3b73c7b2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_51da8279-04f0-4d5e-97b6-03988382ecbf" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ede0e4b2-373b-4cda-8389-aa3b73c7b2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_92c35ead-3cdc-42b3-9735-19cfd238e6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_92c35ead-3cdc-42b3-9735-19cfd238e6bb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_75be6552-509f-4581-a40d-eedb258c3a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_75be6552-509f-4581-a40d-eedb258c3a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_75be6552-509f-4581-a40d-eedb258c3a58" xlink:to="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_6b2271c1-39e3-4fe7-bedc-d889afc6a985" xlink:href="dgx-20220930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_6b2271c1-39e3-4fe7-bedc-d889afc6a985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d6149674-00fc-468c-80f5-4899d5e327bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d6149674-00fc-468c-80f5-4899d5e327bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_2ea32467-d09c-4f37-8f95-8c7326e9580e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4385b73f-3706-4332-a673-8319594f561f" xlink:to="loc_us-gaap_CorporateMember_2ea32467-d09c-4f37-8f95-8c7326e9580e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:to="loc_srt_RangeAxis_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b8fe667f-ef76-4093-ab12-9aa333a095a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_638ac4cc-a7e1-43cb-b41b-dc026cd5ee58" xlink:to="loc_srt_RangeMember_b8fe667f-ef76-4093-ab12-9aa333a095a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e64206c0-2051-45bd-9f89-562c8bf62d6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b8fe667f-ef76-4093-ab12-9aa333a095a7" xlink:to="loc_srt_MinimumMember_e64206c0-2051-45bd-9f89-562c8bf62d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b555a75f-9ccb-4500-8d19-44f262df7f57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:to="loc_srt_ProductOrServiceAxis_b555a75f-9ccb-4500-8d19-44f262df7f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b555a75f-9ccb-4500-8d19-44f262df7f57" xlink:to="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_cb65b6e0-19a1-429c-8bad-6a824487414c" xlink:href="dgx-20220930.xsd#dgx_RoutineClinicalTestingAndOtherServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_RoutineClinicalTestingAndOtherServicesMember_cb65b6e0-19a1-429c-8bad-6a824487414c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_5b8a4bdc-3df2-4c3c-9198-edd18865b2b6" xlink:href="dgx-20220930.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_COVID19TestingServicesMember_5b8a4bdc-3df2-4c3c-9198-edd18865b2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_95ec4f03-f520-4cd2-911d-462afeba9614" xlink:href="dgx-20220930.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_95ec4f03-f520-4cd2-911d-462afeba9614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_b8009e1b-bb37-4add-9f6e-d9c8033d57a8" xlink:href="dgx-20220930.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_b8009e1b-bb37-4add-9f6e-d9c8033d57a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_ed8b13bc-1cf3-4588-86e9-adbef374a6c7" xlink:href="dgx-20220930.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0140f4af-f9f2-414c-a2bf-0b7724b7a25c" xlink:to="loc_dgx_AllotherservicesMember_ed8b13bc-1cf3-4588-86e9-adbef374a6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74d64986-fa8b-44d7-a23b-fb2c0249b410" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_d11b56d0-a58c-4be7-8e9b-c683a46571ec" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_dgx_PercentageofNetRevenues_d11b56d0-a58c-4be7-8e9b-c683a46571ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0c811e5-fe2f-46f8-8c5e-ebd5c5ff6b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0c811e5-fe2f-46f8-8c5e-ebd5c5ff6b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_487b82de-4407-4316-bc18-a475c27f6825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_OperatingIncomeLoss_487b82de-4407-4316-bc18-a475c27f6825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_082d4507-b2d8-47b9-9738-a2bb670f29df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_082d4507-b2d8-47b9-9738-a2bb670f29df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9b321a1-b6b6-452b-8c56-84cac9d20ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9b321a1-b6b6-452b-8c56-84cac9d20ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_73a0c548-e0f0-4aa7-9f56-b4f4eeca23e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_73a0c548-e0f0-4aa7-9f56-b4f4eeca23e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a42f499f-fb6c-41f2-a60d-8b7b076e3d48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a42f499f-fb6c-41f2-a60d-8b7b076e3d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_50d6b7be-d262-41b8-96bc-69014f220308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_ProfitLoss_50d6b7be-d262-41b8-96bc-69014f220308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8886652e-9537-4bc8-99c8-352dd9e08d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8886652e-9537-4bc8-99c8-352dd9e08d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4dd431ab-8977-4a09-bf8e-af49a92c3b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ab2fd099-6562-4fdb-a064-c0a867f1aa99" xlink:to="loc_us-gaap_NetIncomeLoss_4dd431ab-8977-4a09-bf8e-af49a92c3b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_551a5690-50df-495f-b90e-39c017c10e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_551a5690-50df-495f-b90e-39c017c10e40" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2f3e89a8-759f-4d14-af3f-b90541a17885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2f3e89a8-759f-4d14-af3f-b90541a17885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2f3e89a8-759f-4d14-af3f-b90541a17885" xlink:to="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_e8a02909-7fb4-4ab7-9185-e90d5676d46b" xlink:href="dgx-20220930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_e8a02909-7fb4-4ab7-9185-e90d5676d46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_8f7366f4-07a8-4dc1-bc90-a03ae11c92e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b2ac2694-22da-4af4-b51a-bf83f93d721c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_8f7366f4-07a8-4dc1-bc90-a03ae11c92e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_srt_RangeAxis_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6596604-6112-4830-97b5-b41f17965d6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c35e3db4-b3d0-4ea5-bcf1-bdd824e76db3" xlink:to="loc_srt_RangeMember_b6596604-6112-4830-97b5-b41f17965d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ada18da-b1db-4ee8-99f6-379e35d6e531" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6596604-6112-4830-97b5-b41f17965d6d" xlink:to="loc_srt_MinimumMember_6ada18da-b1db-4ee8-99f6-379e35d6e531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_067dc89d-52a1-490f-9b3c-31c7889538cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_us-gaap_SubsegmentsAxis_067dc89d-52a1-490f-9b3c-31c7889538cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_067dc89d-52a1-490f-9b3c-31c7889538cb" xlink:to="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_a56bfe13-b19f-4c4f-a017-806d91a83fd6" xlink:href="dgx-20220930.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_HealthcareInsurersMember_a56bfe13-b19f-4c4f-a017-806d91a83fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_908bee7d-d264-4bc5-b7ec-12aa0e093d29" xlink:href="dgx-20220930.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_GovernmentPayersMember_908bee7d-d264-4bc5-b7ec-12aa0e093d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_50de0ef6-5021-4d0a-b67d-97acc4d72e6d" xlink:href="dgx-20220930.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_ClientPayersMember_50de0ef6-5021-4d0a-b67d-97acc4d72e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_a86fb6d4-14dd-4e4c-823b-cc43a3fbbab5" xlink:href="dgx-20220930.xsd#dgx_PatientsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_PatientsMember_a86fb6d4-14dd-4e4c-823b-cc43a3fbbab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_caa95640-5fa1-4737-abc4-f364e173b22a" xlink:href="dgx-20220930.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e2326667-1ef3-4007-8a5b-e56116e22d55" xlink:to="loc_dgx_DSBusinessesMember_caa95640-5fa1-4737-abc4-f364e173b22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4fbe6b54-4636-46f7-948f-7009976933a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_srt_ProductOrServiceAxis_4fbe6b54-4636-46f7-948f-7009976933a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4fbe6b54-4636-46f7-948f-7009976933a5" xlink:to="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_2c14f72c-6a96-48ca-b8c8-0d283b436399" xlink:href="dgx-20220930.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:to="loc_dgx_FeeforserviceMember_2c14f72c-6a96-48ca-b8c8-0d283b436399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_ac19ab40-340e-4167-9268-d599188f3baa" xlink:href="dgx-20220930.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92dc39c3-7354-4282-b95b-6e0e53afa28a" xlink:to="loc_dgx_CapitatedMember_ac19ab40-340e-4167-9268-d599188f3baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eb605ea1-d236-40ac-a26a-6cbd156fb2ac" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_5939a909-68a4-4ff1-b2fb-88651423ace1" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:to="loc_dgx_PercentageofNetRevenues_5939a909-68a4-4ff1-b2fb-88651423ace1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_8b22db56-f5e4-4be9-bef5-2d389a9d9882" xlink:href="dgx-20220930.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c815ef08-0edd-4137-aee4-a118b271d219" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_8b22db56-f5e4-4be9-bef5-2d389a9d9882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#TAXESONINCOMEDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_01981415-9c2e-4ee8-8994-47bc51e0fa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01981415-9c2e-4ee8-8994-47bc51e0fa4e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d4905e01-327a-4483-b9b4-8d2bc21467c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d4905e01-327a-4483-b9b4-8d2bc21467c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d3b08c9b-7434-420a-bb56-392e34f4bccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d4905e01-327a-4483-b9b4-8d2bc21467c4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d3b08c9b-7434-420a-bb56-392e34f4bccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4acea291-bf9e-47c8-9e8c-b1cb632d680a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d3b08c9b-7434-420a-bb56-392e34f4bccc" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4acea291-bf9e-47c8-9e8c-b1cb632d680a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1fcc35aa-2b8e-428e-bca9-d20e4746efe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1fcc35aa-2b8e-428e-bca9-d20e4746efe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f9a523d-a24f-457e-9c58-0a6c1e73cd58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1fcc35aa-2b8e-428e-bca9-d20e4746efe3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f9a523d-a24f-457e-9c58-0a6c1e73cd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_6c3960e5-92f8-46cd-8345-1e6af8e15a9b" xlink:href="dgx-20220930.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f9a523d-a24f-457e-9c58-0a6c1e73cd58" xlink:to="loc_dgx_Q2SolutionsMember_6c3960e5-92f8-46cd-8345-1e6af8e15a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_8f494e48-4bbd-4763-a391-b68d4bc75fc0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_54525227-2925-4cca-9c4e-208f232f1701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_54525227-2925-4cca-9c4e-208f232f1701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_b2e5d55b-35ff-47b6-a4a8-39220b6f2a1d" xlink:href="dgx-20220930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_b2e5d55b-35ff-47b6-a4a8-39220b6f2a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_c708de87-753c-473b-842b-2f97a3ffd0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1698fa83-9a1a-4264-81c4-37afd0cff77e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_c708de87-753c-473b-842b-2f97a3ffd0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="dgx-20220930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_798f336f-b231-463c-a477-904e21311ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_798f336f-b231-463c-a477-904e21311ef0" xlink:to="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2006f304-4258-49b4-9fc2-36cb7ae7708e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2006f304-4258-49b4-9fc2-36cb7ae7708e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6a9bad08-6b9c-4974-9cdc-490c62881ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2006f304-4258-49b4-9fc2-36cb7ae7708e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6a9bad08-6b9c-4974-9cdc-490c62881ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_495694c2-1cff-4784-a87b-54d51e1963f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6a9bad08-6b9c-4974-9cdc-490c62881ad1" xlink:to="loc_us-gaap_SubsequentEventMember_495694c2-1cff-4784-a87b-54d51e1963f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c0e4804b-958f-4e9a-b355-ffca9d229092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c0e4804b-958f-4e9a-b355-ffca9d229092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_00029723-3eed-43fc-b365-51945c7354c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c0e4804b-958f-4e9a-b355-ffca9d229092" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_00029723-3eed-43fc-b365-51945c7354c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_7e6c9071-09ef-492c-af3b-7b5f7ec45bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_00029723-3eed-43fc-b365-51945c7354c9" xlink:to="loc_us-gaap_SecuredDebtMember_7e6c9071-09ef-492c-af3b-7b5f7ec45bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ed0eea81-8ccf-434b-8f83-a7fa15d2436c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_CreditFacilityAxis_ed0eea81-8ccf-434b-8f83-a7fa15d2436c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ed0eea81-8ccf-434b-8f83-a7fa15d2436c" xlink:to="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMember_b7311348-29ab-4a12-ba34-f4638eb987ca" xlink:href="dgx-20220930.xsd#dgx_LoanCommitmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:to="loc_dgx_LoanCommitmentMember_b7311348-29ab-4a12-ba34-f4638eb987ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_8b0ddfc7-5eee-486e-ae97-5a4c64968b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cdde2656-b130-4105-9ddf-51236274494b" xlink:to="loc_us-gaap_LetterOfCreditMember_8b0ddfc7-5eee-486e-ae97-5a4c64968b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_917bbf0a-6174-4b23-b768-26cd22483db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_VariableRateAxis_917bbf0a-6174-4b23-b768-26cd22483db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_452694e0-f855-40dc-9af1-64a7ae9ad503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_917bbf0a-6174-4b23-b768-26cd22483db9" xlink:to="loc_us-gaap_VariableRateDomain_452694e0-f855-40dc-9af1-64a7ae9ad503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember_70118e01-0906-4dcb-bdde-517ab8ec6e81" xlink:href="dgx-20220930.xsd#dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_452694e0-f855-40dc-9af1-64a7ae9ad503" xlink:to="loc_dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember_70118e01-0906-4dcb-bdde-517ab8ec6e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_535560d6-8c0f-4acf-a90e-664a1845f8c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_srt_RangeAxis_535560d6-8c0f-4acf-a90e-664a1845f8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_535560d6-8c0f-4acf-a90e-664a1845f8c7" xlink:to="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ab22014-3526-483d-ae59-498319782da1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:to="loc_srt_MinimumMember_0ab22014-3526-483d-ae59-498319782da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_79e5cf08-d22b-464f-a642-b561ca694978" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_80081291-e12b-49c1-a566-c04ef3424dc7" xlink:to="loc_srt_MaximumMember_79e5cf08-d22b-464f-a642-b561ca694978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b6b8f12c-a123-4459-9e2d-c5318f667c11" xlink:to="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3cee085-eca5-44d0-8cdc-7fcb7e7d394a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c3cee085-eca5-44d0-8cdc-7fcb7e7d394a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod_c8d95093-6caf-43b4-8daa-601760fbe6f1" xlink:href="dgx-20220930.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:to="loc_dgx_DebtInstrumentExtensionPeriod_c8d95093-6caf-43b4-8daa-601760fbe6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_654d93f4-6694-4c5a-9485-274b67c784af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_ff196025-6de7-4c57-9b2f-5caec29ca110" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_654d93f4-6694-4c5a-9485-274b67c784af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174795810304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,887,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174795857024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 2,486<span></span>
</td>
<td class="nump">$ 2,774<span></span>
</td>
<td class="nump">$ 7,550<span></span>
</td>
<td class="nump">$ 8,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">1,618<span></span>
</td>
<td class="nump">1,670<span></span>
</td>
<td class="nump">4,875<span></span>
</td>
<td class="nump">4,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">464<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">1,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income, net</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">2,094<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">6,257<span></span>
</td>
<td class="nump">6,199<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating (expense) income, net</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">654<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="num">(483)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="nump">899<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 845<span></span>
</td>
<td class="nump">$ 1,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 2.20<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 2.17<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 7.05<span></span>
</td>
<td class="nump">$ 12.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174796327296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 1,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in available-for-sale debt securities, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net deferred gain on cash flow hedges, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="nump">1,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">$ 828<span></span>
</td>
<td class="nump">$ 1,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174796133184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $29 and $31 as of September&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">1,280<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,334<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,707<span></span>
</td>
<td class="nump">1,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,190<span></span>
</td>
<td class="nump">7,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,223<span></span>
</td>
<td class="nump">13,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,447<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,602<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">3,980<span></span>
</td>
<td class="nump">4,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both September&#160;30, 2022 and December&#160;31, 2021; 162 shares issued as of both September&#160;30, 2022 and December&#160;31, 2021</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">8,263<span></span>
</td>
<td class="nump">7,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 48 and 43 shares as of September&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="num">(4,271)<span></span>
</td>
<td class="num">(3,453)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">6,235<span></span>
</td>
<td class="nump">6,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,272<span></span>
</td>
<td class="nump">6,483<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 13,223<span></span>
</td>
<td class="nump">$ 13,611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174796312752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174797524704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 1,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Provision for credit losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision (benefit)</a></td>
<td class="nump">45<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_GainLossOnDispositionOfJointVenture', window );">Gain on disposition of joint venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(314)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">37<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(169)<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,384<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(257)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from disposition of joint venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">(Increase) decrease in investments and other assets</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(369)<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(947)<span></span>
</td>
<td class="num">(1,910)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(230)<span></span>
</td>
<td class="num">(232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,187)<span></span>
</td>
<td class="num">(2,171)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">872<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of period</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 987<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_GainLossOnDispositionOfJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Disposition of Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_GainLossOnDispositionOfJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798508176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 6,809<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,841<span></span>
</td>
<td class="nump">$ 9,303<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
<td class="num">$ (5,366)<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(1,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="num">(3,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2021</a></td>
<td class="nump">6,432<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">7,333<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(2,866)<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2020</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2021</a></td>
<td class="nump">5,940<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,555<span></span>
</td>
<td class="nump">10,246<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(6,894)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="num">(3,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2021</a></td>
<td class="nump">6,432<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">7,333<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(2,866)<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2021</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2021</a></td>
<td class="nump">6,483<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
<td class="nump">7,649<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(3,453)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(950)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (950)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2022</a></td>
<td class="nump">6,272<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">8,263<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(4,271)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2022</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2022</a></td>
<td class="nump">6,450<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">8,083<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(3,901)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2022</a></td>
<td class="nump">6,272<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,272<span></span>
</td>
<td class="nump">$ 8,263<span></span>
</td>
<td class="num">$ (31)<span></span>
</td>
<td class="num">$ (4,271)<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2022</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2022</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798286304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_DescriptionOfBusinessAbstract', window );"><strong>Description of Business (Abstract)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, and accountable care organizations ("ACOs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of Business (Abstract)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174803481376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of significant demand for COVID-19 testing.  As a result, operating results for the three and nine months ended September&#160;30, 2022 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174800227648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.41&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>&#160;&#160;&#160;&#160;The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first three quarters of 2021 did not equal the total for the nine months ended September&#160;30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of share repurchases (see Note 9 for further details regarding the Company's share repurchases).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174814287488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $123&#160;million, net of $4&#160;million cash acquired, which consisted of cash consideration of $105&#160;million and contingent consideration initially estimated at $18&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $96&#160;million of goodwill (of which $78&#160;million is tax-deductible), $30&#160;million of intangible assets, $5&#160;million of operating lease right-of-use assets, $5&#160;million of operating lease liabilities and $(3)&#160;million of working capital. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years. For further details regarding the fair value of the contingent consideration, see Note 6.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On December 13, 2021, the Company completed the acquisition of assets of Labtech Diagnostics, LLC ("Labtech"), an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, and recorded the assets acquired and liabilities assumed based on a preliminary purchase price allocation. During the nine months ended September&#160;30, 2022, the Company revised its purchase price allocation and recorded an $8&#160;million increase to goodwill, a $3&#160;million increase to customer-related intangible assets, a $1&#160;million decrease to inventories and a $10&#160;million increase to the estimated contingent consideration accrual. These adjustments did not have a material impact on the Company's consolidated results of operations. For further details regarding the fair value of the contingent consideration, see Note 6.</span></div>&#160;&#160;&#160;&#160;For details regarding the Company's 2021 acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174802723936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISPOSITION</a></td>
<td class="text">DISPOSITION<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc., its joint venture partner, for $760&#160;million in an all-cash transaction. Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the nine months ended September&#160;30, 2021, the Company recorded a $314&#160;million pre-tax gain in other (expense) income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss. During the nine months ended September&#160;30, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174802841392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Such equity investments are classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the acquisitions of Pack Health and Labtech, the Company has contingent consideration obligations, with a potential maximum aggregate payment of $40&#160;million, that are to be paid based on the achievement of certain testing volume or revenue benchmarks.  Contingent consideration accruals are measured at fair value using either an option-pricing method or a Monte Carlo method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume or revenue and other market inputs, including comparable company revenue volatility (7.5%) and a discount rate (ranging from 2.5% to 3.0%).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding the Company's acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 4.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value adjustments included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, September 30, 2022</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The $1&#160;million net gain included in earnings associated with the change in the fair value of contingent consideration for the nine months ended September 30, 2022 is reported in other operating income, net.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of September&#160;30, 2022, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments. As of September&#160;30, 2022 and December&#160;31, 2021, the fair value of the Company&#8217;s debt was estimated at $3.6 billion and $4.4 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174803481376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in goodwill for the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,190&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of September&#160;30, 2022 and December&#160;31, 2021 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, goodwill acquired was principally associated with the acquisition of Pack Health, and adjustments to goodwill primarily related to foreign currency translation, largely offset by an adjustment of the purchase price allocation for Labtech (see Note 4). For the year ended December&#160;31, 2021, goodwill acquired was principally associated with the acquisitions of the assets of the outreach laboratory services business of Mercy Health and the assets of Labtech (see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K), and adjustments to goodwill related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(796)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2022 is as follows:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174802723936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both September&#160;30, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div>&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174802071552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2022 and 2021, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the first three quarters of 2022, the Company's Board of Directors declared a quarterly cash dividend of $0.66 per common share.  During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2022, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of September&#160;30, 2022, $746&#160;million remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, the Company repurchased 7.1&#160;million shares of its common stock for $950&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, the Company repurchased 12.5 million shares of its common stock for $1.6 billion, including 9.1&#160;million shares repurchased under accelerated share repurchase agreements ("ASRs") as follows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase its common stock as part of its share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock, less a fixed discount, during the repurchase period, which ended during the fourth quarter of 2021. For the nine months ended September&#160;30, 2021, the Company paid $1.5&#160;billion to the financial institutions and initially received 9.1&#160;million shares of its common stock for a value of $1.2&#160;billion, which represented 80% of the total value of shares to be repurchased under the ASRs based on the stock price at inception of the ASRs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022 and 2021, the Company reissued 1.6 million shares and 1.7 million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock Retirement &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended September&#160;30, 2021, the Company retired 55&#160;million shares of treasury stock. In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of September&#160;30, 2022 and December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  For further details regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174800181024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2022 and 2021 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2022, the Company amended a real estate lease and, based on the updated terms, the classification of the lease changed from a finance lease to an operating lease. As a result, the Company recorded a $31&#160;million operating lease right-of-use asset.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174803642144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 15.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2022, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  Discovery is proceeding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the Company has been notified that numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  </span></div><div><span><br/></span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ReproSource Fertility Diagnostics, Inc.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#8220;ReproSource&#8221;), a subsidiary of the Company, is subject to two putative class action lawsuits in the U.S. District Court for Massachusetts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bickham v. ReproSource Fertility Diagnostics, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#8217; private information. ReproSource has moved to dismiss both complaints.  In addition, the Company had been notified that the Office of Civil Rights of the U.S. Department of Health and Human Services (&#8220;OCR&#8221;) and three state governmental authorities were investigating or otherwise seeking information and/or documents related to the incident.  The OCR and one state investigation have been closed, and the other state investigations are inactive.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of September&#160;30, 2022, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $5 million and $4 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;The Company is subject to a series of individual claims brought by persons in Ireland related to allegations stemming from pap smear screening services performed by the Company.  In general, claimants have alleged that the results of certain pap smear screening tests performed by the Company and other providers, pursuant to a program coordinated by the Irish government, were incorrect for individuals who were later diagnosed with cervical cancer.  The Irish government and an independent scoping inquiry commissioned by the Irish government found that the Company&#8217;s performance of its screening services for the Irish cervical cancer screening program were in accordance with both Ireland&#8217;s requirements and international standards.  The Company has settled claims made by certain individuals, is a party in multiple lawsuits and may be served as a party in additional lawsuits.  The Company does not believe that the resolution of existing or future claims will have a material adverse effect on its financial position or liquidity, but the ultimate outcomes of these claims are unpredictable and subject to significant uncertainties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $162 million and $159 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;While the basis for claims reserves is actuarially determined losses based upon the Company's historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although the Company believes that its present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that the Company may incur liabilities in excess of its recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material impact on the Company&#8217;s results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174797792256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, and ACOs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2022, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three and nine months ended September&#160;30, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating (expense) income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174803491104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over 95% of the Company&#8217;s total net revenues for the three and nine months ended September&#160;30, 2022 and 2021 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue and Net Accounts Receivable by Customer Type</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:57.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.770%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174797792256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text">TAXES ON INCOME<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022 and 2021, the effective income tax rate was 23.8% and 23.1%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5).  In </span>addition, the effective income tax rate benefited from $10 million and $15 million of excess tax benefits associated with stock-based compensation arrangements for the nine months ended September&#160;30, 2022 and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798360032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS&#160;&#160;&#160;&#160;During October 2022, the Company amended its $600&#160;million secured receivables credit facility in order to extend the maturity dates for each underlying commitment by one year while decreasing the aggregate borrowing capacity under the secured receivables credit facility to $525&#160;million.  Under the amended secured receivables credit facility, the Company can borrow against a $425&#160;million loan commitment, half of which matures in October 2023 and half of which matures in October 2024.  Additionally, the Company can issue up to $100&#160;million of letters of credit through October 2024.  Borrowings under the secured receivables credit facility are collateralized by certain domestic receivables.  Prior to the amendment, interest on borrowings under the secured receivables credit facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread.  Subsequent to the amendment, interest on borrowings under the facility will be based on either commercial paper rates for highly-rated issuers or the Term Secured Overnight Financing Rate, plus a spread of 0.725% to 0.80%.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174796132464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards to be Adopted</a></td>
<td class="text">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div>&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174803551280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.05&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.41&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174800211216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value, Measurement Inputs</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value adjustments included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, September 30, 2022</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798499536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill, Net</a></td>
<td class="text">The changes in goodwill for the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,190&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Excluding Goodwill</a></td>
<td class="text">Intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(796)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense Intangible Assets</a></td>
<td class="text">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2022 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174803458304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock', window );">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</a></td>
<td class="text">As of September&#160;30, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both September&#160;30, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174800365808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2022 and 2021 was as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174800194480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Reporting Information by Segment</a></td>
<td class="text">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating (expense) income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock', window );">Schedule of Revenues by Major Service</a></td>
<td class="text">Net revenues by major service were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,486&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Revenues by Major Service</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174800221344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:57.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.767%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.770%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798407888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 845<span></span>
</td>
<td class="nump">$ 1,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Less: Earnings allocated to participating securities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 841<span></span>
</td>
<td class="nump">$ 1,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 2.20<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="nump">$ 7.17<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 2.17<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 7.05<span></span>
</td>
<td class="nump">$ 12.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and performance share units</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174797414400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,095<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember', window );">Pack Health, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">$ 123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital', window );">Working capital</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember', window );">Pack Health, LLC | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Labtech Diagnostics, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, purchase adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_InventoryPurchaseAccountingAdjustments', window );">Inventory, purchase adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets', window );">Increase to the estimated contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember', window );">Labtech Diagnostics, LLC | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments', window );">Intangible assets, purchase adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill, Intangible Assets and Inventories</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_InventoryPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Purchase Accounting Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_InventoryPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for purchase accounting adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_LabtechDiagnosticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174797420160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="num">$ (87)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross', window );">Gross proceeds from disposition of joint venture</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Other Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on sale of investment, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale of Equity Method Investments, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174801042176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174797846864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember', window );">Contingent Consideration | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total fair value adjustments included in earnings - realized/unrealized</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember', window );">Pack Health, LLC and Labtech Diagnostics, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Maximum contingent consideration payment</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember', window );">Pack Health, LLC and Labtech Diagnostics, LLC | Comparable Company Revenue Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember', window );">Pack Health, LLC and Labtech Diagnostics, LLC | Discount rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember', window );">Pack Health, LLC and Labtech Diagnostics, LLC | Discount rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=dgx_MeasurementInputComparableCompanyRevenueVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=dgx_MeasurementInputComparableCompanyRevenueVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174796148944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174802760704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details) - Significant Unobservable Inputs, Level 3 - Contingent Consideration<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2021</a></td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances', window );">Purchases, additions and issuances</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total fair value adjustments included in earnings - realized/unrealized</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2022</a></td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174797839760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at beginning of period</a></td>
<td class="nump">$ 7,095<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Adjustments to goodwill</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at end of period</a></td>
<td class="nump">$ 7,190<span></span>
</td>
<td class="nump">$ 7,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798774128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 2,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(903)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2022</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Intangible Assets Not Subject to Amortization - Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Intangible Assets Not Subject to Amortization - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer-related intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(796)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(796)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember', window );">Total Amortizing Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(903)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798499664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798976688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="7">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase authorization remaining available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 746,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 746,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="nump">$ 1,910,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember', window );">ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_AcceleratedShareRepurchasesPayment', window );">Accelerated share repurchases, payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution', window );">Value of shares to be received under accelerated share repurchase agreements at execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements', window );">Accelerated share repurchase, percent of total value to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="nump">$ 1,610,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost | ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AcceleratedShareRepurchasesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AcceleratedShareRepurchasesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174816001072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TreasuryStockPurchasedbutNotyetPaid', window );">Accounts payable associated with purchases of treasury stock</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_Mergerconsiderationpaidpayablenet', window );">Merger consideration payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: Cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Mergerconsiderationpaidpayablenet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger consideration paid (payable), net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Mergerconsiderationpaidpayablenet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TreasuryStockPurchasedbutNotyetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Purchased but Not yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TreasuryStockPurchasedbutNotyetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174803824144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 607<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TriggeringEventAxis=dgx_AmendedRealEstateLeaseMember', window );">Amended Real Estate Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalCashFlowAndOtherDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Supplemental Cash Flow and Other Data [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalCashFlowAndOtherDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TriggeringEventAxis=dgx_AmendedRealEstateLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TriggeringEventAxis=dgx_AmendedRealEstateLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174795867936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="nump">$ 162,000,000<span></span>
</td>
<td class="nump">$ 159,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember', window );">Excludes general and professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=dgx_A401kPlanLawsuitMember', window );">401(k) Plan Lawsuit | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=dgx_DataSecurityIncidentMember', window );">Data Security Incident | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dgx_A401kPlanLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dgx_A401kPlanLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dgx_DataSecurityIncidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dgx_DataSecurityIncidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174796054752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,486<span></span>
</td>
<td class="nump">$ 2,774<span></span>
</td>
<td class="nump">$ 7,550<span></span>
</td>
<td class="nump">$ 8,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating (expense) income, net</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">654<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="num">(483)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="nump">899<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">845<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineClinicalTestingAndOtherServicesMember', window );">Routine clinical testing and other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">1,119<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">3,283<span></span>
</td>
<td class="nump">3,392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 Testing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">709<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">2,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">835<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="nump">2,361<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,419<span></span>
</td>
<td class="nump">$ 2,703<span></span>
</td>
<td class="nump">$ 7,344<span></span>
</td>
<td class="nump">$ 7,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 441<span></span>
</td>
<td class="nump">$ 713<span></span>
</td>
<td class="nump">$ 1,445<span></span>
</td>
<td class="nump">$ 2,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">$ (52)<span></span>
</td>
<td class="num">$ (69)<span></span>
</td>
<td class="num">$ (168)<span></span>
</td>
<td class="num">$ (207)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineClinicalTestingAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineClinicalTestingAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798653520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients (including coinsurance and deductible responsibilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174801967808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">23.80%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share-based compensation, excess tax benefit, amount</a></td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by Sale | Q2 Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140174798720352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Secured Receivables Credit Facility - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 21, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 525,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_DebtInstrumentExtensionPeriod', window );">Extension period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Commercial Paper and Term Secured Overnight Financing Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">0.725%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Commercial Paper and Term Secured Overnight Financing Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Loan Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 425,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Extension Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=dgx_LoanCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=dgx_LoanCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>dgx-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:dgx="http://questdiagnostics.com/20220930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20220930.xsd" xlink:type="simple"/>
    <context id="ie411d34972bb419285874be10c5557a1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3af3b79934d24fb1bd1cbb0bcbf27618_I20221014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-10-14</instant>
        </period>
    </context>
    <context id="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib247069292a644faa219725ce24814d2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0339863356d84ed3995b604e24b5634d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52dab5247a1c4bbcb053e10c176ecba6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id28568ccefa145d1b82a58a63eaad5a4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia66110999ebf47e489970ea681e28bc9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i133ede9bcd2547d88ad254bf768df343_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0f52678681d643878109e96f1420975f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i77f7c6bfef074498a4e11de614453204_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if85ffac6808545d2a1e4b4b8d588cbca_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i71f8587b94614e62972a571a0db167fb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6601d4f897bd4dad9874662aa4fe198e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if9f8b7df600b4b878bba187286fd791b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i38982359ccf14cb991b0c3db0e12289b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i446ca4eb05494f1993ef7b2e312c2037_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8c1a402b7edc4bada7fe43b8bed57c9e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id81266202c6f4daaa1fe7d11c3466090_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie8fcb85a255b4d078c7675e41fd05fb7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8691d08785574903bd93ee4dfa5db854_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0fa63970b08847edb23879db454cfd5a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6d44b0c7e6764a3690dac72ba9bceeb6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id6123cf684d748bfaeb9d6c407ab233d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibee26b45b4834d788993956547c7876e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a5de51ccdd040f8bc396f5bbb026e33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a33f90cea9e41bebf5bc6e0fb60699f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ebb219cb475425591cf0155edc1d443_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebfd0201851442908146535dd57ca675_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i541597114f5944418a137ab87cea7f3b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3118010a65e94107930187af0b9032e2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3680833c24d343c4b94154c01f3fad0f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i430a0954dff34ed2abd3bbf6af3ce92e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7d22acbc549640a3bcff1331465f4490_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i81a2d9b7a5804534a11a487194d959d8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6e937069022b4224ae54a53549450dfe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id99280e00773483bbeab37f6250f0a64_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3bd61be3e49b417b94fe98d76f276f90_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5ebde6c314dc416a9d24bf9416554a5a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icfcdafe6ec384c35ae912ea54a83b7b3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id58c37cc4057489f93440a4c2f4ad37e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i63e96229aac640a599fd3d48159fd084_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d7a467583ec46aa992fbd14a917bb43_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i055da741a38a425dae638290e29c8807_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia920ca1912e3480ebb55fdc231a8da19_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3d3e5ccd81e9421e810e21a4bfa68ce7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i95b59fb6a60d4941848525e7d490105d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0079fdb1f79341858ac4900a117a3803_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i58732cf05c7043b6a8e12b54db21de24_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0089fadb633a4032ac4aaef0b0d2b75e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93981161fc924e7fbcc2631956508614_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6eef6a2ec94d4ff289ccf2404dd21a9a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe1208f398b44195af87535925e86927_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i589ae2a45c0c438dbc9b633c7ad6ae33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i840e894a7ef144038ef94728d7daa256_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0ffd0c3e5b9546b8bfe16c9eb1ec2e7d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f9453dbd4c9422baa1dba8fb9a308cf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i77ef3821374f4ec68ef2864dd77fedec_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89534177306a427980b6ebbaeab041c4_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="i2a00a453622d4c80b1907306cdca3d9b_I20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-01</instant>
        </period>
    </context>
    <context id="i8bc9e3bbed0e42539b9efaaf04edba4d_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic9042842adea48d68f78ed59ef1a76de_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:LabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i08caf8d530cf43008af3a0306e3e477c_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ibcef44e271aa4680b8911a11902d9a4a_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ibf27417747054ef395ca09d3516e7989_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i663fdcd70d744b64b639798c418155da_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7e0679f17ba34e699fbd836abaac5f2d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i298386f964ec4ef8adea12f70e3a5da7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i45473dab00a64ee98b363794ddc1df50_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id0eaed39b10c4747a4466534a16d4ed4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12e12ac865714887ac216f5d036b7039_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3b4e217688f484da0874a661078f82f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic744a596e51e4fda9a38522d60c59682_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0b707eca9294fdaa61759b2009a7077_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i762312568e8b4ea9bdfe5e9cb82f2fe5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">dgx:MeasurementInputComparableCompanyRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3891771b03b74ae6bf6f1e347f984954_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3a7cdccc5b8b4351a6c84a3102569a41_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:PackHealthLLCAndLabtechDiagnosticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i46b26dd13b5045219577db6205b830a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic2dd843e91d24830a207e5a623c8c5f5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i109ee53a89994956b1b78b0354ad068a_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="ic04fac321a00460b82d13cb06da4f28d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibebd5d13929a45809fca7b3d45a757d1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i89346c0905d2439297816ae363b1ed66_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c7345fe4fd94293946d0bf7c21a7d80_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8205d967b9d04f0592030979d313578e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia888a55675b34c1da6c98058a0bfbb00_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i052af85eec62405eb656914f67d3a176_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i193a25bf19ea41e690356bc8c5ce3380_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6c162a22bd874f5a8997350a100e5b4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1465ba55b394e54ae2154b81d8f51fb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iafe0e5ae893b40efa9626f66a5e78820_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67dee3f585f1452888374d9ee3dba34c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic279fc9d23034639855e69aafe143991_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7998a056fa014b5b93a343c7b3bc409c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9ee3230ab4d945ffa507522cd478b188_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39c1dcdf5ded4bc5be532f869db993b6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8892d167ced44fed893e191b22d3989c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1102df7028da465093e08195001df34c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i29663b176c084c83ba8d49b48433f6a7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if16effd867954c738404b7b96d2e8eae_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i67d9eea602464d4fab91b47e890a65ff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieb3a7eac45ff47d6b334f694b10c9c80_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i973ec05c00df4ad6a2a4472b1d8d2332_D20220201-20220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <context id="i0af15cd6ca4d4d5a9a34b91873ffc960_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c0f85b320f34c5db62f1f89cba5a333_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i1fa78c23eb41439b8bceb72de57816d2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i191fbddd79df46e9b0198928feb36a29_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dgx:TriggeringEventAxis">dgx:AmendedRealEstateLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6f0c266cfabc4117a5db448c8bd6d03f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8b2ee25f2ed8463cb9acb8e346af111a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia1a4fda1687b418eb6a88b57bee7ee91_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i71bd2faa4dcb410aac7083d1314895b2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2429a6bcd9bd4c65a106279746ec156f_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:A401kPlanLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ib3f4b1ab656b429792e65b699bbd3194_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:DataSecurityIncidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibad21a9259c74090ab33049d5d123cd2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i049e3ca5238248948e41058b0359b2cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6780bd5df0e2405c8a5497be06f79406_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i778d30c2a5f04d5bbd79b50d49dff45b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i35233092ea214d52af667521fd4f34ba_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2022fe35c0ed49ce8cbcf4e5663b9586_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i69f82d92935446eda7827eecbc1d0446_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4dd75de4a9a04a92817af7be460230d6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie54292d821ae48a68d7b57aa83ce30d5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e38360cd91846de82063fcaaf58e127_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iedba8be9e6d9474cbeea5e69c3817a44_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2213ad4f9e044d1f9f73b935280a85d0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i05844d0d291141408b4c5e911aa1a773_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6fc81340b331406aaaa1e47f50446a3a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia2262f05753a4ec9afdc14f6b0ffdd09_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1ba791edd92545c5a2aef512c9a4b212_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3982f629690f495cbf0e0ba3db8ad100_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineClinicalTestingAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0b2ec2a973ec44539d673cf6d99f87ec_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idfa3c11aef7e473182161c33c456b37b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaeb59228d7c345f18c522deada6d4507_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icf3b88fd5ccc4285a63afa1e6f852f11_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i882d231dd7374595abf2c323937f41ba_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i33932a80efde433c898a298b0df7e2c0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3d4b2c0774334fd9bff7edabc3b2f8d4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id771340b26ba466d84857e28e997aad7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5981a21f65c64729863e38afe9d108b6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7d569efaaa7146efa0ff3406897b8dbc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0c9489e8daf9452f86f8ce2d6e8b66d4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i70c6fc5be8aa4490a60a9c8eb3f467ff_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1b74cfcfe6b74088a041cf19f39f8bfd_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifac9122b4d044d2aac6ae108cb25b79d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9a4fa9bc40c5420697f812025c278d5f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia2463ba51e264dbbb561f3ebd2a7ae68_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id4bb02bf9fa849cb99832a402efd5409_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icafe184efc93430796a2beab39669d01_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i229509c7231549db925bf29fdce1531d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iff5758981e1444b4b9fd02f8aa63d7bf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice963a3c871a4964b7fada36abe521f5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe66bde611c3455b968735afb276accc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idb2da7bb5bdf450d94c7cb844900e0b1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib9ec7b61dbc848dc972c1fd56b0ab080_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iedddff22ba5b4fb0a008f2787a6212e5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee7efe5928604ef39c7c110d8e85cdaa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0dee333059084814b53e9d3f76a165f5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie8f803ca658f4d9ca283e32e2641679d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0abea2ff94d74055876d608a5384541f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0c844b73612e4d969c32144072e69482_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i70b790ee8c6b4795a8b810a63f6d3fbf_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icfc6ae7ce5004bf1a030a03d500851b6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie972687548c145bea8a73606c134780f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic36a1aa9ec14411bbb9b140920cd721e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idb786a9417bf40a9a53c78abcd60b86a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia5ab3f4c5668458b9be3e667d579e95d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0a3b7e0a1ab747b4a88ba384b9c6f5e3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if614926c685244ce8994f73e3407170e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i40c24d1fe9e0422f98322342e1b600dc_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i80681a5902484c9794b52f9ce9a0fe75_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i36f1feca4ebc4193a027d4329c6dbdb5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie2ee8ab6bcc5441f948edbcabba5af31_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib2443278408344ab88c125996c678332_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5550fc4948864d109a0e41c607884cf3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f4871ad170844a7986509f75afcd399_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0ea4dfa98d0b49eeaaccda4c4ae455f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice796a3655d941feb767f6c8fe65158b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4e911465833a4a6798f86e6b37692664_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95ec2390c17341c28ef60e2177b55f77_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i56774b5505024ca583c3885fc53e3512_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e9c25981e2a4d4bac14a20a91cdad7f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2ba474b936bc4d4ab84b4dc85c5d37f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56d1825da4ab49a8b78821022de2b6e8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9190b150986345cd97cfc2aebc94c2c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5cef2104bcc84b258c94c1efe866d9b3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i913e83ce0c8349688375d506afd9d9ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib54a2680ca68495bb80170fdfa0a42bd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i50a1c819b1b44a4aa7ad7742dca1f94f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33d1ee32d81244fcbd386f76884c5ada_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id12e6b7fc3d84f40ab1168ad2af450f4_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="ie53b722a57ce4b9daa9771d76111e184_D20221001-20221021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-21</endDate>
        </period>
    </context>
    <context id="ib0810507aff24122a43695ca80ce0367_I20221021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-21</instant>
        </period>
    </context>
    <context id="ife2cffd951d24830bd6a215df4ae3b0b_I20221021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dgx:LoanCommitmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-21</instant>
        </period>
    </context>
    <context id="i9cee0dfd60be4a578a2484c1cd2ed559_I20221021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-21</instant>
        </period>
    </context>
    <context id="i2cc95a9c78fc4bcb85da10d7ada37895_D20221001-20221021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperAndTermSecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-21</endDate>
        </period>
    </context>
    <context id="i04cac7194168497fb90bd4b4e067a6cc_D20221001-20221021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperAndTermSecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-21</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF8xLTEtMS0xLTY4Mzgy_d76c9d72-41ee-4e5e-a45f-c4e87412fe31">0001022079</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF8yLTEtMS0xLTY4Mzgy_638e2a7f-2765-4cc6-8e61-d96983a7af3a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF8zLTEtMS0xLTY4Mzgy_9a15ccf5-11f8-4cd7-93fe-ff646bca4019">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF80LTEtMS0xLTY4Mzgy_554819cb-146f-4d9c-bc84-66ce669dbae0">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80L2ZyYWc6ODUzYTVlYTFlYWMzNGI1MjkyYTY1NzI1YjVjYzI3OGYvdGFibGU6MDg5ODQwNjdlMWRlNDk3ZThlNmYxMWE0MjEwMDkzZjgvdGFibGVyYW5nZTowODk4NDA2N2UxZGU0OTdlOGU2ZjExYTQyMTAwOTNmOF81LTEtMS0xLTY4Mzgy_94eca8a2-fc42-4236-b0cc-1a703459741b">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE5_69d0a337-48a1-4fe3-9c58-4f108dbd90ea">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTEy_d7bab964-a095-4f2b-8c11-c4b1a3b187c8">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xNTI_2d771878-7ae5-47bc-91bc-523a17cd41b8">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTEz_202fa6ec-ef2a-4b19-b89b-ee90a4280c6a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE0_bfb267f4-7695-4bc1-853f-537abaeca0ad">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE1_1739c9af-182a-4116-b3b3-f109261466c4">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18wLTAtMS0xLTY4Mzgy_8bdee25e-acb0-4f72-a7e6-1b016ab5128c">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18wLTUtMS0xLTY4Mzgy_6c8c61ac-0d3e-4de3-81f6-680a7f33a78e">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18yLTAtMS0xLTY4Mzgy_63403d7f-bfe6-4f50-aa6b-a262a02bea94">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18zLTAtMS0xLTY4Mzgy_59942a1d-0e70-464a-931c-ad81c43d0189">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18zLTEtMS0xLTY4Mzgy_ec579fc4-1fe6-4451-997e-43829488f98f">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y18zLTItMS0xLTY4Mzgy_5fbcbde0-9cf7-4eaf-867c-d9106ba38ca6">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y180LTAtMS0xLTY4Mzgy_e3cbc3e6-96fc-441d-b2db-71aeff2d8093">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6ZGM5ODdiY2E2MDk0NGI1YWJmNDEwNGEwYzk1OWZkOWMvdGFibGVyYW5nZTpkYzk4N2JjYTYwOTQ0YjVhYmY0MTA0YTBjOTU5ZmQ5Y180LTEtMS0xLTY4Mzgy_4c778685-5f26-4e42-9326-13126863e7c7">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6MjQ5Zjc0MjA3YWM5NGQxNTg3YjgwZTY0ZjZmY2M4OGMvdGFibGVyYW5nZToyNDlmNzQyMDdhYzk0ZDE1ODdiODBlNjRmNmZjYzg4Y18xLTAtMS0xLTY4Mzgy_e27e5474-cd49-40d7-b3b3-5da1a1c2e99b">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6MjQ5Zjc0MjA3YWM5NGQxNTg3YjgwZTY0ZjZmY2M4OGMvdGFibGVyYW5nZToyNDlmNzQyMDdhYzk0ZDE1ODdiODBlNjRmNmZjYzg4Y18xLTEtMS0xLTY4Mzgy_354db2d3-e5dc-4253-bf3d-560866d1d8ae">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6MjQ5Zjc0MjA3YWM5NGQxNTg3YjgwZTY0ZjZmY2M4OGMvdGFibGVyYW5nZToyNDlmNzQyMDdhYzk0ZDE1ODdiODBlNjRmNmZjYzg4Y18xLTItMS0xLTY4Mzgy_ff64836e-8145-4460-aad5-d9832811bdc5">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE2_0c914571-70e1-4264-b9af-9c33b9961b4c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE3_63539e8c-e716-429c-a93a-835d29309551">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6NDdjMTdlMWI4MjUyNDcyNDg5ZWFkMGUxYWQ3MTI4NzcvdGFibGVyYW5nZTo0N2MxN2UxYjgyNTI0NzI0ODllYWQwZTFhZDcxMjg3N18wLTAtMS0xLTY4Mzgy_4a77e06d-906b-41c8-94c9-a89d2e3de509">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6NDdjMTdlMWI4MjUyNDcyNDg5ZWFkMGUxYWQ3MTI4NzcvdGFibGVyYW5nZTo0N2MxN2UxYjgyNTI0NzI0ODllYWQwZTFhZDcxMjg3N18xLTMtMS0xLTY4Mzgy_3f8bc1fd-c8ea-4560-ac09-1ba195958809">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGFibGU6NDdjMTdlMWI4MjUyNDcyNDg5ZWFkMGUxYWQ3MTI4NzcvdGFibGVyYW5nZTo0N2MxN2UxYjgyNTI0NzI0ODllYWQwZTFhZDcxMjg3N18yLTMtMS0xLTY4Mzgy_64b7eafb-ee61-421e-9731-efa6abeb96ae">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xOTE4_9701379d-3a13-41dd-bcd0-ca2ade33af46">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i3af3b79934d24fb1bd1cbb0bcbf27618_I20221014"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xL2ZyYWc6MzY5NzBmYTFmZjYyNDlkMWI4YWI1OGRhZjE4MTMwY2YvdGV4dHJlZ2lvbjozNjk3MGZhMWZmNjI0OWQxYjhhYjU4ZGFmMTgxMzBjZl8xODU0_06da57c9-35f7-4173-8198-b72623a14a23"
      unitRef="shares">113887466</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi0xLTEtMS02ODM4Mg_1d204d9a-5319-49b9-94f4-69fa4fd39694"
      unitRef="usd">2486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi0zLTEtMS02ODM4Mg_92e86e86-63c6-4965-8cd0-34fa1cbbaa37"
      unitRef="usd">2774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi01LTEtMS02ODM4Mg_5b50951c-7b80-47f5-ac76-767ab23e37c1"
      unitRef="usd">7550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMi03LTEtMS02ODM4Mg_e3fc457f-b7c8-4c7d-a104-f2d0e1537fa0"
      unitRef="usd">8044000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS0xLTEtMS02ODM4Mg_c48e42d1-34d1-4d7b-9864-5acdc618240d"
      unitRef="usd">1618000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS0zLTEtMS02ODM4Mg_f4401a57-1ebd-4d35-bba9-0712f63f3118"
      unitRef="usd">1670000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS01LTEtMS02ODM4Mg_a00b9a98-f4a4-45ba-9f61-457ca45cf045"
      unitRef="usd">4875000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNS03LTEtMS02ODM4Mg_02e0dfdd-ce8c-40d8-8f47-0d14444eaf0a"
      unitRef="usd">4861000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi0xLTEtMS02ODM4Mg_d5f575ed-133f-4436-9ce6-026f8425aedf"
      unitRef="usd">464000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi0zLTEtMS02ODM4Mg_0e76af64-7056-4518-b08c-bb095af48b96"
      unitRef="usd">427000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi01LTEtMS02ODM4Mg_8f3a0aff-c258-4613-af4a-5dcfab52085a"
      unitRef="usd">1311000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNi03LTEtMS02ODM4Mg_c3c8efd3-1aed-4ada-965d-5f4f7e24f8fe"
      unitRef="usd">1263000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy0xLTEtMS02ODM4Mg_eef4ee17-d683-4022-8fda-6d75db956051"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy0zLTEtMS02ODM4Mg_8b3903b8-e8e6-4e50-b91f-0b546742fd3e"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy01LTEtMS02ODM4Mg_680e0a6f-8742-47d9-a1c4-7885bdb704d8"
      unitRef="usd">81000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNy03LTEtMS02ODM4Mg_262041bb-6050-49ee-a8cc-aaafea7624dd"
      unitRef="usd">77000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS0xLTEtMS02ODM4Mg_a068dd77-0c1b-4fd4-a07d-bf9a6c3add55"
      unitRef="usd">15000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS0zLTEtMS02ODM4Mg_6dcbecbd-d733-4d01-b9b8-db2caa271982"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS01LTEtMS02ODM4Mg_54f3bf16-d9f8-4e69-bb4f-960617b77dce"
      unitRef="usd">10000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfOS03LTEtMS02ODM4Mg_33f0f801-1cdf-455b-af76-ccc0ed045684"
      unitRef="usd">2000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtMS0xLTEtNjgzODI_131ebed0-1b69-4591-9cd3-0ca4afb54719"
      unitRef="usd">2094000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtMy0xLTEtNjgzODI_61e0ab6f-d498-445b-ba2d-4e9595cf7749"
      unitRef="usd">2122000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtNS0xLTEtNjgzODI_450e13c4-8a84-41ba-8950-19693a9d12e2"
      unitRef="usd">6257000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTAtNy0xLTEtNjgzODI_6a560da9-dfde-4efa-8c1e-0a550e5488e6"
      unitRef="usd">6199000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItMS0xLTEtNjgzODI_95d2d2c3-ba8f-4ec1-b7a8-65dce7c00074"
      unitRef="usd">392000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItMy0xLTEtNjgzODI_521bd912-9f83-4384-942f-6b088ff5b3b2"
      unitRef="usd">652000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItNS0xLTEtNjgzODI_2fddf2bf-ebae-4f29-a175-52dec7348615"
      unitRef="usd">1293000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTItNy0xLTEtNjgzODI_4b9d2f43-b428-4fc3-8882-469aed0ed64a"
      unitRef="usd">1845000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtMS0xLTEtNjgzODI_cc0141cc-c0b9-410a-8752-c4a82eeb4ce9"
      unitRef="usd">-33000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtMy0xLTEtNjgzODI_00b868dc-a02b-46f0-a659-4d40d256791e"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtNS0xLTEtNjgzODI_5be72f81-5fd2-4c0d-8dcb-654e8a9f7f59"
      unitRef="usd">-106000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTUtNy0xLTEtNjgzODI_03e0c0ab-f6ab-47a7-afc0-33d51bf970c7"
      unitRef="usd">-114000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtMS0xLTEtNjgzODI_e8e88dde-6a60-469f-aa6c-60364cb76973"
      unitRef="usd">-8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtMy0xLTEtNjgzODI_d1aa0808-6ecb-4fdf-adbe-14d2e10760a4"
      unitRef="usd">40000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtNS0xLTEtNjgzODI_5230e4b2-2f4e-430a-a26c-c14610972137"
      unitRef="usd">-61000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTYtNy0xLTEtNjgzODI_dcba9cf4-b43a-40ba-b178-d4040b0f0032"
      unitRef="usd">366000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctMS0xLTEtNjgzODI_88080f73-0777-44dd-9e01-2eb2dd483743"
      unitRef="usd">-41000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctMy0xLTEtNjgzODI_51f3a2ed-df02-4898-8961-1b2170f7a375"
      unitRef="usd">2000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctNS0xLTEtNjgzODI_4c7e7711-f6d0-46d6-b9e0-460e9d74a940"
      unitRef="usd">-167000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTctNy0xLTEtNjgzODI_6a516a5c-7282-42fa-889f-df4c91f6705a"
      unitRef="usd">252000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktMS0xLTEtNjgzODI_65ddfe60-a419-46c0-8b62-c6d24f5024a7"
      unitRef="usd">351000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktMy0xLTEtNjgzODI_32918cb4-da4d-43f7-bfdf-47037ef6132c"
      unitRef="usd">654000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktNS0xLTEtNjgzODI_32dc352d-ccdb-433e-bb21-8bf22ebd449c"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMTktNy0xLTEtNjgzODI_99a4bfd9-da23-474d-a508-fd5ae04d899a"
      unitRef="usd">2097000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtMS0xLTEtNjgzODI_151987d9-ecc8-4563-a6a2-76c814f46a34"
      unitRef="usd">81000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtMy0xLTEtNjgzODI_9e76fd08-9f6f-4115-8202-a2fa10e4fece"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtNS0xLTEtNjgzODI_ab827632-f527-41b4-ac80-1d39be642727"
      unitRef="usd">268000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjAtNy0xLTEtNjgzODI_6680b582-d998-4251-b199-733ff2eb2dcd"
      unitRef="usd">483000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtMS0xLTEtNjgzODI_0c8925c5-7333-467e-952b-a62c47feca2c"
      unitRef="usd">6000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtMy0xLTEtNjgzODI_e2c0aa41-f9f9-4c9a-bbce-e8f546c47117"
      unitRef="usd">26000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtNS0xLTEtNjgzODI_cfbd7f53-7950-4ec3-93c8-e6cec3b60275"
      unitRef="usd">41000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjEtNy0xLTEtNjgzODI_e7a97980-092c-41b4-8123-ecdce68b9aaa"
      unitRef="usd">53000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtMS0xLTEtNjgzODI_7e2749fd-c906-44b7-9045-683f14963fab"
      unitRef="usd">276000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtMy0xLTEtNjgzODI_48491f4a-1e1c-4f0c-b3bf-a6d99a443b9e"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtNS0xLTEtNjgzODI_61431ae7-0fde-4acf-ac90-c0f9b29996b7"
      unitRef="usd">899000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjQtNy0xLTEtNjgzODI_5084862b-0006-4aa8-9a45-2a0524b8c18e"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtMS0xLTEtNjgzODI_5c515df2-d40b-40ca-b776-2121828d00ca"
      unitRef="usd">20000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtMy0xLTEtNjgzODI_97549feb-1b39-40e1-a781-c6820d95f740"
      unitRef="usd">22000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtNS0xLTEtNjgzODI_12d66b37-92e7-4365-8110-154c29fae806"
      unitRef="usd">54000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjUtNy0xLTEtNjgzODI_01c5b90e-4a28-4d85-a446-bc805819e641"
      unitRef="usd">62000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtMS0xLTEtNjgzODI_750f8746-396d-44d7-a064-34b8c1293e17"
      unitRef="usd">256000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtMy0xLTEtNjgzODI_e586363c-46e9-475e-b01f-b94161abfc0e"
      unitRef="usd">505000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtNS0xLTEtNjgzODI_bc876f59-ada6-40b2-9f27-50b29033e5c5"
      unitRef="usd">845000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMjYtNy0xLTEtNjgzODI_7f2148d1-1c24-4280-af40-d1c4dfe3f735"
      unitRef="usd">1605000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtMS0xLTEtNjgzODI_fa6464cd-8958-4ab8-b0a6-5ecb05beab34"
      unitRef="usdPerShare">2.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtMy0xLTEtNjgzODI_852e199a-b17b-4f2e-9052-ececbf49b01a"
      unitRef="usdPerShare">4.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtNS0xLTEtNjgzODI_6a759c08-a398-4eff-b836-76859785b281"
      unitRef="usdPerShare">7.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfMzYtNy0xLTEtNjgzODI_696aaac0-fa9a-42ad-92e0-a68532f16f48"
      unitRef="usdPerShare">12.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtMS0xLTEtNjgzODI_d97c6210-8929-4830-a202-36f6e60ae1e4"
      unitRef="usdPerShare">2.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtMy0xLTEtNjgzODI_f3039175-fbb9-4100-8e9b-dcd0d2b43471"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtNS0xLTEtNjgzODI_200d991e-4bd4-4cc2-9b3c-bb46d2315429"
      unitRef="usdPerShare">7.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDEtNy0xLTEtNjgzODI_8df072cf-9f41-4fe4-bf7b-56ceff202e3d"
      unitRef="usdPerShare">12.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtMS0xLTEtNjgzODI_8138ab62-9dbc-4fb6-89e5-3130730892a6"
      unitRef="shares">116000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtMy0xLTEtNjgzODI_14a36b42-9fb6-4be1-8196-62ab7aaf8fb6"
      unitRef="shares">123000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtNS0xLTEtNjgzODI_e6137305-c2d5-40d7-880a-8167ac3d2aae"
      unitRef="shares">117000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDQtNy0xLTEtNjgzODI_86cce5dc-bc51-4f7f-9eb2-db88988efffe"
      unitRef="shares">127000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtMS0xLTEtNjgzODI_a557d1ed-8eaa-4063-80c9-caf6bf737907"
      unitRef="shares">118000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtMy0xLTEtNjgzODI_c44dfead-fc16-4ac0-b65f-67e9ba8fef49"
      unitRef="shares">125000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtNS0xLTEtNjgzODI_ea398523-2a8e-42bd-989e-370f1ecd9424"
      unitRef="shares">119000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMy9mcmFnOjk3MWQyNDg1ODQwMjRlODA4NWFlNTJhM2ZlNDRmMjJiL3RhYmxlOjMwNjBiZTQwNmZkZTQ0NDE5OGY1MmJiOGM5ODFmNmJlL3RhYmxlcmFuZ2U6MzA2MGJlNDA2ZmRlNDQ0MTk4ZjUyYmI4Yzk4MWY2YmVfNDYtNy0xLTEtNjgzODI_6b5303a2-692d-47a3-a1a1-4bcf7960dbbe"
      unitRef="shares">129000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi0xLTEtMS02ODM4Mg_7e2749fd-c906-44b7-9045-683f14963fab"
      unitRef="usd">276000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi0zLTEtMS02ODM4Mg_48491f4a-1e1c-4f0c-b3bf-a6d99a443b9e"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi01LTEtMS02ODM4Mg_61431ae7-0fde-4acf-ac90-c0f9b29996b7"
      unitRef="usd">899000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMi03LTEtMS02ODM4Mg_5084862b-0006-4aa8-9a45-2a0524b8c18e"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS0xLTEtMS02ODM4Mg_ce974f26-0239-43c2-8ee3-7efa4dafad6b"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS0zLTEtMS02ODM4Mg_613ee4f1-cee4-4068-8a7d-dbe0cda17fad"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS01LTEtMS02ODM4Mg_bd71adcf-62a8-40b3-83a9-3c4f18274fb3"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNS03LTEtMS02ODM4Mg_2219934c-a0b4-4aa0-ae26-6f0b428d179b"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi0xLTEtMS02ODM4Mg_4a20e24b-a013-4da2-9e9d-754c64c0a752"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi0zLTEtMS02ODM4Mg_0a01e24f-7389-4a31-ba7e-7377688dc788"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi01LTEtMS02ODM4Mg_1c616193-0439-43ab-821b-eba55369fb46"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNi03LTEtMS02ODM4Mg_c4b5ae56-886e-4a52-86c2-9d289526a30d"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy0xLTEtMS02ODM4Mg_93dd0be4-959b-4dc6-9513-535a908cd85d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy0zLTEtMS02ODM4Mg_8aa20d30-81db-40be-95c7-3ee7fe07a92a"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy01LTEtMS02ODM4Mg_2a7186d7-043b-45f3-99c1-cf5621e4e556"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfNy03LTEtMS02ODM4Mg_7bd6ef5c-179f-4f72-9b54-37efe2056343"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS0xLTEtMS02ODM4Mg_596ad227-b71a-4018-a75d-0a0e7bfb06ad"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS0zLTEtMS02ODM4Mg_21bc9819-3d81-4533-a090-e8610459678f"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS01LTEtMS02ODM4Mg_cee450e6-6a2c-4369-afd4-4f848dcec8aa"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfOS03LTEtMS02ODM4Mg_f1399c6b-a91c-4f44-a8b0-3760eb28f97a"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtMS0xLTEtNjgzODI_3d39a547-da39-4e6d-960a-8796a636e92c"
      unitRef="usd">268000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtMy0xLTEtNjgzODI_9662d735-726a-489d-8397-2bd166e831b2"
      unitRef="usd">524000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtNS0xLTEtNjgzODI_ca398a72-9884-4dee-994d-4bfbeec95ccb"
      unitRef="usd">882000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTEtNy0xLTEtNjgzODI_77538e19-e78e-4143-acaa-1e1e0c6c5be2"
      unitRef="usd">1675000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItMS0xLTEtNjgzODI_cbe9567a-073d-4adc-8a12-62e20b5a1d4e"
      unitRef="usd">20000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItMy0xLTEtNjgzODI_32b924ae-642e-48f7-999b-f95ea091489c"
      unitRef="usd">22000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItNS0xLTEtNjgzODI_f40fe8a5-6bdf-4a92-b728-c39ce80742d7"
      unitRef="usd">54000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTItNy0xLTEtNjgzODI_e47be4a4-0244-4a7b-89b7-9d5698f79d8e"
      unitRef="usd">62000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtMS0xLTEtNjgzODI_04a8fd3d-0296-4da2-a55a-8c02e24cf52c"
      unitRef="usd">248000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtMy0xLTEtNjgzODI_4c930a38-8468-4a92-b563-4b16e01fb80c"
      unitRef="usd">502000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtNS0xLTEtNjgzODI_13d7d20c-8101-4ab1-9035-4e54e2b6092f"
      unitRef="usd">828000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xNi9mcmFnOmYyNWY2MzJhMDczNTRiZmQ5ODZkZmNjYzg1ZjRjNTRjL3RhYmxlOjBkNjExYjgyYTJmODQ1M2U5MzdkNmIwZWNmNzUxYzNmL3RhYmxlcmFuZ2U6MGQ2MTFiODJhMmY4NDUzZTkzN2Q2YjBlY2Y3NTFjM2ZfMTMtNy0xLTEtNjgzODI_7e949290-4467-4e6e-b9c8-3ac774c9c76b"
      unitRef="usd">1613000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMy0xLTEtMS02ODM4Mg_d0a0c2a9-3403-4990-891f-112ee61915ee"
      unitRef="usd">700000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMy0zLTEtMS02ODM4Mg_c3852abb-d768-4f63-aa46-cc208ce1129c"
      unitRef="usd">872000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0wLTEtMS02ODM4Mi90ZXh0cmVnaW9uOjI2NDdhZWY5M2U1MzRkNjI4NzQ4NWNiMzU2ZmJmZTY5XzYz_e0c53c7b-1bb8-4a15-a006-996b1dde2c09"
      unitRef="usd">29000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0wLTEtMS02ODM4Mi90ZXh0cmVnaW9uOjI2NDdhZWY5M2U1MzRkNjI4NzQ4NWNiMzU2ZmJmZTY5Xzcw_05b769ca-399b-4fd5-a0d4-7e19b03a9300"
      unitRef="usd">31000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0xLTEtMS02ODM4Mg_354b244a-2187-4958-918c-1fc9395081cc"
      unitRef="usd">1280000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNC0zLTEtMS02ODM4Mg_fa082474-4e46-478f-a2fa-5b65d63d95fd"
      unitRef="usd">1438000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNS0xLTEtMS02ODM4Mg_e0db085e-3738-4d19-af10-ba4808ed3106"
      unitRef="usd">183000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNS0zLTEtMS02ODM4Mg_5e19a25a-483d-418f-94d4-8efa1372c07e"
      unitRef="usd">208000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNi0xLTEtMS02ODM4Mg_0349399f-d210-45f2-8c79-887258971329"
      unitRef="usd">171000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNi0zLTEtMS02ODM4Mg_b000efe8-717a-4a7c-bafe-d45e894a7247"
      unitRef="usd">223000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOC0xLTEtMS02ODM4Mg_303c8c89-9070-47f3-b9f9-abb6a8fd345c"
      unitRef="usd">2334000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOC0zLTEtMS02ODM4Mg_c6a81ab2-1c97-4126-8189-00e69bd395df"
      unitRef="usd">2741000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOS0xLTEtMS02ODM4Mg_6b8ed43b-3e37-4d7f-9056-0af2e39948f4"
      unitRef="usd">1707000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfOS0zLTEtMS02ODM4Mg_8ea596b5-576b-4fd8-a48c-00c52bd665d7"
      unitRef="usd">1707000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTAtMS0xLTEtNjgzODI_677c5632-6798-4430-a353-07442cf7a88c"
      unitRef="usd">607000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTAtMy0xLTEtNjgzODI_9e6a42d1-67da-44a2-8650-dddbce5e8ef7"
      unitRef="usd">597000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTEtMS0xLTEtNjgzODI_becf113e-312c-4730-b9bd-30ecd3d811ae"
      unitRef="usd">7190000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTEtMy0xLTEtNjgzODI_5e00d998-ee68-49e3-87a2-3ecc6fbd9cd8"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTItMS0xLTEtNjgzODI_b64169be-9ef5-4b8f-8397-0f1100eae422"
      unitRef="usd">1115000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTItMy0xLTEtNjgzODI_49d4a430-cda0-4b03-a672-d2409c5d3a0f"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTMtMS0xLTEtNjgzODI_803bb143-dd28-45d2-bc64-3741a6a8e2c0"
      unitRef="usd">138000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTMtMy0xLTEtNjgzODI_49c8b43a-6d72-4e75-ad24-3b7bd66974c4"
      unitRef="usd">141000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTQtMS0xLTEtNjgzODI_b8459ef9-6b23-457a-9acc-92812ad90156"
      unitRef="usd">132000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTQtMy0xLTEtNjgzODI_3682dfa0-f667-48bb-9fd7-4499ea0fe4b3"
      unitRef="usd">163000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTYtMS0xLTEtNjgzODI_57967f05-bd7e-4fe9-8a15-be2a86b7653b"
      unitRef="usd">13223000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMTYtMy0xLTEtNjgzODI_1fd0fb07-2229-4bac-be9e-96efd407a9ea"
      unitRef="usd">13611000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjAtMS0xLTEtNjgzODI_292f61f9-898f-4930-8b94-4cbbe7f68c0a"
      unitRef="usd">1447000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjAtMy0xLTEtNjgzODI_bdb83532-f301-4871-8871-a168ae742392"
      unitRef="usd">1600000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjEtMS0xLTEtNjgzODI_7e8d5144-1b56-4bbc-ac47-41ae66dcf51e"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjEtMy0xLTEtNjgzODI_a603417f-1c3f-4f67-9a51-593c6b5272f6"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjItMS0xLTEtNjgzODI_62f8bc65-3e19-4a1f-b238-92de5a97ffb0"
      unitRef="usd">153000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjItMy0xLTEtNjgzODI_13b42da3-abda-47ca-93ac-b92b1830599c"
      unitRef="usd">151000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjQtMS0xLTEtNjgzODI_bdf8270d-58a2-449e-a610-11fd222eef74"
      unitRef="usd">1602000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjQtMy0xLTEtNjgzODI_882213ab-648a-47a4-8a4f-5adbd8e53f9e"
      unitRef="usd">1753000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjUtMS0xLTEtNjgzODI_96f3452c-7fa6-4e45-90a9-346f4cbe3e3b"
      unitRef="usd">3980000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjUtMy0xLTEtNjgzODI_15b1957c-8a22-4beb-aa85-e519d9d3c142"
      unitRef="usd">4010000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjYtMS0xLTEtNjgzODI_6585973f-c46b-422e-b00c-e1ea9c56cd09"
      unitRef="usd">505000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjYtMy0xLTEtNjgzODI_e0c1bc96-d1ee-4e41-95d9-f953c635f6b1"
      unitRef="usd">494000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjctMS0xLTEtNjgzODI_4c406989-4d7e-4ca9-b67e-bc393476c672"
      unitRef="usd">787000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjctMy0xLTEtNjgzODI_2c3567cd-516d-41fa-a35c-edf74c09e804"
      unitRef="usd">792000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjktMS0xLTEtNjgzODI_2b6a8261-4a01-4e86-8325-05e9104442ab"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMjktMy0xLTEtNjgzODI_ac03faf5-e6ba-4611-bb31-a125ff5ed726"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzAtMS0xLTEtNjgzODI_69e7f3fb-45ef-4e6d-b3cb-62eceb291f37"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzAtMy0xLTEtNjgzODI_f2827e29-6319-49df-8e07-d3bb66c45e5e"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8yOA_79b23141-03d1-4d66-a8ce-045a5bd2c9c7"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8yOA_9dd5baf3-9e5c-4120-9f17-2fb89ea887b2"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV80Mg_916f4f77-89c0-49dd-9d16-b974208f118c"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV80Mg_db1699cb-9c73-44fe-8e19-d21ec7fabaf4"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8xMTE_b3dade48-07f3-4860-833f-1dc5d536fe3d"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjozYzkzYjY4YWVkM2M0ZjYzYWUxMTZhNjUwYTZmMjIyMV8xMTE_bddcf38c-5eed-4ad2-a9ba-d3a54cfc4f4c"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMS0xLTEtNjgzODI_b502fe12-f231-48db-8a69-abde6fc50da9"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzMtMy0xLTEtNjgzODI_6c2d4012-09dd-45cc-be1d-0d0b0bb194bf"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzQtMS0xLTEtNjgzODI_9dfe7c68-9928-4fc3-89f9-33e0d432c0ac"
      unitRef="usd">2272000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzQtMy0xLTEtNjgzODI_4b4ed76f-7992-45ed-8327-419c6ffc9996"
      unitRef="usd">2260000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzUtMS0xLTEtNjgzODI_1251dcf6-eee4-4c89-b32d-74c4ecc9e55a"
      unitRef="usd">8263000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzUtMy0xLTEtNjgzODI_77898ff9-a919-4284-b5dd-2f31bac2082a"
      unitRef="usd">7649000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzYtMS0xLTEtNjgzODI_c6ed925c-ac5c-40ca-b0b9-501ac5c56b62"
      unitRef="usd">-31000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzYtMy0xLTEtNjgzODI_392e65a5-f706-4871-87c0-700f069cca1d"
      unitRef="usd">-14000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjo1NTI5ODQzMTc2NTE0OTI4YjMzODg5NTY5ZGI4OTgwZV8yOQ_3546cbc0-5662-452a-ab9b-95b31f9fe904"
      unitRef="shares">48000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMC0xLTEtNjgzODIvdGV4dHJlZ2lvbjo1NTI5ODQzMTc2NTE0OTI4YjMzODg5NTY5ZGI4OTgwZV8zNg_261d91cf-f7da-44f5-8a72-4600cd20e089"
      unitRef="shares">43000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMS0xLTEtNjgzODI_f4da91fb-890f-40bf-ac9c-7cbf1e78bec5"
      unitRef="usd">4271000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzctMy0xLTEtNjgzODI_167bdbd0-3228-4443-aabe-24311960496b"
      unitRef="usd">3453000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzgtMS0xLTEtNjgzODI_8dba03b1-28bc-4bad-a892-cd9bd1da37f5"
      unitRef="usd">6235000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzgtMy0xLTEtNjgzODI_1b787ff1-7363-45cb-8d36-1aa6c26262f8"
      unitRef="usd">6444000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzktMS0xLTEtNjgzODI_082dfaa0-7ea7-4153-8561-c6eb01915b11"
      unitRef="usd">37000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfMzktMy0xLTEtNjgzODI_8e557095-6a84-4bc0-a8be-a353510d857c"
      unitRef="usd">39000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDAtMS0xLTEtNjgzODI_39af5a1b-852b-4dd0-adac-eceb52558924"
      unitRef="usd">6272000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDAtMy0xLTEtNjgzODI_4ae78553-e6cc-4fa3-8d77-23752e9dff0a"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDEtMS0xLTEtNjgzODI_908be517-07d0-4313-b5b0-82c94efc68d0"
      unitRef="usd">13223000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xOS9mcmFnOmEwNzU2YzI3Y2E1NTRjZDI4ZTBmNmQ2Mzg0ZDYwZWFkL3RhYmxlOjMxYTFhODVmNzZmZDRmYmQ5MGMyZjc4MWI5YzNjNjgzL3RhYmxlcmFuZ2U6MzFhMWE4NWY3NmZkNGZiZDkwYzJmNzgxYjljM2M2ODNfNDEtMy0xLTEtNjgzODI_36ae775e-452b-4240-abba-9d3fc7a66b77"
      unitRef="usd">13611000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMy0xLTEtMS02ODM4Mg_61431ae7-0fde-4acf-ac90-c0f9b29996b7"
      unitRef="usd">899000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMy0zLTEtMS02ODM4Mg_5084862b-0006-4aa8-9a45-2a0524b8c18e"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNS0xLTEtMS02ODM4Mg_1b076d3c-fdf7-4003-a7b7-173a63b96712"
      unitRef="usd">321000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNS0zLTEtMS02ODM4Mg_fcd3382d-abdb-4320-a7b1-fe117009f5aa"
      unitRef="usd">302000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNi0xLTEtMS02ODM4Mg_c16462d4-7366-4f0d-9031-ac26c5c32b58"
      unitRef="usd">1000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNi0zLTEtMS02ODM4Mg_ae856e5f-5438-4d87-974f-1fd596d57800"
      unitRef="usd">3000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNy0xLTEtMS02ODM4Mg_6bab9e61-ed87-43c0-a92a-b877f6c0c94f"
      unitRef="usd">45000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNy0zLTEtMS02ODM4Mg_f33c92da-0eaf-4fda-9144-ae850ed8f0cc"
      unitRef="usd">-87000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfOC0xLTEtMS02ODM4Mg_6efda924-fec5-4e9f-9b39-180b27081727"
      unitRef="usd">55000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfOC0zLTEtMS02ODM4Mg_1f5eba1d-fb62-4680-a31f-8819e5904427"
      unitRef="usd">60000000</us-gaap:ShareBasedCompensation>
    <dgx:GainLossOnDispositionOfJointVenture
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTAtMS0xLTEtNjgzODI_2f65e40d-9b81-44a4-9765-625a5ca0a374"
      unitRef="usd">0</dgx:GainLossOnDispositionOfJointVenture>
    <dgx:GainLossOnDispositionOfJointVenture
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTAtMy0xLTEtNjgzODI_b2b4cae2-ecac-4037-a6e6-853f8e211533"
      unitRef="usd">314000000</dgx:GainLossOnDispositionOfJointVenture>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTEtMS0xLTEtNjgzODI_3c38389c-ff8e-412b-81e9-9503fd18da32"
      unitRef="usd">-37000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTEtMy0xLTEtNjgzODI_207c7685-840d-4513-b617-3ca1a133d1d3"
      unitRef="usd">48000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTMtMS0xLTEtNjgzODI_34f00886-b744-4d46-8a0b-74c6add5c9a9"
      unitRef="usd">-162000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTMtMy0xLTEtNjgzODI_1a20aedf-aacc-4ec4-b6d0-dccc079be431"
      unitRef="usd">-45000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTQtMS0xLTEtNjgzODI_9bdf29b8-5d97-4a2c-9372-5d11e0d718f7"
      unitRef="usd">-169000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTQtMy0xLTEtNjgzODI_c967c2fd-406d-47d6-b8e5-028c42fa81ed"
      unitRef="usd">36000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTUtMS0xLTEtNjgzODI_99a007a6-9b96-4bba-8c13-dc7b0f0286f6"
      unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTUtMy0xLTEtNjgzODI_80f57a97-eb78-4e5e-aae4-a26559a0d222"
      unitRef="usd">49000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTctMS0xLTEtNjgzODI_34a46e80-807c-4bbb-a857-8993f3899544"
      unitRef="usd">-34000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTctMy0xLTEtNjgzODI_d607edcf-674f-4b5c-ab85-0255a11da627"
      unitRef="usd">-39000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTgtMS0xLTEtNjgzODI_9968b376-9d07-4876-88ee-27f065b50aec"
      unitRef="usd">1384000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMTgtMy0xLTEtNjgzODI_fbedce14-9e02-46a2-9a38-204bd2b5b2e8"
      unitRef="usd">1752000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjEtMS0xLTEtNjgzODI_bcd7cf5f-1dc4-42de-a991-9b80b9e6afbf"
      unitRef="usd">106000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjEtMy0xLTEtNjgzODI_1e3ac586-e66e-4bb8-8f6f-6de0e68ccc6a"
      unitRef="usd">251000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjQtMS0xLTEtNjgzODI_c791ee01-ba4d-4e8b-a8c2-57cd3e83f588"
      unitRef="usd">257000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjQtMy0xLTEtNjgzODI_9e355b61-b99d-46ee-96dd-2f9d50a2dffe"
      unitRef="usd">259000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjYtMS0xLTEtNjgzODI_36fa2b1d-8850-4bfe-91b8-35b24d6a1a91"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjYtMy0xLTEtNjgzODI_928250eb-e100-4e34-ad33-b7c0f4a26070"
      unitRef="usd">755000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjctMS0xLTEtNjgzODI_55adb015-f54a-44e6-8535-298bce412e82"
      unitRef="usd">6000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjctMy0xLTEtNjgzODI_8faffaa4-5455-4f1f-9a53-ae65a896fbcf"
      unitRef="usd">-3000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjgtMS0xLTEtNjgzODI_17b58fce-9785-47b8-9124-0dc5330ad22d"
      unitRef="usd">-369000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMjgtMy0xLTEtNjgzODI_fef78cce-c029-4cae-93d4-6b08857b432f"
      unitRef="usd">248000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzItMS0xLTEtNjgzODI_1feaf213-9a2f-4436-81dc-baf5c60aa085"
      unitRef="usd">1000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzItMy0xLTEtNjgzODI_7bf3b086-7944-4816-9cd4-d906a08adfa8"
      unitRef="usd">2000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzMtMS0xLTEtNjgzODI_f8f02970-6425-404b-856f-d7380c63ecb0"
      unitRef="usd">947000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzMtMy0xLTEtNjgzODI_03499fa5-17c3-46a6-907a-416378f2c4f9"
      unitRef="usd">1910000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzQtMS0xLTEtNjgzODI_212c5d53-2be2-4034-9921-80c44b833bac"
      unitRef="usd">96000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzQtMy0xLTEtNjgzODI_b74d71f4-cc14-4c0f-ab26-4697e0c08f43"
      unitRef="usd">108000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzUtMS0xLTEtNjgzODI_013c79bd-f1f9-4d6b-94be-6c537571d55d"
      unitRef="usd">28000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzUtMy0xLTEtNjgzODI_24668a11-ff38-4e2a-8318-29aef9f9f61c"
      unitRef="usd">22000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzYtMS0xLTEtNjgzODI_67bad9c8-6550-431c-8c8a-34164fdaa515"
      unitRef="usd">230000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzYtMy0xLTEtNjgzODI_69517525-6f4b-4c4e-a016-eb506e3d6746"
      unitRef="usd">232000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzctMS0xLTEtNjgzODI_003fd28c-85f1-4daa-846f-793a4a771f58"
      unitRef="usd">58000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfMzctMy0xLTEtNjgzODI_ff080b61-4024-49d2-aa89-fe13d3010e54"
      unitRef="usd">75000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDAtMS0xLTEtNjgzODI_6e9ecdad-9e39-4ee1-8fe5-80104295e508"
      unitRef="usd">-19000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDAtMy0xLTEtNjgzODI_ac124e68-ae01-4c55-b626-277baca7b6b6"
      unitRef="usd">-38000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDEtMS0xLTEtNjgzODI_a65c7b8a-a0c1-47a9-8b3a-fdb54204a480"
      unitRef="usd">-1187000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDEtMy0xLTEtNjgzODI_0b73c16f-c44b-4fd1-8fae-b846400c324a"
      unitRef="usd">-2171000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDMtMS0xLTEtNjgzODI_24512018-598b-4303-9c56-cb2f262d5616"
      unitRef="usd">-172000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDMtMy0xLTEtNjgzODI_be0a7974-39ee-47eb-b78f-6aeff1b984a3"
      unitRef="usd">-171000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDUtMS0xLTEtNjgzODI_068a875d-2144-4b39-ade9-56dd1bccf49b"
      unitRef="usd">872000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDUtMy0xLTEtNjgzODI_dd3649a7-7fd9-408e-8589-02a8e3318e79"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDYtMS0xLTEtNjgzODI_cdc1e327-feec-4e9b-b9cb-8a1665068ef8"
      unitRef="usd">700000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yMi9mcmFnOjY4Zjk4Y2Y4ZTQ4YTQ1MDBhYmE0MDQ3ZmQ5ODQwZmQ0L3RhYmxlOjYwODMzMGY3M2M0MzQ0ZTU4YjczZmUyZmQwMDlmZTRmL3RhYmxlcmFuZ2U6NjA4MzMwZjczYzQzNDRlNThiNzNmZTJmZDAwOWZlNGZfNDYtMy0xLTEtNjgzODI_efbc541f-a6a2-4c8d-b67d-ff025c90655c"
      unitRef="usd">987000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia66110999ebf47e489970ea681e28bc9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xLTEtMS02ODM4Mg_02463d09-7a54-4772-9673-495e88c76a49"
      unitRef="shares">117000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia66110999ebf47e489970ea681e28bc9_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0zLTEtMS02ODM4Mg_6b46f57e-ac60-47b1-aa9f-720d909ea577"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i133ede9bcd2547d88ad254bf768df343_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi01LTEtMS02ODM4Mg_f2f0c7ce-fa68-4625-9e9e-9d4a2cfa5fe0"
      unitRef="usd">2250000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f52678681d643878109e96f1420975f_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi03LTEtMS02ODM4Mg_a0c72a7e-9089-4b30-94bf-931d4c723bcd"
      unitRef="usd">8083000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77f7c6bfef074498a4e11de614453204_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi05LTEtMS02ODM4Mg_b7fb2e9d-d99a-4c47-80af-f65decb4f03e"
      unitRef="usd">-23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if85ffac6808545d2a1e4b4b8d588cbca_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xMS0xLTEtNjgzODI_b6eea336-4dc6-4a8d-8d8d-bdee04480d74"
      unitRef="usd">-3901000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71f8587b94614e62972a571a0db167fb_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xMy0xLTEtNjgzODI_f2671754-9781-495b-8602-54ee76d7936e"
      unitRef="usd">39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6601d4f897bd4dad9874662aa4fe198e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xNS0xLTEtNjgzODI_770cf9fc-5522-4883-80dc-2f387c0ce847"
      unitRef="usd">6450000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i6601d4f897bd4dad9874662aa4fe198e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMi0xOC0xLTEtNjgzODI_2a9c0b9a-20d6-4e82-8251-38be356c2e54"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="if9f8b7df600b4b878bba187286fd791b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy03LTEtMS02ODM4Mg_1567b1cf-2bdb-4aa6-9db6-3149c918b1b6"
      unitRef="usd">256000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i38982359ccf14cb991b0c3db0e12289b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy0xMy0xLTEtNjgzODI_e48c6c67-b3ed-48fd-b933-7136ceefbfc5"
      unitRef="usd">19000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy0xNS0xLTEtNjgzODI_02a45580-57b2-4b05-b5c3-7ca5dd57544f"
      unitRef="usd">275000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMy0xOC0xLTEtNjgzODI_1b2a63f2-cfad-42d6-851a-52ee9c69f4e2"
      unitRef="usd">1000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i446ca4eb05494f1993ef7b2e312c2037_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNC05LTEtMS02ODM4Mg_315ccdb6-9e10-4bef-9603-fc27dca8dd05"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNC0xNS0xLTEtNjgzODI_2d5057e4-11a0-49d6-8721-59719cdc9ce1"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="if9f8b7df600b4b878bba187286fd791b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNS03LTEtMS02ODM4Mg_f09a90f9-2320-4912-a23e-cc2efd950fed"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNS0xNS0xLTEtNjgzODI_99b70328-024f-436a-9361-e16949e3c9d6"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i38982359ccf14cb991b0c3db0e12289b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNi0xMy0xLTEtNjgzODI_3f3f68d5-db00-4848-8f4a-0bc0e300e244"
      unitRef="usd">21000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNi0xNS0xLTEtNjgzODI_d564480d-c2c7-4aed-a8cb-52369bbb641e"
      unitRef="usd">21000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNi0xOC0xLTEtNjgzODI_e687866f-b40b-4bbe-a065-f72fd62974ea"
      unitRef="usd">1000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNy01LTEtMS02ODM4Mg_87b015c3-2471-4af4-a663-1fc8606b4abb"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNy0xMS0xLTEtNjgzODI_6793272c-4cd0-48d1-9b1b-81cb9df35847"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfNy0xNS0xLTEtNjgzODI_2b52a5e7-40b6-406e-86af-54376ec704e2"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOC01LTEtMS02ODM4Mg_13903caa-0f86-4450-b3d8-916996b9daba"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOC0xNS0xLTEtNjgzODI_dc8eed1f-6366-484c-8852-aaed29abbc85"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie8ab1be3fcb0435894f826e16abba396_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOS01LTEtMS02ODM4Mg_5dece60f-b68a-4806-bb3e-c9bdbcd8b8fb"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOS0xMS0xLTEtNjgzODI_4730b794-c1f9-44b7-a8b0-2a5fd332d7b3"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfOS0xNS0xLTEtNjgzODI_fbb1d804-8fa7-4d89-8eaf-b615443d5ccf"
      unitRef="usd">28000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTAtMTEtMS0xLTY4Mzgy_83f0456d-bef8-470a-b59a-0ee52d13b426"
      unitRef="usd">1000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTAtMTUtMS0xLTY4Mzgy_c0abd9fb-82b7-41e0-8c9b-3f3b8968acb0"
      unitRef="usd">1000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8c1a402b7edc4bada7fe43b8bed57c9e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTEtMS0xLTEtNjgzODI_1be86e5b-f834-4c53-8f20-e5fa7d62458c"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="idd1a7a0b495043dbb5748fe4705e611b_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTEtMTEtMS0xLTY4Mzgy_5b68ca63-86eb-49de-b387-0abcbaef2897"
      unitRef="usd">400000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTEtMTUtMS0xLTY4Mzgy_f488279f-ffbf-4c78-af84-829068d26e07"
      unitRef="usd">400000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMS0xLTEtNjgzODI_2679d8e2-c696-4d27-a00a-2c32d33b3f53"
      unitRef="shares">114000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMy0xLTEtNjgzODI_ba0c4977-6676-4915-916d-a3b5d204eea6"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id81266202c6f4daaa1fe7d11c3466090_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtNS0xLTEtNjgzODI_4c05dca2-ebad-4cdb-a412-e97d42b84c0c"
      unitRef="usd">2272000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie8fcb85a255b4d078c7675e41fd05fb7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtNy0xLTEtNjgzODI_995ec749-67bc-457c-b235-3632f48b5b6d"
      unitRef="usd">8263000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8691d08785574903bd93ee4dfa5db854_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtOS0xLTEtNjgzODI_295fbe76-1f03-46c0-8e33-391204909d9b"
      unitRef="usd">-31000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fa63970b08847edb23879db454cfd5a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTEtMS0xLTY4Mzgy_90f6606e-349f-4916-9525-b974b9f01683"
      unitRef="usd">-4271000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d44b0c7e6764a3690dac72ba9bceeb6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTMtMS0xLTY4Mzgy_253cc517-9e48-4d3c-bea3-0eb67a9c8759"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTUtMS0xLTY4Mzgy_8deab2e5-e019-4ba8-8a99-927fecdb7618"
      unitRef="usd">6272000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTMtMTgtMS0xLTY4Mzgy_fce1cdc0-2a91-43e7-8180-a0a0543b76e6"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id6123cf684d748bfaeb9d6c407ab233d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMS0xLTEtNjgzODI_68776a98-a0a4-463e-9505-bb34ab01dd4a"
      unitRef="shares">119000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6123cf684d748bfaeb9d6c407ab233d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMy0xLTEtNjgzODI_5368bcf9-6e46-4a05-a149-73942c781317"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibee26b45b4834d788993956547c7876e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctNS0xLTEtNjgzODI_2e134013-1fb3-420b-b3d4-8e4cc06baffa"
      unitRef="usd">2260000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a5de51ccdd040f8bc396f5bbb026e33_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctNy0xLTEtNjgzODI_b0fc7b54-7c9c-420f-ba00-9099c14e391c"
      unitRef="usd">7649000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a33f90cea9e41bebf5bc6e0fb60699f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctOS0xLTEtNjgzODI_7b49beba-39e6-4baf-8bba-248ea1a953b0"
      unitRef="usd">-14000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ebb219cb475425591cf0155edc1d443_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTEtMS0xLTY4Mzgy_2a813882-c6de-4fcb-8de1-50f9e93bc3af"
      unitRef="usd">-3453000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebfd0201851442908146535dd57ca675_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTMtMS0xLTY4Mzgy_cef7d9e1-1962-424f-b3af-b3d10cdad78b"
      unitRef="usd">39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTUtMS0xLTY4Mzgy_2198ba10-6560-4e99-a3f0-d8db2d6ce684"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTctMTgtMS0xLTY4Mzgy_17a54f60-145a-4cf4-a32a-71dd23111ede"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i541597114f5944418a137ab87cea7f3b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtNy0xLTEtNjgzODI_f819598e-408e-42ec-97c8-1f8bbef50e7c"
      unitRef="usd">845000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i3118010a65e94107930187af0b9032e2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtMTMtMS0xLTY4Mzgy_12f3f1e6-ffb4-4daa-8e1e-0c7dedc84589"
      unitRef="usd">49000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtMTUtMS0xLTY4Mzgy_531110c2-9c7a-489c-a64e-5abe2f2dcede"
      unitRef="usd">894000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTgtMTgtMS0xLTY4Mzgy_69a81bf0-3c08-4baf-acf6-ba9dd2f40fca"
      unitRef="usd">5000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3680833c24d343c4b94154c01f3fad0f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTktOS0xLTEtNjgzODI_6a92ccbf-edb0-45d9-830d-5186bb4e5bc8"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMTktMTUtMS0xLTY4Mzgy_385df9c7-fc53-451f-8338-595f46fcbc74"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i541597114f5944418a137ab87cea7f3b_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjAtNy0xLTEtNjgzODI_df98dd98-3683-4890-9b2e-9325b3c39a7a"
      unitRef="usd">231000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjAtMTUtMS0xLTY4Mzgy_cd4dcc28-aade-44de-9712-84aca7bf12a9"
      unitRef="usd">231000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3118010a65e94107930187af0b9032e2_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjEtMTMtMS0xLTY4Mzgy_a7a7a5b9-89ee-4842-bff0-ac280ae50ba2"
      unitRef="usd">51000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjEtMTUtMS0xLTY4Mzgy_19e19ea4-241e-4437-989a-4b017639b3bc"
      unitRef="usd">51000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjEtMTgtMS0xLTY4Mzgy_fd0b5e48-6cf4-4064-8af3-e0948de5cdba"
      unitRef="usd">7000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItMS0xLTEtNjgzODI_10a3e2de-499f-4f58-9677-199f517c5a1f"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItNS0xLTEtNjgzODI_d0599403-1630-449b-af46-1d226c6b673e"
      unitRef="usd">-38000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItMTEtMS0xLTY4Mzgy_69fb9dfd-5d86-49bc-acb0-a64bbf5438b8"
      unitRef="usd">59000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjItMTUtMS0xLTY4Mzgy_f7db0112-3e41-4aa4-9d1c-91404546a35f"
      unitRef="usd">21000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjMtNS0xLTEtNjgzODI_192d314b-e191-41a9-9ad3-4a2709c9623e"
      unitRef="usd">55000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjMtMTUtMS0xLTY4Mzgy_361c8f4a-71df-46fe-a811-dac810c4bc1f"
      unitRef="usd">55000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtMS0xLTEtNjgzODI_09a431b1-6d78-4888-bebe-8a9eba5e4825"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtNS0xLTEtNjgzODI_3a06a975-b16e-4707-bae5-ce15c70ef522"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtMTEtMS0xLTY4Mzgy_7f5cf1c7-1642-4861-bbc2-05a085458186"
      unitRef="usd">91000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjQtMTUtMS0xLTY4Mzgy_f02abb3b-de3e-4296-af71-619301def00f"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic5f99be06ffd4bec826de802b5a76323_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjUtNS0xLTEtNjgzODI_f8d69a38-67c3-412e-a295-9d609623f7d5"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjUtMTEtMS0xLTY4Mzgy_aa3cdc40-4599-4808-b425-e25eeb219e6b"
      unitRef="usd">18000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjUtMTUtMS0xLTY4Mzgy_1605d943-438b-4680-afcd-f9d3e72f1365"
      unitRef="usd">28000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i697f4010a31345e6a413072d98e5e63c_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjYtMS0xLTEtNjgzODI_cd5c3131-23ce-4b48-9de4-042e5f5fd67b"
      unitRef="shares">7000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjYtMTEtMS0xLTY4Mzgy_2492740f-5658-4460-a84e-5724cac5eaae"
      unitRef="usd">950000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjYtMTUtMS0xLTY4Mzgy_11c1db76-c954-45e6-94f1-3b1e04aab5a0"
      unitRef="usd">950000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMS0xLTEtNjgzODI_132d5398-b620-44af-8899-b4f13420e4f2"
      unitRef="shares">114000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie66cbcf0444e4df9b6a42207fd08cb31_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMy0xLTEtNjgzODI_d3a2f04c-8305-4008-9eb4-52deac46eb19"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id81266202c6f4daaa1fe7d11c3466090_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtNS0xLTEtNjgzODI_a6a5e426-053b-4fae-8241-278df7aee590"
      unitRef="usd">2272000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie8fcb85a255b4d078c7675e41fd05fb7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtNy0xLTEtNjgzODI_bce5c8e9-46b4-4843-add5-1a9641b26c10"
      unitRef="usd">8263000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8691d08785574903bd93ee4dfa5db854_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtOS0xLTEtNjgzODI_be07002c-7adc-4997-b699-2062d37d91fe"
      unitRef="usd">-31000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fa63970b08847edb23879db454cfd5a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTEtMS0xLTY4Mzgy_a0379805-14e7-4a2e-8b71-1668130c7dee"
      unitRef="usd">-4271000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d44b0c7e6764a3690dac72ba9bceeb6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTMtMS0xLTY4Mzgy_09319c38-2c4f-4c98-aa33-b73d7878cdac"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTUtMS0xLTY4Mzgy_48bce5b9-a9e3-4d6a-a644-8bfa4c29170f"
      unitRef="usd">6272000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjhjMDM2MmQ3YmMxYjQ4ZTA5YTA3YTBmYTc5ZGM4MWM2L3RhYmxlcmFuZ2U6OGMwMzYyZDdiYzFiNDhlMDlhMDdhMGZhNzlkYzgxYzZfMjgtMTgtMS0xLTY4Mzgy_e7a62003-45d0-49ed-a777-a62be470938e"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i430a0954dff34ed2abd3bbf6af3ce92e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xLTEtMS02ODM4Mg_038aa26c-cd03-4fac-9e3d-33936178d77c"
      unitRef="shares">122000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i430a0954dff34ed2abd3bbf6af3ce92e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0zLTEtMS02ODM4Mg_4a87963f-4574-4133-94a9-e9ad0353123f"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d22acbc549640a3bcff1331465f4490_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi01LTEtMS02ODM4Mg_6de54e9b-200e-49a7-bc47-36c0284bad18"
      unitRef="usd">2555000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81a2d9b7a5804534a11a487194d959d8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi03LTEtMS02ODM4Mg_51a9e0f6-13a8-494c-93f1-2c4b33af496a"
      unitRef="usd">10246000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e937069022b4224ae54a53549450dfe_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi05LTEtMS02ODM4Mg_6fbe087b-d76c-45d6-b6f4-a4404642415d"
      unitRef="usd">-10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id99280e00773483bbeab37f6250f0a64_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xMS0xLTEtNjgzODI_cbc4163f-cdd3-4fc4-9e6a-377923702ae5"
      unitRef="usd">-6894000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3bd61be3e49b417b94fe98d76f276f90_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xMy0xLTEtNjgzODI_2cece0ae-5ffe-41e6-8bd9-174b7356f0ed"
      unitRef="usd">41000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ebde6c314dc416a9d24bf9416554a5a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xNS0xLTEtNjgzODI_c165865f-1fd0-461a-9fd7-37bd082737ad"
      unitRef="usd">5940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i5ebde6c314dc416a9d24bf9416554a5a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMi0xOC0xLTEtNjgzODI_43730ef3-aeb1-450e-b52f-2cd8a58cd485"
      unitRef="usd">78000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy03LTEtMS02ODM4Mg_3dd21f12-42d8-4ac1-90b7-f90830c26fad"
      unitRef="usd">505000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="icfcdafe6ec384c35ae912ea54a83b7b3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy0xMy0xLTEtNjgzODI_1ef76042-4765-4caa-9c8c-b4c08a9c0f7f"
      unitRef="usd">19000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy0xNS0xLTEtNjgzODI_ba7a3cee-2fcb-4249-b25e-4f2be67c77cb"
      unitRef="usd">524000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMy0xOC0xLTEtNjgzODI_d79f1230-8181-4d52-b5ef-ca9a4dd93def"
      unitRef="usd">3000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id58c37cc4057489f93440a4c2f4ad37e_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNC05LTEtMS02ODM4Mg_a533ec43-ef13-428b-8d71-f78f7d48bac0"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNC0xNS0xLTEtNjgzODI_4b6d3b4c-c129-489a-a264-7b328c524c66"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNS03LTEtMS02ODM4Mg_2307b3b3-c4b0-43c1-8320-d6c00194931a"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNS0xNS0xLTEtNjgzODI_e5e3c179-23a0-4c63-9783-d0c753513c12"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="icfcdafe6ec384c35ae912ea54a83b7b3_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNi0xMy0xLTEtNjgzODI_5c48ff65-96d8-4d59-8344-69fa282f360c"
      unitRef="usd">20000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNi0xNS0xLTEtNjgzODI_7f85b300-3ec4-4e73-84ce-d3b94d2adc5a"
      unitRef="usd">20000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNi0xOC0xLTEtNjgzODI_8623b6b2-7d15-4888-a646-ec63be253ed0"
      unitRef="usd">2000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNy01LTEtMS02ODM4Mg_1d8918ed-8110-4b03-8fcb-e4680c5c09c0"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNy0xMS0xLTEtNjgzODI_98e5c6d8-884f-461e-86b0-222dc49bcdf3"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfNy0xNS0xLTEtNjgzODI_c776ee73-86e7-44ad-908a-e6f13ade4b11"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOC01LTEtMS02ODM4Mg_4a709e28-49e4-459b-b1f8-a2af13c5a3bc"
      unitRef="usd">21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOC0xNS0xLTEtNjgzODI_7fda095b-0a05-4f1b-96e5-ca567a890826"
      unitRef="usd">21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i63e96229aac640a599fd3d48159fd084_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS0xLTEtMS03MDE4OA_189f4095-aff3-418d-9ea3-7758e53f7445"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS01LTEtMS02ODM4Mg_3f154041-d1b9-4bb1-8727-a6807a075ac0"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS0xMS0xLTEtNjgzODI_0f622f88-c5ce-44de-a449-a5e0e061b3f0"
      unitRef="usd">33000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfOS0xNS0xLTEtNjgzODI_84a3f08e-f18a-4e30-a2ad-d0f01208983e"
      unitRef="usd">40000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i09932419fb4e407c9245ec42d512beb8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNS0xLTEtNzAyNDc_ab21f54a-f9dd-4a34-b06f-978616635161"
      unitRef="usd">649000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ib3c12026e66c4017b76d451e41a8eb8a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNy0xLTEtNzAyNjI_23cb238b-75b1-41ca-a06e-85a0b04a3d52"
      unitRef="usd">3342000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5c1fcd11cc2f430c8c4add1bc6230a09_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTEtMS0xLTcwMjg3_90e67bd0-3eda-4d72-a833-cba6dd899be3"
      unitRef="usd">-3991000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTUtMS0xLTcwNDIw_fd44ff90-dc1f-4109-a056-0077bff0dce1"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMS0xLTEtNjgzODI_909f467b-91a4-4322-b85e-d1781f725ad4"
      unitRef="shares">123000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMy0xLTEtNjgzODI_8a9fd783-1320-4f63-8122-875f3b8c83e4"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i055da741a38a425dae638290e29c8807_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNS0xLTEtNjgzODI_c6b7c1c5-27c5-4680-b265-42dc49351932"
      unitRef="usd">1936000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia920ca1912e3480ebb55fdc231a8da19_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItNy0xLTEtNjgzODI_18d69334-e559-48fe-9b4c-37cc495ceb37"
      unitRef="usd">7333000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d3e5ccd81e9421e810e21a4bfa68ce7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItOS0xLTEtNjgzODI_ee9a31e0-69de-470a-ae18-f50f86d91e73"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95b59fb6a60d4941848525e7d490105d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTEtMS0xLTY4Mzgy_54f23bf3-de6a-4b3d-8e97-01f10b79a0be"
      unitRef="usd">-2866000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0079fdb1f79341858ac4900a117a3803_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTMtMS0xLTY4Mzgy_b7d9d93c-f98c-44ff-a34b-69319ba8ad7e"
      unitRef="usd">40000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTUtMS0xLTY4Mzgy_2d429e9c-91e9-4bc3-8e3e-624b996b4125"
      unitRef="usd">6432000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTItMTgtMS0xLTY4Mzgy_b6a2d9fd-b8bb-4be1-a481-44ede033bbd5"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i58732cf05c7043b6a8e12b54db21de24_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMS0xLTEtNjgzODI_cfb03ec7-7b58-47ea-a708-9b15e4fc908e"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i58732cf05c7043b6a8e12b54db21de24_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMy0xLTEtNjgzODI_44cd9597-326f-49f5-90a1-12fca6d717d0"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0089fadb633a4032ac4aaef0b0d2b75e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtNS0xLTEtNjgzODI_2a1fea34-6f64-430f-aa7a-605330cf2b42"
      unitRef="usd">2841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93981161fc924e7fbcc2631956508614_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtNy0xLTEtNjgzODI_a19680f5-3e40-440b-976d-fa0a87ab1b1f"
      unitRef="usd">9303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6eef6a2ec94d4ff289ccf2404dd21a9a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtOS0xLTEtNjgzODI_e2bc22c9-6558-4aab-a53b-8512e659a69b"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe1208f398b44195af87535925e86927_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTEtMS0xLTY4Mzgy_9665c1f0-6734-43d1-bca0-966b40e5d62a"
      unitRef="usd">-5366000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i589ae2a45c0c438dbc9b633c7ad6ae33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTMtMS0xLTY4Mzgy_abdf760c-d8df-4446-b0bd-58ef45d6799c"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTUtMS0xLTY4Mzgy_34f5e26b-bf8d-411b-b0b5-ed69f0af1c37"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTYtMTgtMS0xLTY4Mzgy_d50879cd-fda1-44e4-938f-9ead6127e42a"
      unitRef="usd">82000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i840e894a7ef144038ef94728d7daa256_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctNy0xLTEtNjgzODI_7fde0912-b0a8-43f9-b846-d69916ec350f"
      unitRef="usd">1605000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i0ffd0c3e5b9546b8bfe16c9eb1ec2e7d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctMTMtMS0xLTY4Mzgy_6b737e7c-b1b4-4d88-be07-699ff858cfbb"
      unitRef="usd">53000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctMTUtMS0xLTY4Mzgy_9d584e7a-59d9-4230-b947-286b4db3a217"
      unitRef="usd">1658000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTctMTgtMS0xLTY4Mzgy_418f8691-8fd7-49ae-a401-a8d83a988add"
      unitRef="usd">9000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8f9453dbd4c9422baa1dba8fb9a308cf_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTgtOS0xLTEtNjgzODI_2befb711-ddd0-45c5-bc9f-4a8cf4aef9a9"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTgtMTUtMS0xLTY4Mzgy_30431ae5-cf57-4b63-a8f1-4c5a85e627bd"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i840e894a7ef144038ef94728d7daa256_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTktNy0xLTEtNjgzODI_35e6662e-c6aa-407c-9b16-4ec9512adea6"
      unitRef="usd">233000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMTktMTUtMS0xLTY4Mzgy_5fb0ef91-6135-4da1-9b64-99e86f9e72c3"
      unitRef="usd">233000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0ffd0c3e5b9546b8bfe16c9eb1ec2e7d_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjAtMTMtMS0xLTY4Mzgy_ba788c08-48ee-431a-96d9-631d56fc95d8"
      unitRef="usd">63000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjAtMTUtMS0xLTY4Mzgy_59003420-5424-49a1-8270-677a81c90197"
      unitRef="usd">63000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjAtMTgtMS0xLTY4Mzgy_2f75c98c-cc5f-4e02-a8ed-0c9d30a79a8b"
      unitRef="usd">12000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjEtNS0xLTEtNjgzODI_0e799733-61b6-427b-8d6d-3825343b920b"
      unitRef="usd">-25000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjEtMTEtMS0xLTY4Mzgy_77cb941d-c45d-47ae-9302-32bcca14dddb"
      unitRef="usd">42000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjEtMTUtMS0xLTY4Mzgy_8a45551e-5d76-4e51-b243-1d3bce17574c"
      unitRef="usd">17000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjItNS0xLTEtNjgzODI_6674fe73-dedd-4ba0-acf1-7e2b566902d8"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjItMTUtMS0xLTY4Mzgy_14cc5bca-6b79-4b20-8df1-a170d822b227"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i77ef3821374f4ec68ef2864dd77fedec_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtMS0xLTEtNjgzODI_5d045198-b7f2-4deb-9cc7-4c63aec12495"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtNS0xLTEtNjgzODI_1ba510dd-e8a8-48ed-85bb-e1a7ea7344a1"
      unitRef="usd">19000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtMTEtMS0xLTY4Mzgy_47e3bbc6-6ad4-4b71-8be8-8ed31d52e9d5"
      unitRef="usd">89000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjMtMTUtMS0xLTY4Mzgy_974ce67d-112b-4b99-bd63-19b845d1d9e6"
      unitRef="usd">108000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjQtNS0xLTEtNjgzODI_f892c2f1-7e88-49eb-aa03-e42f601e66e2"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjQtMTEtMS0xLTY4Mzgy_f74e09b1-6cba-4169-a7ea-dd8c62f9d40f"
      unitRef="usd">12000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjQtMTUtMS0xLTY4Mzgy_b6d02264-da61-476b-8b2e-a65d66a06558"
      unitRef="usd">22000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i77ef3821374f4ec68ef2864dd77fedec_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtMS0xLTEtNjgzODI_29c31369-1932-4aad-9108-f4d421e00def"
      unitRef="shares">12000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtNS0xLTEtNjgzODI_6e306e8f-a899-4e85-9d27-1ac6bdf4d971"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtMTEtMS0xLTY4Mzgy_ceb5dbfb-99a1-4009-9288-24011ebb2cd6"
      unitRef="usd">1610000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjUtMTUtMS0xLTY4Mzgy_12030ddc-50b7-4fc9-b909-cc47bfef3e48"
      unitRef="usd">1910000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i15b2bce2d5b44fda8828d756e376be5f_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctNS0xLTEtNzAzNDg_f7040a75-ab4d-416c-b9e2-e293458a59e9"
      unitRef="usd">649000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i840e894a7ef144038ef94728d7daa256_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctNy0xLTEtNzAzNzE_331d001c-40f1-4809-8e82-a405306133de"
      unitRef="usd">3342000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctMTEtMS0xLTcwMzk2_85724da8-8362-4cd4-b3ca-9b2ba4ceefa7"
      unitRef="usd">-3991000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjctMTUtMS0xLTczMzMz_e6c0162a-d531-4b12-9c03-764465f1b041"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMS0xLTEtNjgzODI_1ad9c215-ef2d-431a-bbfa-d9086cc08095"
      unitRef="shares">123000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d7a467583ec46aa992fbd14a917bb43_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMy0xLTEtNjgzODI_00ad7ef4-10fd-4cdf-962b-4db06113150a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i055da741a38a425dae638290e29c8807_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtNS0xLTEtNjgzODI_5dc5bc1a-a765-464a-bfa7-62e6c0129327"
      unitRef="usd">1936000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia920ca1912e3480ebb55fdc231a8da19_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtNy0xLTEtNjgzODI_c01a3c16-ef76-40a2-a7c1-888c2f76b77d"
      unitRef="usd">7333000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d3e5ccd81e9421e810e21a4bfa68ce7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtOS0xLTEtNjgzODI_124396d4-d937-4d1a-8a5b-d379bda66b93"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95b59fb6a60d4941848525e7d490105d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTEtMS0xLTY4Mzgy_40536817-f9c3-4c81-a41f-112bc37a42f7"
      unitRef="usd">-2866000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0079fdb1f79341858ac4900a117a3803_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTMtMS0xLTY4Mzgy_5b1433b0-2a4f-4820-bab6-f9f5dd260307"
      unitRef="usd">40000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTUtMS0xLTY4Mzgy_edb809d8-0b01-4163-8c1b-d3c9f8af0afc"
      unitRef="usd">6432000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8yNS9mcmFnOmRjMTEzMDZlZjA1YjQ5OGZiOWY5ZTFmODFlODFmZjI4L3RhYmxlOjE4ZDJjMWQ1Mjk0YjQzODI5M2UzOTE4NzNlMWJlODY3L3RhYmxlcmFuZ2U6MThkMmMxZDUyOTRiNDM4MjkzZTM5MTg3M2UxYmU4NjdfMjYtMTgtMS0xLTY4Mzgy_27b83c78-281f-44f3-85a6-5c27daee4c16"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zMS9mcmFnOjNiYjIzYzdmYzQ3MDRiN2JhOTMyZGZkZTI2OWYzMDE0L3RleHRyZWdpb246M2JiMjNjN2ZjNDcwNGI3YmE5MzJkZmRlMjY5ZjMwMTRfMTY5OQ_fa899b37-a76e-4a1d-bc37-8aed16528cd8">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, and accountable care organizations ("ACOs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI3NA_d5661c8f-a891-4045-8447-9b6b197bbb6c">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of significant demand for COVID-19 testing.  As a result, operating results for the three and nine months ended September&#160;30, 2022 may not be indicative of the results that may be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI5NQ_26f0e654-16df-4131-ad66-8abea3fa0c0f">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2021 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2021 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDMwMg_16fa2743-293c-4110-aa3c-d1d9351856e5">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI4MA_b6c90af4-79b4-4be1-89c7-047f7f07ba8a">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNC9mcmFnOmYyNjUxOGFiZTQ1MTQ4ZDFiOTBiMzNlZDc3YmVjN2JmL3RleHRyZWdpb246ZjI2NTE4YWJlNDUxNDhkMWI5MGIzM2VkNzdiZWM3YmZfNDI3MQ_fafc62a3-09c6-42c3-a542-bdf536016d96">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied to contract modifications through December 31, 2022.  To the extent that, prior to December 31, 2022, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RleHRyZWdpb246ZWI3ZTM2ZTM3N2FlNDEwNWI3YzdkYjc3Yjc4NjgwYTVfNzUx_67b0635e-7ba7-4c71-a876-fab137d7208a">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first three quarters of 2021 did not equal the total for the nine months ended September&#160;30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of share repurchases (see Note 9 for further details regarding the Company's share repurchases).</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RleHRyZWdpb246ZWI3ZTM2ZTM3N2FlNDEwNWI3YzdkYjc3Yjc4NjgwYTVfNzUy_b24cb53c-a979-4321-a1df-287aae1fb081">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy0xLTEtMS02ODM4Mg_2c138ee6-b99d-4fd0-976a-4a40892ed810"
      unitRef="usd">256000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy0zLTEtMS02ODM4Mg_ecdddcb3-3992-4ebe-ae30-b7a8e546ac65"
      unitRef="usd">505000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy01LTEtMS02ODM4Mg_12c4e3fb-4833-44b1-a4f7-a86f489c14cc"
      unitRef="usd">845000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfNy03LTEtMS02ODM4Mg_f3799f67-1622-4a83-8b97-d333f717011e"
      unitRef="usd">1605000000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC0xLTEtMS02ODM4Mg_055d543a-8c46-4906-bf0d-755540e05413"
      unitRef="usd">2000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC0zLTEtMS02ODM4Mg_0dafadf2-a74e-4889-9c4f-2d10841ac737"
      unitRef="usd">2000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC01LTEtMS02ODM4Mg_f5ef24ca-db99-49c1-bbb4-9b3bf102793a"
      unitRef="usd">4000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOC03LTEtMS02ODM4Mg_0210ede0-173c-44a8-ba4c-2411dc3753e6"
      unitRef="usd">6000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS0xLTEtMS02ODM4Mg_57b175a1-e750-453a-970b-760baf6298c7"
      unitRef="usd">254000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS0zLTEtMS02ODM4Mg_f60096aa-4fd5-4b07-85a9-e9c063e7abd6"
      unitRef="usd">503000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS01LTEtMS02ODM4Mg_0ce2d755-8b5d-41f3-9866-9f84efc229ff"
      unitRef="usd">841000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfOS03LTEtMS02ODM4Mg_b1bea801-ebcf-4d13-b482-2d76298e8e7d"
      unitRef="usd">1599000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtMS0xLTEtNjgzODI_8138ab62-9dbc-4fb6-89e5-3130730892a6"
      unitRef="shares">116000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtMy0xLTEtNjgzODI_14a36b42-9fb6-4be1-8196-62ab7aaf8fb6"
      unitRef="shares">123000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtNS0xLTEtNjgzODI_e6137305-c2d5-40d7-880a-8167ac3d2aae"
      unitRef="shares">117000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTEtNy0xLTEtNjgzODI_86cce5dc-bc51-4f7f-9eb2-db88988efffe"
      unitRef="shares">127000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtMS0xLTEtNjgzODI_8ed8ed4a-d9fd-43e9-b5ce-204cc618f10c"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtMy0xLTEtNjgzODI_e1afd929-11bf-4dfb-97c7-10de8b226152"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtNS0xLTEtNjgzODI_4dd8cc18-4b53-4923-aecf-9e07a528715c"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTMtNy0xLTEtNjgzODI_ad118807-b562-460f-82fa-92db3c4bee06"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtMS0xLTEtNjgzODI_a557d1ed-8eaa-4063-80c9-caf6bf737907"
      unitRef="shares">118000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtMy0xLTEtNjgzODI_c44dfead-fc16-4ac0-b65f-67e9ba8fef49"
      unitRef="shares">125000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtNS0xLTEtNjgzODI_ea398523-2a8e-42bd-989e-370f1ecd9424"
      unitRef="shares">119000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTQtNy0xLTEtNjgzODI_6b5303a2-692d-47a3-a1a1-4bcf7960dbbe"
      unitRef="shares">129000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctMS0xLTEtNjgzODI_342f6e9e-06d0-464a-b1be-c7539e2a08cc"
      unitRef="usdPerShare">2.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctMy0xLTEtNjgzODI_d4b87099-cf52-43c3-a38f-f9742d404843"
      unitRef="usdPerShare">4.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctNS0xLTEtNjgzODI_b68f645b-1001-4bcf-adb9-5225067c0380"
      unitRef="usdPerShare">7.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMTctNy0xLTEtNjgzODI_e67e4dcf-fa6e-4636-9bb8-c7fd7eb9462f"
      unitRef="usdPerShare">12.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItMS0xLTEtNjgzODI_faf847b9-c49e-46b9-88cb-fab8da89fdb5"
      unitRef="usdPerShare">2.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItMy0xLTEtNjgzODI_8afb246d-c753-430b-b4b0-f120b0d7c150"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItNS0xLTEtNjgzODI_b95faf30-4ca6-4434-b38a-8d1b65d24b43"
      unitRef="usdPerShare">7.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmRiYzg0NGY3N2E3MjRiMjQ5ZDljMWRlNTJmMDFjYjM0L3RhYmxlcmFuZ2U6ZGJjODQ0Zjc3YTcyNGIyNDlkOWMxZGU1MmYwMWNiMzRfMjItNy0xLTEtNjgzODI_804d421d-417b-4adc-aad8-e2a4e85a4d79"
      unitRef="usdPerShare">12.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RleHRyZWdpb246ZWI3ZTM2ZTM3N2FlNDEwNWI3YzdkYjc3Yjc4NjgwYTVfNzU2_4f331f6d-fdc6-4882-ab0f-246453263e0f">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi0xLTEtMS02ODM4Mg_ff245f90-1bf2-4e8c-87b0-969b09bffe00"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi0zLTEtMS02ODM4Mg_f2ac4203-0405-4041-b0df-f6abeff59145"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi01LTEtMS02ODM4Mg_b4affb8a-e0af-4baa-a630-7b6734d0cd26"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8zNy9mcmFnOmViN2UzNmUzNzdhZTQxMDViN2M3ZGI3N2I3ODY4MGE1L3RhYmxlOmU0MjViODI1MGE4YzRhYzlhNDEzM2VmODlmODY4OGNiL3RhYmxlcmFuZ2U6ZTQyNWI4MjUwYThjNGFjOWE0MTMzZWY4OWY4Njg4Y2JfMi03LTEtMS02ODM4Mg_c41f9c6c-eb1b-42ba-9110-7dfac44c2d64"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjkyMw_06532897-6708-4b2f-a1ef-9460add81165">BUSINESS ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2022, the Company acquired Pack Health, LLC ("Pack Health"), a patient engagement company that helps individuals adopt healthier behaviors to improve outcomes, in an all cash transaction for $123&#160;million, net of $4&#160;million cash acquired, which consisted of cash consideration of $105&#160;million and contingent consideration initially estimated at $18&#160;million.  The contingent consideration arrangement is dependent upon the achievement of certain revenue benchmarks.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $96&#160;million of goodwill (of which $78&#160;million is tax-deductible), $30&#160;million of intangible assets, $5&#160;million of operating lease right-of-use assets, $5&#160;million of operating lease liabilities and $(3)&#160;million of working capital. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years. For further details regarding the fair value of the contingent consideration, see Note 6.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On December 13, 2021, the Company completed the acquisition of assets of Labtech Diagnostics, LLC ("Labtech"), an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South Carolina, North Carolina, Florida and Georgia, and recorded the assets acquired and liabilities assumed based on a preliminary purchase price allocation. During the nine months ended September&#160;30, 2022, the Company revised its purchase price allocation and recorded an $8&#160;million increase to goodwill, a $3&#160;million increase to customer-related intangible assets, a $1&#160;million decrease to inventories and a $10&#160;million increase to the estimated contingent consideration accrual. These adjustments did not have a material impact on the Company's consolidated results of operations. For further details regarding the fair value of the contingent consideration, see Note 6.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;For details regarding the Company's 2021 acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i89534177306a427980b6ebbaeab041c4_D20220201-20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjQw_fc8a5c98-bf4d-4060-b773-f5d8966148e3"
      unitRef="usd">123000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i89534177306a427980b6ebbaeab041c4_D20220201-20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjUx_975f778d-445b-4691-ab5a-b1953eefc15b"
      unitRef="usd">4000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i89534177306a427980b6ebbaeab041c4_D20220201-20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMzEw_0cf327c6-9645-424a-b6b2-7097d7c1b4b1"
      unitRef="usd">105000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMzY1_3dcd174b-e5b4-4fa1-b7b2-f86209f01a7c"
      unitRef="usd">18000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:Goodwill
      contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNjgw_4a4362df-71ed-4157-b17e-3846d5caa4a3"
      unitRef="usd">96000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzA1_7b86cac1-7d01-4b05-a257-9eb470e5c8ae"
      unitRef="usd">78000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzI4_01374ca7-849e-4f23-9404-bd136d0d7e67"
      unitRef="usd">30000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzUz_9fdbb51b-278f-4aa0-9abc-5aa4a2758adb"
      unitRef="usd">5000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfNzk2_00a23941-c2f5-4c8a-b683-0819fe47cf42"
      unitRef="usd">5000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital
      contextRef="i2a00a453622d4c80b1907306cdca3d9b_I20220201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfODM0_942659dd-039f-4d17-a97d-f52bfb199611"
      unitRef="usd">-3000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8bc9e3bbed0e42539b9efaaf04edba4d_D20220201-20220201"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfOTcy_4a610bd3-f8eb-4140-8615-8688f664a2ff">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjM5MA_9a11d0c9-0f4f-4824-b85f-da2bdaa45baa"
      unitRef="usd">8000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
      contextRef="ic9042842adea48d68f78ed59ef1a76de_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjQxNw_4bbf3c6a-fadb-4115-83bf-13dbf7394f75"
      unitRef="usd">3000000</us-gaap:FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments>
    <dgx:InventoryPurchaseAccountingAdjustments
      contextRef="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjQ3MA_4be5a6b6-c1d8-4d7f-b9d4-9d47609c73cf"
      unitRef="usd">-1000000</dgx:InventoryPurchaseAccountingAdjustments>
    <dgx:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets
      contextRef="ia8edf5ee14454beeb5e20c4ca89c0c10_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80MC9mcmFnOjlkNGZkYmJhYzUwMDRhNTY5MmMyNThjZGM3ZjIwNzJlL3RleHRyZWdpb246OWQ0ZmRiYmFjNTAwNGE1NjkyYzI1OGNkYzdmMjA3MmVfMjUwMw_616f62cb-ab1f-41d2-9d8d-b3ee9b023545"
      unitRef="usd">10000000</dgx:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfOTgy_8df21730-8aa2-476b-9350-a887454c39aa">DISPOSITION&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc., its joint venture partner, for $760&#160;million in an all-cash transaction. Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the nine months ended September&#160;30, 2021, the Company recorded a $314&#160;million pre-tax gain in other (expense) income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss. During the nine months ended September&#160;30, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.&lt;/span&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i08caf8d530cf43008af3a0306e3e477c_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfNjE_bdb6d20b-c700-4642-88b1-e1d29633a1f8"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross
      contextRef="ibcef44e271aa4680b8911a11902d9a4a_D20210401-20210401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfMjQ3_66681f86-fa06-4fc0-bc0b-edd994f4295c"
      unitRef="usd">760000000</dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ibf27417747054ef395ca09d3516e7989_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfNDcx_0d7af0ae-de03-476f-9e5c-65198408f7a3"
      unitRef="usd">-314000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i663fdcd70d744b64b639798c418155da_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfNjY5_77e04f91-ca39-4da6-8ee9-fd279a2b2eac"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfODM0_a0681ff6-9798-408e-a741-3de2ee0be412"
      unitRef="usd">55000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfODk0_99a43f97-0a78-4fa8-9c76-d1b48b6afc70"
      unitRef="usd">127000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i68bc8367cd0d427f9fcf85a2a8b3550d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80My9mcmFnOjQ5ZjhiZGIyYjQ5NTQ4NDVhMjkxNDFjMDc1NWMwN2RkL3RleHRyZWdpb246NDlmOGJkYjJiNDk1NDg0NWEyOTE0MWMwNzU1YzA3ZGRfOTQ4_a6a30af1-fcf2-494d-9215-c0a4e4cb6e33"
      unitRef="usd">72000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjQ0Mw_bf2a3fb4-f871-46cd-a825-f65388da351c">FAIR VALUE MEASUREMENTS  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Such equity investments are classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the acquisitions of Pack Health and Labtech, the Company has contingent consideration obligations, with a potential maximum aggregate payment of $40&#160;million, that are to be paid based on the achievement of certain testing volume or revenue benchmarks.  Contingent consideration accruals are measured at fair value using either an option-pricing method or a Monte Carlo method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#x2019;s estimate of volume or revenue and other market inputs, including comparable company revenue volatility (7.5%) and a discount rate (ranging from 2.5% to 3.0%).  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding the Company's acquisitions, see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 4.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value adjustments included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The $1&#160;million net gain included in earnings associated with the change in the fair value of contingent consideration for the nine months ended September 30, 2022 is reported in other operating income, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of September&#160;30, 2022, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments. As of September&#160;30, 2022 and December&#160;31, 2021, the fair value of the Company&#x2019;s debt was estimated at $3.6 billion and $4.4 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjQ0Ng_628b23c3-6d32-4f97-92f1-f394b3589a40">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:TradingSecurities
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi0xLTEtMS02ODM4Mg_f8a3e0a9-6520-40aa-b538-e6f6d9617776"
      unitRef="usd">63000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi0zLTEtMS02ODM4Mg_dd4def8b-9a33-42e0-a6a5-bde8d722b8b9"
      unitRef="usd">63000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi01LTEtMS02ODM4Mg_bc0a9fc9-8be6-40c6-8484-eaf75b0a874b"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNi03LTEtMS02ODM4Mg_8f8088fd-7a2a-4f66-9dc5-3bc568f5aec8"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy0xLTEtMS02ODM4Mg_56e6365a-b836-4c11-8ae7-7a41c46a4506"
      unitRef="usd">43000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy0zLTEtMS02ODM4Mg_60a9d861-5f80-454e-8ee2-e7024bb93df6"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy01LTEtMS02ODM4Mg_7b5adcd3-056d-40ee-b217-5dce31f21af9"
      unitRef="usd">43000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfNy03LTEtMS02ODM4Mg_2c70df5e-5374-4813-88a2-69969ac36b35"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC0xLTEtMS02ODM4Mg_757a1832-a8c3-4d8d-8b84-65485b088f34"
      unitRef="usd">14000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC0zLTEtMS02ODM4Mg_27f01a78-e7f5-4eea-851d-f0a5d9467add"
      unitRef="usd">14000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC01LTEtMS02ODM4Mg_cab2a405-f773-4135-97f7-c722ff041006"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfOC03LTEtMS02ODM4Mg_5a508c5c-4278-4382-8c9b-223f6a7c1379"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItMS0xLTEtNjgzODI_62bf9538-ccf9-4ff2-84ba-2c17f28c4c4b"
      unitRef="usd">120000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItMy0xLTEtNjgzODI_d7aa6801-00c6-465d-aa57-416d250a658b"
      unitRef="usd">77000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItNS0xLTEtNjgzODI_8d77bc45-806e-4270-85b9-70a2321e9a48"
      unitRef="usd">43000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTItNy0xLTEtNjgzODI_49d0dab8-faa4-411c-ac56-0de9fbe2cbc9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtMS0xLTEtNjgzODI_4140cfdd-1fa0-4580-992f-f497d9f6d3ac"
      unitRef="usd">113000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtMy0xLTEtNjgzODI_7fd46be7-71fc-4793-bfd4-26b1a5ae0b9b"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtNS0xLTEtNjgzODI_f96626bd-dbc1-4ea9-9d56-db4fa3d46a20"
      unitRef="usd">113000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTUtNy0xLTEtNjgzODI_90f2f5de-2153-417c-92fe-dc51257dbb33"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtMS0xLTEtNjgzODI_8fbd44ec-c695-4a71-a380-8c99008aff6f"
      unitRef="usd">17000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtMy0xLTEtNjgzODI_ddce91b6-f27b-4ff0-83d7-3fc573212ed6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtNS0xLTEtNjgzODI_602e5eae-0c9a-4e71-95bc-96939b8b9299"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMTgtNy0xLTEtNjgzODI_9fb062ed-bd86-4d7e-92d8-59a46ccb4b68"
      unitRef="usd">17000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtMS0xLTEtNjgzODI_f8ce4aea-65fd-4cfd-96fc-fef95e0a3cac"
      unitRef="usd">130000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtMy0xLTEtNjgzODI_5bd91181-769b-4332-aa32-fbe0b0dc313c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i298386f964ec4ef8adea12f70e3a5da7_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtNS0xLTEtNjgzODI_50cf3ba5-831f-44ca-884d-086f6a43d164"
      unitRef="usd">113000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjAtNy0xLTEtNjgzODI_2429a6b2-6ac6-497a-a389-9bcb7e7777ac"
      unitRef="usd">17000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i85cfff7f104d464ba21b477d5e3fe5bf_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjItMS0xLTEtNjgzODI_8e7b074a-5aca-4129-84e3-ba89d521d0d1"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i7e0679f17ba34e699fbd836abaac5f2d_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjItMy0xLTEtNjgzODI_720e4c23-84f0-4313-ba00-6157fc044fd2"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i45473dab00a64ee98b363794ddc1df50_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmE4MTE2YjY1ODMyYzRkODBiZTA3YjY3YzlhY2E4MWRmL3RhYmxlcmFuZ2U6YTgxMTZiNjU4MzJjNGQ4MGJlMDdiNjdjOWFjYTgxZGZfMjItNy0xLTEtNjgzODI_e85a6699-dfa8-489c-8927-71ca6d3ca5b8"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy0xLTEtMS02ODM4Mg_436969e4-0113-4194-ba03-948d316d6780"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy0zLTEtMS02ODM4Mg_c19dbd5a-4e55-44f4-8fb9-035142ade902"
      unitRef="usd">77000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy01LTEtMS02ODM4Mg_1f499a2a-bbcd-48f7-a4f1-59bfaa13373c"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMy03LTEtMS02ODM4Mg_08be0986-1392-4370-92dd-636241b9ec1c"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC0xLTEtMS02ODM4Mg_854a7e3e-2a23-4204-806c-4cc4a5405183"
      unitRef="usd">57000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC0zLTEtMS02ODM4Mg_170e659f-b19d-4327-8bb5-b2c9683b0f4d"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC01LTEtMS02ODM4Mg_38d80a29-d523-4c9f-8401-3e044e1de245"
      unitRef="usd">57000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNC03LTEtMS02ODM4Mg_3346ddef-8e89-4450-a58f-bc42cc94dd59"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS0xLTEtMS02ODM4Mg_6bca3e9b-1939-499e-80bf-eb2a2655ba97"
      unitRef="usd">44000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS0zLTEtMS02ODM4Mg_6d88d05e-eb18-45b9-bc76-a415695265d9"
      unitRef="usd">44000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS01LTEtMS02ODM4Mg_6177def1-7517-4f0d-b95b-7fcd43ea816e"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNS03LTEtMS02ODM4Mg_83300846-7fbd-4271-b8b7-16e6c90e9d26"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi0xLTEtMS02ODM4Mg_9cddf1e2-15c2-4b47-b65c-44dcc6c3af19"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi0zLTEtMS02ODM4Mg_3f761d2e-cfe4-41b2-94e6-8739fd953164"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi01LTEtMS02ODM4Mg_f857405a-04c6-4fd9-9ba5-582dfd3fd7da"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfNi03LTEtMS02ODM4Mg_e776a03f-6671-441a-82d8-877dc22573b1"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtMS0xLTEtNjgzODI_0c593724-bb61-4820-818b-d944396dca68"
      unitRef="usd">179000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtMy0xLTEtNjgzODI_b1176e6c-e6f2-4acf-9ab6-86771cf26564"
      unitRef="usd">121000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtNS0xLTEtNjgzODI_6966c77c-73d3-4388-b510-9e6167f46028"
      unitRef="usd">57000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTAtNy0xLTEtNjgzODI_92394f26-420e-4347-acdc-da3e1f030831"
      unitRef="usd">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtMS0xLTEtNjgzODI_d2176748-df04-49b3-8e39-17d7442fd3cf"
      unitRef="usd">143000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtMy0xLTEtNjgzODI_2368dd59-3fa8-4b28-900e-624f24573f8f"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtNS0xLTEtNjgzODI_af590607-ab5a-45bd-984b-fabacd1fed8c"
      unitRef="usd">143000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTMtNy0xLTEtNjgzODI_2fcd815f-6f49-4e23-85bf-ae2af6f7edad"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtMS0xLTEtNjgzODI_4068b5fb-ea97-4409-853d-c61b86f4a06b"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtMy0xLTEtNjgzODI_e25b8f8b-a08e-4bdf-a769-623808aef093"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtNS0xLTEtNjgzODI_4fea6d32-caa6-4c41-a3fa-fc419607c52a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTUtNy0xLTEtNjgzODI_e0a4fe2c-5bcc-4878-bb6d-b2b7430ef49b"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktMS0xLTEtNjgzODI_ee4e5a7b-3c8e-4897-bdcb-859da2204e50"
      unitRef="usd">148000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktMy0xLTEtNjgzODI_f0d1a601-9af4-4b23-834b-634cdbe7b3e1"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib3b4e217688f484da0874a661078f82f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktNS0xLTEtNjgzODI_af88456a-6567-4358-983f-c139b449a8d6"
      unitRef="usd">143000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMTktNy0xLTEtNjgzODI_416eb141-4068-4d18-b3e5-49baeed13fb3"
      unitRef="usd">5000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="id0eaed39b10c4747a4466534a16d4ed4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMjEtMS0xLTEtNjgzODI_ad9914ea-5f4c-4e7a-83a2-d4f10bbbc48c"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i12e12ac865714887ac216f5d036b7039_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMjEtMy0xLTEtNjgzODI_d5997442-2c5b-43e0-bbab-80f14e076393"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ic744a596e51e4fda9a38522d60c59682_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOmJlOGVmYzk4Y2ExOTRhZDViNzIxZTQ4NzIzYmU2ZjM5L3RhYmxlcmFuZ2U6YmU4ZWZjOThjYTE5NGFkNWI3MjFlNDg3MjNiZTZmMzlfMjEtNy0xLTEtNjgzODI_df90a2e1-e6b6-4c78-a67c-919f012b4115"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ib0b707eca9294fdaa61759b2009a7077_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfMzkwNw_e5a9a4d1-0875-4620-9abb-d01846ead180"
      unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i762312568e8b4ea9bdfe5e9cb82f2fe5_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDUwNw_7ef18834-336f-4acd-bf7e-c41113f43069"
      unitRef="number">0.075</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i3891771b03b74ae6bf6f1e347f984954_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDU0NQ_5eda8a26-d0ae-4a6c-9ada-02a677441e26"
      unitRef="number">0.025</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i3a7cdccc5b8b4351a6c84a3102569a41_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDU1MQ_88605cdd-8b4c-4478-8c9a-d97bf208a220"
      unitRef="number">0.030</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjQ1Mg_24b1c48a-bb58-4ea3-9d2f-a507e069a53c">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value adjustments included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i46b26dd13b5045219577db6205b830a5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfMi0xLTEtMS02ODM4Mg_3b09a408-d6cb-4917-8a55-1aa9fca0e4f5"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances
      contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfMy0xLTEtMS02ODM4Mg_84d0e03f-df5a-4812-8532-ab7582feb182"
      unitRef="usd">28000000</dgx:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfNC0xLTEtMS02ODM4Mg_3930f288-829f-4e42-88c1-aa8299c6ae90"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfNS0xLTEtMS02ODM4Mg_a8f2a905-82b6-4944-b401-378717ff0f0b"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic2dd843e91d24830a207e5a623c8c5f5_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RhYmxlOjQ3OWIxYzg1NmVjZTQyZWZhNDBhNzZlZWNiOGFmZTcxL3RhYmxlcmFuZ2U6NDc5YjFjODU2ZWNlNDJlZmE0MGE3NmVlY2I4YWZlNzFfOC0xLTEtMS02ODM4Mg_a4fc7cbd-c381-4830-9cc1-fbe33f1045e7"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i7a5dca9737784233896329b1e173c9f8_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNDk0NzgwMjMzMjc0MA_6065b824-88cd-40e4-bd3b-589135348832"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i109ee53a89994956b1b78b0354ad068a_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNTExNA_2fd2bf05-f18e-410e-a16f-c846231a02c8"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjA3NA_81c57c6e-3ad5-4351-8a00-194b663c29fc"
      unitRef="usd">3600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80Ni9mcmFnOjM0YjZiMDhjZGRlNzQ4OWI4ZDI4MjM5ZjAxZDQ1NWUxL3RleHRyZWdpb246MzRiNmIwOGNkZGU3NDg5YjhkMjgyMzlmMDFkNDU1ZTFfNjA4MQ_c224b7bb-c6d6-46df-9d00-4a3b8c00107b"
      unitRef="usd">4400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTE1OA_dba60658-47c7-4403-8ab4-3af37a3f8443">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in goodwill for the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Principally all of the Company&#x2019;s goodwill as of September&#160;30, 2022 and December&#160;31, 2021 was associated with its DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, goodwill acquired was principally associated with the acquisition of Pack Health, and adjustments to goodwill primarily related to foreign currency translation, largely offset by an adjustment of the purchase price allocation for Labtech (see Note 4). For the year ended December&#160;31, 2021, goodwill acquired was principally associated with the acquisitions of the assets of the outreach laboratory services business of Mercy Health and the assets of Labtech (see Note 5 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K), and adjustments to goodwill related to foreign currency translation.  &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(796)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTE2MA_f3d9391f-d08a-4453-95fb-5c89aeb7f942">The changes in goodwill for the nine months ended September&#160;30, 2022 and for the year ended December&#160;31, 2021 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMS0xLTEtMS02ODM4Mg_a7ff36c4-341e-448e-9c81-2b4005be12b8"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i52dab5247a1c4bbcb053e10c176ecba6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMS0zLTEtMS02ODM4Mg_c55483d8-9d88-41b1-bf7b-dd1c47433d0d"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMi0xLTEtMS02ODM4Mg_3e0ac40a-aa15-4fb4-b999-59cd914b9a8d"
      unitRef="usd">97000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic04fac321a00460b82d13cb06da4f28d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMi0zLTEtMS02ODM4Mg_6247172f-38d0-4462-9e36-9ac41d4ddf95"
      unitRef="usd">228000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMy0xLTEtMS02ODM4Mg_ba70ea9f-35c9-4cbe-afd0-0b1345addf5c"
      unitRef="usd">-2000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="ic04fac321a00460b82d13cb06da4f28d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfMy0zLTEtMS02ODM4Mg_c21e1755-5171-4a87-a16a-bd5d2773812c"
      unitRef="usd">-6000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfNy0xLTEtMS02ODM4Mg_3343e061-7d10-421b-8369-dfdb90b26e62"
      unitRef="usd">7190000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmE5OGMyMTAxZmFlNTRhY2ZhMDRhNTgxZjk2NGUwMDFkL3RhYmxlcmFuZ2U6YTk4YzIxMDFmYWU1NGFjZmEwNGE1ODFmOTY0ZTAwMWRfNy0zLTEtMS02ODM4Mg_bd3bd1fe-b1ba-4426-a269-07ca1e494ddd"
      unitRef="usd">7095000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTE1NA_b6079e24-66b7-400c-935f-e0c233715164">Intangible assets as of September&#160;30, 2022 and December&#160;31, 2021 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(796)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibebd5d13929a45809fca7b3d45a757d1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0xLTEtMS02ODM4Mg_889176d2-9194-4a78-b2aa-2a441e9474a5">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i89346c0905d2439297816ae363b1ed66_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0zLTEtMS02ODM4Mg_b49e6809-8503-4e5d-a809-b4716abd882d"
      unitRef="usd">1608000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i89346c0905d2439297816ae363b1ed66_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy01LTEtMS02ODM4Mg_59b2d3ec-45f8-49e6-9be4-7bb31dae59dd"
      unitRef="usd">796000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i89346c0905d2439297816ae363b1ed66_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy03LTEtMS02ODM4Mg_64335d80-3a97-418c-8df9-c56796cd96bf"
      unitRef="usd">812000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy05LTEtMS02ODM4Mg_32b1b78b-0346-43f9-8654-27e2de1c3325"
      unitRef="usd">1581000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0xMS0xLTEtNjgzODI_e0da9d7c-a83a-47e1-82b0-8db1825224b3"
      unitRef="usd">726000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3c64483ec98d4f6995fa3d41d3e8ce12_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMy0xMy0xLTEtNjgzODI_4db303bb-ae90-4aad-a8a4-02c6ff9108c4"
      unitRef="usd">855000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4c7345fe4fd94293946d0bf7c21a7d80_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0xLTEtMS02ODM4Mg_c571b94b-c153-40c2-a1f7-6e2aa0a0ceb4">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0zLTEtMS02ODM4Mg_3be7e5a8-a56a-4500-85b8-f32696808d47"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC01LTEtMS02ODM4Mg_38fd1ea1-b61d-4a98-92f0-7b7f66472cd4"
      unitRef="usd">3000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i188f69749f934a8aa6f33bdd88e9f2ad_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC03LTEtMS02ODM4Mg_34b1866e-cd07-4b41-b452-9d4ccf0aff6e"
      unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC05LTEtMS02ODM4Mg_9ed264c3-3cf7-43db-bd6f-f1260b280d22"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0xMS0xLTEtNjgzODI_1a54ea28-28d6-428a-a127-4d141982effd"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6c0251b5b7ab4e2c800f50044731e5ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNC0xMy0xLTEtNjgzODI_286ec22c-4b2b-4ac9-b52e-8dcf88780c86"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8205d967b9d04f0592030979d313578e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0xLTEtMS02ODM4Mg_1fa22576-d86e-4057-a3dc-dc9ab51454b8">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia888a55675b34c1da6c98058a0bfbb00_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0zLTEtMS02ODM4Mg_b62c93ce-be34-47bd-829c-cc3ef0c60be5"
      unitRef="usd">137000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia888a55675b34c1da6c98058a0bfbb00_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS01LTEtMS02ODM4Mg_50ab64b2-7f53-49e2-989f-bca0f4eeba44"
      unitRef="usd">80000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia888a55675b34c1da6c98058a0bfbb00_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS03LTEtMS02ODM4Mg_86269440-edd8-46e9-a02f-ce90dfef7e8b"
      unitRef="usd">57000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS05LTEtMS02ODM4Mg_b3dccec8-5999-43c9-ae44-a58cc9854a41"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0xMS0xLTEtNjgzODI_9f37b754-ef31-4977-a330-0c63b2576e8c"
      unitRef="usd">74000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ifd0956fcb87a4cf8bbc375e3fc56b428_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNS0xMy0xLTEtNjgzODI_335135f4-36ed-4655-8f6c-d336a19cb9d6"
      unitRef="usd">67000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i052af85eec62405eb656914f67d3a176_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0xLTEtMS02ODM4Mg_8a07de3d-8eef-4d54-8a75-47ea6964c895">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i193a25bf19ea41e690356bc8c5ce3380_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0zLTEtMS02ODM4Mg_5a1f3ebf-aeb3-4a48-9888-904b836cf5bf"
      unitRef="usd">114000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i193a25bf19ea41e690356bc8c5ce3380_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi01LTEtMS02ODM4Mg_7e8aca3e-1826-4945-bf30-411008323a69"
      unitRef="usd">104000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i193a25bf19ea41e690356bc8c5ce3380_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi03LTEtMS02ODM4Mg_def5d8eb-0536-4b0a-bbee-3bdbf25d57c0"
      unitRef="usd">10000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6c162a22bd874f5a8997350a100e5b4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi05LTEtMS02ODM4Mg_808d086c-b3b4-48f5-bcc2-2f1db6e580eb"
      unitRef="usd">109000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6c162a22bd874f5a8997350a100e5b4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0xMS0xLTEtNjgzODI_237ab8ea-45dc-4c55-9325-a027ae53d228"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6c162a22bd874f5a8997350a100e5b4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNi0xMy0xLTEtNjgzODI_6227428b-5caa-456d-8b4d-a5a08248402f"
      unitRef="usd">8000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id1465ba55b394e54ae2154b81d8f51fb_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0xLTEtMS02ODM4Mg_f00a47b3-1ecc-43cd-a7ec-3572322eaa87">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0zLTEtMS02ODM4Mg_6489e22a-b3c6-415c-a392-0e4820dd3b66"
      unitRef="usd">1862000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy01LTEtMS02ODM4Mg_9d32d13e-3f7a-4769-aefb-c112db7eb345"
      unitRef="usd">983000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4edb1132e1c64f57aafabf1e8dd5b4e0_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy03LTEtMS02ODM4Mg_86def8ab-6f00-4eaf-b92d-b1b4415afce5"
      unitRef="usd">879000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iafe0e5ae893b40efa9626f66a5e78820_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy05LTEtMS02ODM4Mg_1842e853-8dc5-48d8-8ce3-9747e83038c2"
      unitRef="usd">1834000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iafe0e5ae893b40efa9626f66a5e78820_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0xMS0xLTEtNjgzODI_86c212a8-cf51-415b-b850-12ed337e4df7"
      unitRef="usd">903000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iafe0e5ae893b40efa9626f66a5e78820_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfNy0xMy0xLTEtNjgzODI_625ef06b-a356-4d8c-967f-55144d24c1b9"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i67dee3f585f1452888374d9ee3dba34c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtMy0xLTEtNjgzODI_fc6478ff-d2d0-4c11-b8ff-2264933ac0e1"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i67dee3f585f1452888374d9ee3dba34c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtNy0xLTEtNjgzODI_86dd8c42-2f97-47da-a0c1-f3fb8a8f07eb"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic279fc9d23034639855e69aafe143991_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtOS0xLTEtNjgzODI_d5cacb26-edd5-4128-a97a-fc7c27185b3b"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic279fc9d23034639855e69aafe143991_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTAtMTMtMS0xLTY4Mzgy_b8b3d378-3fb6-4052-935f-1617e6bdc5fe"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i7998a056fa014b5b93a343c7b3bc409c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItMy0xLTEtNjgzODI_8b72efd9-9353-485d-b732-48644ec6b307"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7998a056fa014b5b93a343c7b3bc409c_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItNy0xLTEtNjgzODI_df76cb7b-e660-440a-83db-c1ff45131c40"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9ee3230ab4d945ffa507522cd478b188_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItOS0xLTEtNjgzODI_32374557-f9f9-4d8b-88e0-112cb20e31af"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9ee3230ab4d945ffa507522cd478b188_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTItMTMtMS0xLTY4Mzgy_a08d011b-e480-4493-b049-707495e56b0b"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtMy0xLTEtNjgzODI_103bd451-ebd5-4d5b-b31c-d72d685901be"
      unitRef="usd">2098000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtNS0xLTEtNjgzODI_5cf174df-8a27-4721-9864-fe7eadd8ba21"
      unitRef="usd">983000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtNy0xLTEtNjgzODI_9b4a915f-a9f0-4248-ab4a-5c434ae1ba56"
      unitRef="usd">1115000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtOS0xLTEtNjgzODI_12e65125-f95e-4cc5-924b-857d3a1c1403"
      unitRef="usd">2070000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtMTEtMS0xLTY4Mzgy_ee51c699-4ce3-43f0-a7c7-f0065383f7b8"
      unitRef="usd">903000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOmQ3N2UyNmMxNjAwNzRlZDE4ZjQzNGE5YjJkN2M3Njk4L3RhYmxlcmFuZ2U6ZDc3ZTI2YzE2MDA3NGVkMThmNDM0YTliMmQ3Yzc2OThfMTMtMTMtMS0xLTY4Mzgy_07138a44-b759-4938-8499-747a759f8d36"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RleHRyZWdpb246M2YxYjViZDdlZDJkNDA2OThiZGRjZmQyNDYyZmI4ZDlfMTEyNw_b7877dbb-f7ed-400a-9f0b-50347f01d559">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2022 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfMS0xLTEtMS02ODM4Mg_97a9d7cc-5a46-4ccf-87b2-611530ac9d8b"
      unitRef="usd">27000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfMi0xLTEtMS02ODM4Mg_97bef4bc-d350-4c47-b906-b04d2c95a26e"
      unitRef="usd">105000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfMy0xLTEtMS02ODM4Mg_3df29c97-4159-4580-950b-818a7c9644b7"
      unitRef="usd">102000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNC0xLTEtMS02ODM4Mg_78b1236e-d5a4-47dc-b246-f5f487da0c3e"
      unitRef="usd">100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNS0xLTEtMS02ODM4Mg_6220597e-e12e-4197-8783-36c1fa8f0918"
      unitRef="usd">95000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNi0xLTEtMS02ODM4Mg_507245b9-c1a0-454c-9214-373628969b8b"
      unitRef="usd">84000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfNy0xLTEtMS02ODM4Mg_bf76466c-e650-4139-9147-aa869d9e2770"
      unitRef="usd">366000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV80OS9mcmFnOjNmMWI1YmQ3ZWQyZDQwNjk4YmRkY2ZkMjQ2MmZiOGQ5L3RhYmxlOjVlMzFmMDVhNjg3ZjQ3NWViZjU4MmJkNDkzYzBkYjdiL3RhYmxlcmFuZ2U6NWUzMWYwNWE2ODdmNDc1ZWJmNTgyYmQ0OTNjMGRiN2JfOC0xLTEtMS02ODM4Mg_a7049001-875d-48f4-b9d5-b58e017ad325"
      unitRef="usd">879000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RleHRyZWdpb246MTZmNDhlOWZlZDE1NDE4YjgzZjc2MWM1MTIwYTAyY2ZfMzMzNw_39d08351-df88-4c67-9858-7e1018dc0511">FINANCIAL INSTRUMENTS &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of September&#160;30, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both September&#160;30, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RleHRyZWdpb246MTZmNDhlOWZlZDE1NDE4YjgzZjc2MWM1MTIwYTAyY2ZfMzM0MQ_a87900bd-c681-48a2-911d-a458d9fd8989">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</us-gaap:DerivativesPolicyTextBlock>
    <dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RleHRyZWdpb246MTZmNDhlOWZlZDE1NDE4YjgzZjc2MWM1MTIwYTAyY2ZfMzMzNQ_9628f7af-c465-4c8a-8c5e-5f8558a0186a">As of September&#160;30, 2022 and December&#160;31, 2021, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both September&#160;30, 2022 and December&#160;31, 2021, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i39c1dcdf5ded4bc5be532f869db993b6_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RhYmxlOjI0MTM5YWVhYWM5YjRjYmFiZmU2NzkwZTY5MzdlNWQ5L3RhYmxlcmFuZ2U6MjQxMzlhZWFhYzliNGNiYWJmZTY3OTBlNjkzN2U1ZDlfMi01LTEtMS02ODM4Mg_947dbeb0-9009-4d3c-9c8b-4de3c9f2ff00"
      unitRef="usd">29000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i8892d167ced44fed893e191b22d3989c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81Mi9mcmFnOjE2ZjQ4ZTlmZWQxNTQxOGI4M2Y3NjFjNTEyMGEwMmNmL3RhYmxlOjI0MTM5YWVhYWM5YjRjYmFiZmU2NzkwZTY5MzdlNWQ5L3RhYmxlcmFuZ2U6MjQxMzlhZWFhYzliNGNiYWJmZTY3OTBlNjkzN2U1ZDlfMi05LTEtMS02ODM4Mg_487c4ca1-5ea3-42ca-ac21-80f8a264456e"
      unitRef="usd">38000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMzgxMQ_83b210ca-f3f5-4ce5-b1f1-610133b4e349">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2022 and 2021, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During each of the first three quarters of 2022, the Company's Board of Directors declared a quarterly cash dividend of $0.66 per common share.  During each of the four quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In February 2022, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of September&#160;30, 2022, $746&#160;million remained available under the Company&#x2019;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022, the Company repurchased 7.1&#160;million shares of its common stock for $950&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, the Company repurchased 12.5 million shares of its common stock for $1.6 billion, including 9.1&#160;million shares repurchased under accelerated share repurchase agreements ("ASRs") as follows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase its common stock as part of its share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock, less a fixed discount, during the repurchase period, which ended during the fourth quarter of 2021. For the nine months ended September&#160;30, 2021, the Company paid $1.5&#160;billion to the financial institutions and initially received 9.1&#160;million shares of its common stock for a value of $1.2&#160;billion, which represented 80% of the total value of shares to be repurchased under the ASRs based on the stock price at inception of the ASRs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022 and 2021, the Company reissued 1.6 million shares and 1.7 million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock Retirement &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended September&#160;30, 2021, the Company retired 55&#160;million shares of treasury stock. In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of September&#160;30, 2022 and December&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  For further details regarding the fair value of the redeemable noncontrolling interest, see Note 6.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i1102df7028da465093e08195001df34c_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTEyMQ_30b21e40-e699-489d-978e-06f2fca02f8d"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i29663b176c084c83ba8d49b48433f6a7_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTEyMQ_4e62fcd0-c684-4edb-b8c4-9b4d15264e1a"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTEyMQ_5f34ef54-2fad-4cd9-8387-99a7bf156e77"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_10abde4e-c924-41fe-af45-c3c35c72236c"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if16effd867954c738404b7b96d2e8eae_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_32705575-917f-439f-bd33-1f5198ea2c5c"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i67d9eea602464d4fab91b47e890a65ff_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_d4d75a05-1386-4ae6-b008-4fb7a8b02826"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ieb3a7eac45ff47d6b334f694b10c9c80_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTI1NA_dfcc52be-16ff-47f4-b705-b987aa7b5cdd"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i973ec05c00df4ad6a2a4472b1d8d2332_D20220201-20220201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTQxMg_db8c068b-d673-4053-a757-aed7c784a536"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTQyNg_9abbac54-a1db-43bc-a684-9cf7a231289e"
      unitRef="usd">746000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTY1NQ_81ef4097-9b35-446c-aabe-e72b48d04ad7"
      unitRef="shares">7100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9a6af5617ec74123afd6325e39c86e31_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTY4OQ_6600cd6c-6d12-47f6-bd72-f82d27596223"
      unitRef="usd">950000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTc0OA_c04dd649-2e7e-4b29-8e48-a2709c1453da"
      unitRef="shares">12500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8bd244a11729432f9e2ee48c85e9c4ba_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTc4Mg_2f67dddc-bfea-4fa5-858c-2871b5e3bc00"
      unitRef="usd">1600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0af15cd6ca4d4d5a9a34b91873ffc960_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMTc5Ng_50f43e9e-9fcf-4908-aa54-d05147f7f667"
      unitRef="shares">9100000</us-gaap:TreasuryStockSharesAcquired>
    <dgx:AcceleratedShareRepurchasesPayment
      contextRef="i7c0f85b320f34c5db62f1f89cba5a333_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjM5Nw_582200ec-d461-46e6-bc20-ab7f6296634b"
      unitRef="usd">1500000000</dgx:AcceleratedShareRepurchasesPayment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0af15cd6ca4d4d5a9a34b91873ffc960_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjQ0Mw_50f43e9e-9fcf-4908-aa54-d05147f7f667"
      unitRef="shares">9100000</us-gaap:TreasuryStockSharesAcquired>
    <dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution
      contextRef="i1fa78c23eb41439b8bceb72de57816d2_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjUyNA_d5f552d4-404f-4039-a474-190e357d3c03"
      unitRef="usd">1200000000</dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution>
    <dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements
      contextRef="i1fa78c23eb41439b8bceb72de57816d2_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjU0Ng_956c0057-1737-44f9-89a8-b2c965f610cd"
      unitRef="number">0.80</dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMjcxNg_214a8f8e-1dd9-42f4-b3e3-d9280746ce70"
      unitRef="shares">1600000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfNTQ5NzU1ODE3NzY3_94ba7aaf-0db2-46ae-a5b6-2b1206b10f2d"
      unitRef="shares">1700000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfNTQ5NzU1ODE4MjA1_52601e17-fd4a-4ca2-b295-0657bec8e104"
      unitRef="shares">55000000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i109ee53a89994956b1b78b0354ad068a_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81NS9mcmFnOjQyNGUyOWNmNGY1ZjQ3MTBhZjViOWJiMTdkOWMwN2Q5L3RleHRyZWdpb246NDI0ZTI5Y2Y0ZjVmNDcxMGFmNWI5YmIxN2Q5YzA3ZDlfMzA4Nw_2fd2bf05-f18e-410e-a16f-c846231a02c8"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RleHRyZWdpb246MTgxZGIwZGI5ZDY2NDdiYjhkZWE5Y2JjYTI0OTFmMmVfNDE1_34dcf5d8-3c29-4083-8870-46d3f883a90c">SUPPLEMENTAL CASH FLOW AND OTHER DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2022 and 2021 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with purchases of treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2022, the Company amended a real estate lease and, based on the updated terms, the classification of the lease changed from a finance lease to an operating lease. As a result, the Company recorded a $31&#160;million operating lease right-of-use asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RleHRyZWdpb246MTgxZGIwZGI5ZDY2NDdiYjhkZWE5Y2JjYTI0OTFmMmVfNDI0_71f95f10-f6a1-486a-8d7a-e2173f005678">Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2022 and 2021 was as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with purchases of treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi0xLTEtMS02ODM4Mg_7a5926d5-60cc-4498-8c02-49ee3a822fc8"
      unitRef="usd">81000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi0zLTEtMS02ODM4Mg_05763185-fee4-4a4f-b309-fed8df2a0eff"
      unitRef="usd">76000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi01LTEtMS02ODM4Mg_80af1dc8-e858-4fc8-88d9-cba78b39ad46"
      unitRef="usd">240000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMi03LTEtMS02ODM4Mg_5c698d8f-218b-4f8a-a559-25bb3e537fc7"
      unitRef="usd">225000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy0xLTEtMS02ODM4Mg_eef4ee17-d683-4022-8fda-6d75db956051"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy0zLTEtMS02ODM4Mg_6cb276b3-85a4-40f1-9acf-8810276b7469"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy01LTEtMS02ODM4Mg_680e0a6f-8742-47d9-a1c4-7885bdb704d8"
      unitRef="usd">81000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMy03LTEtMS02ODM4Mg_7452c21f-c1b7-4e4c-8ebe-c5d3527cdade"
      unitRef="usd">77000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC0xLTEtMS02ODM4Mg_0a7f0d1e-b306-4a2f-93ea-81976401f598"
      unitRef="usd">108000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC0zLTEtMS02ODM4Mg_f079f2f9-e182-4785-93aa-85d7fa0ef8ed"
      unitRef="usd">101000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC01LTEtMS02ODM4Mg_585935d7-0875-4522-bc20-acc2dcb1dd86"
      unitRef="usd">321000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNC03LTEtMS02ODM4Mg_d06dbb8b-3a69-403f-8d87-cad7df3551b2"
      unitRef="usd">302000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi0xLTEtMS02ODM4Mg_82f21e54-a964-424e-b177-bf85151814b3"
      unitRef="usd">37000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi0zLTEtMS02ODM4Mg_f5f0d26e-158c-4784-a24a-f798c6875eaf"
      unitRef="usd">38000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi01LTEtMS02ODM4Mg_9f7cbd3a-e374-4048-a4be-285b24389d5e"
      unitRef="usd">112000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNi03LTEtMS02ODM4Mg_bedc7518-cb69-4fbf-ab9c-1c17fe6447ef"
      unitRef="usd">114000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy0xLTEtMS02ODM4Mg_625ae616-51ab-4df2-a2cd-2524773d4226"
      unitRef="usd">4000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy0zLTEtMS02ODM4Mg_19d8916e-2db3-4e75-9041-8cbe0b807218"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy01LTEtMS02ODM4Mg_1f88ea9c-f458-465e-a240-e0bd6e29f8da"
      unitRef="usd">6000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfNy03LTEtMS02ODM4Mg_e41e0cc2-f25d-4315-80bb-77290b907ff9"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC0xLTEtMS02ODM4Mg_7aa3214a-83bd-467d-a752-225cdbcaf9d8"
      unitRef="usd">-33000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC0zLTEtMS02ODM4Mg_9223dceb-b351-4898-9ec5-344818ba47e4"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC01LTEtMS02ODM4Mg_a05ca972-0452-4cab-a24a-bdd63668770e"
      unitRef="usd">-106000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfOC03LTEtMS02ODM4Mg_ef1c4209-3d52-4fc9-9212-aa84ba0f687e"
      unitRef="usd">-114000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestPaidNet
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtMS0xLTEtNjgzODI_03b749e0-fe09-42e0-888c-ca5ac2da6b64"
      unitRef="usd">32000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtMy0xLTEtNjgzODI_56fdfc99-28b1-422a-b0b4-1bab7bdc2857"
      unitRef="usd">33000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtNS0xLTEtNjgzODI_0275dbad-bf2b-4e9a-9282-b35179a79884"
      unitRef="usd">110000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTAtNy0xLTEtNjgzODI_44cc28b1-8fdf-47da-8145-5146749954af"
      unitRef="usd">111000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtMS0xLTEtNjgzODI_bb70a9b8-a783-4c47-ba82-256e803ed0bc"
      unitRef="usd">5000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtMy0xLTEtNjgzODI_7b98c482-e3da-45c0-a2b0-99e387e434a2"
      unitRef="usd">187000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtNS0xLTEtNjgzODI_4c8613a7-4bb4-4a39-8bca-3493ce531635"
      unitRef="usd">187000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTEtNy0xLTEtNjgzODI_8a635181-da4e-4bb4-903b-32d8925e4992"
      unitRef="usd">522000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtMS0xLTEtNjgzODI_4898eec5-1ee5-459e-811b-a95e4f63c0f6"
      unitRef="usd">30000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtMy0xLTEtNjgzODI_c00605a9-37dc-436f-bb61-5ee4166d9106"
      unitRef="usd">24000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtNS0xLTEtNjgzODI_d6880963-fe07-40ce-a3d0-4f49e4657948"
      unitRef="usd">30000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTMtNy0xLTEtNjgzODI_6fd67760-8ad1-4bdd-b4e9-de1e4190ca9b"
      unitRef="usd">24000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtMS0xLTEtNjgzODI_1481d2dc-1b09-411e-8c4c-f227861f9025"
      unitRef="usd">26000000</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtMy0xLTEtNjgzODI_4d82eec7-9ac0-4628-8a56-49b10ae4d797"
      unitRef="usd">0</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtNS0xLTEtNjgzODI_f26e6def-a98c-49e4-a63a-2a9d0b1b725a"
      unitRef="usd">26000000</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTQtNy0xLTEtNjgzODI_e8755d13-73c9-48d6-8430-2c90c86931d1"
      unitRef="usd">0</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtMS0xLTEtNjgzODI_5a5086e1-c208-423b-a5b6-4d584edecf75"
      unitRef="usd">75000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtMy0xLTEtNjgzODI_757af959-019a-40dd-a915-afae43b7408b"
      unitRef="usd">77000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtNS0xLTEtNjgzODI_e88d7064-f626-4cb1-9715-d8d04eff6064"
      unitRef="usd">75000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="id28568ccefa145d1b82a58a63eaad5a4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTUtNy0xLTEtNjgzODI_da8b2f77-e272-4fbc-a79a-7601bdd2f99e"
      unitRef="usd">77000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtMS0xLTEtNjgzODI_bbbbd84e-189a-4316-97a6-41dfeb0cced6"
      unitRef="usd">0</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtMy0xLTEtNjgzODI_0ed7e36a-5b3f-44a4-af7c-fb37fb7f09c4"
      unitRef="usd">20000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtNS0xLTEtNjgzODI_7d219304-6908-4695-b268-4b7a8aade43c"
      unitRef="usd">143000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTgtNy0xLTEtNjgzODI_4a6acb80-3e25-4e7c-bb72-fb0c77a1ebc2"
      unitRef="usd">254000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktMS0xLTEtNjgzODI_0b73d643-402b-4221-99d3-cb0c7e51da76"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktMy0xLTEtNjgzODI_a7b42530-036d-4ea5-8c01-3fcd5b203897"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktNS0xLTEtNjgzODI_4e57d6cd-9e96-4c63-9410-ec307377be11"
      unitRef="usd">15000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMTktNy0xLTEtNjgzODI_25588c0d-c02f-4082-a317-aef0ba51f783"
      unitRef="usd">3000000</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtMS0xLTEtNjgzODI_440908d2-dd5d-44a3-b10e-31b21d077331"
      unitRef="usd">0</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtMy0xLTEtNjgzODI_0a4f7d08-e53c-4ad4-81e4-d6d898a30fbd"
      unitRef="usd">20000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtNS0xLTEtNjgzODI_114de2c4-ba55-4f58-9b0a-a9eb2dd84301"
      unitRef="usd">128000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjAtNy0xLTEtNjgzODI_552b0cde-40de-4913-98a6-2a3031bba1f7"
      unitRef="usd">251000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtMS0xLTEtNjgzODI_eb570fbc-b3b9-446c-b5d9-02749cb3782e"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtMy0xLTEtNjgzODI_479270f6-eb5f-477c-8a04-e23c258fed34"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtNS0xLTEtNjgzODI_126c128f-78a0-4d9f-80da-0c718ff705b0"
      unitRef="usd">-18000000</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjEtNy0xLTEtNjgzODI_32d63a26-4e8b-433a-837f-a4098c247555"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItMS0xLTEtNjgzODI_a6dccc9e-d712-4169-a957-b20eac7b5d9f"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItMy0xLTEtNjgzODI_e585b5b3-a081-45cf-b056-a63af26ece9b"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItNS0xLTEtNjgzODI_431cb5f1-fd04-4122-a52b-57bb7f6d877a"
      unitRef="usd">110000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjItNy0xLTEtNjgzODI_31b34d62-d9fc-46eb-8653-e3ae90517b75"
      unitRef="usd">251000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtMS0xLTEtNjgzODI_46d8b55c-5291-4771-8dd3-095f39f325dd"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtMy0xLTEtNjgzODI_afa07ba0-39d4-4929-b9cc-ccb2563f9365"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtNS0xLTEtNjgzODI_95316f80-1ca5-44ca-9bf1-8d2a62eeda52"
      unitRef="usd">4000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjMtNy0xLTEtNjgzODI_07e16212-ffff-40df-8e34-d4fc36810b44"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtMS0xLTEtNjgzODI_bb42f230-c76f-480e-824a-d8c99f6b7828"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtMy0xLTEtNjgzODI_2ca725de-db22-4702-bf9a-cafea22bf246"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtNS0xLTEtNjgzODI_27ae9dbf-5169-494a-9f07-1c0348c1b4b5"
      unitRef="usd">106000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMjQtNy0xLTEtNjgzODI_c8d2f481-2252-4e26-9219-41956f9f7334"
      unitRef="usd">251000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtMS0xLTEtNjgzODI_6bcee9a9-acf1-437e-a2b9-257c447ee1d3"
      unitRef="usd">49000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtMy0xLTEtNjgzODI_924a8ed0-9710-4fc2-b094-1d8d769df1b6"
      unitRef="usd">46000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtNS0xLTEtNjgzODI_d2d162ce-009f-468f-8c4a-501e7dbd3a67"
      unitRef="usd">133000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RhYmxlOjk1MjhlNDUyOTViMjQ4ZWRiOTdlZjNkM2JkMWU2ZTY2L3RhYmxlcmFuZ2U6OTUyOGU0NTI5NWIyNDhlZGI5N2VmM2QzYmQxZTZlNjZfMzEtNy0xLTEtNjgzODI_59c75e9a-d0e4-41a0-bede-5bf3d3eb62cc"
      unitRef="usd">115000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i191fbddd79df46e9b0198928feb36a29_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV81OC9mcmFnOjE4MWRiMGRiOWQ2NjQ3YmI4ZGVhOWNiY2EyNDkxZjJlL3RleHRyZWdpb246MTgxZGIwZGI5ZDY2NDdiYjhkZWE5Y2JjYTI0OTFmMmVfMzY4_ab41dd01-5aee-4ba2-84b6-4bbbfc981a05"
      unitRef="usd">31000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTE0OTc_8164391b-347a-48d2-8b7c-291bcb7a3b5d">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K and Note 15.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2022, providing collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#x2019;s 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  Discovery is proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, the Company has been notified that numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ReproSource Fertility Diagnostics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#x201c;ReproSource&#x201d;), a subsidiary of the Company, is subject to two putative class action lawsuits in the U.S. District Court for Massachusetts: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bickham v. ReproSource Fertility Diagnostics, Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gordon v. ReproSource Fertility Diagnostics, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#x2019; private information. ReproSource has moved to dismiss both complaints.  In addition, the Company had been notified that the Office of Civil Rights of the U.S. Department of Health and Human Services (&#x201c;OCR&#x201d;) and three state governmental authorities were investigating or otherwise seeking information and/or documents related to the incident.  The OCR and one state investigation have been closed, and the other state investigations are inactive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of September&#160;30, 2022, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $5 million and $4 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;The Company is subject to a series of individual claims brought by persons in Ireland related to allegations stemming from pap smear screening services performed by the Company.  In general, claimants have alleged that the results of certain pap smear screening tests performed by the Company and other providers, pursuant to a program coordinated by the Irish government, were incorrect for individuals who were later diagnosed with cervical cancer.  The Irish government and an independent scoping inquiry commissioned by the Irish government found that the Company&#x2019;s performance of its screening services for the Irish cervical cancer screening program were in accordance with both Ireland&#x2019;s requirements and international standards.  The Company has settled claims made by certain individuals, is a party in multiple lawsuits and may be served as a party in additional lawsuits.  The Company does not believe that the resolution of existing or future claims will have a material adverse effect on its financial position or liquidity, but the ultimate outcomes of these claims are unpredictable and subject to significant uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $162 million and $159 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;While the basis for claims reserves is actuarially determined losses based upon the Company's historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although the Company believes that its present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that the Company may incur liabilities in excess of its recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material impact on the Company&#x2019;s results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6f0c266cfabc4117a5db448c8bd6d03f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTEx_857b6fcf-9c62-474a-b7ea-fc9f2a048206"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8b2ee25f2ed8463cb9acb8e346af111a_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTI0_a11e985d-6732-455b-8549-0bfe8b105213"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia1a4fda1687b418eb6a88b57bee7ee91_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTY3_b4803782-3d7b-4773-9d5c-fd93c766009c"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i71bd2faa4dcb410aac7083d1314895b2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTgw_2217652b-2033-4dc1-bfa9-09895bc99f01"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i8b2ee25f2ed8463cb9acb8e346af111a_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfNTE0_2840aba6-59d6-42b2-98f5-fa94d5a75de6"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2429a6bcd9bd4c65a106279746ec156f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTg1OA_5d795f4e-9cbf-4b0e-a3f9-958f380d892c"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2429a6bcd9bd4c65a106279746ec156f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMjQwNg_ef845bda-469a-4cd7-9507-0b12b3b245b8"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib3f4b1ab656b429792e65b699bbd3194_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfNDkzNw_34c84fd2-91f6-4aea-8ad6-8b12ab9abb25"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationReserve
      contextRef="ibad21a9259c74090ab33049d5d123cd2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfODQwNQ_0b12dad3-2a2c-4483-8bba-04bb6e3354f3"
      unitRef="usd">5000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i049e3ca5238248948e41058b0359b2cc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfODQxMg_930ade11-8756-4ed6-b643-ff3e6968a056"
      unitRef="usd">4000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTA2NjU_88774796-19aa-4f7b-8879-4e040bed97a8"
      unitRef="usd">162000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82MS9mcmFnOjkxY2FhOGQ3MzJlYjQ1Njk5NTQzOTgzNzU2YTE5OTY4L3RleHRyZWdpb246OTFjYWE4ZDczMmViNDU2OTk1NDM5ODM3NTZhMTk5NjhfMTA2NzI_3c1b6515-fa2b-46b6-92c3-0ffb346c4acc"
      unitRef="usd">159000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfMjQwOQ_1bac2924-c771-41a1-ab82-7c23fc6a62e3">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, and ACOs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of September&#160;30, 2022, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three and nine months ended September&#160;30, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i6780bd5df0e2405c8a5497be06f79406_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfODA3_3b7b5a7e-f459-4fc8-8f40-b94115283395"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i778d30c2a5f04d5bbd79b50d49dff45b_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfODA3_9897c76b-cb90-4fc8-9ca7-0a5322db0d1a"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfMjQxMw_5ccbd409-76ea-4b64-852e-a40aec1963bf">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2022 and 2021.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35233092ea214d52af667521fd4f34ba_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy0xLTEtMS02ODM4Mg_afc52c15-845f-490d-8ffc-b68fb5bc8ee1"
      unitRef="usd">2419000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy0zLTEtMS02ODM4Mg_eec19ff4-4b28-4ee3-8a59-24377c4ce2ad"
      unitRef="usd">2703000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy01LTEtMS02ODM4Mg_41f7c35b-8477-4d38-b8c7-99d01eddd9c4"
      unitRef="usd">7344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMy03LTEtMS02ODM4Mg_31d755ff-e35f-4335-8103-315c9f1ddf75"
      unitRef="usd">7820000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2022fe35c0ed49ce8cbcf4e5663b9586_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC0xLTEtMS02ODM4Mg_98737cfd-4af0-4243-84fe-8462f94f9486"
      unitRef="usd">67000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69f82d92935446eda7827eecbc1d0446_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC0zLTEtMS02ODM4Mg_d1d96944-8213-4fbd-9a8c-2f8c550b0b44"
      unitRef="usd">71000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4dd75de4a9a04a92817af7be460230d6_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC01LTEtMS02ODM4Mg_2039b1d9-a368-46b3-8e3b-34575fe840ba"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie54292d821ae48a68d7b57aa83ce30d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNC03LTEtMS02ODM4Mg_8df6cf44-8824-4532-9080-3c4497679ca7"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS0xLTEtMS02ODM4Mg_6d18262b-f012-4920-bdb7-08019c3e7f90"
      unitRef="usd">2486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS0zLTEtMS02ODM4Mg_801c2c89-a122-4cd6-ba5a-951e8ffd1cd2"
      unitRef="usd">2774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS01LTEtMS02ODM4Mg_6a3529ef-b84e-4df4-960d-6fe65e5a6f0b"
      unitRef="usd">7550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfNS03LTEtMS02ODM4Mg_fa23fde1-7f55-4812-8841-bc66cf170400"
      unitRef="usd">8044000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i35233092ea214d52af667521fd4f34ba_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC0xLTEtMS02ODM4Mg_1fdfb0de-0955-43e3-b925-462469604e5e"
      unitRef="usd">441000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC0zLTEtMS02ODM4Mg_f36a1a4d-01f3-477c-81d7-5f8ba06cb29f"
      unitRef="usd">713000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC01LTEtMS02ODM4Mg_c7e378ce-f306-4aba-aee5-c01d0ff61b93"
      unitRef="usd">1445000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOC03LTEtMS02ODM4Mg_f5557a5c-056c-4240-a5ff-0d70a72fd6a2"
      unitRef="usd">2026000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2022fe35c0ed49ce8cbcf4e5663b9586_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS0xLTEtMS02ODM4Mg_03860901-92f1-4bd2-81be-693cb376ba22"
      unitRef="usd">3000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i69f82d92935446eda7827eecbc1d0446_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS0zLTEtMS02ODM4Mg_88ccb905-f82b-4f03-89bc-756ca7058e96"
      unitRef="usd">8000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4dd75de4a9a04a92817af7be460230d6_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS01LTEtMS02ODM4Mg_bf46e8c0-8ccb-4edb-b17f-9e98ec19125d"
      unitRef="usd">16000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie54292d821ae48a68d7b57aa83ce30d5_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfOS03LTEtMS02ODM4Mg_a12b35f5-07db-4ad6-98e1-38665c39b00b"
      unitRef="usd">26000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3e38360cd91846de82063fcaaf58e127_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtMS0xLTEtNjgzODI_0e329d57-1d1e-4f58-acad-6825729058e1"
      unitRef="usd">-52000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iedba8be9e6d9474cbeea5e69c3817a44_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtMy0xLTEtNjgzODI_38600909-22d5-406b-b7b4-bffdf389bbff"
      unitRef="usd">-69000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2213ad4f9e044d1f9f73b935280a85d0_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtNS0xLTEtNjgzODI_33feedd6-5a97-45d2-b2c2-6d956a0ec07a"
      unitRef="usd">-168000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i05844d0d291141408b4c5e911aa1a773_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTAtNy0xLTEtNjgzODI_4adb8445-dcf0-41a1-8854-8d89f15e11dc"
      unitRef="usd">-207000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtMS0xLTEtNjgzODI_f68f6c40-4f9c-4099-aaf8-774831641ebe"
      unitRef="usd">392000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtMy0xLTEtNjgzODI_a37dc0ed-b73e-486e-b55a-3618892eb66d"
      unitRef="usd">652000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtNS0xLTEtNjgzODI_47436938-b389-43bc-86e7-f1e3fb35e374"
      unitRef="usd">1293000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTEtNy0xLTEtNjgzODI_f13e0ac9-eef1-4579-bc82-36ffac3e1eb4"
      unitRef="usd">1845000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItMS0xLTEtNjgzODI_88080f73-0777-44dd-9e01-2eb2dd483743"
      unitRef="usd">-41000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItMy0xLTEtNjgzODI_51f3a2ed-df02-4898-8961-1b2170f7a375"
      unitRef="usd">2000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItNS0xLTEtNjgzODI_4c7e7711-f6d0-46d6-b9e0-460e9d74a940"
      unitRef="usd">-167000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTItNy0xLTEtNjgzODI_6a516a5c-7282-42fa-889f-df4c91f6705a"
      unitRef="usd">252000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtMS0xLTEtNjgzODI_65ddfe60-a419-46c0-8b62-c6d24f5024a7"
      unitRef="usd">351000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtMy0xLTEtNjgzODI_32918cb4-da4d-43f7-bfdf-47037ef6132c"
      unitRef="usd">654000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtNS0xLTEtNjgzODI_32dc352d-ccdb-433e-bb21-8bf22ebd449c"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTMtNy0xLTEtNjgzODI_99a4bfd9-da23-474d-a508-fd5ae04d899a"
      unitRef="usd">2097000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtMS0xLTEtNjgzODI_151987d9-ecc8-4563-a6a2-76c814f46a34"
      unitRef="usd">81000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtMy0xLTEtNjgzODI_9e76fd08-9f6f-4115-8202-a2fa10e4fece"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtNS0xLTEtNjgzODI_ab827632-f527-41b4-ac80-1d39be642727"
      unitRef="usd">268000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTQtNy0xLTEtNjgzODI_6680b582-d998-4251-b199-733ff2eb2dcd"
      unitRef="usd">483000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtMS0xLTEtNjgzODI_0c8925c5-7333-467e-952b-a62c47feca2c"
      unitRef="usd">6000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtMy0xLTEtNjgzODI_e2c0aa41-f9f9-4c9a-bbce-e8f546c47117"
      unitRef="usd">26000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtNS0xLTEtNjgzODI_cfbd7f53-7950-4ec3-93c8-e6cec3b60275"
      unitRef="usd">41000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTUtNy0xLTEtNjgzODI_e7a97980-092c-41b4-8123-ecdce68b9aaa"
      unitRef="usd">53000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtMS0xLTEtNjgzODI_7e2749fd-c906-44b7-9045-683f14963fab"
      unitRef="usd">276000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtMy0xLTEtNjgzODI_48491f4a-1e1c-4f0c-b3bf-a6d99a443b9e"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtNS0xLTEtNjgzODI_61431ae7-0fde-4acf-ac90-c0f9b29996b7"
      unitRef="usd">899000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTgtNy0xLTEtNjgzODI_5084862b-0006-4aa8-9a45-2a0524b8c18e"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktMS0xLTEtNjgzODI_5c515df2-d40b-40ca-b776-2121828d00ca"
      unitRef="usd">20000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktMy0xLTEtNjgzODI_97549feb-1b39-40e1-a781-c6820d95f740"
      unitRef="usd">22000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktNS0xLTEtNjgzODI_12d66b37-92e7-4365-8110-154c29fae806"
      unitRef="usd">54000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMTktNy0xLTEtNjgzODI_01c5b90e-4a28-4d85-a446-bc805819e641"
      unitRef="usd">62000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtMS0xLTEtNjgzODI_750f8746-396d-44d7-a064-34b8c1293e17"
      unitRef="usd">256000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtMy0xLTEtNjgzODI_e586363c-46e9-475e-b01f-b94161abfc0e"
      unitRef="usd">505000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtNS0xLTEtNjgzODI_bc876f59-ada6-40b2-9f27-50b29033e5c5"
      unitRef="usd">845000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOmI3ZDBmMTgwOWI3ZDQxYWViMGNhNjNlZTRmNWNkYjE0L3RhYmxlcmFuZ2U6YjdkMGYxODA5YjdkNDFhZWIwY2E2M2VlNGY1Y2RiMTRfMjAtNy0xLTEtNjgzODI_7f2148d1-1c24-4280-af40-d1c4dfe3f735"
      unitRef="usd">1605000000</us-gaap:NetIncomeLoss>
    <dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RleHRyZWdpb246MzYxOWQxMDQ4YmE1NDdiZGI5MGZiY2JjNmEwM2QwNGVfMjQyMg_ac4e16ff-9473-4ecc-9697-e4a232950da2">Net revenues by major service were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fc81340b331406aaaa1e47f50446a3a_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy0xLTEtMS02ODM4Mg_a291ea36-c433-4db9-89e8-9e5934a3da4e"
      unitRef="usd">1119000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2262f05753a4ec9afdc14f6b0ffdd09_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy0zLTEtMS02ODM4Mg_969b5619-7755-4051-8d24-8287714d269e"
      unitRef="usd">1210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ba791edd92545c5a2aef512c9a4b212_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy01LTEtMS02ODM4Mg_bc507ca3-e065-41ea-ad6f-08f5ec0f2c52"
      unitRef="usd">3283000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3982f629690f495cbf0e0ba3db8ad100_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfMy03LTEtMS02ODM4Mg_7a7cf7de-8491-4d02-813a-d10b196310d5"
      unitRef="usd">3392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b2ec2a973ec44539d673cf6d99f87ec_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC0xLTEtMS02ODM4Mg_9e2384d5-6609-4dc7-b2e2-23fc1b2730ab"
      unitRef="usd">316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfa3c11aef7e473182161c33c456b37b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC0zLTEtMS02ODM4Mg_15989171-094e-4c1a-b3f7-1395952ea7ba"
      unitRef="usd">709000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaeb59228d7c345f18c522deada6d4507_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC01LTEtMS02ODM4Mg_efd9adfb-8bf5-4532-a75f-12cf8a5e995b"
      unitRef="usd">1270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf3b88fd5ccc4285a63afa1e6f852f11_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNC03LTEtMS02ODM4Mg_77c20633-141b-4f13-b0cf-725429ca5fd7"
      unitRef="usd">2048000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i882d231dd7374595abf2c323937f41ba_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS0xLTEtMS02ODM4Mg_987e48c5-1788-4b11-a738-4f979714ca48"
      unitRef="usd">835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33932a80efde433c898a298b0df7e2c0_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS0zLTEtMS02ODM4Mg_092d4da4-0be6-4e10-9fed-0e45c294d75a"
      unitRef="usd">646000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d4b2c0774334fd9bff7edabc3b2f8d4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS01LTEtMS02ODM4Mg_8dabda31-6f4f-49cd-988e-60d8835f8b2a"
      unitRef="usd">2361000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id771340b26ba466d84857e28e997aad7_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNS03LTEtMS02ODM4Mg_8f9d5846-c7ba-45d3-9fcd-bb7b91f10ab4"
      unitRef="usd">1972000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5981a21f65c64729863e38afe9d108b6_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi0xLTEtMS02ODM4Mg_33f8a70f-f271-4bfe-a6ee-0429ea83812f"
      unitRef="usd">149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d569efaaa7146efa0ff3406897b8dbc_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi0zLTEtMS02ODM4Mg_c582df19-f0a8-4955-96f3-accc82e7c2c7"
      unitRef="usd">138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c9489e8daf9452f86f8ce2d6e8b66d4_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi01LTEtMS02ODM4Mg_7e6313d9-2f76-4c8f-8b6a-c0d01586b099"
      unitRef="usd">430000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70c6fc5be8aa4490a60a9c8eb3f467ff_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNi03LTEtMS02ODM4Mg_8cb2c6b1-7145-4bb6-88a6-22b922bef9f9"
      unitRef="usd">408000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b74cfcfe6b74088a041cf19f39f8bfd_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy0xLTEtMS02ODM4Mg_a7f917c9-0a0b-4c82-86f3-84c09ac4fd75"
      unitRef="usd">67000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifac9122b4d044d2aac6ae108cb25b79d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy0zLTEtMS02ODM4Mg_a0a1d20f-d666-4554-ba18-bfbc5b38bd1c"
      unitRef="usd">71000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a4fa9bc40c5420697f812025c278d5f_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy01LTEtMS02ODM4Mg_e05c783d-2cbe-46ee-8cfa-3423251d757f"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2463ba51e264dbbb561f3ebd2a7ae68_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfNy03LTEtMS02ODM4Mg_3018cda7-e343-4f69-9dab-236ca7238935"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC0xLTEtMS02ODM4Mg_6b963640-1b64-4596-ab38-f00fe408a2bd"
      unitRef="usd">2486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC0zLTEtMS02ODM4Mg_6af83162-66fa-4b8b-ae0e-b0598a6bcfe0"
      unitRef="usd">2774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC01LTEtMS02ODM4Mg_fb4b14db-850d-4ff9-b716-2d9ec7c73f64"
      unitRef="usd">7550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82NC9mcmFnOjM2MTlkMTA0OGJhNTQ3YmRiOTBmYmNiYzZhMDNkMDRlL3RhYmxlOjg5ZGJmNzBiNzE4ZTRhNGE4ZjY2YWJlZGE1MzM4NDNjL3RhYmxlcmFuZ2U6ODlkYmY3MGI3MThlNGE0YThmNjZhYmVkYTUzMzg0M2NfOC03LTEtMS02ODM4Mg_8d6fb942-39e3-47a5-a5e7-0be6b2fa0889"
      unitRef="usd">8044000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfMTYwNw_0a028e8a-f61e-4a69-9788-0ad9e75a71b7">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for over 95% of the Company&#x2019;s total net revenues for the three and nine months ended September&#160;30, 2022 and 2021 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Revenue and Net Accounts Receivable by Customer Type&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i6780bd5df0e2405c8a5497be06f79406_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_0f14eacf-e8e1-4c59-9b28-78e16dba5b07"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i778d30c2a5f04d5bbd79b50d49dff45b_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_a6da3724-1d21-4b4b-a9df-a643c59fd9fe"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="id4bb02bf9fa849cb99832a402efd5409_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_d74171ff-15d5-425a-9faf-ddd0ebd8e053"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="icafe184efc93430796a2beab39669d01_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfOTk_f21178b8-4211-491e-9ba0-6c59e65641c8"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfMTYwNA_b15a7aa1-efe7-49da-aac3-45040b85c62f">The approximate percentage of net revenue by type of customer was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i229509c7231549db925bf29fdce1531d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy0xLTEtMS02ODM4Mg_54c8845a-cda4-4abf-9f43-eebfb04ec637"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iff5758981e1444b4b9fd02f8aa63d7bf_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy0zLTEtMS02ODM4Mg_1ca30e8f-f169-48bd-9dcc-e450d213dac5"
      unitRef="number">0.41</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ice963a3c871a4964b7fada36abe521f5_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy01LTEtMS02ODM4Mg_6777704c-8c23-434f-9cde-f011e3200504"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ibe66bde611c3455b968735afb276accc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMy03LTEtMS02ODM4Mg_be2130bf-1359-4308-b1c0-dd1a0bf44fae"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="idb2da7bb5bdf450d94c7cb844900e0b1_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC0xLTEtMS02ODM4Mg_63aeb50a-b28a-483a-9ac8-947663ff1aa6"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib9ec7b61dbc848dc972c1fd56b0ab080_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC0zLTEtMS02ODM4Mg_eb7bb871-9ac5-4da4-b080-a4c4902e741b"
      unitRef="number">0.02</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iedddff22ba5b4fb0a008f2787a6212e5_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC01LTEtMS02ODM4Mg_28dfe9b4-bf7d-46ac-9fd9-8b6ee41014e4"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iee7efe5928604ef39c7c110d8e85cdaa_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNC03LTEtMS02ODM4Mg_bc3e67fe-ead4-4f69-82b3-ca5551463e63"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0dee333059084814b53e9d3f76a165f5_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS0xLTEtMS02ODM4Mg_b0cde1f9-2da4-42f5-b4a9-642fd7e6db12"
      unitRef="number">0.42</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie8f803ca658f4d9ca283e32e2641679d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS0zLTEtMS02ODM4Mg_c5c386ba-9827-47d7-92a3-40af37e268f7"
      unitRef="number">0.43</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0abea2ff94d74055876d608a5384541f_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS01LTEtMS02ODM4Mg_25994741-52f1-4f07-9c59-cab5db672cea"
      unitRef="number">0.42</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0c844b73612e4d969c32144072e69482_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNS03LTEtMS02ODM4Mg_1c77a672-f4ae-40a5-92f7-a04205dc27f8"
      unitRef="number">0.42</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i70b790ee8c6b4795a8b810a63f6d3fbf_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi0xLTEtMS02ODM4Mg_631becbb-89d8-4854-af43-9a2eb01c9da5"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="icfc6ae7ce5004bf1a030a03d500851b6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi0zLTEtMS02ODM4Mg_f538b8e0-6a42-4a61-9fb0-8d0785703178"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie972687548c145bea8a73606c134780f_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi01LTEtMS02ODM4Mg_a881ddfb-fd2f-42da-b62d-31fe7ee9bfb5"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ic36a1aa9ec14411bbb9b140920cd721e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNi03LTEtMS02ODM4Mg_89eaecaa-e1ae-4e7a-be90-27b5a22df402"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="idb786a9417bf40a9a53c78abcd60b86a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy0xLTEtMS02ODM4Mg_fb37a8e2-e913-42a9-82cd-1c13304362d5"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia5ab3f4c5668458b9be3e667d579e95d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy0zLTEtMS02ODM4Mg_f3871121-1c88-4542-af88-43202154d01f"
      unitRef="number">0.31</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0a3b7e0a1ab747b4a88ba384b9c6f5e3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy01LTEtMS02ODM4Mg_d3cca410-1591-4002-a948-2714e15ecb68"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if614926c685244ce8994f73e3407170e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfNy03LTEtMS02ODM4Mg_db3f681d-c0bc-4eea-a77c-2a3a3fc1b3f1"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i40c24d1fe9e0422f98322342e1b600dc_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC0xLTEtMS02ODM4Mg_7c4742e5-c477-4938-8fa9-b985661a30f9"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i80681a5902484c9794b52f9ce9a0fe75_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC0zLTEtMS02ODM4Mg_7e25b426-0904-4d23-a4f6-b992225ba952"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i36f1feca4ebc4193a027d4329c6dbdb5_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC01LTEtMS02ODM4Mg_c7fec2b3-ce02-474a-9475-cbc24c3a2662"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie2ee8ab6bcc5441f948edbcabba5af31_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOC03LTEtMS02ODM4Mg_c5f3eb26-1e33-45e2-ba01-84f6cc84ffad"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i35233092ea214d52af667521fd4f34ba_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS0xLTEtMS02ODM4Mg_c2a7dc42-a013-4f48-983b-e78eda19000a"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i367b99cc6dc9477ba41d1ebd11ff5877_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS0zLTEtMS02ODM4Mg_ce790de4-a791-4789-aa4e-abb9a12ca037"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ic0dd7c3573144231886b6a6cf9489411_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS01LTEtMS02ODM4Mg_6fe64b3e-4013-4402-8c15-1a2be9f2555c"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9268b9f59a0f4f1a9911e0a6e7ea8319_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfOS03LTEtMS02ODM4Mg_c7c9857f-1cd8-49e2-8777-ec5ea987714d"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib2443278408344ab88c125996c678332_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtMS0xLTEtNjgzODI_5bfe9895-e93f-41d6-9111-c8825376b1de"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i5550fc4948864d109a0e41c607884cf3_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtMy0xLTEtNjgzODI_e41f0312-8ad3-42a1-91b0-e53b4d8d7706"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i1f4871ad170844a7986509f75afcd399_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtNS0xLTEtNjgzODI_de00dca0-d0fd-4ae9-8427-3c50788dccde"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0ea4dfa98d0b49eeaaccda4c4ae455f7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTAtNy0xLTEtNjgzODI_004b2e16-b388-4611-83bc-ce46cbdffcc6"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if883c75ce2ae48428a8545f972fa559f_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtMS0xLTEtNjgzODI_627397fc-80e3-4e4f-bd47-b4554722d2b4"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ibe4eee14ceb04b16b73ae1dc1ae61536_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtMy0xLTEtNjgzODI_acf751e2-158a-4796-89a9-588b29b5650f"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtNS0xLTEtNjgzODI_fde95081-75dc-42e6-9a0d-aac199e1a366"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOjFiZDlkYjdhYWQ5MDRkMWM4N2Q1YjZhMzU5MzY3Zjg2L3RhYmxlcmFuZ2U6MWJkOWRiN2FhZDkwNGQxYzg3ZDViNmEzNTkzNjdmODZfMTEtNy0xLTEtNjgzODI_e2b107d9-e4cb-414e-8dab-eac88e166bfc"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RleHRyZWdpb246NDc4NjdjMDYyNDVkNDk0ZmIxZDk5OWE5OGMyOWE5MWZfMTYxMw_4bede27e-f4b7-428b-99a5-8f733cefe398">The approximate percentage of net accounts receivable by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ice796a3655d941feb767f6c8fe65158b_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMi0xLTEtMS02ODM4Mg_61a0f0ba-5445-4eea-a704-9508ff6e1a64"
      unitRef="number">0.28</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i4e911465833a4a6798f86e6b37692664_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMi0zLTEtMS02ODM4Mg_e9148dea-6a1d-4e62-a0e2-10f77862dbff"
      unitRef="number">0.32</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i95ec2390c17341c28ef60e2177b55f77_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMy0xLTEtMS02ODM4Mg_30184065-f60a-4886-bf85-d63a5f226421"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i56774b5505024ca583c3885fc53e3512_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfMy0zLTEtMS02ODM4Mg_b488e089-9412-4dc0-9091-fe965f169f4b"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i2e9c25981e2a4d4bac14a20a91cdad7f_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNC0xLTEtMS02ODM4Mg_fd9a16cd-4d3f-46a0-afcc-01b591c15d26"
      unitRef="number">0.43</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i2ba474b936bc4d4ab84b4dc85c5d37f6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNC0zLTEtMS02ODM4Mg_b19cbb98-3627-4234-bc6a-56f6c9da7d58"
      unitRef="number">0.38</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i56d1825da4ab49a8b78821022de2b6e8_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNS0xLTEtMS02ODM4Mg_0d8c9d61-12d5-4d1c-837c-3b7b36ebb22c"
      unitRef="number">0.19</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i9190b150986345cd97cfc2aebc94c2c3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNS0zLTEtMS02ODM4Mg_cce9705d-111f-466a-abb0-aebbb7d62797"
      unitRef="number">0.21</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i5cef2104bcc84b258c94c1efe866d9b3_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNi0xLTEtMS02ODM4Mg_6f461d92-afd4-4aea-b9e3-01520ca6cb79"
      unitRef="number">0.96</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i913e83ce0c8349688375d506afd9d9ea_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNi0zLTEtMS02ODM4Mg_0fb55dce-4f82-479d-8a72-b7f1c8c05fbb"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ib54a2680ca68495bb80170fdfa0a42bd_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNy0xLTEtMS02ODM4Mg_f62e9d49-8461-4c5d-9917-7d55e7f3ab98"
      unitRef="number">0.04</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i50a1c819b1b44a4aa7ad7742dca1f94f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfNy0zLTEtMS02ODM4Mg_eb2bedb1-31be-4899-af0f-0fcc062238f3"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ib247069292a644faa219725ce24814d2_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfOC0xLTEtMS02ODM4Mg_5b9a0d6e-e4ab-47c7-b4fc-a8d8bcaf7b5c"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i0339863356d84ed3995b604e24b5634d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV82Ny9mcmFnOjQ3ODY3YzA2MjQ1ZDQ5NGZiMWQ5OTlhOThjMjlhOTFmL3RhYmxlOmUzOTYwMzJlYmY2YzRlNjlhZWNmNGFjM2E4NGIwYmQxL3RhYmxlcmFuZ2U6ZTM5NjAzMmViZjZjNGU2OWFlY2Y0YWMzYTg0YjBiZDFfOC0zLTEtMS02ODM4Mg_9cc68e10-c37d-4f3b-8c3c-674093030fb4"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfMTAwMw_aade7aac-425e-4f65-8947-5c5cf5a0a369">TAXES ON INCOME&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2022 and 2021, the effective income tax rate was 23.8% and 23.1%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions (see Note 5).  In &lt;/span&gt;addition, the effective income tax rate benefited from $10 million and $15 million of excess tax benefits associated with stock-based compensation arrangements for the nine months ended September&#160;30, 2022 and 2021, respectively.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNTk1_74feac62-f48d-48af-b31d-a23acf972eb8"
      unitRef="number">0.238</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNjAy_ad8a286f-7e1e-411c-a0d8-48cddc251f87"
      unitRef="number">0.231</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i33d1ee32d81244fcbd386f76884c5ada_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNzI5_e72fd4d6-ee7c-4d59-a5fa-2e76a130d2c8"
      unitRef="number">0.176</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i08caf8d530cf43008af3a0306e3e477c_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNzc0_33f5175d-7a84-4283-971f-2d2c48fa5c4e"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfODg1_59761e71-8195-4405-ad69-d51bfab826c2"
      unitRef="usd">10000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i3b66f8aa13e54282b0ffe80c7b6ae25e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV83MC9mcmFnOjU4YTUzZWFkMmIzZDRkMTc4OGE4MTNiMDI3NzljMzcxL3RleHRyZWdpb246NThhNTNlYWQyYjNkNGQxNzg4YTgxM2IwMjc3OWMzNzFfNTQ5NzU1ODE1NjA4_43636ac9-6f35-450d-b5de-8411723920c7"
      unitRef="usd">15000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ie411d34972bb419285874be10c5557a1_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV80OTQ3ODAyMzMyMTcw_caeecb82-874b-4679-8e26-4654e2e003b4">SUBSEQUENT EVENTS&#160;&#160;&#160;&#160;During October 2022, the Company amended its $600&#160;million secured receivables credit facility in order to extend the maturity dates for each underlying commitment by one year while decreasing the aggregate borrowing capacity under the secured receivables credit facility to $525&#160;million.  Under the amended secured receivables credit facility, the Company can borrow against a $425&#160;million loan commitment, half of which matures in October 2023 and half of which matures in October 2024.  Additionally, the Company can issue up to $100&#160;million of letters of credit through October 2024.  Borrowings under the secured receivables credit facility are collateralized by certain domestic receivables.  Prior to the amendment, interest on borrowings under the secured receivables credit facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread.  Subsequent to the amendment, interest on borrowings under the facility will be based on either commercial paper rates for highly-rated issuers or the Term Secured Overnight Financing Rate, plus a spread of 0.725% to 0.80%.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id12e6b7fc3d84f40ab1168ad2af450f4_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8zMjk4NTM0ODg3MDU1_acd418d0-543d-4dec-a1d8-db794190a0f2"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dgx:DebtInstrumentExtensionPeriod
      contextRef="ie53b722a57ce4b9daa9771d76111e184_D20221001-20221021"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8zMjk4NTM0ODg5NDg3_e4ea0347-6229-4018-9eda-2ff85a51f4cd">P1Y</dgx:DebtInstrumentExtensionPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib0810507aff24122a43695ca80ce0367_I20221021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc2NjYy_9caa5331-1c00-4e21-8d54-5cf623ff54b6"
      unitRef="usd">525000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ife2cffd951d24830bd6a215df4ae3b0b_I20221021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc4NzE0_3ce435ac-788e-400c-b36f-d52cc5046fa4"
      unitRef="usd">425000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9cee0dfd60be4a578a2484c1cd2ed559_I20221021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8zMjk4NTM0ODg3NDc4_93400d3f-1824-41bf-8aaf-5d7047f20544"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2cc95a9c78fc4bcb85da10d7ada37895_D20221001-20221021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc4ODI1_29969679-e45d-4b3b-8468-2f3f5517346a"
      unitRef="number">0.00725</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i04cac7194168497fb90bd4b4e067a6cc_D20221001-20221021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMTA4L2ZyYWc6N2JkZmJkODYyNDM1NGIxZDk2NjFmYWI0NTJjN2U2MzUvdGV4dHJlZ2lvbjo3YmRmYmQ4NjI0MzU0YjFkOTY2MWZhYjQ1MmM3ZTYzNV8yNzQ4Nzc5MDc4ODE4_508670f4-7048-4085-9441-1ed1d0b8d83d"
      unitRef="number">0.0080</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i973ec05c00df4ad6a2a4472b1d8d2332_D20220201-20220201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzOTZiNmNjZmI1YzQ5MmZhZTkzZmZhYjMxOWUyYWRhL3NlYzo5Mzk2YjZjY2ZiNWM0OTJmYWU5M2ZmYWIzMTllMmFkYV8xMDAvZnJhZzpkNDYzNjI0NzczMGU0ODFiYTZkOThkMTVlMjY4ZGVlZC90ZXh0cmVnaW9uOmQ0NjM2MjQ3NzMwZTQ4MWJhNmQ5OGQxNWUyNjhkZWVkXzMyOQ_db8c068b-d673-4053-a757-aed7c784a536"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>63
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M'D^A/SNRHA["(='2(M%:'JE +1KO1,GG(/;L"<8U[WZV@A["';'2';%:[J@
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MQP-XO\JW2_,3+5?9CN-,:BVC[' IN"^4>0#NSZ74VQ/S@F+3>O0O4$L#!!0
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MV@AR2[XE2WGU%STW6&N$ECLN6-8,EC/(DKS^'[\T@3@8('G@ :090-0!3L\
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MPT(\GKJ: "#;\WH4=W86&^U7TV1SEI]VC?;G];OZO!VL!D ':7T'X)'V2@T
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MPW=U5.H<>77>V5UR0 &>D5CQ1!B22JTY6II&#05UC4V+$%<X+A6.?[.22ZY
M5QECT6,16T[UT8+G?"G,,:9VW-#2']3D-DVZXY9$F92")U[!<R/C7UT+QH2
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M%H$5\:@?>2XU6V*^/6,1IO7K:A&;-K45]Z@??#<O[5-0U0@'PW%#-V(U&K0
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M\7Q\0O_>VTZV[)C!=TI\X9DM9L$H@ QS5@N[48</>+2G[_!2)8QOX=#(=J,
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M0=\_J)T [>=*V=/$'=!^4<W_ E!+ P04    " #G@U553-_<P7H&  #=#P
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ML%Q9FV^P% ^P2)#[C[L8<^2"O'Z$!E2#'4 %>O9GXWT+R@0$FM\U<"!QN"^
M:<<Y@2N:.%2.N_HCNWQ4^V]5N>$3?.P_F#W<E^<QQ=*9K%20.E'C*V!=&) L
M)%:!7)SW.!'(/4):$\V2< J&=,P$MBU+ZX+ZFWFP1H%) ?C+6@/;DMC.Y%!L
M23JP!;--+&N'!#GP#J1"?3I:29>W^5Q*Y<1:ZCIJAGMX/!">2+RQ@<11<BLF
MVT<*B0WS*<ML;1@X5VX-DKN&WCNYDD)A8UTVTCAJ*,X\+@Y9\7U4VI!C.F?6
M@11Q>K>% 9=VM;KSD%4[+[7U'(,<,D,QKZM*1U*C%M"A1*P&[G08)VP#-68R
M]46AH-R$L0%9(2/BF# I:_$$M#KTL?:\_1BHI,;P'-M$7]SKSS\E=EBM\H2_
M.]L';#!(G^+?54P7A!V=E,ETG5."0M<5[DEX[[>&W(J#"+2XVG $ELZ6C:<M
M*1K2\Q#=A\_)P.DJ;'&/">C5A?4=;;KI@FSQ.G$*N;+ SF='%6[U2&^)4LAC
MK2":W*V@9"-+ORZ5.&9R&T/V&1-&+;>17YXJ"92) BL30PLF(1P-HBX\'7CT
M5(36-'?&QH>;N>&<QGPV#11:7Z7G\FHN%LV5X]]JK)4#W%6: #L"[5749#KD
MP7U)&6(#0Y-9G-R3FY.;)Z^FB.D+V%Q/*5QX>B47@= Q+I5<&8M"R'P[WYM7
M<;;S:-L-HPRW"Y6!97FG)=#]+4)L>;Q@;',K$'P78L>J8NL54FM2'VSN"?X&
M!<4<<[X0%]*!S48.X*N[L7ZAK0/-HX5?"%\?2@[BHF/T]S2$K@7(;YN,0W&Y
M&VP@/Z9;NN=R2'*!6VI(V6BOJC>ST4Y2Q5[?=<9-;Q#S_MY(,YF+0P4,:\G*
M=Z[^[%:1K\;#+?,.RI-..:>=LC*X2R"3[=QBP?&MQ\2&T77/NV\U688[9AIP
M/#WSOP O-B<P*(_5BGL?7NSZ7-L1S7WM+C4FOS=[\?9_G&2W7>='>Y]<"/@J
M?E@R3LRK]/75[7;?KF?IDVTGGCY\7TN0&C6B:0G5\?#Q82]=.]I%L%7\@%O8
M@.S&1]R= 94%\'YI@;-9\ '=%_WI/U!+ P04    " #G@U5535D[*0$$  #!
M"   &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6RE5FUSVS8,_BLX+=NU
M=ZYE*T[2I;;OG+1;_:%+6F_=A]T^T!)D<:4(E:3LY-\/H/R6-<EVMSN?)9+
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M4=F\D]HR@^27=B-#3]PFV_7$\ZW)I#VT:NBBSK$=)*PT(.RSU5K,52:KH'A
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M=W?7%S<7MX_C:S@?/US!Y?6W'W LLN(,OCU>7=S#=/PX'C0L&6.51K0"GE3
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MZI]VVU[E1;VQJG"-SDQ9:IO<,J$^%34+T/E<*5MOV,"Z\QW]#5!+ P04
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M[==B9J;;:_AY97O-R4"*/+<65+R("TK&'7W;P _9=_AY[V"8WGCJG^C7B;_
M!?A]%1T5O.0.K%RRYRQQTV/RE-$GIFI;:9:22'GS7/T7HB7"-_2Z P>V A+_
M>'9QHM[:[)'"%5O/KE8A>9:>;ZC!8,WE(QF:>3U'0J>Z4/)9 ^HD#B<4TCK>
M2<S6(H;3@I'8R?GIB:*&!24?!8**W1DJ4TUF>]^I7X?.J$>$ (Z^7\Q\V',I
MX@WA6Q\-0L!<ZN;;<QVX_@A(=?CT!H! #PNBNW]PTAI/*4:=X^<*L8TN+C>&
M)X3^K]4#<O?CPQ?$&G\\>O$0J8:"CFPWEY&5^+Z/0_OHZ:%Z^_94^-$$2@%"
M-LXC1=9J /9G&KJJ3&#7RN0YL,(UN&[A;O&*ROS)L$;'IXY8\&>\Q[GV0 6"
MAHZ^5P^(AX+16W28^=^?>!08Q?GKTG1 [ 7*HP[%5B9LQ;^X.6^35J.2F&5D
M():45R[->R7SKJR',#NUEW+ 75[@Q-V.'HOD^W/%Z=4*#(!JTB!@1C/4,X@C
M&XO+/S#[Z_U%1J$5L+WJ!L*9DD&6NOM")F( 4:Q[N%!M\I>2VI1'$=>4379N
MQE"G$31,DJ4-89-/%*("/5)V)V"31=A'&K=,/>MSE+I+A70[/XL2N%0C?/62
M,2431K9!WS%5#IO4FTRDF^!V6XC=N92JE_*8LK&(W^BE0_9TE-=':,TS"]+L
M%<HT;Y"-1>@U9V+==8Z B"3JWW6'A?P8W$"P#=X8D_]-B9"+(EG2#WU$/%.N
ME&I5/)QJ]02N4XIBS0_@W WA#Y3D785V#A'NDDL89-9_!6)GC_F@.].P_\-!
MT/FD,E]D<)2L+JR,]\EH%1N<3<:<X1DB,Z)=([@J?:R3:-XN*RT#A]Z;;[$+
M-B_!C.T6]X0;7!W> 8BU4LIRUB[*3'+ =B9388Z=96BW&0KT<0O*&;,>ZZ33
MY-VZ1NS;%*VU13H#TF2@7' I")<R.1R"ZXQ6EX1;(B<M[-R*'P@" '?H./TU
M\6=;%A+\=\DW<X]SMP- <[]JM%G^NL  8POE+L6/YG6T4-&HC!>BWQN5E\(0
M/7R7D##A&&8^%>[TB W,4/J:.JW),,Q@UMV<N3&"D+ZD!1!UYR"2%A>-H?,=
M("G*+/?N;K7BBI$35 ;+!!]31W5E \T1S!=!3+/42]U$[:HAM66CQ3)^9V]%
M<Z09!? F.R@MI.G[=Z,6';%W%X@$]!D_40?$_7H!NP1WW/N]##Z*]W,-AXC4
MM@1$#?E(RI5CB;:S <0]VHG?Z2$ I + ^$"];WBNWMCJRT:WZO+^LI!%?G:^
MQJ9_8!6W%07#^!^6*VRBN;9-]327,K&^JW@<Q/Z<8!1/,/!5!BO;T(R<7D84
M&PU="4"CEMSC\V^#)5JISN#3QJ#IW]Q  ;G^-V"'>$$4<&M1O@>#E3KH\53
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MW(7:^3[]D52OHCQGSYL%P0UPSBP[*5%Q3\DZP9'[S0%TD*#6[K.N)*86TF"
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M\=F]#0<,PA@U4"7UCP[6?\B[0?/9>);V>ST$_'3\N;QJF25V(TM^*O4SNEW
M0SW3WWDBW=62Z>A0](DPM'B^J=G<QZ?AMYF!*(/#_X'9(P*<%J?[#9O#ALGG
M:&@1^=Q[5;?U'@R&9N%M'P]O\5._$J]F5S\HSNKWZ/7V^M?(9V5GB(8RGL*T
MMW?PKD.V?L.O;[PIPUOUQ'C($2Z1Q2A^V8#UJ4%';&[D@-7/K-$_4$L#!!0
M   ( .>#557]+BYWI@(  ! &   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;)55VV[;, S]%<)#=P$"V['3R[HD0))V6!YZ6=-=@&$/BDW'1BW)D^2Z
M_?M1<N)E0Y)M+S$I\1P>2B(S;*1ZT#FB@2=>"CWR<F.J\R#028Z<:5]6*&@G
MDXHS0ZY:!;I2R%('XF40A>%)P%DAO/'0K=VJ\5#6IBP$WBK0->=,/4^QE,W(
MZWN;A;MBE1N[$(R'%5OA LVGZE:1%W0L:<%1Z$(*4)B-O$G_?#JP\2[@<X&-
MWK+!5K*4\L$Z\W3DA580EI@8R\#H\X@S+$M+1#)^K#F]+J4%;ML;]O>N=JIE
MR33.9/FE2$T^\LX\2#%C=6GN9/,!U_4<6[Y$EMK]0M/&QK$'2:V-Y&LP*>"%
M:+_L:7T.6X"S< \@6@,BI[M-Y%1>,,/&0R4;4#::V*SA2G5H$E<(>RD+HVBW
M()P9WT^^7B[@YAKFU[.;J\MA8(C4;@7)FF#:$D1["-["E10FUW I4DQ_QP<D
MIE,4;11-HX.$"ZQ\B,,>1&$4'>"+NPICQQ?OX9N+1'*$>_8$%X5.2JEKA?!M
MLM1&T9OXOJODEG&PF]'VR;FN6((CCQI!HWI$;_SR1?\D?'= [Z#3.SC$_B\W
M<I!@M[P_6(&>-)@<01 8>'N#:&\0Z/P-\B6J[A* B=0:_9Z#8):AZR4HVJ,U
M=+2*&82&:8AB_^RH1<1^_ZA'G:NK-KY\]O\G[U_3+5%@5AC"9DIR8$ 3AN![
M 3WHG_HG)(FF@65>T<S:V)J5"#)S]DSRBHGG5QH&X1'(1J#2>5$1G4&JQI !
M'R&"A2QK.UHTO-:(<"U)T_$;'^8"=KV#8*M+.:J5FT4:$ED+TS9LM]J-NTG;
MY;_"VUEYQ=2JH+PE9@0-_=-C#U0[?UK'R,KU_%(:FB#.S&EDH[(!M)])$KMV
M;(+N3V#\$U!+ P04    " #G@U55==1V)J@#   <"0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6RM5DUSVS80_2L[K-.3*]*4Y#BNI!G+42:9:6+7
MBM-#IP>07)&8@ "S "VKO[X+4*)EU_;8G5XH?.R^??L6P&JR-O3=5H@.;FNE
M[32JG&M.X]CF%=;"#DR#FG=6AFKA>$IE;!M"402G6L5IDAS'M9 ZFDW"VB7-
M)J9U2FJ\)+!M70O:S%&9]30ZBG8+5[*LG%^(9Y-&E+A$=]U<$L_B'J60-6HK
MC0;"U30Z.SJ=C[Q],/@F<6WWQN SR8SY[B>?BFF4>$*H,'<>0?#/#9ZC4AZ(
M:?S88D9]2.^X/]ZA?PBY<RZ9L'ANU!^R<-4T.HF@P)5HE;LRZX^XS6?L\7*C
M;/C"NK--WT60M]:9>NO,#&JINU]QN]5AS^$D><(AW3JD@7<7*+!\+YR83<BL
M@;PUH_E!2#5X,SFI?5&6CGA7LI^;+:_GR\7OUXLO7V'QC;_+2>P8UF_&^19B
MWD&D3T"\@\]&N\K"0A=8W/>/F4[/*=UQFJ?/ BZQ&< P.80T2=-G\(9]CL.
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MN/TH'B:?;B8?)Y?CFZ]B?'EY^^WFZ^3FD[B[_3RYG%P_B-=W-M>)5O[-Z2"
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M56D=0L,(PF)Q,-S[6U2&]=I3</%4YN"A1*QEX"O%$NZ#QV$OB.!L\5\**#D
MK^" 8JI<3-[#@WX4;%J!B05*D)-J53@LB$<=*? Y)0NBS8'']!DUJ$69$H&1
MZ#+'CKDRB(H\Y_>(NI5)OAD6]8%D\N(UF68T//DT'M_QSX.3-_L[T.2H19.C
MG3#P#1%Q.Q/7/NB"&&T"DMT4R!'(GE+&5"6S;7$YF9U:"<H_CAE2IK&1[R)%
ML%@](IP;L3B1I4?[4#(>Q*"7LQE!44P&"A+82Q9D9?8>]JL0C^9:3G4.?*A)
MK9Q$&R$7^84Q:LN9R(4"IDF_S6&#<]O$<6JA3%4+0(EJ/!9IQ2BQ.L0!PD"
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M4+, K<^4LLV$"5;/N=%_4$L#!!0    ( .>#554DR%X-#08  *8.   9
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M'T$M!GF(5(9S_62;_B](.<<N))\K="99^/SK4?;U(LJ7W&<-R.!KRPF@UYX
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MOI_<?+0G$W(U_N/^9G+SY\VGCQ/RWN*"^4'R&SDF]Q.+O'_W&WE'_)!\\(-
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M%>#WA1#Z^<8TL#TG.?D74$L#!!0    ( .>#557W[:RO% 8  /PB   9
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MU0_$A]!"W8LI2PQEB9^R^U4/_J [3P<;UG7M,J@F?E37L\5FK3T,'#OJFF%
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MAJ$E:ER"85+1,"EIB)ZAX0W,R//6N+0P_=L^)$IK7J,#KY/HI,,%YI?0:5U
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MDVGKLD^9ZW*)E >K<C^X5\K2&O#BEO8N:J= ]VNE[.'@ M2;//X-4$L#!!0
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M@=N7P3LT\/HR^(<&?M\&P:%!T&B_%ZM1.HQ8-+LL\A=4U)^NT.H73;B:UI7
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M+Y=V:J-R#O9\+J5Y,=Q@:/\#Z5]02P,$%     @ YX-5543!\S9 "0  RFL
M !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&ULS=W]4^)(&@?P?Z6+W=J;
MJ7*$1 %QU2HU[R_JBL[5U=7]T$(KJ0D)FS0Z7MT?OYT0 L&F%W:_5S7SPRC8
MSR>O3]-)GI"SMS3[ED\8X^3[-$[R\]:$\]EINYV/)FQ*\\-TQA+QE^<TFU(N
M7F8O[7R6,3HN@Z9Q6^]T>NTIC9+6Q5GYWEUV<9;.>1PE["XC^7PZI=G[%8O3
MM_.6UEJ^<1^]3'CQ1OOB;$9?V)#QQ]E=)EZU:V4<35F21VE",O9\WKK43D.]
M7P24+;Y&["U?^YT4B_*4IM^*%^[XO-4IYHC%;,0+@HH?K^R:Q7$AB?GXO4);
M]32+P/7?E[I5+KQ8F">:L^LT_F<TYI/SUDF+C-DSG<?\/GUS6+5 W<(;I7%>
M_D_>JK:=%AG-<YY.JV Q!],H6?RDWZL5L18@''F 7@7HNP8<50%'NP8<5P''
MFP''6P*Z54!WUX!>%=#;-:!?!?1W#3BI DYV#1A4 8-= [3.<LMU=EVQ6KVQ
M=][:VG)S:Q^V]]896VYPK=SB[<6^6.[(!N7TXBQ+WTA6M!=>\4N9#66\V'^C
MI$C<(<_$7R,1QR^&#[?7OG,;&.;]\)>?3G2M_RLQ?WMT'_Y%+F\,<F\:IAE>
M7@4FN;F]N;Z]>;B_#0+WQB;NS8-Y;PX?R">#<1K%^6?RA3P.#?+IY\_D9](F
M^81F+"=10AZ3B.<':V^$41R+K,W/VEPL0C$C[5$UN]>+V=6WS*Y&PC3ADYR8
MR9B-)?&&.O[HS^)]=?Q $=\6J[Y>__IR_5_I2M!B3X>DHQT0O:/KLO6A#K^<
M98?DJ%.&:[+5H0X?LED=+INZJ0[WYHDRW%*'A[28^>W+;JO##3:JPV7+[NR^
M[+)P=_=EEX5[NR^[+-S_>QLN^'O+'O[9LL?+G5;K*I+@J.Z$CDKO:-OLB.'(
M>!XSDCZ3(4]'WR9I/&99_@]B_CZ/^#NAR9C<LS$3@Y8GT>PF348B#;-4="/)
M"W$3SD3/PLF_ P$3E[-I_A_)4ETMYN)8/A?%$.DTG]$1.V^),5#.LE?6NOCE
M)ZW7^566F$C,0&(F$K.0F(W$'"3F(C$/B?E(+$!B(0AK=!G'=9=QK-(OC.@U
M&K-DG),9R\@HG4[%44 YPI EOM+:-_&1F+' ^B56'&2]7G0.>[VS]NMZ0N_2
MR-JED2UMI#<;.;LT<G=IY.W2R$>NSP")A2"LL8-WZQV\J]S!+\?CJ#BTI3&A
MTW2><$+G?))FT7^EX]:KA=9;6]5:9_FON<*OE1/>=P=&8B82LY"8C<0<).8B
M,0^)^4@L0&(A"&LD=J].[)XRL8?%AQ3)V&R>C28T9W5>4[XX&5:<;BN&M?15
M'%87XUU9NBNGL>\G&A(S>A\ZHOYQ3]8/F<C)6DC,1F(.$G.1F(?$_)VW>X"<
M; C"&JG<KU.YKTSENRJ%\^+ E6>,YO/LG>3%$>P!>:7Q7)JZ2G/?U$5BQ@+K
MKFW"8_D0PD1.UD)B-A)SD)B+Q#PDYO<_I.Z@*]WNP<>6VD"3-@U!<]A(S),Z
M,4^4B7G/HCR?TV14GE*J3CP_IQEATUF<OC-&GEC"GB-.9C%-9$FJ]/=-4B1F
M(#$3B5E(S$9B#A)SD9B'Q/P%=K*>G8<;9P "69O^1NJ"9JJ1NH,Z=0?*U'UH
M?(R*X3"/,C8FGZ+J]$[^69:N2G/?=$5B!A(SD9B%Q&PDY@P^C$.ZW8W33\CI
M>4C,1V(!$@M!6".MM<[J0G-'?4)K>"^[X'NE#MLW=Z&: =5,J&9!-1NJ.5#-
MA6H>5/.A6@#50I363/BURA+MA[BJ6\T&J@-!:@94,Z&:!=5LJ.9 -1>J>5#-
MAVH!5 M16K,#T5<=B*X>,8Q&+&89Y6+\GV^<-<\/R(R^3UG"I5V"$MZ[2] _
MGO7HRD^,&= IFU#-@FHV5'.@F@O5/*CF0[4 JH4HK9GPJS(P35DR<O&U.&6^
M=L:.I^2I2/H1BUY%'S!/Q/"!4$6O0.A+)H83HE?(">6$?6>C>7%53=I'0*O!
MH)H!U4RH9D$U&ZHY4,V%:AY4\Z%:4&F-3SA=_@D7HJ;<["-6=5^:NO!+-2@X
M*(K!1B+[R^MQ*:?QXBI<W9$L&THK:-03WKM#@):)0343JEE0S89J#E1SH9H'
MU7RH%E3:8*U#Z!R>;/8$H$DV>X)5@9RFKI![#&F>$R^-1+Y_%4D_E]=^JI6]
MTQI:/ ?53*AF034;JCE0S85J'E3SH5H U4*4ULS_51V=UOLQSB]":^V@F@'5
M3*AF034;JCE0S85J'E3SH5H U4*4UNQ 5M5[FKI\[_8M$=W%))HM#QOH"R-/
M[R1I=A1IV4S:,T!+^:": =5,J&9!-1NJ.5#-A6H>5/.A6@#5PDK3],8!B'8R
MJ ]!FCF_*@S4U)6!=7G1<%&E2SFY3G/Y101H#2!4,Z":"=4LJ&9#-0>JN5#-
M@VH^5 N@6HC2FGW JL)0&_P8!P[0JD2H9D U$ZI94,V&:@Y4<Z&:!]5\J!9
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MS'?@6JXOP"_O<?#W?,U%)J?\/[;*E]P#.[=:!Z<\Q0&YZLF%CI/LD?1FK_^
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M8WJ\49H FI\)H5\ZYGVH_PX$OP!02P,$%     @ YX-553_>11)&!0  /RD
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M7M&R!O#?GXIZ T+[I3[!_D7(Z;]02P,$%     @ YX-55=6 =XWI!@  ^4
M !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&ULM9QM;]LV$,>_"N$!0P>L
ML43Y,4L,-!;9!EC3(%F[%\->*#)C"Y-$3Z*=%MB''R4KHJ72-.6>WR2V<OR=
M>"??F7^)N7KAV3_YBC&!OB9QFE_W5D*L+_O]/%RQ),@O^)JE\B_//$L"(=]F
MRWZ^SEBP* <E<1\[SJB?!%':FUV5Q^ZSV17?B#A*V7V&\DV2!-FW&Q;SE^N>
MVWL]\! M5Z(XT)]=K8,E>V3B\_H^D^_Z-641)2S-(YZBC#U?]]ZYE]2;% -*
MBR\1>\GW7J-B*D^<_U.\N5U<]YSBC%C,0E$@ OEKR^8LC@N2/(]_*VBO]ED,
MW'_]2J?EY.5DGH*<S7G\9[00J^O>I(<6[#G8Q.*!OWQ@U82&!2_D<5[^1"^5
MK=-#X287/*D&RS-(HG3W._A:!6)O@.3H!^!J &X/&!P8X%4#/%L/@VK P-;#
ML!HPM!TPJ@:,RMCO@E5&V@]$,+O*^ O*"FM)*UZ4Z2I'RP!':7%E/8I,_C62
MX\3L@7PA=Y\)>B#S3^_O;O^X_72'WOA,!%&<_W+5%])%8=@/*]S-#H</X#ST
MD:=BE2.2+MA",]XWCY\:QO?EU.KYX=?YW6 C\)&M+Y#G_(JP@['F?.;VPUW=
M='[,._DQ[]0\W&>A'.[JAC=BZ=77BE?RO(.GLY0U1: 'MN:9B-(ENDUWM:VH
M$7_]+LW1K6!)_K?NPMFQ!WIV44 O\W40LNN>K) YR[:L-_OY)W?D_*;+&B3,
MAX012!@%@C6R/:BS/3#19_<L"V6V97M!_!FELLEE;,O2#<MUV=VQIB6KZ&;;
MF;SBMOLI.VKA'[4@1RVH<4XG1FQ81VQHC-B=C%$0AGR3BEP&*V31-GB*F2Y<
MPZ/A,KKJ>H4?=4<@W5&3NT9D1W5D1\;(^K>/Z&F3RZ.Y]NHSCNY:6R!A/B2,
M0,(H$*R1SW&=S_$9.\D8,MN0,!\21B!A% C6R/:DSO8$L)-,OBL>SL5TW*J.
M-D:^C1&Q,:+&^9T8O6D=O2E45YGJYC)JA<[HK>L%;^.10'JD6H]C?7MQ';4*
M<JP;#/H/?6!!+%9AD,DRE.:;C&7:2]4,[5J)0&D^*(V TB@4K9GLO26O>\;N
M4\&AD@Y)\T%I!)1&H6C-I&.5= S8A"I8L\P,<*N4ZJV\5ANR8A$K*VJ>Y*E!
M5 * :UQQ=NE%%:DY'SQI1Q!T(6_EDX#ZI%J?'C[0D-3BVS6OOH\W)'F4,O96
M%JZWQ4E&H3X-0 OB*EV0-!^41D!I%(K63+]2$MSA.5L4Y&I^#DKS06D$E$:A
M:,VD*Y'#-:L<'5O42%=XINT"J[,:M)4W*Q:QLJ+F29X:1*4LN,:EK%WAG ?K
M2 1">X?BQNR@\Z<'5&  I1%0&H6B-1.O1 9W<LZ2";3$KY(.2?-!:0241J%H
MS:0K;<0UBR,=2Z9./'"\=LG46N%VR;1A$2LK:I[DB4'$2OS G<2/]WS+LK3\
M+-T'WPY('V9DU\\+*,T'I1%0&H6B-5.MI ]\3ND#@TH?H#0?E$9 :12*UDRZ
MDCXPI/2!=4*$V[X]J;=JU4@K%+%!4?,43PVA$CXPF/"!=8* TU;AS?XZ7_PV
M/@FH3WK,9S/22OC G82/>1P=:42@ @<HS0>E$5 :A:(UTZP$#GQ.@0.#"AR@
M-!^41D!I%(K63+H2.#"DP(&U<D/[V[K>ZKM.9,,B5E;4/,E3@Z@$#FP6.+JT
MHK'%_8FYV5_GR]_&)P'U2;4^O<F!5J04!6Q^;J'5BNYE;6)%T-]$:1AO%D71
M"GE4J$I!&C(4I NT8(M-*"*9#YF:?,W3/'J*XD@.U#]-:SZ#SH4,5'8 I1%0
M&H6B-:\,)3O@Z3F[%^0#$7-0F@]*(Z T"D5K/ORL9!+/+)-TZUX5[,@R2F_5
MOH-LQ2)ZJ_8=9/,D3PVB$B \XUJW2_>J2*WYM&]PF/UU?A3<QB<!]4FU/O&!
M)V8]M>KWS*O^5O?Z&*51LDFT@09:6U<)@:3YH#0"2J-0M&:"]W9CG'4[!NQ^
M#-@-&; [,F"W9)QC3X:GY!'/+(]T;$(#36F9#MLEU,;*M[(B5E;4/,E3@ZC$
M!\^\4>-='",N5BQ#?,VRH/SLY+M/4U$J_4=T4Q7. V$%E1] :3XHC8#2*!2M
MF78E/WBC<Q9,T$TFH#0?E$9 :12*UDRZDDL\LUS2L6#JE(3O[A!;6?E65L3*
MBIHG>6H0E1+BF960+M_:=1LJG$$[@J!*A95/ NJ3ZGUZK6_M_;V=V0G+EN4>
M^AR5D=QMO*V/UOOTWY6[TUO';]S+N:LY[KN79+<+7^%W_Q3@8Y MHS1',7N6
MKIR+L2R^V6Z?_>Z-X.MR7_@3%X(GY<L5"Q8L*PSDWY\Y%Z]O"@?U?SN8_0]0
M2P,$%     @ YX-55><OAC^( P  3PT  !D   !X;"]W;W)K<VAE971S+W-H
M965T-#<N>&ULU5=M;]LV$/XKA%84+9!8+W;\DMH&;"O= BQ-5K?=@&$?:.EL
M$Z5(C:3B%-B/WY%R--N0A:;0EWVQ2>J>Y^Z>$T_D>"?55[T%,.0IXT)/O*TQ
M^;7OZV0+&=4=F8/ )VNI,FIPJC:^SA70U($R[D=!T/<SRH0W';NU!S4=R\)P
M)N!!$5UD&57?YL#E;N*%WO/"1[;9&KO@3\<YW< 2S.?\0>',KUA2EH'03 JB
M8#WQ9N%U/++VSN +@YT^&!.;R4K*KW9RFTZ\P 8$'!)C&2C^/<(".+=$&,;?
M>TZO<FF!A^-G]O<N=\QE134L)/^=I68[\88>26%-"VX^RMTOL,_GRO(EDFOW
M2W9[V\ C2:&-S/9@C"!CHORG3WL=#@#(4P^(]H#H%- [ ^CN =WO!?3V@)Y3
MIDS%Z1!30Z=C)7=$66MDLP,GID-C^DS8LB^-PJ<,<6;Z:?;'S9+<?R"W'Q;W
M=S?D30R&,J[?DDOR>1F3-Z_>DE>$"7+'.,="Z;%OT*T%^\G>Q;QT$9UQ,2)W
M4IBM)C<BA?08[V.X5<S1<\SSJ)%P"7F'=(,+$@515!//XOOA80T\;H;/<M4A
M05@'/\JF6U6@Z_BZ9_AN12(S($M##>!^,A=D3CD5"2ZY?4]%2F9IRNPVH9S$
M3"=<ZD*!)JMO=II+C>L_*UGD^H(@'2]2)C;.$H5GHH"4W.>@J*70Y,]?,0)R
MB][T7W75+,/MU8=KV]"USFD"$P_[C ;U"-[T]4]A/WA75XHVR>*6R([*U*O*
MU&MBG]ZLU^!Z%&X&5S!#GPA*"G42EE1A^0K9SOLX#3I1=SCV'P_%.6,6'IO%
MC8']8-I75=I7C6DOMU3!I>VL*<&T\6NCW6MT0> I :V=#"L0L&;XYM),%L+4
M*5)ZZ1]D>AD&)W+4V5R=:-$8[0]JT:^TZ#=J4>XU%$*N[=9;4@[D'_);1):2
M%^9<<VSD?.EV:I,L;HGL2,M!I>7@_]7U!FV6J4VRN"6RHS(-JS(-V^MZC50O
ME7!8UQO#0?^D'[3D\TB<427.J%&<!U )OKJV'<B= *6W+$>=#* K0[3D:9U*
MC9PO5:E-LK@D&QTIWJOT+B7R#XZ:&:B-.[)K_#1@WR]/<-5J=2N8N</PR?H\
MO%Z4A_O_:,JKQAU5&X8[EL,:*8/. 'N^*H_OY<3(W!UH5]+@\=@-MWCC 64-
M\/E:2O,\L0ZJ.]3T7U!+ P04    " #G@U55KR0BSG8$  !\'@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T."YX;6RMF6MOVS84AO\*H0U#"VR12-^2S#;0
M6 X:(&FSN.D^#/O 2,<V44ET*=I.@/WX4A=+5BIS$7#\0=:%YR'/*QY!KSC>
M2_4M70-H\AQ'23IQUEIO+ETW#=80\_1,;B Q5Y92Q5R;0[5RTXT"'N9!<>0R
MSQNZ,1>),QWGY^[5="RW.A()W"N2;N.8JY<KB.1^XE#G<.)!K-8Z.^%.QQN^
M@@7HQ\V],D=N10E%#$DJ9$(4+"?.!WKILUX6D+?X*F"?'NV3+)4G*;]E!S?A
MQ/&R$4$$@<X0W/SM8 91E)',.+Z74*?J,PL\WC_0K_/D33)//(69C/X6H5Y/
MG'.'A+#DVT@_R/U'*!,:9+Q 1FF^)?NRK>>08)MJ&9?!9@2Q2(I__EP*<11@
M..T!K Q@KP/Z)P)Z94#OK0'],J"?*U.DDNO@<\VG8R7W1&6M#2W;R<7,HTWZ
M(LGN^T(K<U68.#U=/%XMYG\]SC]](?.O9KL@[WS07$3I>_('64"P51"2!PA
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M97/(9]UOSNDG4$L! A0#%     @ YX-550=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #G@U55\A'.
M3.T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " #G@U55F5R<(Q &  "<)P  $P              @ '+ 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( .>#554N* )\R 4  , >
M   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " #G@U55RHX!@) &  !3'P  &               @($*#@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ YX-553*L4;9%
M!   <!   !@              ("!T!0  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( .>#555*0#Z@EP8  !H<   8              "
M@4L9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #G@U55
MLS=27.("  #Y!P  &               @($8(   >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ YX-55;\2JGJ_!@  VAP  !@
M     ("!,",  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M .>#557-/NC4-Q   ,B[   8              " @24J  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " #G@U55HU&9%18"  #6!   &
M            @(&2.@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ YX-555-O"YI<"   CA4  !@              ("!WCP  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( .>#555Q(4&;N0,  %T)
M   9              " @7!%  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ YX-554S?W,%Z!@  W0\  !D              ("!8$D
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #G@U5535D[
M*0$$  #!"   &0              @($14   >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( .>#554B,,PO> L  %DC   9
M  " @4E4  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
MYX-55>_ASYYK!0    T  !D              ("!^%\  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " #G@U55 #ULK\$&  !X$0  &0
M            @(&:90  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( .>#557YX$+/90@  * 6   9              " @9)L  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ YX-55=N'&,Z1!
M!0L  !D              ("!+G4  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " #G@U55J">B\;X1  !$,@  &0              @('V
M>0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( .>#556Y
ME,;GKP<  $X3   9              " @>N+  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ YX-55?JF]V&4!0  <@T  !D
M     ("!T9,  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .>#555P164QE00  &H,   9              "
M@0>O  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ YX-5
M5?U:6RR1!   %PL  !D              ("!T[,  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " #G@U55/#+@3#4#   2!P  &0
M        @(&;N   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( .>#556>U3[U'P0  -H)   9              " @0>\  !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ YX-5523(7@T-!@  I@X
M !D              ("!7<   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " #G@U55D,S/+&H#  !N"   &0              @(&AQ@
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( .>#5561WZIA
M0P0  $$0   9              " @4+*  !X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ YX-553Q-_;R)!P  @TT  !D
M ("!O,X  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #G
M@U55=G=BSYT%   S*0  &0              @(%\U@  >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( .>#557W[:RO% 8  /PB   9
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M970S."YX;6Q02P$"% ,4    " #G@U55J5^,<G )  !86P  &0
M    @($T\   >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M .>#5547U^GW;@(  !,&   9              " @=OY  !X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ YX-5543!\S9 "0  RFL  !D
M             ("!@/P  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " #G@U55158Z^+8%  !^&@  &0              @('W!0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( .>#555EC$]KK0(
M !H(   9              " @>0+ 0!X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ YX-553_>11)&!0  /RD  !D              ("!
MR X! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #G@U55
MUH6#1P((   4.0  &0              @(%%% $ >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( .>#5575@'>-Z08  /E    9
M      " @7X< 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ YX-55><OAC^( P  3PT  !D              ("!GB,! 'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #G@U55KR0BSG8$  !\'@
M&0              @(%=)P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( .>#556X?-N(30,  .H4   -              "  0HL 0!X
M;"]S='EL97,N>&UL4$L! A0#%     @ YX-559>*NQS     $P(   L
M         ( !@B\! %]R96QS+RYR96QS4$L! A0#%     @ YX-55?A\6^Y-
M!   -B    \              ( !:S ! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( .>#5562+*"6N $  .<<   :              "  >4T 0!X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .>#556,3^J/N@$
M .X<   3              "  =4V 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     X #@ /P\  , X 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>221</ContextCount>
  <ElementCount>250</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>59</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107104 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109105 - Disclosure - DISPOSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITION</Role>
      <ShortName>DISPOSITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2111106 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2117107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121108 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124109 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2126110 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2130111 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2132112 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2135113 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2138114 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2140115 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - DISPOSITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITIONDetails</Role>
      <ShortName>DISPOSITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DISPOSITION</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2419408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2425411 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2429413 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2434415 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2437416 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2439417 - Disclosure - TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOME</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="dgx-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2441418 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="dgx-20220930.htm">dgx-20220930.htm</File>
    <File>dgx-20220930.xsd</File>
    <File>dgx-20220930_cal.xml</File>
    <File>dgx-20220930_def.xml</File>
    <File>dgx-20220930_lab.xml</File>
    <File>dgx-20220930_pre.xml</File>
    <File>dgx09302022ex101.htm</File>
    <File>dgx09302022ex22.htm</File>
    <File>dgx09302022ex31.htm</File>
    <File>dgx09302022ex311.htm</File>
    <File>dgx09302022ex312.htm</File>
    <File>dgx09302022ex321.htm</File>
    <File>dgx09302022ex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="802">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 25,
   "contextCount": 221,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 426,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 25,
   "keyStandard": 225,
   "memberCustom": 30,
   "memberStandard": 29,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - EARNINGS PER SHARE",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107104 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109105 - Disclosure - DISPOSITION",
     "role": "http://questdiagnostics.com/role/DISPOSITION",
     "shortName": "DISPOSITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111106 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121108 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124109 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126110 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130111 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132112 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135113 - Disclosure - REVENUE RECOGNITION",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138114 - Disclosure - TAXES ON INCOME",
     "role": "http://questdiagnostics.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140115 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAcquiredFromAcquisition",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i89534177306a427980b6ebbaeab041c4_D20220201-20220201",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - DISPOSITION (Details)",
     "role": "http://questdiagnostics.com/role/DISPOSITIONDetails",
     "shortName": "DISPOSITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ibcef44e271aa4680b8911a11902d9a4a_D20210401-20210401",
      "decimals": "-6",
      "lang": "en-US",
      "name": "dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i85cfff7f104d464ba21b477d5e3fe5bf_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i85cfff7f104d464ba21b477d5e3fe5bf_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i7a5dca9737784233896329b1e173c9f8_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Business Acquisition) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib0b707eca9294fdaa61759b2009a7077_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i46b26dd13b5045219577db6205b830a5_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i46b26dd13b5045219577db6205b830a5_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i0339863356d84ed3995b604e24b5634d_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419408 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i0339863356d84ed3995b604e24b5634d_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i39c1dcdf5ded4bc5be532f869db993b6_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i39c1dcdf5ded4bc5be532f869db993b6_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425411 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428412 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429413 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i191fbddd79df46e9b0198928feb36a29_I20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434415 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i6fc81340b331406aaaa1e47f50446a3a_D20220701-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "if883c75ce2ae48428a8545f972fa559f_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437416 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i0339863356d84ed3995b604e24b5634d_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dgx:PercentageofNetAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439417 - Disclosure - TAXES ON INCOME (Details)",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i8b2ee25f2ed8463cb9acb8e346af111a_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441418 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib0810507aff24122a43695ca80ce0367_I20221021",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ib247069292a644faa219725ce24814d2_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i58732cf05c7043b6a8e12b54db21de24_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "i58732cf05c7043b6a8e12b54db21de24_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20220930.htm",
      "contextRef": "ie411d34972bb419285874be10c5557a1_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 59,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_A401kPlanLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "401(k) Plan Lawsuit",
        "label": "401(k) Plan Lawsuit [Member]",
        "terseLabel": "401(k) Plan Lawsuit"
       }
      }
     },
     "localname": "A401kPlanLawsuitMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AcceleratedShareRepurchaseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Agreements",
        "label": "Accelerated Share Repurchase Agreements [Member]",
        "terseLabel": "ASRs"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseAgreementsMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AcceleratedShareRepurchasesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Payment",
        "label": "Accelerated Share Repurchases, Payment",
        "terseLabel": "Accelerated share repurchases, payment"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPayment",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AmendedRealEstateLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Real Estate Lease",
        "label": "Amended Real Estate Lease [Member]",
        "terseLabel": "Amended Real Estate Lease"
       }
      }
     },
     "localname": "AmendedRealEstateLeaseMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill, Intangible Assets and Inventories",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Goodwill and Intangible Assets",
        "terseLabel": "Increase to the estimated contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationGoodwillAndIntangibleAssets",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "terseLabel": "Working capital"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 Testing Services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client Payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CommercialPaperAndTermSecuredOvernightFinancingRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper and Term Secured Overnight Financing Rate",
        "label": "Commercial Paper and Term Secured Overnight Financing Rate [Member]",
        "terseLabel": "Commercial Paper and Term Secured Overnight Financing Rate"
       }
      }
     },
     "localname": "CommercialPaperAndTermSecuredOvernightFinancingRateMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS Businesses"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DataSecurityIncidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Data Security Incident",
        "label": "Data Security Incident [Member]",
        "terseLabel": "Data Security Incident"
       }
      }
     },
     "localname": "DataSecurityIncidentMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Extension Period",
        "label": "Debt instrument, Extension Period",
        "terseLabel": "Extension period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_DescriptionOfBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business (Abstract)",
        "label": "Description of Business (Abstract)",
        "terseLabel": "Description of Business (Abstract)"
       }
      }
     },
     "localname": "DescriptionOfBusinessAbstract",
     "nsuri": "http://questdiagnostics.com/20220930",
     "xbrltype": "stringItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_EquityMethodInvestmentOwnershipPercentDisposedOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Ownership Percent Disposed Of",
        "label": "Equity Method Investment, Ownership Percent Disposed Of",
        "terseLabel": "Percent of ownership interest sold"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentDisposedOf",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "label": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ExcludesgeneralandprofessionalliabilityclaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excludes general and professional liability claims [Member]",
        "label": "Excludes general and professional liability claims [Member]",
        "terseLabel": "Excludes general and professional liability claims"
       }
      }
     },
     "localname": "ExcludesgeneralandprofessionalliabilityclaimsMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, Additions and Issuances",
        "terseLabel": "Purchases, additions and issuances"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesAdditionsAndIssuances",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ForeignCurrencyTranslationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation",
        "label": "Foreign Currency Translation [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GainLossOnDispositionOfJointVenture": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Disposition of Joint Venture",
        "label": "Gain (Loss) on Disposition of Joint Venture",
        "negatedLabel": "Gain on disposition of joint venture"
       }
      }
     },
     "localname": "GainLossOnDispositionOfJointVenture",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government Payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare Insurers"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_InventoryPurchaseAccountingAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Purchase Accounting Adjustments",
        "label": "Inventory, Purchase Accounting Adjustments",
        "terseLabel": "Inventory, purchase adjustments"
       }
      }
     },
     "localname": "InventoryPurchaseAccountingAdjustments",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LabtechDiagnosticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Labtech Diagnostics, LLC",
        "label": "Labtech Diagnostics, LLC [Member]",
        "terseLabel": "Labtech Diagnostics, LLC"
       }
      }
     },
     "localname": "LabtechDiagnosticsLLCMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LoanCommitmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Commitment",
        "label": "Loan Commitment [Member]",
        "terseLabel": "Loan Commitment"
       }
      }
     },
     "localname": "LoanCommitmentMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MeasurementInputComparableCompanyRevenueVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Comparable Company Revenue Volatility [Member]",
        "label": "Measurement Input, Comparable Company Revenue Volatility [Member]",
        "terseLabel": "Comparable Company Revenue Volatility"
       }
      }
     },
     "localname": "MeasurementInputComparableCompanyRevenueVolatilityMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_Mergerconsiderationpaidpayablenet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger consideration paid (payable), net",
        "label": "Merger consideration paid (payable), net",
        "terseLabel": "Merger consideration payable"
       }
      }
     },
     "localname": "Mergerconsiderationpaidpayablenet",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_PackHealthLLCAndLabtechDiagnosticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pack Health, LLC and Labtech Diagnostics, LLC",
        "label": "Pack Health, LLC and Labtech Diagnostics, LLC [Member]",
        "terseLabel": "Pack Health, LLC and Labtech Diagnostics, LLC"
       }
      }
     },
     "localname": "PackHealthLLCAndLabtechDiagnosticsLLCMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PackHealthLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pack Health, LLC",
        "label": "Pack Health, LLC [Member]",
        "terseLabel": "Pack Health, LLC"
       }
      }
     },
     "localname": "PackHealthLLCMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PatientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients [Member]",
        "label": "Patients [Member]",
        "terseLabel": "Patients (including coinsurance and deductible responsibilities)"
       }
      }
     },
     "localname": "PatientsMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements",
        "label": "Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements",
        "terseLabel": "Accelerated share repurchase, percent of total value to be repurchased"
       }
      }
     },
     "localname": "PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Sale of Equity Method Investments, Gross",
        "label": "Proceeds from Sale of Equity Method Investments, Gross",
        "terseLabel": "Gross proceeds from disposition of joint venture"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestmentsGross",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_Q2SolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 Solutions",
        "label": "Q2 Solutions [Member]",
        "terseLabel": "Q2 Solutions"
       }
      }
     },
     "localname": "Q2SolutionsMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_RoutineClinicalTestingAndOtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing and other services",
        "label": "Routine clinical testing and other services [Member]",
        "terseLabel": "Routine clinical testing and other services"
       }
      }
     },
     "localname": "RoutineClinicalTestingAndOtherServicesMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Revenues by Major Service",
        "label": "Schedule of Revenues by Major Service [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Major Service"
       }
      }
     },
     "localname": "ScheduleOfRevenuesByMajorServiceTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "label": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt"
       }
      }
     },
     "localname": "ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior Unsecured Revolving Credit Facility"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAmountAuthorized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized",
        "label": "Stock Repurchase Program, Additional Amount Authorized",
        "terseLabel": "Additional amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorized",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Line Items]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Line Items]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataLineItems",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Table]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Table]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataTable",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TotalAmortizingIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Amortizing Intangible Assets [Member]",
        "label": "Total Amortizing Intangible Assets [Member]",
        "terseLabel": "Total Amortizing Intangible Assets"
       }
      }
     },
     "localname": "TotalAmortizingIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TreasuryStockPurchasedbutNotyetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Purchased but Not yet Paid",
        "label": "Treasury Stock Purchased but Not yet Paid",
        "terseLabel": "Accounts payable associated with purchases of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockPurchasedbutNotyetPaid",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TriggeringEventAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Triggering Event",
        "label": "Triggering Event [Axis]",
        "terseLabel": "Triggering Event [Axis]"
       }
      }
     },
     "localname": "TriggeringEventAxis",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_TriggeringEventDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Triggering Event",
        "label": "Triggering Event [Domain]",
        "terseLabel": "Triggering Event [Domain]"
       }
      }
     },
     "localname": "TriggeringEventDomain",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution",
        "label": "Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution",
        "terseLabel": "Value of shares to be received under accelerated share repurchase agreements at execution"
       }
      }
     },
     "localname": "ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution",
     "nsuri": "http://questdiagnostics.com/20220930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r256",
      "r258",
      "r259",
      "r260",
      "r279",
      "r303",
      "r351",
      "r353",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r541",
      "r543",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r256",
      "r258",
      "r259",
      "r260",
      "r279",
      "r303",
      "r351",
      "r353",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r541",
      "r543",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r195",
      "r258",
      "r259",
      "r337",
      "r339",
      "r500",
      "r540",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r195",
      "r258",
      "r259",
      "r337",
      "r339",
      "r500",
      "r540",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r247",
      "r256",
      "r258",
      "r259",
      "r260",
      "r279",
      "r303",
      "r341",
      "r351",
      "r353",
      "r358",
      "r359",
      "r360",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r541",
      "r543",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r247",
      "r256",
      "r258",
      "r259",
      "r260",
      "r279",
      "r303",
      "r341",
      "r351",
      "r353",
      "r358",
      "r359",
      "r360",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r541",
      "r543",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $29 and $31 as of September\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r35",
      "r57",
      "r58",
      "r59",
      "r526",
      "r548",
      "r549"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r56",
      "r59",
      "r66",
      "r67",
      "r68",
      "r121",
      "r122",
      "r123",
      "r418",
      "r483",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r362",
      "r363",
      "r364",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r354",
      "r365",
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r165",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r39",
      "r202",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r102",
      "r226",
      "r233"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r26",
      "r114",
      "r177",
      "r184",
      "r191",
      "r207",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r413",
      "r419",
      "r463",
      "r484",
      "r486",
      "r504",
      "r524"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r19",
      "r41",
      "r114",
      "r207",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r413",
      "r419",
      "r463",
      "r484",
      "r486"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r447"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r204",
      "r205",
      "r211",
      "r508"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r350",
      "r352",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r350",
      "r352",
      "r388",
      "r389",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r406"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r399",
      "r400",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Maximum contingent consideration payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r398",
      "r401",
      "r404"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r393",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired from acquisition",
        "verboseLabel": "Less: Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r21",
      "r104"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r97",
      "r104",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r97",
      "r464"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW &amp; OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r509",
      "r531"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r261",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r32",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r32",
      "r486"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both September\u00a030, 2022 and December\u00a031, 2021; 162 shares issued as of both September\u00a030, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r76",
      "r516",
      "r537"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r75",
      "r411",
      "r412",
      "r423",
      "r515",
      "r536"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r74",
      "r410",
      "r423",
      "r514",
      "r535"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r210",
      "r326",
      "r336"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate activities"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r81",
      "r114",
      "r207",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating income:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r373",
      "r379",
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current income tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer-related intangibles"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r285",
      "r294",
      "r295",
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r113",
      "r119",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r316",
      "r317",
      "r318",
      "r319",
      "r474",
      "r475",
      "r477",
      "r478",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r115",
      "r374",
      "r379",
      "r380",
      "r381"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r102",
      "r240"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r102",
      "r172"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r441",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r428",
      "r431",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r433",
      "r434",
      "r437",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r118",
      "r424",
      "r425",
      "r428",
      "r429",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r239",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "netLabel": "DISPOSITION"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r28",
      "r30",
      "r505",
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r77",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r134",
      "r136",
      "r146",
      "r147",
      "r148",
      "r152",
      "r153",
      "r444",
      "r445",
      "r517",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r77",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r136",
      "r146",
      "r147",
      "r148",
      "r152",
      "r153",
      "r444",
      "r445",
      "r517",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r367",
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "negatedLabel": "Share-based compensation, excess tax benefit, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r66",
      "r67",
      "r68",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r133",
      "r155",
      "r208",
      "r315",
      "r320",
      "r362",
      "r363",
      "r364",
      "r375",
      "r376",
      "r443",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r483",
      "r544",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r78",
      "r79",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "verboseLabel": "Gain on sale of investment, before tax"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r22",
      "r178",
      "r206"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r447",
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r285",
      "r294",
      "r295",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r448",
      "r490",
      "r491",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r455",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r447",
      "r448",
      "r450",
      "r451",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r285",
      "r342",
      "r343",
      "r348",
      "r349",
      "r448",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r285",
      "r294",
      "r295",
      "r342",
      "r343",
      "r348",
      "r349",
      "r448",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r285",
      "r294",
      "r295",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r448",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3",
        "verboseLabel": "Significant Unobservable Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r452",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value, Measurement Inputs"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedLabel": "Total fair value adjustments included in earnings - realized/unrealized",
        "terseLabel": "Total fair value adjustments included in earnings - realized/unrealized"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, September 30, 2022",
        "periodStartLabel": "Balance, December 31, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r285",
      "r294",
      "r295",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r490",
      "r491",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r455",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r452",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful life",
        "verboseLabel": "Weighted Average Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r24",
      "r232"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Intangible assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r227",
      "r229",
      "r232",
      "r236",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r227",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r232",
      "r501"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for purchase accounting adjustments.",
        "label": "Finite-Lived Intangible Assets, Purchase Accounting Adjustments",
        "terseLabel": "Intangible assets, purchase adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r23",
      "r212",
      "r213",
      "r220",
      "r224",
      "r486",
      "r503"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Balance at end of period",
        "periodStartLabel": "Goodwill, Balance at beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r214",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r219",
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, purchase adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r177",
      "r183",
      "r187",
      "r190",
      "r193"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r71",
      "r102",
      "r174",
      "r206",
      "r511",
      "r532"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r242",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r370",
      "r371",
      "r372",
      "r377",
      "r382",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r132",
      "r133",
      "r175",
      "r368",
      "r378",
      "r383",
      "r539"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r99",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Non-controlling Interest [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r148",
      "r355"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r228",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r228",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets Excluding Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible assets, Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r225",
      "r230"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total intangible assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r171",
      "r473",
      "r476",
      "r520"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r519"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r95",
      "r98",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r40",
      "r486"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "verboseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r38",
      "r114",
      "r207",
      "r463",
      "r486",
      "r507",
      "r529"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r44",
      "r114",
      "r207",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r414",
      "r419",
      "r420",
      "r463",
      "r484",
      "r485",
      "r486"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r447"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r47",
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r262",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r255",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r114",
      "r207",
      "r265",
      "r269",
      "r270",
      "r271",
      "r274",
      "r275",
      "r463",
      "r506",
      "r528"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r156",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r97",
      "r100",
      "r103"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r14",
      "r60",
      "r63",
      "r68",
      "r72",
      "r103",
      "r114",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r132",
      "r133",
      "r144",
      "r177",
      "r183",
      "r187",
      "r190",
      "r193",
      "r207",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r445",
      "r463",
      "r512",
      "r533"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Quest Diagnostics",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r63",
      "r68",
      "r132",
      "r133",
      "r416",
      "r422"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r135",
      "r140",
      "r141",
      "r142",
      "r143",
      "r145",
      "r148"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards to be Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r320",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating (expense) income, net",
        "totalLabel": "Total non-operating (expense) income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r177",
      "r183",
      "r187",
      "r190",
      "r193"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Total operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r480"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r480"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r479"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r54",
      "r55",
      "r57"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in available-for-sale debt securities, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r53",
      "r57"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net deferred gain on cash flow hedges, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r66",
      "r67",
      "r69",
      "r73",
      "r315",
      "r465",
      "r470",
      "r471",
      "r513",
      "r534"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating income, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r86",
      "r89"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "(Increase) decrease in investments and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r87",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for business acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "terseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r91",
      "r94"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from disposition of joint venture"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r90",
      "r361"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r14",
      "r60",
      "r63",
      "r68",
      "r96",
      "r114",
      "r124",
      "r132",
      "r133",
      "r177",
      "r183",
      "r187",
      "r190",
      "r193",
      "r207",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r410",
      "r415",
      "r417",
      "r422",
      "r423",
      "r445",
      "r463",
      "r521"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r241",
      "r486",
      "r522",
      "r530"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r59",
      "r66",
      "r67",
      "r69",
      "r465",
      "r469",
      "r471"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r34",
      "r320",
      "r486",
      "r527",
      "r547",
      "r549"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r133",
      "r208",
      "r362",
      "r363",
      "r364",
      "r375",
      "r376",
      "r443",
      "r544",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r168",
      "r169",
      "r182",
      "r188",
      "r189",
      "r195",
      "r196",
      "r198",
      "r335",
      "r337",
      "r500"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r338",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r388",
      "r389",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSBusinessAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill, Net"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r177",
      "r180",
      "r186",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r177",
      "r180",
      "r186",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Reporting Information by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r165",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r198",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r224",
      "r249",
      "r250",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r177",
      "r181",
      "r187",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r111",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r165",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r198",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r224",
      "r243",
      "r249",
      "r250",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r50",
      "r66",
      "r67",
      "r68",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r133",
      "r155",
      "r208",
      "r315",
      "r320",
      "r362",
      "r363",
      "r364",
      "r375",
      "r376",
      "r443",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r483",
      "r544",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r155",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r31",
      "r32",
      "r315",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r31",
      "r32",
      "r315",
      "r320",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r32",
      "r315",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r31",
      "r32",
      "r320",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r315",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase authorization remaining available"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r32",
      "r36",
      "r37",
      "r114",
      "r203",
      "r207",
      "r463",
      "r486"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r67",
      "r114",
      "r121",
      "r122",
      "r123",
      "r125",
      "r131",
      "r207",
      "r208",
      "r320",
      "r362",
      "r363",
      "r364",
      "r375",
      "r376",
      "r408",
      "r409",
      "r421",
      "r443",
      "r463",
      "r465",
      "r466",
      "r471",
      "r483",
      "r545",
      "r546"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r320",
      "r325",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r472",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r472",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r472",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r472",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r487",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r48",
      "r114",
      "r207",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, Value",
        "periodStartLabel": "Balance, Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Intangible Assets Not Subject to Amortization - Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r18",
      "r27",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Deferred compensation trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r49",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r32",
      "r315",
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r49",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r32",
      "r315",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "terseLabel": "Purchases of treasury stock- shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r32",
      "r315",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "terseLabel": "Treasury stock retired (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r49",
      "r323",
      "r324"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 48 and 43 shares as of September\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r315",
      "r320",
      "r323"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock, value"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-Lived Intangible Assets [Member]",
        "terseLabel": "Intangible Assets Not Subject to Amortization - Other"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpatentedTechnologyMember": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based innovations or scientific advances that have not been patented.",
        "label": "Unpatented Technology [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "UnpatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r135",
      "r148"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in Shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r134",
      "r148"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in Shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r553": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r554": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r555": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r556": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r557": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r558": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0001022079-22-000140-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-22-000140-xbrl.zip
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MANT(G<E#1L\;'YYPB5</G.&%48;$CL-T\> )#ST8\=##8;I^S+L'GGWY,'O
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M_'&I8#&K0QB>#FJI$WZH"D'\PZ(G8;:\L@PYF46CJE"*$GR4,GAO>%!Q9?4
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M^?U+(QP=YK]?G/;-$[X\OHL3"^9=^<(H28%UQZJ>BU")"^3^.5Q_4*/%//^
M&_,]BWE*//#N=LTP[[28]\!Z-?6[*OU V=NMY=WIM@_D=%8(%S.W8^;1GD]M
M$_J/27X/>_WS&X(]HY-&DATG)]4Z[K.]GMYL[:=..6_KS4NZ)M*?0_WZU9.W
M6T]?GAV\>B&W]C?5]H=X->[#ML76V;:@<]X<GF_O;[+M#P1'UCL=NN;]Z_TG
M1Z_7X]G6FT.Y?5-]HP)KD9E4>69"I7ATE5?15^!\$B@3:N975I_=K'47+LMZ
M:G:?W8!]II>*.U?17;M.Q>6CFOK]^RK#Z)7)T(\_BT7.M/[" OE-<.PGH&]M
M$N1O?J6]+X'1^R#=797/=*EW[\!A-)<7>Y\N8Z>XF0(& @I;5]9:LPN1YU1%
MAU I71:*(O,5#\"]]MJY AB^T6GN>[N)3Z?6>;&$?^-F%_,V2],0W])%I]U4
M30:;1__=_\IQS73"Q10_'<WPXPL?OM$-/Z0;SJ_I!J."1<BE[:0I"TX<*V\E
MKS"#@8#!FY*'<6O=4+M%X_R5P-9OK?;-\;AVOFF%8K0N00BNVQLM*YP.QD$Q
MDHMQC^4;^C?V^J-G=<[+P]^WZ='TV%:7WJU7H,6[]F"$"$>[-)'T$DXLO8/*
MR667N 3]-&B59D'M]*5\=?D+_'ICK*O5!&AG$Z ='&&G<\%2K5^(449A4B+8
M-P.2OSYH'>!@OH2Z?_17YF>)%?P/+4*I?[QE7%J?*@E<5HJG5(686!5!0$(I
M(2LSK3;!2[@&9&JG8M9&:R<[<=@+V"_KS^QWKL8MWG\K&J*/K??EK][I<&0$
MBC68".F3T;HMJ?W3;GLLHH,CZ"/Y5)?$EGA&!NN]5$FH''A(/(; 0@Q96,/=
MQ2:U7*V0KHIM<L\&_UK9W'YR0^;.*'=YE%JV-WK4SJ=17>[QWST]KE)OM+E9
MN2$A8L*R="_VLPGU^DOV#S.I;'+O*ZE+U3:WI2.7=U6PPI0V_PJ$7%GE7/[F
MG/U-&7,AV!<47FV-*7MA-3X9G;(6QNWO@V)Q2EKY8))67K+*3Z#?>E>RRK^\
MTC5A12$>E'6HD]X8L#SJ8\F*>(?7=NS[M.(UDB+VZ1((@U[G='C]DF_M.G?7
MG0;MRL4U1_U/KN0A5J&/\+:"3-[3(^B\A_/!RL,O;4>HQ .KFQT):[XCX8QK
MID?Z^OG:[GYKLU6UGFQNKVT_WEQ[UB)5N;.[M;;_^=9S"[^D[/T#-UX5O6E)
M^6M+K>R!$]-?^W7^@;'3KSJU#\BP37/MMQ:!K:L[Y'TI3E_0QMP7'Z;:TN Y
ME&3W;]46?G>[AOF]V.80CUO\0>O)Q_# J/?3.)'[E],NG*;V$-,=BE6G5-.R
M2.P[W?R-17JSI>@L>M]TK85NON6BPR8!K[-18/%"M(M7-Y+5R<+QA1X8?-(#
MD^J608'^PX_YR^-%RT<U4?0-DRRG :\?73^NN<W#,60+Y!A^?2RW=PRY+.7O
MGRFQSR!,"8*=X/CFGRK3]NG>.$KTW:9'M;;&A18;HP66ZWLBCDZD#_RZLSEM
M:?\^S[1AEKLQB_@"(1M5WZCZ1M4OM/2:KZKZL@#8QR/L#DH%7]E\X1@;I=^P
M36$;^76E?V7I0DXW&>T'^]DVFJO^+.BO:*X_H4.>-K;VCA!)>\%(@7U!#ZUC
MG/S*?VN4TA)QA&J0:(-$&WV^,&.YO?0*\74D"H.CUI-.[_VGH$.#.G]"%M$-
MZFRTU!Q94']52XU2[HYZ';KQ8)+RU=KXSVE[>-YXS0WS%.8QC?YJ]-<<6="5
MVN8AC6G8:UU29#<EK!1>O3%II5% M:6^FYF'_%-FN_Q@RMH,]-Q->6OSXO0[
MCN4.N<URDHHG'K2VH N'(X7V,0M_O3V(IX-!*<HH &NM"YWS07L$X3[I05*/
M:5P86,[9Q<%IY^H"^+1064V9O0F@-71=>'WW4UCVHN]JH.<:\#=?%A&S6Q]I
MT-]":L.? OTY-T%_\D'K16F^T!Z.ZB1'"HY^Z%Q\+_JQTQN<EIK-M= ['1)8
M[+_%86NW/7C;@+L&W#5T76QU]M-8[M+,^<*AG71>OD>\-VG=W,"^^C-/L87R
M&ZL.#>QK8-\2P#[/)[!//1@U-.@3?48Z[GF_%S$5E-=@N@;3-71=;%WU4YCE
MHJON64<UJ&N^Y/TZZOIB3\XKK8_NI=G3MZA_4ZN?N3;YN;DI&Y]&HRK.5E9_
MO%.5-$V;JJ9-U5U0[XB#7[S<V-MOK6^N/=W>V=O??+S7VMQ^O+/[?&=W;7]C
MO;6VO=[:>_GGWB:=L;NYL;= $GGS^SS>V=[;>;:Y/AK]WC[]L[6QO;_7VGG2
MVGF^L3MJOK7X;_%D9[>U_^\-^K.[L3$BPO;F]D9K:V=[_]][K8WM]?)R&\_I
MY?[<V!UCM(\)F^7LDK#96OBW_&)BUR*.M=UMT6T[)3CU6PO/(IX,2[_F<</%
M5H(AW/TEOF3E;FDWY,HMGS7;CG%D?AZPL0FZZRYDVCSP:OJ[D+D'3MVNN=O=
MCFG9C+5.8[4S:?#G9[>CRU0[QXT+ [Y<#S"-/F-UG9MOE$K<4X!DN@WXYCJ!
M!9I,J^7@3S=S?!JBMZR3T[#5=-BJEGN:?D%;X[!LDX+=T\^VR;AB]V]-2M9:
MK%>^.5#_/W_X-3]_O7ZY\T*]WQ>W,C@=I"O[&&3G9+0ZDI>$RBGAP&FEL[?D
M0VGM\V3[$7MI^Y%/&QI4YF(_@]-!=0AP\FAWS$I/^KWC4<2<AO"J/3QZ?#J@
M^<#^QEGLG)9Y7!L,D/Y/^W!VNTT.S)PW.=@Z]\?Q^$EWIVQ4\.I%V5J*[ZR_
M>+_U9K>SL[ZFME\]Z6SO_W5$UW:VUW>/M][\U7XF=X\.CL\Z.V^VWF^_^;/]
M>O_%^^WCUV_I7[:]OJ%WGA[PK>._VCM/M_3.^I/C[>._.A?7T+-.7XN79NO#
MFMAZ^A?=<XU&M4O_OF!;^V_5ZS?T+L>;ZN##6[7UZD <'/^=M]IE6ZJ-LCV5
MV%G?4EN'__ DF$H>*DV^<*5\\)57657&9U YD=_L%2FXWY2[OD'"S6MTWZ'>
M6W<4FN\PW8VF6G)-%5 A(E<1 U.!FV E($^1 QJNI1EI*GZAJ7BCJ19=4WVX
MHJF\0&?H_\K(:$A3&5VYLDN35!G*YCH TA9-9:UJ-%6CJ1974WW7EFZ-IEI<
M3<6O:"H=-/.:Q\H&QRIELZX@6E-98R$(B=)&OK)J?].:-9JJT52+JZED,"8[
M "Y1D^\G LL9'8LV&$"A<8*I>(.I:J*IY!5-A3)'I6VN@HVN4M&F"CA351:)
M(:%FFX&MK+K?F%HT3+70+7:6]-0EBFI.JF.ZA_0B@^$X:1//3K!+>F?TI3?:
M;+CW\;3VJ%WV#^[GLGC&8,:['C43T$Q #2:@EHKNYK=[3.JM)%O2Y>_:L>2C
M?X'0XL;7NQ&R+QX-Y[FB469X)T^0;8-6IX56M_>NK55$Y5")Q"NIZ"^5;*B\
M,ZK2$%,TW G%TLHJ_XT^W@VMSMYU_NG$;NKA^4;L[DOLK@;>LU*,@[85QY!(
M[*2N0@!?,<M%-C)+SMU([.P=PUF-V-4OUMR(W7V)W=4H,C 6/'A7906J4CI
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M&:)61\2I"\AH$Q%3.)'H@^&49]EG"OJ:A[['\@X4],T+?9.YO$XPS"Q%TM"
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MZ4S_G+;8/()O?EA_\98^@,+WIH/TA9$V4*J04R2W/R,:624"PA9'Y9+#,@<
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M.G.O=_"[]]L'A]76SL:OK;V#PYW-@VJGM;FW_W9O?^-P>ZO::&U5!^]?'^S
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M(PX.:Q$14PPLI4!R@RR"D;-<8PW,3K $'M S)MT4$;PR(KB@Z>%HFI2J DQ
M2T5NI)"+KA*0JH:#::ACLH0IZK&JBZX6F?HC('G;CV>V':KXY2QVLT,P6\Z]
M4</H&]$#1>+.2>*.9WQ[-.$;W5 WR1O%)16?U .HHSTEB#'C8/6:A (%\<M%
MHDA[99#6L&#:*,*HR9TJI]U*11 _#4%<0#9WD$W*9P>;)J:HD2+*YK*3'A3=
M%%'@(FH#?P-?YE+,2]!V_T$^7T:QPYCB]W'Y6%<^H).$&F7 -5FW..P-;6=V
M->))M<=>AA/^)LL5Q]]\*'#O%J\[9EY[;9#!"O0,E1AR)H'5[YRL2T-RD0M
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MYWGFWO;Z>10;PV&_[<Z'N3#H8>_VTJ#%1)@7,[6VIBOS,F.3L 0, T$=XB$
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MW [CZ5FO;_L7(V;;M/U^+G:R<=H[[PX?PG/-*3FV*ERVMSG1<<,:CYVQB.(
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MHTURN7M"X=I9N/9@2MG,?1ZBQ DYJ2U0+9;(N1RC;UQP/FBG4SD$*"2Q.H<
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M5["YE8R/35<E9&M^7#;5T#T2QC%AB"3'$*?8Y8;!'.G(O<?2V91LG= LITO
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M?<U[E3(XRB =LL1RQ+U2R 8L$< Z1E4J%ZU=VRCG#%%X1&/OB8"/62&B,H8
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M-5[MM#?;+W<V_RSV#^"'UG;[8/_V9&O+4I=_CGMF[*M1\/]:_K)6O0(>VP$
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MNCLH1;="81;@JU+@AR[ES1SSNW&?#@=]T&#NO2')G93?N_7S;S,(>!"6OKG
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M&6)UWE?=4V!)#KH_!ST81J\'8M UV^7:7JSYF\DE'PO'6N M)/ .9UQT.KG
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M?/FC/TYL][#91M4(7HG3F;&5[ZLN_W'6#/VC5\:L:<$REPS] L,75U?)6LE
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MP3D9=)&BQ"?A^ZD+&.?5*GS%C1^'9_#,']O''F^O?Y%8"J<ISZ[S@#B.'+G
M'!+:$"88UYK1>4Z>2[6,13OVB\-<FSC7Q6I[O8YOEJG\XXK=JM!_?@^4*XMR
M1RU@X+&Q.(&[CGHY31F>.VM^YJ+!;ED&4(VFJM?KG);/*GNRY)+7EWGH4_4
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M/6)0OD*M>.1@K].WK6<5.0B$2^&L$(X9'@6WD9*<J4X"*% DN3IR\/"@,'L
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MM"@/U/2$8U9:L6K!4WMJT*M!;^5!;Q$K=EFH5UNQ]^^JJYK]741@8A3$2V,
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MYP@6/A!!)8_$?M=V)JV95[F_KHVPAU1;+;A(1M%DA3"IWDYUP>_>;N</;J<
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M4=O&?_<QEK;Q7]OX;YTFUS;^^[[&?S=+-5LOU_)Z!12*\I@S<"=#?VQA_]K
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MH40^[U=D*6%YX/G<$,NX,T0KEI(W<B$4W:+$+1"! .-<X,19-!&9Y!/B!@-
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M[E;OYX/M2PU#/O>^.4 S>^EMKS?PU:&<]9GUPUCWPHYVF)-4ZY-UIZG-Y5W
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M!?#9 EO,+/Y,Y_AL9 TJZR?[$=,*6MI7?LYI#OBS&_+:FAR+^,UEG3ML3;(
M%PH?".5:24.L\\18BQ5CRK-R@M!5IT$NJ!(G=G@$QD,^2K4<VG#%X6G??.?_
ME/-2YPYHA87MV=-1?-9\^*TYP+G;+\M3;OJM'D-M-V9C<^Y\UJ+O5#^?FS9/
M<67>Y--:SX^&K7]^6GZ:.S:V^DW(IX9?_3-^2J[\[;K'ZJ>:7WWG=4^]_C?!
MVK$^I+&J&SVUG#%<4^[W')YN%BZ]Y%#SRC:XIY._%Y3DPJV'!>7W*G#?N0CN
M'<#U^0.??Z:UV<]R[X9+\Z/T<W[IE6=IX\7CM-=\ ;-.< ,"NM&,?[J5(ZM@
MO<>Z."U9K8:L;@A;E\PNGRQV3W-;4.;+W+9S'83O5DIR?9K</)4LNZ.X\Q!F
M_E\_/,W9Z94@ZEK-;XF2J!\\%F4Q=VN6JM8F(>L[/13';T^^]&!L9._#<6]_
M^\W9P>%_NGL?7O)W\(R#P]![]V'_XQ[]\^/>/V_HN\.WM+D'WC5Y1]_(@T.X
MY\4;O'^X*_;_V85G'_>RAV.?_N=DC[[\^O;DY9=WA^]Z,.NTU\5?_CK<&>^]
MQO1@>R_W*E!6&"J#0!)[CS@W&FF/*>(F1F8UI2GG#NBKBNE^E,KSKTM2^W>(
MWA9B'CG$K#P]M(68[X>8KW,0@X62C&B!4HP<<<L3<@P;^&?0(5&+8TH;F^JJ
M+I4MQ+00LP80\Z.E:"W$K!!BR!S$Z-R=(7B-(FP+XJ"S(*V#0=Y9I1TS-G )
MEA:_JC5>BS$MQJP!QOQH26.+,2O$&#:',<)+HX-.B!+M &.T1=E\150X!_O%
M5/(*,(9>5?%R7QCSB-Q)6R<#&,S7:]U)TRG22Z=X*28^:-!8N7ME=I4/TFY_
M;/M'7=>+6Z-1G&D TL+(#6#D;,'A$F,"6Y4H%*3.ISQ0BG0*%LF@1'!&2"P(
MP,AB+?2U*'+WRLA/QV<K]S&T?+9*/IOW.DCOJ)*.(2UL;NN4"#+6)[ +",X_
M*"X-\-F2TKKELX=G:+=\MDH^FS>]I<816PF,I7CN2@]6MR6>(Z6U<,$IS,-W
M!!!:/GMXQF;+9ZODLWGS4W%!/24)>>(4XI%[I*.+R(O !%4^V) />[H'O7$Y
M [.\0JVYH7DA;Z'T?;B!Y=FZYQZY>^Y6$QG@<R_F#UO],(ND+6XN@9O[SQ?L
M;6Q5PH'$''.4B%N:D&'1(DV,DAR3)$QNCH#UFKGMVM! BSUWE>'08L]JL&?>
M!Y&P,HDF@R+1V3;2 K#' O:(H%+.>] Q-S[$;795BSUKC#VWFOK08L]JL&?>
M+R.T, QP!F&M! +CD=9':WA/@W<D!"TW-AEML:?%GC7&GEM-B6BQ9S78,^^K
M"E@&Y[1#S,K<3X(EI(-6R-N@0F)"$$<!>_!5IVG<<ZI$\[Z&9JN:[U56>]$?
MJ7UJ7_G#KWQ$.3%-N\QO>"4?CQ!\0'+NE_MT+C:$L5/112O3EI%IBX52FB9*
M0 =!UDB...41.:(4<DD+(H@FW#&0:8OQEU_7)L390L'#@(*5^_I:*/@A*%AP
MZXF$ Y41D7RJ,U<:0(%RBY(RVDLPMZ--  6+$846"EHH6 X*5NYZ:Z'@AZ!@
MWLMFDO(N,(LB4^7P2(TL[ ^"C7*4,VV"B!N;A"Q:NBT6M%BP'!:LW!768L$/
M8<&\U\O%  8<T<B[[/5*+B'KC$?$$Y6BY%S%E+& WRD6/$971[?O!R=MY<^M
MN0RV^F&[^ZD;8C_LEJ4^.,W' L-*MABQ#$8L5O](*K(1)Y$@UB$>$@73P0=$
M!>5*L< IE1N;BPC1)DL_LO2;F[#:[#ETJ?LE!O0U#@<M"R['@O/6.S%!&P+6
M.PV.(1Z50 9S@K1W$3N-%24Z=^?6E-#?6D9<,T:\-8.XE7FK8KAY&YF GA(M
M*,*)Y^8<4L3L+L,(N"W(2$W2P6YL+MG^IV6UAY=ZT<J\NV+!>=,44#-B[RE*
M5 3$&1%(8^>04M1@9[!*R=RCS'N$%43S8?DGG7X<MQ5#CR%[[8ZC^B.8,'RZ
M"DPK!*U=>/MQW$+E$E!YL%@OI*QEE'"+-', E5(%9)6@B%+A@_,VF5S/S-B-
MG7AMQFR+.0\M?:#%G%O%G'F7A*&4!=@NY)C(!TT9C4ST C'.-='.<A7Y4@D%
M+>:TF//0\A1:S+E5S)GWRE@LO(7]0IB#=L.]=542DPM!,BFU4CAG+N!%OTP+
M.BWHK 7HK,!!U8+.K8+.@A\J$<\!_1$+&722-\A00I&UFCN+$\!.7"Y%HJT)
M:E_9U@1=Y7P\M=W0%@2MSQ36(;GG;Z")5I0MV8_M<"N+L>(KW/]P]/5@>_<]
M9DYQ$S%*$00:I_!):^V1M\)Z&JQT,AOM2]:XMNF_+1[<;092BP??B0=G%_%
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M3&"JYO%%)QF=P:A/0%*//V=_V=;D: +P0\K$=7G'GAWZXT[EW":F\TL>P\Q
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M,M,]^?I97;:I=7N\VO<,^E)Q_H%,[5]=;-ZO:[XOGENJ-'9!A(3!<L+":RM
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M\BZ,;"X;Q4%AJV@*TI8T"TSO(<W]$;E1VCK1NZP3;8V1'P2*Q<Q1S+3$!G;
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MI9(F+)1@0%O>V!0\X4GF4$D(V"R=KM)"ROU"RM<Y2#'2."&)04H)@3@6!.E
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MYFLK.B("IA$0F[C"!YE-N!UY(;>])$R\0":)ZV*\6&S$=?,(+":QDQ#?B:/
MHSX7<<@5=YF.*N$N]XRXW@&!S95(Y#(.'5_8A!#4AT%2LR0!I1AH*PD%R/ X
M/'KK[J!&^0&):U/O>&6AS*4"(4P3K-^=N'Z$O()():,@$''B&:'\Y#QCP;VY
MH@$1,;:[%!0K7# [B:4'-K3O.IP%/ GCH[?QFNXU4[RQV:09$T]&'I<.CSP:
M!Q'H8;[PG0"0(!:Q9$:<[X T9\6YHQ+?%US:5$78<B06=L1"UTY"17C$'5\E
M20.K-QZ0K#>5%G42N4^9&T0H#2(:^TD2.21TE%#,8=1-A)'C3\XL%C2(#UP9
M"XKUJ<#"IARL@#@FH1T*WY>A\E@21T=OJ;&MFT=?OL. GY,X(0FEC#(6,A&&
MU!6<8:\B983Q#NAK+@(M<1,I$F)[) &)',4Q:,R.LAW%N1.XKA<I;R>5J@Y(
MW%XNSJ@R!:9^O%1RZ 2Q&[LLH%0QYI(X=+'@%(T(%>YB 7Y_&K5A,3_&8A:T
MR/43K,P02%M2EH"^S[&VE.(VBT24<*;"Q#?YU*940Z-8B^-Y>"7@^8&(J,2Z
MM7X2.!0X2^(''A6+=1?#6K;,6F:U%^QM%4GBV-P+A4V5E]@1][@=A!39ON<H
M4[ON<='WH[(*<TG;\[\TJGS!;'6%-1+,RS>3_.>W2VHT+'E8DF[LQ4$2<*Y
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M\(;5A6G:A25[0@IKE%%?#JS3ZG5H$^H'Q_H]J90$H?-56JDF 6O OEDY%M[
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M-BS&^Q^1WC1\@)]TB]+I7[Z.^*4D\%/>EF*(7*N-7!3;)+1DZUC[<( P@$B
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MPLDAQ0JAZ/4EU:OCZI"=:/Z0CZU^GG99#G! C,AXRO#9;3IH6[=9_@58%9>
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M<\E!] (J/M1:[72]8(=GN9<.AUFKN(>=:1I@%$?&*&XVDWC0*([(#QG%OK/
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MHAB3LJMB-K#?MNR(25$&M@6<1 )TSPJ$QW]T&(E*)=BWK R<J.,!@*@!:AU
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MC1[]((X>1=Y)\*3GC&&>S_(B0^:=D7F$#7F$@!NA!/@)0SIR(XX5*5@SU=\
M4059*H1MHO$]0W,SET"),H@^#X ,^QPY#3'K@$?P_939:!H5@TGB9WMX!H'_
M(M'K*\*/[X+N-.V B&* OE"/+/\>8WBJ]9EW1SP;T240I.,#O8/-@3UWCE.
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M*Y>H,CC2 6YOE_8@'2CLW)S@H(%/?47SY\PV;6T !P6F"!,$._7> W2J0 /
M3O"(9F"V#C"I)A@9IH6-R'W( /8L7G(K& $\'X9(+<+A>?,%)_WM59VQ9J9S
MC(T$PB]!9UEC'%A?^#^^D@!K[!B3+[:+%,2'OHX,_Y9H.&99YC19Q._1VTSS
M-:JJ5J^"\F.XE>S#3"^JJ!=G,*/HO7)%+17UA;>+JO;*>Y52^55/+ANLIJGZ
M*U^[@<$65;U8S<M@=56OYH8-=+5277Q[YK5S8/6XV+D>&N<5?SD7'U:OI8&]
MINIA0Z!RSTP8NDNM;O>*A(UG5Q<'?S6[1UVE<ZP<G5^U+J^5[M'!U47KLG74
M70A\_:XT31Y9!;\NX_0^PV18"H*FFO-"E.>MI-TE'@T_Y5OD:)6Q^U* _SSC
M76XD=5]#W289#(F_B MJ]RU*4&B!#!762&1)U?7RK)+P*UPTR 6#GA$\BWJ.
MW7<F>+WINEZ$QU3/H,@#KQ''EW7Q"W*P*DN!9+.5;*6"D)R:SE V9OY8#R&4
M\)6?T)4 V"OKXV6LSXLG,C_>:RM4OEO*<].2U0%?Q3M 5%UD?;SS5-GFQSH?
M@/E#.EPLI=8NEC)Y$7F'&>S-Y,)RYIQG#E_\[\B9*!IK$(,U6MI7!2\RU!X]
MA;'] 'OZ@<CD]5?(A22.)(XDSD<2YUW5^PS%%/B[1@^395F9+VI[KNPV]];!
M;_I< A65S3)62N+H>JE0K9;F,]B2=2^FG]8K:)N6GIGCM4\I2+@"Z38Q!:U4
M5K6L,804-BEL6REL!4VK%!K%ZH9X0OH+S]?D:#1VO(EE*9?0X(.=]U)VOTMG
M 2-A?;8B4>JO/U=_99,C7M9%V:;JZ>?F>@/A+9S]1UJN3&N19G0;!>&S;"6[
M_#[YRO?]Z59E9.3\_^SY2P];9N16# GU4J5 O*J,.572S=YL3JY1SQA#2'&3
MXK:=XM8H-PI:K2QS<IE9$9F36ZR_2KHF=9?47;&KT% ;E8PQ1&:#/9F0DPFY
MM4>WO&W^LYQ<<H?WTL]36BY//Y4II"UW"&4*::E/6-4KA5JID3$W0/J%&^0)
MO:(6LU9Z),5-BMMVBENM#&5=FTK92H]!II#R7L0CM9?DB)S$>S*+)+-(ZR87
M=HO81G:1]45R_G+^,CDHDX.;(4ZI4*R7"U5M4^4-TM_/'D]H>D.MROHR*6Y2
MW&1R\$_T&&1R4-:72=TEZ\LRG1O[LV>_!K/U&=OJ?\LTK)@0HG[\YWE3K'W0
MG%]T7=5TX+26JQQ;/3\"T%,*80;H7M\]PT=DMT/;MR@2JNWV 1^,H>?!=SEH
M7C"DX&%Q2#YF(7EOHGSZC_T(BW7L4\.K1*X=7@ V2128.PJ AQ'VQ0MVHU:R
M^L5*OU@T!V7#K!JZ42[7])YFUDV]5-+_/80!%O6BML__L:.85M\>&4[POSNM
MT^,=Q35&P"6WCU^Z  :1Y E8FJ!I4I1)PVF.O,@-FU$X]'PR&3(8"DI!!O(8
M?G&CT;[I(;H*O)[P'Q$H\N;&#H6^,4L_)[U#[_>)?O'[NM2.S+NCWS<_&G>=
MN_NGSN6-?3HZO;L9M;3KI_-*>W0SO+F\?[HA?U_?M1\[OZXFU[\NAB>E4^?Z
MR:NTG^[UZ[N;NVN=//>K7>Q<_CVZ_G55:>LWY._64_O2<=JCX_OKG_7']F'S
M]XW[]_#F:7Q_>GC]='K7*IX^]9_:/ZZ*G<-C^_KRYKYS.;QO7_YTVG?7Y9L?
M/YV;@T;QYI]AL3_ZZ1J_&E%G=%X\O6OK[;OSTNE3^^'F\KS<_O7W\'1T7NG\
M.'\\)>,[O1O>W_SZ>?_/4WO2.?_7[-7[Q6J]MV]6:Z7]<K%2VC=JE=J^89FU
M?JU>-BJE*K$?__D\O=HLU87XR)ZK*DJ7<)%%&6@!T\2HN?#+,;*,[2("KUXL
MEA9R)^ [&O%:*I_XF1_V:?CQ[!=CT,<I])!PZ'O1[3"IYZ3OX46=*D*$/Q\]
M_S8%-8'1N![ G@!2MTWA>0#()+3\D>W2_P)65B[0$ 57.0-JJUJG:@MA+(,O
MRJZV1Y<#$!,=FZ)/ J!A"'C:"#@.'!00H@<#IH0X>N6CY?=MY#V[C\#!GV&-
MC$=$I1EZ#GQ8\7H.APT'C0:7 3$;. HYQANSB(*PKQO&J* "3$W,TTT*Q<@A
M;D-$2XOCDQ./3/.2<(A"9F>Y"+4)[7WWE(>A%P_6Y!^DL-.[>CQ]'+3ED&O)
M"(#A<*PXN$ 8VVO'0LCI#0; VLL(1=%%^WTB7@S$U.++,Z%R%Y)/4KQV+G]T
M%A3$:F(CMGD0DI6!@5%2@_%@X*26C^H:U D51KSW7)XXMXJ(2EH]'9R2Q));
M#Y9<;3U8<J6=;V_'DBOK-&.QB-9DDOU]0CBP8%^":#0BCM%BNFT<:6YJN-;C
MT.[9X=>-#W!+X>>6\<BTG0(-\U54.?N"SGF_Z2S!KZNJ'T/1N<BV4[2IJD6,
M/(XHMP;*Z[3OM%]0FZ4W7-D0O1>AXO$)?UDX)P8*!TV-*>+?!P/,-=1ZI00*
M<56 N;I:*S;6#@%6;ZC%1CI,LO56!Y$%V-26DJJMD"U::3J;0$PM9MV.+1\@
MLV/F[6.Q42I"_&<]EC1U&(YVOL4^\P$0>T#(':(5(_ZRYX_9NT1+)N W,&Z=
M<229R+_+D;IMD0^M* 4DXP*B%9F$S(TPSR/R+^70-FY=+R!K$ @" P'HH]6/
M,-KL#(A, 2J9!8AE$.=!_*E GH>]%T$[] H_;2LE;<T-K:6<95K.=)V*63?J
M!;9I0P+_1V1 FL>CZ:D$>UH*Q[K=-$V:H8R+1TGCCEI$0BBM9.QKY5UC3W#7
M6";X8&A;@^>&9[G,9)>#WZD&.X<3ROQ2I5<VTA9G7=GHJRB;8]LE'JUM.%+9
M;,N$,K]4:96-+CV;K"L;G7DVQ,%'O:*5*D7IUTA5DY69I5<UTJ_)NJK1TZL:
MZ=5LW80ROU2IMPTTM77:S<5BI9Q2"S=[E7^^7YPH+1>*J?J6<NCUHY'EALH^
M5ES9_+K)KYN>!:6)H6*,QY;A*S8MS6I!>1 4QQ$_X= (#2++)([I67TC"LAK
MPH!^)S1N P6*K: RTH0</-1_Q>](!L2_ER]FDG*?FZ5:0>Z[!W_E8K%>(?>7
MQJ/G>J,)\?)#RPW &G?[0VMD)(J : )BT6G!/#'KZF-@YFNEI5#F9JE6$,J#
MYDDN%FL]0GE@./W(H>[RB>W>]^#(@&"K10G]E\Q'?1PY^5IZ*:6Y6:H5I/3P
MZ#@7B[4>*3VT!K9KIQ-2TQI((<WOA#*_5"L(Z4GS>RX6:SU">F+T+.=E^72,
MGI3/_$XH\TNU@GR>71SE8K'6(Y]GOA40>4SIZXY]:Y&8RJJT5W!;>9LX[< C
M0U'.C-M%^<E=>F(?ZH9M=RK_""7'T%O (%?P)CM[HQ"!W$O!;:7WYK9G[2IF
M!L"/*6;Q7.G<XV^9.6Q:7\]AT^I['C;-[GG2C8]E2X^.;N8D8I>(HQ%&/E2
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M?G^/4WZMG3MSO$"??_HW4$L#!!0    ( .>#555?C@?_=QP  "@+ 0 4
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M6JU4"QN7/+[5X/M9*<ECQA(*D6FE;5;T<9.7VXJSAL2<->53=Y_W>\P5TG)
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M$B-6EH"$9TF<M&BGLE="X%=G:RN"NRAJ96C?^2\E.5@Z'L38GD-:,F",NXQ
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M2.N=]O_:P&/W([YGT1?T6N' 1;N(5\WX? YI! D=(A"2\%"*H*ACQ/FLB)=
M56+49*B=*'DPR J;@%]?./*>RD2I*E=A Y'>*5PM*A$6/3 9E5&YAWK\KP &
MM@76(U^65,VO*8>*!2PMKL[FK--M1Q#/VTZ%OFIFBS:ZD-!O>S])7[^_;+54
M,%].@I72B(CQIS<V$FE]J>DWC!@?/%4\9 ?5MU!K !]:(?$6N;=]P5?C[!^=
M.!#@1[3))_#V_#2@@<X7F+ILZ^S@?#Z;^TDI-1QQH(8))HA+I5\35^4"M>")
MP'E*D?/DJM]/^T"(/<W(G?>\\+,FCJ1A6EK%B8^9HM!*,S0O"W=B4!1GQ5<_
M@/4@@$,R"'UR[?:2[$^*=4.;4METU8ZQ W>SZ?K7_8Z+,JC=MBUGS18]0W V
M#,]2$\TM(U*&@"&9E809""I(,.![2>)LA'I(=1?;I.26Y=U[E/1Z]\WA[[O[
M[_=^V]L]>G^X:#EV"'%Z,FG^A5/:W=V(\W8M1>7GKWW3=MW?UH^IZKRW5@36
MPRQ4BM>NO?'K^YI9'$]GW?X82TX:&T@":<OM;98XC.A)-LX;FAU5NG:;S/L1
MU:KSN+XQ_/7.NK&?S9K<0+K6%1Z7;*#!"Z*T0+4O-:[K*'BW!R1-TJ!=[0-Y
M#P8Y) ->D5'?JO_H1WC5;/9E8SB$&9I)A_*JB?P<_S9K4I?;N@9^I%D2TB><
M%@JE85QVQ.D2FOJ$@*E@7-;.@JP!<TA6N4>>]2W >EV/.\.Q;/C).6=S5$1Z
MG4J<J,JI0D4P>N40@H4HJ[=0_Q:8S3OQ^G0C9AYIE07Z.$# ETM%&0_$&B.)
M<=$I*UG$^:X\NCL@AJ1SZ_#@;C?>3>:]:M^NHTZ?XYQVXUNZWM''M=X 2BX(
M(E5I*099$V5D NTYL]7O]%P)V)!49C\TJ2^?*L5WBQ::7\G[^O>W;_8^7W1C
M6>9)W*4[-Y(YECE1UJ/WD%"G!^TBL2)!8")(Q?(*M7F;(QE2P7A=$CV"I.I9
MW\N4<3E;[<=P+:D+87X-71+ =3EIEJD$]$6H(YZ)2%3,- ?F,"K/M8WQBMB&
M5$7>CWKJ14J]YTU^.3AX]<>;_?W=MZ_>O#W>??O+FQ?[>[M'1WO'1T?Q Z3S
M<<&_;G;D(4^OE0-9>T25,AVOFPG2;[_Y6(H8YGYRTI0:J8YRI;9 X']21XP4
ME?1(,8'^N\R6<)M#D-I'6GT;^GY$FVJG>YY^_23718'K?X-OCW%<I21:BJ!H
M)E39L@P$KC6A->'*F9B!NBQJ1PYK0AV2!UZ17;<5V#8$6<TF/@SL;IY#6Q"_
MQG\P\LJ(1)TC-J=2FN@%"=$#8=0PJX&* +7//V\ =TB._6#8M[Y 'XF!'=;I
M>3MR-B9CM"5:!(/Q"8O$42V)4Y)S*R*3U2LJUD,ZI%A@,+Q;2XR/2+GC3],1
M3:K< \)(9.AJ2HMAL3,VD\3 )2L41L2UJP+6 CJD$&%0A'NH$!^);X=PZIN2
MFSG(KS&D\N."?12E,=Z")L$[1J3C&#'[[DXUZV7IJLU#[;N6*L >TF'6P7!Q
M<P$_$C/?8FAW_ G&'^&WZ63^83:R046NN"5&T$!DJ<VTWJ$RCU1K'814HG;7
MALT0#^GV],'P<2.Q/J8?6'S6%$+(E!6%;BE&3:6G*T^!&$:]R\:97+V7_WI(
MA]3P:S#46TN,%8OU[HS]*H_]RW2:/C7C\4AS;[0N?<Z$MQ@4185Z&2*A )$J
MT(SRVCIN%5RUQ_Y+V[5TN3UZ;PW$7)K1)U_.49=M>< (44L-W">#AJEV*GPU
M9$-*)E7GT=TJP^K"VHK>_GIO\(UF5 &=[ S "-,*]4NVLDP%?@&=P:3(DMEF
M)+4<Y:"./O3.L)ZEV/O^R]'[=^_VNSK-W?W+^W$/CG_=.WRU>[Q[N5^Q_@;,
M@QY?:P=F_3%5VH)9J;,<9]93@UP3M'26TS(0'S# ]BXEC&1$=+[V8GYX(\#-
MQC[R@B;#4).F4I<FG<$Q4E[:,)9F-%XF7KT#YO7W#\G65>?$?>T,'S3Q]>H$
MK@WE(-]6AR,-6B;PG%#O'9$^1.(3",*$-]909G3U)AOW(QK2SD;O]*@HG"IE
M2U?E#P<9C?*EQ;RX5CK39*76F=ALD+Y4,Q*0N=W--<G)J)F-W[$\WWO'QN[;
MUV?? A\$PZ +HS$;2@58Q+\Y(U%H8"(XKB7SM0OIOPEF"!JPJK3O^%]5Q%!-
M!5XKUD8XYZ>0V C*D3D*.#( 1:0M=UF7PJT4,#Z7ELH M?7>$AB#<,M[I<*F
M<U\S/=*U_+_16:WDAT ZC_%$)CK)<I.$]\2KP(@Q%+R1P$6J77OS+2RUQGC9
M-TZ&I /7FD 4KK0L<<1%C&P$X#KTD6N;^QK: _KX;:VG3!4*+,EFK#WGU<F-
MOLGE71>+05XULAF9DNUFN-1"N?11>A&(<PYQB2B"TU:95'O+[?NHAN3L]<J.
M2H)9,?-P\?/R)?@9_/RW_P502P,$%     @ YX-555<P&@1Z20  JA<# !0
M  !D9W@M,C R,C Y,S!?9&5F+GAM;.V]V79;.9(N?-]/D2?_VX-.S$.MKCY+
MEN5,G2-++DFNZK[BPA"PV$61;I)RVOWT?X"#!HJ4.&!ORK*[:SDU4'M_B/@
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M.(]( FN)]%01QYDBT3&N 5*2JO:)PA8P7S?_FM;;8ZJ9AJCV=]^[@16(DX/
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M43C% VA#I$N9!.XI22)J*;6)1J3O(!:E1LS@)5Q_'@S]\-OCF9--E!'G",D
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M!)0YD!PT;M/<6.5JGR4^ K'WD(%=E#2H*>$&C)*G6[)K#5J %:4,)(+3#/T
M6AHJNZR\C-[QZ@V+GP3TTS!9;9C4TV0# 7'+FWJN ZHADV0IH/V8(A45MS3V
MO(;4&TN#6 07HQ&92D4\8[C"HHM8&K/B<BB,EUDI+JM7[VF1"L\8'6TS81-A
M5[XO>C<80O=3?QI>&;]-&EU.$VMG^Z+V&A(7F3C@N!0"3<26/F+ A78&W?;@
MZ1K71\^]YZ7T-]Y(%8.&Y-A>;O*[@^/SOQ^<?#QZ?W1P\?$<_W-Z>7%7('^:
MP_VP&+X?O_/=X=]][P:V3V>N\]Y*&= -"&$A:=H:Y)6U+!HN)* ]"=P"!>08
M-\HDT:D#8<?Z&?/'W3>K)D836DOONGW\6=?W;M?&0_]Y(0@1_;%H3.:$!DY+
M$&(DSD1)DHNX2NK >?7.6+MBWG7SQ'E>;,D+B#?#:;L22961$CB)($OM]D!)
M,.B52&%9YL%Z%6M[:H] [*$"1)O<6=Q4=U-"0RV:+R8[ 3YO(I:[J7KKF708
M G'2<L*]8F@]^$B\=9$80[EUQG$/IG;VR3K ?C#VU%=691-M:JC<L?O=WT^/
MC[[.O=A9MD*Q8]"ZG7<K7Y@/S'A%I:<H'X&&JM 4T4=6SDNL8D8QS=>OQ; +
MDA^$6WM06P,1( =?T*HHYR%HW)9[O3MD;R&,[^/T-'JT:PAUQ;85.$,L@T!R
M!L%Y2>87M5>R=;']((1K5&4-7)%-#=IE"ZV505/M$DFA5,/TI2>)<YH(Y2SW
M+FBF:J="K 3SHY&GBE(:.+5<MEK>-CF?QS9 .AWTXS1-M -94\Y<(+A2XG:=
ME"86I"561:.DRC'RVG=G&X/\P=C5K!+;:2"]HN/([3 Z/DF>6,;-VJ*%**66
MQ(H02<HA4<HLM4Q4YMT6,'\PYC6MR :R?.^=\RQ;CR%JT,&(<DHYZ>;+"<("
MXG2IOZ08Y[[V(</3B'XP1E543\5FRW-TYY  KHL56!939#K*%3_[Z;@_AB&,
M9K<:M\ [(C*'(]:$*LBXNSM! O.!)"N92NAUY%R[KM6&$'\P>C6IP(HMDA_+
MZMLR:4VOU#,33*;D28I0.F\YE$=0EABO&74FT>2J5UM> U=;Q0#VRJ?J"GHI
MZ?GW!O8>?%E[RU/?#>&_;\HMW.2Z%J(72J1$A!.XDYO@B2T^;XZ4@6,Z1M;<
MK<1*6/N*H*E/A=5<JZ*2)@K%SR$N W@;7/8\Q*9Z$3P/;T_]!VJK=A5U*NME
M3Q22"B PR4DV)4@19,E!MCA+16GO+"A(0U\+=9[K*? "F+.).EIBS.B\',@.
M<=V=%[#7D4>=)$$T* ,><^FGH$AB,<6@8V*L]N'G.KCV:'[74N@:A-E)&PW<
M(M^;-+=?_M&%(;[DZML)?('>=-Y(2)R;0,J>C6+(D02:!!'96B]-N9VLWI-I
M+60_@HE32S%-=%]:1O''>.?[ZAI@6[1W5@+=N^533>/KK$A5U=76IK82-(_>
M&X%;>F">E1T^$VNU(LPQ"Y9IJ8U^?=Q:WS1Z&=3:1$M-4NJX__EF/)I(@,TV
M9*^-2Y)YDA7G* 0-Q"I>+$9)A:;@N:I]N_($G)=A%552Y"K*[*B%)LVB>]#X
MO%>J ^ZUPH%.\G98:9/*LB<@4Q;<TH1N1 L$X3\F0;;10DLKB)AS5V3%='9$
M*YZ)C):CV<<E4ME!A#Q)X&B!(.+'),@V6EAI&;>3"[&DHVOEK(<GWM!D?L.Z
M UO(9!!9AFS !Y&DU#1,>)"IUBP'QX-;GLGPQ,NJMZ&_NS+1@5-03A,EF4*:
M44F\R8RH9-%WGY3QKAT$]!2>]N)1#H9#CS^='FJ4K\[RV<VXI,Z.9O/\TU4G
M,25"S(8PG^FT"HO//N.8@C:!N6AX[7N1NB-X$?W!MV/;]A$JU57;@(6V1;S-
MO>UHLE]T6-+44&M)TKCK2%NZ+R7A"5,6-2UX]KSVX7D%V#\D)>LHL:73B7]T
MQU<?^X,P@N&7<A XM4Y*IET_XB F [H]!W[C1]W1[?#F/<*F%01*@X@C/^SC
MQT8=(3CH:'%D(:!W'K7!@2I*G-6X5PK):&SCW+Z1P;TB3K],0C1P]GL1KR#=
ME :,2V0Y>O/MWG?3XW#GLX2,**-RI7^$1*F6@"('(G%I4::I=N7833&V%:G3
M&/L:5<I+B<A9,K3)^:41H(S-F5"16.D4GXESPA&NG='*&,.K]\Y< 65?UU+-
MJG_%[KV+&AK8D9?!*E\.85ZK>QV #=U#/0MN/W=/552Y!CUVU\->",,Y J7H
MYB1N;"G5!"0(I4C@25N</S[:IAR%EHGRS$72?GBRB?@KYT5_\/&??X#OC:].
M3@X/^NG$AS'$J[=W1V#X\WDHARDI_Y")$LX0B188\0! 3 A69^\R#^M4L=G@
ME2_";-Y%68/F)=W V<.B#WJ)?S>9!MZRZ*651)B23%82>GP,EJA(4Y*6V\AJ
MYRBOPO)#6"!5%-& :[0,UVQZK(.L(=MC-:K]&!UUM+<&)780?0/FQA,(5:;<
MTR"(AJ")Y$X07ZJ#E7HR^!N50W4[HVU2/&-@M,V)321>V;181%5REOVPK(F3
MK_K?SN$+]&_@[X-2XVUZ]CG9_3+J0CDF2#*\M!K2;%IX*'IMC76:42W6L#.V
M?7_[1D<M_0U:%GX+IL>DP.Q-?WSNQ[=%AEV4,BC$%:P@TEE+@DZ:,,:L,@Y
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MT"127I;<S(D/UI"$UJY@5#GA:N>G/@'G!Z15+>4T4&/P ;2)4S1'=HAF^7M
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M)0 GHCP>C6X@O;TI_3AQD-U!FLW%^R;".70G'^MX =K0G C3:&M*:G&"%>M
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MTV-.:9AWOG0X*NU#1%#HNII$('AN!7695O</'Z-X+1;?CO)M($3G(:(YU=?
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MM[^N5-?OD@:G.PFQ@2NG&8YW*(P2SS;T<?R/[OCJ\&8T'ES#<'K)7*Y!1B/
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MJC(SM':;V/71M>];OE0.+QZL-Z3ARKOD\BX99W_V83BZZGZ>I7),Q8<RRIW
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M1G&211E/.8,8,0JU/: I@D<<9HQ&B:*AR/3@-L9!O_FG1B"-"J#6H7P;=K4
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MK_W!^..^[J?4.WC-3U[H)S[&=-$S1S&F!TKC%*&(4XXH%*$),HRU/4 #A*#
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MRH]',5.4$;V5PC C2+.(( *R+*0094ID89QI \BIK*O]U%-CE8WDS4G)FOX
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M/.;KIYE*0^-$)I!SEII:LB$D69Q"B:*82T2PBJ+9>KFF<TLG\L$43NRUF6C
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MIR>-<8S/4)%MPTI#AU/;"9J&UNZQ-K785CAPBGD!ZA%W*K7L><3M9[9QC/Q
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MFT69(B*BD., ZX42YQ!CBF"6$L$P5HC&3HP.1^2,S2V\;V+2W2L< ];.*7B
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M\Q[DXC7GLLZJ2$D0F0-JB%F<0<0B 9GB"8RBA*:!:;_+8]L<'A?!8W..E>Z
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M?TPPHF$<IA2&&1$Z!DLQQ%@FV@%QEDB":8 <8S!G'<;FC@P'\:(TPW$KO<L
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M:4-7>/8Z.71^4.?V#OI=RS>UAUK^]8\JU:;>Q9H0BE..,PYYS#!$* X@Y9Q
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M=KFR[B_O:"G%C8F]7)25DQ4C+,XRR4&1"I,=E'- 1<Y S J<<DADJE*W:*@
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MZHFR"696HZQ?BU,?3!WHHP&4[5V6(XS_F>OE.!^BAD;GPW !92.>39$;&D3
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M#U@?Z S68G!+8NE$+(4!8DU09&XV%2 #L398'M/0FO_=6]9@*^4TL'G5$>7
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M*GJTK*5 ^Y8'6/#P8*D,'U6#Y<?58+-7JL$T.E ,(T)BH0Q\!,E)H#*1D*1
M7C-5\=&!Y=(*^TZ);*T0OS)8VU)R._F #O83K8./C$FB>)FE%U4@02A/.%H
M#4(99FH?)_7D3NPPT_KCN!/KJ+_U'JYO#T[W3PX_GAT>'QV_>_/I]/#HX/3T
M(?$KM6M=_IQJG5E7('/+)JS%?+Z%:9P,Y^?DQ_G-U11#M>G=>(=L,S?!2F*$
M*/T62B\6BN%\Z?RCI:/!,[K"'O?B2[;NJ>%G5Q,XSL<(G[FHIX.05'9)EG/]
M%-'YU9)8!NBC4!N >O2,7>T+QD^IZ"=VJ:O3)STTMI-U-7^P ZMP^NG#A[V3
M_SQ^=WKXV]'AN\/]O:.SO?W]XT]'9X='OWT\?G^X?WBPB9E8\<'5[,8FC%3J
MYKP78]EBYIO+Q3#>'Q0#!C^>F24JBD!DQOW,QJB)L& Y8BADWD&OK6>HV3H1
M/CP?#?,P^M'LZ4O.4)AO+LJ .:FCTP)7FK4R%.<1PV\3& F,,A<#@*+56[*L
M1%F_:95**'F2LJZOE);MU<'>R1&NY]./!R>GO^^='&Q@F9X\HIH->IFX2M;F
MIDWA1UB42]VBR  XIKDD(H-"%($C/F1/@C61X9[$<O7^(L_1LG6_YD?/O8=C
MFI(&A+#WO@0('#WRA%\Y'[12QAH#M8]UGR6FYR:\-7#PI&5S%<&W;$!N0HJ]
M_7__='AZ6.*,3=R;I8^I9DA>)[*2,;EQD_?'EV$X6OBV][8EFZ5VD1A3AFIK
M -P]E"*"*R,,ZIQ73S^_1,^V1F7)L]\.I_%B/+VZ#W2ED-&L8VD\7;IQ*D.L
M9HIH:9G@0N=H:]^Q6XVR?LU--:0\-CD=J*5E^_/V\/3C\6));Y)\N??7]5(N
MSY%4R<@4=8Z+7WH%Z2Z$WALE_,67\=1?_#897WVY0Q-E.@E@G(@R34]J]%J#
M4B4%[632UC-??>[-FB1NW^'C_E-O<Y/+J5BV&H1)0@OE2%2E]P1'=]Z6W9YE
M+;P*W*M4VS1O2W._YJM+##[M&+)#[6YQ_#+KUM*]VSL\^=O>^T\''P[V3C^=
M+$9L;6#SEC^GFO5;@<Q*=O"='T[FY=]W.K\#G,K***8\<9R*4K;&B57,D&1B
M,#P+*EQMH_<2/=M:N&7/O@,X=YY#II)P!^@O>(&K2PI-5!;<(X@E-;M@MA';
M5 T7CPU1/26T[%']=GS\]H_#]^_WCMX>'IWM'?UV^.8]+N73@XVLS4M/JV9S
M5B:YDN7Y;3Q.?PXO+G"_.T2B1^?#< %[TRG,[NT_=PD$ 1CK"T:"+I,KHT?(
M15,&NE+.,LT^5!]PM!:!V]JFE5YVMTZRL<HI7'<A:X6[,2Y#IW#%T)RI0D<@
M>5G;UUJ/PGZM5W?8>FS..M1;R_;MW>'1WM'^X=[[PZ/3LY-/&[M1RQY3SXMZ
ME<A:P21,AE^1R-+J$3%U-;]1C(CX'=)YJ?:(^*OA; A+P6=X "$",=*6CGT<
M<1>S(^AM!^\9HA%J5_-L0>[60>;ZK[Y;/. CI<IE@G%0:6J1&;$"W0['HI8Q
M9C"/R_SZ$%4C)G!7F'P2:.Y*PRV;QZ<CF]&K.CEX>W#P80^]JJ/CH_WCH[.3
MX_=HFGY#;^O@Y.#T;)."AHW>4Z^^87LVJPVO?G9*,4V"61TT[NFEF7XJD_:L
MD419(04W3OOJ$Z"Z'%/]^,E'XQDL74I&*RD#)4)B."6CQJ64@R>@8I!!)QM5
M[7ZH*Q/7]_B0*EAY_9Y>#=4T;>4^??SX?IZ;VGN_OW?Z^[OWQW\<G_U^</)V
M[VQOH_*LEYY7L2IK9;)K6:>K+\A]V0G]16G3_.YB_.?!X@?WB@$CS0FL)\QE
M4>Z[*Q(,YR09;W6TNG0&K[U@5Z!KZPOQU\^]_ZZEJ9^$_.7 @>@0,32B&M=>
ME)QH:[F"H!5Z))7Y7Y6VGNU5;?0\N1S?A8I:-ES[QQ\^')[-XT%T6(J/@O[)
MP=&&5:4O/:V:T5J9Y$HFJS1,&,YNG/?]^1G1.8SB\H!!^,08BY2D% HP<FE5
M9( HQERT#KRNWHUO+0)K=/5X]65WZ\1I21D3$G=TCHN144J\%$"\L]FYI+VO
M/@!P/0K[-6C=86M9VX^.]-:R?;LIU3H]^*U8C,.C=\<G'_8V+.]XX6'5:\M>
M([B6/P;G!1,G\*5<O!J=WV(M>4-M0 "8I%@IZ-'$!QI)C%()Q7VI-ZSM@SU#
MR]:1XJ/G+L-[,I;SP#RA2ELBI<C$4N DLN",L8EK4]WE?)VLGKVM&MAX$AM6
M5D;+QN?DX&\'1Y\.3@[VCW\[VK2F;,E#JAF;UPBL9&1.X"N,KN:C3<K&4S!4
M&HON7TUGXTN8W.*JG#>E1 W1V91&N-Z588^>Z 0\:9,,T-H#E%8D;5L3],IK
M[J#OE60)HQ>B<L"EI:DGEDD@W(*+RJ,@<FVSNRIM_1JC+C#TV#9UHJ66#=39
MWG\<G!X?'1YA3+7)79V'?U_-++U 5B6+M&@;<N:_+?&RN=<>@'L291G&:1TC
M'O5,@C8FY11+B[S*2_ %<BIT#GO\Z'MG\-0S'[@B7.>R6!PEMI0PI6PB4"8P
MSNA@O/:S]/3>6*D*)I:T"*NC@98MR>FG-^7<"R.6XE)L5 'QY!$5T]PO$5<M
MLQVF@#2,9@=?'^0CN50<9+1$AX11N^".6$]1Q3H+3;/CV54?X_P,+5M'4H^>
M>R]?$*+QP2L2 T3<$7TDWJ9$0&D5$Y4Z^JZ9;,2,5,'!DZBIBN#;-B"K- BX
MN3F]D7E9ZP4[[GRPG+'N.R!$JIW,'DB(93J.CZ8,Y</(GJ+K;"VU$'Z<#@AO
M_'0X/<Z/7O!]\>^]0V<1M(M2(\^EWZ>,B01?9@\;@P$",RGZVJU^5Z.LV0X(
MZZ#DR07"^DIIH#?JIRD<YP-<ZI=^!M.!BL:J9$VY4EEF6R9*'+61J) -0\ZX
M2[4=Z8<4]-L LB/H;"'D!B#R^++^8\3[K RGS!$-KN#<!>++>%2FDG3"6&#5
M4\ZOD-1O8\:.0%13#0V@Z@C^O">HR7B$7\9%!<1RPRIY,F5M$#4?'L&C),%D
M35B..<F0DY"U=[MU:>RW V)'N.M440T \:ZZ>?J8$V4$US)G(JW6940.(\%A
MI./ NB0Y8TK6#@:?IV8E<'4V2Z8C<%42?LL!X>-N36>E%^@F@=\S#^JLK=0R
M0KMN+A6Y$C8Z38SSJ'2!9L-21PF/ @(WW##;==^E:CFF^!G2U47Q_!Z]H402
M<=X3X.*J=":>-X>],Y^1:95+\Y$H<!^W)A 7,)2@-E/N7894/\VV&:F--J9:
M!T-/\E,[4%H#>]X=FWMHTU-A"4WP*<2KR?PBS\&WTDP"TN($\?++U4*M3Z5R
M)P&6=!GQ&E#JM#3.T8E821GAS =E,C@+U=LQ5N>BW^BS8T3WHNJ6=^:E+3DV
MWIY?>EJW740ZW*A?[!E!=8(<+2?*LU#R&,71CY8$I8-5P6B=:P?^.^DE\F$^
MRG >XAR.<$$L+2S5+$D()A&-?BB1F2+?3'BBM>'>2*_KS]==B\"&>XVL@YMG
M>XU45U(#V_(M<^^'/@POYO;YFL]T/#HI-KL,8I]GHC^-QF$*DZ]E[<\%@+\>
MCR+^U5S)]P[61!(!7""1"@RF0@K$HDM"&-42HDS>0NUBM"[XZ'=K[A[/?:F\
MY0WZA?XU&V_3KS]S%^UW.MRRUVN4(J(SVG)./)_WNS2B'+LK0K-(8"AU&FKO
MX3MMPG/G_MZ\]EYG*NE0W(J37&H89"B[@W.EG2BZL5IZ2D/MJ=$OD/,CM==9
M!S7/!R3;::2!_7J5]D ,(&8>-&+!E;M.Y0Z LIH(;9QVI9B7U>[S6ZN74V>[
MZ>[ 5EM##8#N9OV,\[OA:#A#Q^$K/!'CNZLR2F;OLMQ-^9^Y7@^^?8'1%![E
MK11R:)B6A,N KDN"4K=@*;%6*"4$,)M=1R:P!OW]'O3NWF;N7.<M>X?+>H%M
MGKUY_F&=-B_KT!'<IET4*)1.C"5D$+RD^ 0)0@-)FIG$DF-!U X:>VAA5L9Y
MW2VMMQ!F=Z^^#<SFH==>^J^KZ?S6\?V)?K-Q(0Y2^<M'B\PY9KP7CD19VL[(
M(L!L/<E9&99\2/EQG]VEL]VZH>[';6.V#B[OSS%M0,LMF](7^^=L;%-7>>IN
M6@!U:&57:N7"K87L+6ZY.ADBA9'$RY (94(:$%D'6[LCY"X: =V%<J_UFWFX
M;*).H+S&, ^<(%([]$ 8?NN9T\%Q=(UB[2K3#4GM^PI&96P]'XMWI\"6[=[S
M32HV-GJO/G(''3:Z-'?/]5*0H)F3O%1JE9XN(4EB3?#$<I4QKO 0=/7FA%WU
MV;A=%8_?<#C*X\GE7%]OOE__\EXB@4MT09PCU)72?^MQ05C-2-31&$--MM7'
M#6Q(:J/].-;!T/.FK#NE]9C]N>_$'N?K"_[3-]\_^/\:3TYA\G48'\?Y.6@I
MN4>7U$=*I"I3.;VR!+U2"\$FGA]/&'LQ!%GMK?TF%JLBJV.1M[PO/NVGLO%^
M^.RC.FS^TN'^MVK[#@@&_Z<IL26_)A5EQ+JD,%HU7 !53O$?M 4,>H7^_'P"
MY]=U8M>O?;02F/<FN9")2JZ4K 5<$^5*BE3&>NUQ:<3J/?!7(>S':/ZR#GJ6
MC 6KK)^>M[WKJP?3$X@PG!<_/&3Q<6RBM!+"),)M*B.HP1'+N"$:&%?4A,A9
M7&';6^^M_6Y[7<*J8PVTO L^OA#Q%F9^>%'CZL;-DSJ[N[&4U*XO;] 8LRK-
M9;Q$%TBZHG<5'.$A>"U\1D^K]E%W5Y<W%KUN]B[GL+^?##X;WSJ7!Z/9</9]
M64%8]H9;C!N(,KC$)"O#@9(0)"N3I==9"5:[L&0K@AN]R+$.GI8W*]J% ALH
M"3B"V8+?]^/I=&!]A,2LPQ 6@,AH,PFRS"*0Q@@!1@I=NQ7& P):Z'ZU$\4_
MN2B[J18:@-!'CY*)PR^^R.?N=@C*:"%!2'NC]&F4[KZ_6;:%V^M+48.$ J,1
MW4B=5"08;W/B'9<DX99OF6,\TMK0JT)XO^Y;?Y#=O=8;@/J#=;KW%?VDA:Q+
M9_'QZ/[,EQL&M8D1G"@BUA(W(DN)\S$2'V1D7*>$:[U+B[H*D?V60C5B=:MK
M<W.XCF?^H@I<_X#A^>>R$K_"Q)_#T=5E@,EQGKM*T^.KV73F1^GZBD <0-16
M"0XDI=(%A$E&'+)(' =#7;(B59\]N!:!_;;(Z ^FW6EQ8X@B)6%<K1(Z3FX.
MJA<+;\[80Q'?W*.&]-%_GU?93"9^=+XXSQXH9:D6-A#.6&DC00VQQGD27([>
M^X"+MG;&='NJ^VW*T1^<=ZSO!KR&9Q;P]:;R9!T/%*A2&U9*T\JQDTV,>"LS
MH3KZR$%C"%#[?NB:)*Z$7?WS8;=+33;@+RQM7#'(5GC!G",.XTX,1R/ZZ)YC
M=!J0GQ0@H^_3<6YN]?W?_'R@VUXK3>SSC]FX\:FMR$DG8TB$0(G4(J%/38$H
MY,L()<%4W[R?(64E@-F?'V";:*8)B&W9IF0A^X&GO"2)#1KMLK*,3QC?6>1=
M,:O*":>EM<\BJA#>: >:;5+QNU=HRX>*-U6;>_O__NGP=%ZN<KKYP>)+3ZM>
M:/HJR94.&-]<38<CF$X1%F$XFA-]9R,]3YQ:;PD+Q9[Y,A>'62 Z"J;+=4TA
M:OO5+]%3K];TYBU[\;^OAM/A_"UOOM_[;G[*/K"L9 *D)='K@"NQI 9*<Q-J
M)0.)*R+*ZE<)UJ2QWP.@:NAYOL*T U4U$.$NX6KOV[ $ZD9[QS()UF12JF5)
M"#(0X$RB3Q*3K+Z5/D-*SV7+G>K_<;?Y"LIH%%/ERPG V_&E'XX&C/&,2X^1
M[((L(1"4.6>E1,E+9D-,[O%%R4[0]8"H-@S85JI? 4Z;ZZ'G@L"//O[]=_ 7
ML\_OW^]_@)*^0?(CV)*:"669R:!0.!X XR?0/BJ1S./:HZ55?TL>W1X8ME#<
MN)X4>P8!/F &\?/;.X?UC@U03@#8<B,W\C)Y@Q.K52#>F6AT2B)0L0(87GA%
MOV%:=Z"H)=4&MIX7.F5<W^'8O_ HPV):J8G:HER(R"!+DL03IWDBD+QRN"9"
M#+6=ZC7(Z_E.S2[=GJZ4UC8>[Q@[\I<W2YA:B++T90$AY_=Z+?$A"L(EY\J"
MR8;5;LVS)HD]MQCM"BJK0W)KO34 RYM+ B=PL8B5/P^_3*\MOJ.4&V<SH:9<
M$HE.E$)^] Z4,-J(:!VO/7+E!7*:A=OV,!AWHY,&X+5DSWB//SB<P>5T( T'
MK:0D00IT*S)'&47.<5F&H*WB@5;O&?\2/?V6T/6=7MA,+0U![%[";Q\E-D1U
M+6XG3?QHNJ",#;CTV:4$A >#RR<S0USB@C -SBCA<A2U=]5UZ&LNV-P0%<_
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M^>KB_3##  -M3G6.Q @Y+_$,Q-%@B>8VH;AY$K;Z4-D5Z%H-F3_>L51UG32
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MYT?I8)3F6;OY8I^.\[+!WD^3?QV,.>^&P.[GH>] L+M(LPD5C#>E/$*4N=C
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M;YR=YTU$,1#6"DI1[)J7:FL:@'B&OZ(0HA)@=6!B W ?@K9^FE,U@?'>5=V
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ME?]9LAZ&:9"D3L)P22SR3*3EAMCR;&:H4D[Q:'.J'=<](*'? 3VO@)?=!=X
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M"?IW-]/A&' ;3/^:=-/IP,ALDZ"4)&L#D1 8L3$+PCSEP(VB,M7.LGN)ILT
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MSYQR,BO-ZK_8_49 ST"JI]A'CW:[2KGO6N!;-^2WO70)DQ_H-TY78EI>W^G
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M&H/],N@^$$^U))%Z6U*PO7>U^^%M0E>_S7!>/8>@MJ9ZMC^?81*+OKY"E\\
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M#<0 ]S@\'OGI=)B'<:'M<A62I$.OE3(BN/%$2BLP- J2V,1#Y$QJ$VM7O+Y
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M^5HO-&IQ_T1BGASA0V.E+*I/L9G"QI&<3D[.UR!=W;W&8<05)DL$#ULL62W
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M\\((1XDY9=@FN+SHE.(;@(4U"1V,;.3YZ]THB+$!V3PB:%DK%&#58,L,@S&
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M=9C70[4#@P$16*:8_BFRMI3W( \HR"><5405A&Z!_2E[@D?R)!\J<5'DSUS
M!1*72."ZI1O;47OP-N&.QZ^V]E'+/MH@ ^E@]YCB9.)75LU\;EQ6C*F44U6&
M]$V1I8DDX,"DJ!NP!Y9X$$NLU!;3!Z,K*0PY*@/*[U.F0$KWX5S8G9/F-T5V
MH\,+K;. P05P#<V1($/).122*B[1K2PEOPS>*NB3J%U';:RAJB[BCWA&,&QU
M.^/XC(D&N4,3^R>M\ RP#^"<*0G,U-XIV&R+Z#7R 6$8'>9D+ [^1AA#.KSO
MXN^MP*>%Z1O[UN7JBI23S9$H>[LOCG BK/MR?)_[8E &+(4,]KP-[!G<$D_
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MUF6J-CN,=ZSQM=D0I%[K"!1)8V*;FJ@$&[2& 5T=PHD1UBFVP;+H-FR?'O?
MFM%3/AI?81.C$8]X?EX]^?-SJ=+Y&#Q3I2N#SL1:>]QS]'95IXN0=<"2\A74
M5Y.Z]BXP72I8*?*'VHEEQX/R2[RB_K*E%<%+<E-<?VP2I5E34D@!3DI3X3%K
M)<.M IPTTC.YK[J?N0CQP!63/HQ_J5>L(SJPK"D@$QM1PTA(P1X;7201326>
MY429 &0F) &\[GIRPP>;ZTRBUUF140D/+).,O-Z)"Z&O^25W,)8ZY4Y3="?3
M]CK-+>6&#YX%EW4.]Z$FHRBS%D59$Q!KZQ1Z=MFON/A7-1@Q=?#WHL&"WL?U
M$3%%"LN:%Q*GG<&W+NAM'MVE\V8NNY312WA8JXKX743K60U'*HRVGMDU"%2(
MXQ+5ZRRE!K:'>U(3Z+>6=<^6A(6'V_N1!C4H*GJB.4/&PQ5Z&?L(V\I0[W;L
MH>2>!]UC34<-!QX?9U$Z1_W<+&8J$[1V#"M*0IO;\N)3?FM ]"5IK/L'X_DI
MQVDM&7BXI\JVT9,-C)YLU\,,1^ ,&Q#,:JL]$WURK630/@@U=5B+38R455?5
M2F'V(L;T8>X_LG#RJP:E33!)<R%F1D@82$(5920)&5U4J9H"L2"DQ)[0 "I-
M@"6OI>-0TF&\1\=C_<:D3,'**1H*)T?)#9HJ0P;!.$K0#*IG6R?!VTO[>T_>
M2[@H@A^;J(2%5LKG1'A<-^&BJ(F R6L'V .'%H*O/AR39M),[K7W:\1GC:L4
M3GF9JFJ[R_U=OO_D=_F5[GHG/&FO859Q=YD@X.-N]DY38'_#2\#5H?$8LR9Z
MK9/6L)G'FMXK.&\QT@[],A1_RZU-ZCEK8YDK0BQ06413WC"RY[0H%S+;#-[A
MQIA]WP\VW-;GT$2^MJ=O75B,&Y)T\'!]+OSP'D@%0L5P4+]%) G79=O&:7*X
MNP:'9O1U!#8,>.V4(>1 @!MU;X5+[$H';W5LI1-085Y^L;7P[@LVF=R$MF&C
MR,7C,M99WZORW%C\?=4?@#+[- HP604W\XX%[7)-U*R1_#\6!7+<8" F<"*X
MYJ<KE923/\<K.'X[#%]*G>86$C^AR_IZ7G3L/@T'-K28=K3=W@B]X3+XO2N(
M5O:M13'%X2D.Q?73#6%(T"]>2N<"E38AN (\ZP+^"AW_6Q<4KUYT)BZI'.:2
MCA&A[^BNHJZBMFLHE=%]( J8.@],Z 4=M^+LD^J4[ZDA KNN-$D679E0</Z0
M]C=LF5B1]]1U:2R]JBHK0KACMPX.2ZE%J1 32SE_I/TEY%A!>R&!%4^KF@KG
MJ]#*2?@WO"/^3X)?(UVHPFL3!9I51Y*XY3 8E]*4L\?[3%)BR,I8#&L/TQQ:
M\$7IA7I22VY181<B:PUA1/_#>S&:S/5CL84/QZU0_-QBC/W+QDX.-B)\L3I8
M 9.:YF$+F+(RMN^I"NPL)$S40A[,_ZHPREE@4)/NAEW"J>2UZWH[I,5>T*$H
M*9:?%_K>6 =>V-N&/7O$2G.*=V[%DN_C'#QY'^>",/4;Y<BT%;O3%%WWC(E%
M/++9@SW)FSR-Q7 TL3@^.]2NW+59G$).<XP\C6WC!+:@+&G 9IVBU8@1>D24
MH$B4ITSPK(V./:+!1%%$35M>O^0ICN(*3Q%20J=@-,8*SAD52'+BK6[*G(_N
MHK:V08BAN1I;?2PPLI@FJ%,2T#<5NT-L3%6;BO]^Q..)*K.?^(P^E%G4C!E=
MR]<(/_W+U"N(;!D$&)6=@!I>$0AZRM @.YEK%1RL;!+^>_;<_L"=-@7^_0^J
MS7B31M,<CFT:5\$Y>+X<T5!K0N4W_1WW#U[M>:GD7^&=OXY7>[?,DQDX<748
M7/P]V'NQ]V+_ZWBQDQJ32]PA$P3@C^#]E."ZG()M6*EL\!VW &=$[;[8 IPW
M .#\V0R41SJ"'(,DGXP-5VU7(#$>$SEB=R)&BI+I.0&+D#D"1/?R=8[AZCN6
M:.2B<QD&4J$C! !L,2,PA*-M&/.09QNKU\:ZBAQL72DU)&/TZ[1H5O(TXOR"
MP-0UQRN*=_MB>^UN+V6WE%/,S1A)8)E8*O0664<03!$C)E1B#5,2;I780RZ:
MI(R?_P11C3X&+FCH-I#V0 <60A42U0;C!=+<10HFJHZ$Q&,2Q4(+Z->4$2Q)
MT/W"/1PYT,,6SG*-T+'EQK!O5R';!$\&NT[P4OJM>&*6'N*J=FMJ.?Q+7YFM
MCZDRBF,1[ P9I[E5-WATN:X)I:^03&R)_&L=3GFI6M>,)KQM5O-RN#L$=P!,
M-L8P04E2+\@8'$(*[\>QRA0AW^C6#%4KVHPR%-[1?5'A%&?+D&M(^V"A%)/*
M%(H8MW+>95_1 -:> %/AD9603'-WC#,!%)+$O=*N/I1E,(V25,5\0M6,\P(P
MCUY@O0Q.*=-D4YNW$1.*+P.2+'U-#%KCM!& @AL>94W2,SO^18S3!U^[K,TT
M];X0O#C'CW7Z8: ]79\#26]0;9.90^[&X9,/L[UMT%E2=9TYI=.7B@QB$89O
M&!_-4O44?,='AMQWX 7=?6O3M7AZY]%'Y3*==<MX_82H31HX4/AV[55_V ZD
M7J,[XB%XGF!NF:E9H(PR64H5RELZGY8OJIL(T9G79><J3&<[G=T-G^-8U;=*
M^+'Z*!P]<A+*-=J!X/O[J6M"7Q@(-+]H^\YCDQUG]5HI]5&&Z[9R*0F_I^W+
M6%LCX%(00ST8C5-/_>KDP(HTD3,[DY7@#VQZJPW/R%E]"9O=U^<E]-,5K;+!
MI$&DX6ITM.3_J\Z\; 7JVI8ODG%+I0:J.,K)P]:MEE1$0Y >K4-[$",]2" ^
MF@B*!X5;D65"Z6X'T@HWPC?[.SQ&+=GB@/UA?E((449/ @U#_PIT+D)@G1N6
M3:8,@N0$?@'&(NPZYQ<G557$TN!:-[4^.3DQ#9QK#/*C3B>O:#=XG[OC<=_.
MY^?PV) $E3',](H%"4GP&^;?,GEQ5?DOCO5_C++ .<.*!WU.21I97LM6:8.\
M/$U0'EO1Z,R!'8'S9IHBSF8;9?PP.SN[P=^;9$KW$C)<BLHH@R1Q1JX;[D:W
M49EH&@L&-8-OBQO)K4WH!Z"QP;MZ.XH!&_4TNNHKEQHCKSPC<:JZ5:ZA;SD
MA?)0V(;MHA]$XUG$7L7R*T]H;B63;^H=/7E3[ZP%&W8QPH]KT;5'YODY0TE7
M YUA=ZD-BL9KS1MN)#G98^[FI]\*D6&YCULER $)H6V@ *7C(#!V2_>IF$RP
M["5I@T\-D;//GN5:J"*CJ^ H&/74X_125J,^+FXY=QPYC:"B=J#+.366=:ER
M:>+P N_<[03'8? \#%[JML'[>YH)EY9$F<N\@-I6K?0>Q*=/\_[C^W^>75Z<
M7_P8O#OYE>,'_SQY=_[F_/I?CWPV?SH+SB^NSRX_7)Y=GUR?O[\(@]/W%U?7
ME[^<XE_!R<6;X,/9Y=OWES^?7)R>!>_?PC7G5\&'=R<7P=5/)^_>!:_/ GZ_
MLS?!ZW_1%7(+^ #_.KN RT_ACW.XW^GI^\LW=*M?SZ]_L@.X.'F'DW/%3S@+
MKF X]+B+LU^#OY]=7IW]*Z1+WO]R'5R>_7AR^2:X?D\__7!Y?G%Z_N$=_1P>
M_?;=^>DUW0AO&-(83CY\@$]/7L./WIZ].;N4I^D9T*L1O+\,?KF0 9^\/G]'
MG[V%6_P+'O/^G^=7."D]DW#Q_CHX>?OV[/2:[NC>K_]N[^%GEP/WA!?]Z?ST
MI_9OKN19EV<_G\!4PO^__07^I+OS1-, MN+#%Q]/GZ;Y!)MSFXB+XRH]OF)_
M7:"#B/XD=1 /G#R1A.<IN,1=%) @<UNOOJU7W^3UV)QZ=9,\-M;MX6B\$P9'
MHXB-RB/L2X5'3^*L= +9(([@\SQ'#A;=0V^._:A2JMZ*$@S"2!YRZ<//,7+6
M[4*F$^MPNE\;'E"*[S@7_U=E$N_",NYFK+NLRA+=DBA,7S$1Q7=R+TZCL! -
MOL@1P%L1GY9$X[MU74;\C-@!IFHBW74QNBG21'/')44SQK0^^L/RRE6HVZ=I
MO/+9W2P=@^?0.^>NW#-1-Q:.FB9X Q:DG7 GH>QZ(26_D)]L^1)3R#P)I1J8
M!KR]YH Q=7X/G)=0/$?MLO43>Z-.@H6<IGEN=J(0RF"$=G2XHUO'F$+$*/A0
M$!X/(7B\[;80O)6XLI=;"-[F0/#^:'6V4J#W@(ILHK95OBMAH/;9ZRWE1=&D
M"]Q$^'%DJ5M^%5&6"+[=EG .^E!/GUOT7#=^LW77)[:Z<R-\*3_UJFM/5=DR
M*-J.5Z*XT-1EP%V %5M6#@!/ER?JP*HI0(<_J,C*P"3YQB/+#B_, +'^X<YN
M\&N+BI>[>CGGIZ*&<JC?T4X::F*W_UP_%#YN2NZ9<G8G.->3F.*Q^Z\.C[BU
MBYA:([Q LKY_S**]>&@6R7F%Q]Q6.B%N4JFRTI^V:V:I0D91W5;C/;?5Z*!A
MS.8,5VVV5?O+ G$&'MF*\6MD"X]>OU@B[31VY$@1)IOD?0/;M426"Q>T25@?
ML;!<!&==<,V%\<;4'6(6*H_Z0AX])5(E5C-UNXR=P[[6(2*]5C8JM#TI&16E
MJ1!Z+M778L5Z7*8(.^:PBW0? F<J$?P$?S)M,E-8V=/5(0R,63]PV103]F09
M$[CK%K3T0O&.K_2P;F14C"&C/H..6J^"7.$2"_<Q&/EI12@(](N,C&/#W'_?
M&S-39<FMF9;4+#.N$6U$';1I\Q*AI,CT$AW$6!?4ISFU':VP,^#2 [&9_B?P
M&.,-T51ZU=REFB!$1*#W%3=^M MFV4[:+)8"8BG=R>2SX5.X>4(7WP&F#URB
M&K>3OV3*@N]<K@"#_>H!VQ&]7&CH? CQ7>2"Y-%/PZH%D+O;N-PV+K?)Z[$Y
M<;F5!#@A&CP8D$%DN9RZ90^OG1QIW:0SM  K> JBZH6CI$L>R9&3Y+>&BR@J
M%HL,LPH]D!4J56*:U= H#7R-5L->"Q<PFI9&HY(\<RE0J,*$C<!!XNU^!J!0
MFOBQ$/^:M_DGNBO)%Z)U>-*3DA<WQ9]T6K[Y@00*60G(/763PETE7MPRM[A]
M\M)CHM%,?7_2V=N>M.U)^X23)OTG2$FUU3K5#981NY]4QN(XC=86ER/:8H4"
M=Z*,8G1[_F/[5AC(M(JY5+)]AJNV0<^@:M>>IP*>LMYB.5OQRZ??V^44+3GV
MST^()_R1\<A>L \#2E4SGJ<U6YQ<,&R@EN.E+K'M[0*-V.6J$?8S/T!XX ,C
MD4@O:E569:FZT32H,RHTJ.!_L#LPAAY-A^ 8C6(D8G('AFV1*!]K+X1'&:I,
M/Q#6;9(M>6!=LJS3O7]:^CR=6"%G@%V/"<FH[M0;3L35/\/E2+ [+O/FS0KB
MQL=_HY@+G6DW%6=Z-20BD]=NRD>7>.,]HVRP_F;$NT*7R6"848#)[2)RB;A@
MX3K<SZNGEY:I7DFUQ^C?"BQZU !<N5^97#L/N!U#-%$AIZJ/N!]X_/9"G,=Q
M5*FD$TJD6%*BN7U-.IYGF?KKD8*R,3R3_3?S*Q6@Z ;B2>7VQ;RP3IC-A FE
M"C%620/>(]U/^-+8IQ;C5B)C//[=X)<%I^;Y=9P=YJ9&>H]H:YIU!^[^!_G0
M#2S+OT5EKG]K8\<S:N"LB-# A)Q#H[.Y>LQJ?.%5CBJ]J1)5I=,>M A/+[;1
MY8*.]I+K@2 >HH % /._@#U'@(T2QG$C*[)J)2SA LMLW8\BUZ <"_[0\T#A
M7Y,S,.@-]XGU3$_3;G!"77AXHGF!:=3SIB+4#+DH+08_(ZE;*^ _64YL^QCJ
M-=2H0[LYS6U],I T3RF'S*MNN%![#[(F)236!I0%E8[<(G:$BF]P.U<88W&3
M<]VQ4W 7@^0&F%,VF9,--\.V[ +=2>QV!>D*"[$@3>G$.C*"FX4MX&>+,J4.
M@UIHX$NE57O,)LQ,JWE/*:-9F?ZI\3HVK34+GVO!0E8L1&B!="Z1G3U=35FB
M]"^Y4J0JV!*'HTE-K+@)%G&01+7N?=7/-*+)(4W?M/8[P;%!YG ]X,J,V!)A
MTMEHMU'=?VZ&:G\I'"5M0A(_W^"O@M')_&U2*+:A-!E,6[:2=NOGVK%BVI%#
MW-^F(Z-;;;':3)ZL_K<.C6=I'3S]-C37RP5M%]9BCXV^,&TE*\KN:7./,JPN
MO:Q)_4GA6 Z":-+0S[E.#*NZ539!Y4AD$6P@>N?U<+2_HP_*F;[H$LYGR7E?
MY)R<&TS$T@(A7K2 $)L-@K@\OSK9!/0#+:"W  ?'<'[V]X[P%WNOOC\XTJOQ
M!EDN:EUN_RX:@^2ZM G<$+E_<V2I@-G'KI51"<,V:E<L-NH32"(3M61G5VC7
MQC"&N96*J9&V5<\%^"+>?JJ"@[W],#C<VV= ./PO-G3"F>>=PGN0;UW9K8H_
M?OBK8.Z=>HBZ'2SN?0UI)>I>@=0,D5:XU-54J!B":5DT"R([B7)P!34M"C:6
MS);V+LYIV[9N:FF&I]^ZZ:((WC1D FJ3Y;4<@4<NP3?L.);]2-TA%J>"S6GJ
MD=UHEH.TZ6%7T1 @/I >X*];PT%H>RP[]F:FTTS&1$Z\$$:KMX9E2UK0V.#K
M:1G-D:T<E7%HNXI'98D9;N+A\5D^_#A<6G'\QG:J6GE_#&##@!K"_>=J"L8C
M$P(:[&_?"$)+ZD*KX%F7/52.DK GN)M,&UNQ79(KOX@<;GG, M1A5G0CEFEE
M0C7T"B"-$ *F>T@BWQ%Y_5GJE,*9I;OIZWJ"<M /./*$1Q\-=QU30O%(MA4'
M*V'TK[85!W_>B@-]2K57/&WHA$E@":R='*16II,&8(WK:!B>L9:+J]GH2-K;
M7G9AGZDD2&:6(B(?4*B-"VS DQ=,1DKT9TQ9.@&A7H)T67+<@"@I2.@-0JD=
M(>O&&3^GE.4@X8$?K74XX[[8<]T:,Q-5 0'*D-H0K42)]M@'! L.EKC?LIV*
MK&)QK+NE_?4O1R^^9TM3?H4A(G"N*,#%F=P=K6EEKEUYK8&^GZ(X:!-)O2#A
M41.MXC5R@QP%T16BR/6 29GP[>$"LA],#F5K^7J6[]?0T">/*LH+C-,,=N?C
MVKO:ZFX7!+CEKS3:WB[2' D73C5&'G.6R<2$^YN.ZDI?@S-DXY@>U&XLN3T!
M_@EX^ER[9X;('NWYQXX*ZL2_$W232HN:C8 > GYV3'[&O",%Y_="#-(<#&_5
MK<%^3(W5/[?%CG=(D__^)GTYV3^>)),#=3S9/XI?3EZ^F.PESU_!ZAQ-QD?'
M\?\<?;.U\M>Q\GE_#HB_/W0//308K?D!@I/U!/W FZZE,5:VU5@YA8^O0:YJ
MM4!FA9]V@\NFBC\6M]7'=&CK=/][.HO2<HX2<ZAT#\7G!Y"?:>*T8/^JIO!G
M<"$BE05GN_BB-\5_\O3CT'Q=J1PY)?Z)F5,S*S1'Z[9X^AQ6S4./]>I;;]49
MBEL0.+O!R;/A_F-?7*F]V"JU/XM2>_U5"M*_1W@S$*-OHINT6E\)?=I_3\_>
M/SO#'.17.9=7T3PXV0W@?Z+D2\^D5?J^2F.3X&V:1SD%X,0D^,,,LOYVIFO[
M]8\3SR8Q=QIAK!0^#J[A-!3P[WKYT%7I-35"1#<P\/=U4\$#JLKRG*\UCUN3
MX&$FP>O'- GV][8VP5=@$WSS@]#JW:UP9S]=6SWZ^ZTL@VKJ<11_Q#3[P<N]
M'T&C353P4U2.J<O<@BKQ03Q&^+\>)/C9GVVF;,B# 7#&6/22BU^EM8,$J2?K
MT"ZTJSI#W>Z*(2YI[:*1.56GA%)RE.ZX_=)";I43ZN0<9@(3Y!;#!HG4ITA8
M%4Q'2*?L<\U[[+1;D^I["GU3! 95QIE6*C=)5;6CR1RD_H03G!RL;I@]HH=W
M=9W[PDS"KW02W(RXV\AQI-M^^;@HG1KRVI7HM# FVW>> -'7!TD';P3,];9H
MLH3:6EFZ-09F$EU5'=TAMU11<;;. \0>O7KU2J\=$>6A17B)AZ#!W98HQA^_
M?/[$B-APZ!NQ-B,"3=B58 S71L_=&0_V.KK;A!D,=>G:CA3/""KBP:T0.[I@
M'MVE\V8N=]"<HW*4J-=NS[TTY;*4-9>II2VV\_8$#DC+?-J$E18YMK+H* JF
M!,,JN;3J&<HVNWXY%K)Y[2@1FBGEX-2*DHY?_JD;Q]@$NK'E2*.5QBHK;H/_
MJ++8T3=JS;!NA]3:OEJ1Z!H\V\[;*[(;+_E20V.MX4@>\M?"-2Q55:4Q2IZ^
M%6O'_@P;,)6F8%8KB> 8+"HF<W<^&N_8<E+GXW@'@5QT7[I;3W]I]\<[N\';
M5OLR[Q4_M%J_MN8SY(;W[55L+]D(1YH7!EW']]SI+*4I@;M7P%B*#]ZOO+NH
MB11AM[T-2LI7ONUN,((&WO<&G4W7@9D;E-XPU.!)&_6PWTZZY))2ZBG56GQ,
MG+G3GK(FAN^<IP@F<@S'38,%J;(V+>>F: 9I'E,'XF3:DOFUK>E\KA(TDJD4
M0)CBZ?==\WKCU<*)G8NW,!>;H1;(=>'UT\HAP;5!I@ZD RVXRWL<9;&A+QT7
M6")]?S\YJ5Z>I'!:03&,]H_!V9*(J%?'[!3Q2L4K-9EW[R\ND=^M@,MQ2V5Y
M R(MAD*AU0/[,(+YQYV+1;]1Q;N/JH2[VV\$"Y QY"A;/@%S\HU[;#=A0['>
M(='>T\<"/V^= L(]-A6;).\7I!PNE4_G>L)&R"C"JNH)B0WF*HFF9;28P:KM
MA&PE[+3QO[U:YQ[MMQM<]-!2@;)5TZ(;SO"81ES6%!/;N$]RZ7W<F1I2/XJZ
MC"9\(J0GO*E=@=6ZH3X@4H%D^7*C)DEKHAM)% IK['AL^7-]LI,3_.T09[EY
MC<I4(9H:]EMI&M(9N=.^WA_G6,51P[C^WA$B\Q8XRGJ0WBB[LT.W1::+2BN:
MB&'P^MZFG( H0T9@FPBD4!9UH+^-NXS2]1D$')LYO"<)A(^TR-,<3DDRJ.X*
MIJ;@ZOU^%6MM'B'(:=^$QT&V-5DJ4B^*)&A5[^R;.^XP^<%$J59;9]T'O'6A
MA0T79<XT!Z8)MV4R;5&;RE44K\5*;N9FLU4)S*-!]1@=N=M9T[[^Z4KO)2U-
M",FL=Y1Y66-EMF_:WL%@%SKN9&JM0S)</!/2Q"HG39FGU6S(<=)\#<4"Q [Q
MFXONF3"Q-DV9!(ZXTHY);T'/-J7B\C94M2U?EQT78H_-!PD>G$,_ <%94B4'
MU;JS?5S#T&VUA+6F\7X4NDI-U!3+2K)T2B<1U6<*FB)"PAW8[_6R5:JXSE1[
MTK9C; \Y'Y]GUMDI]#3DT+;KP.6)RN4>\^8K=0C TSSQ>_?B>S<HEM%DKY=Z
M[\B^TYMG,/1)D4[9"V2#&5J VBTJ)<8DPP##V\=L'=J^U&N K#QR,[!XB4EG
M;*FG'S4/V[1V+4%F"Y.P O8.*R/TX*A"2B2U6Y7TP1H=$;CD*'S@#82)QA/,
MX%UNM.GX_D:5$NG8!,,QY*/KC*K#64.<!NBGZ*@&.Z=1D!4V\.C3E"5*2TY#
ME>3^P-!8D?'I/+K/F^'A@)R.EIW?MYRA HU0F!H,B1533M20S-+=U_2HO&?6
M[K%RQ7F)8V]9OSK:LW_PXFB4[+B';<=Z3XF4;P_I#L?QZDP_"LC,NPO]A":
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M?44D@^AF%7NSB3:QU6I!0TE&)P_G)Y@H*:!78RLS/9FY3AFJ;>>6P$JJI+_
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MKG#\P8R#X><@B$+2W7L8PMUH#G8$E$<$;]@3TX"X![O2D#5&46-V?WJ0+]7
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M74G'R>^27D;>F@CDM64Z;&IQ]WK%@YH"1S%UK7TR2;0B";7 (C=\FU::3OB
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M!508YL[A,6MQN.@U(K+AP[R0S288FUP;Q;=70@]C9(L*% -;X]E'Z5;=T!T
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MHF94Y@-J&3_TM8P@[#F(9@X&&0U<CSG\VA&<.T<-,]YMY&1+ '@M&3ED7X8
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MSW7,\"36FYM78.ZP?#1C(&.-&Q 40M[P&;?U'J'U$@G:I[BI27&)@0,?#N'
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M(EEV/./(RD0SJ9W:2M,^?0.2H(@Q2+  *%G]]=T%2%ULV9&;-%'\U0^R2"R
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M"%8LM>V@H%_1Z3HE*R:H!5Z1>U?@J19TC84<J!5\T5+PT)X%Z-S7/.14<1P
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M$1LRS&*EP19I'C!P]/<QL,/3U]ZYZ7M##4P:3$\Z)[>9FDG.QKSN9[&<.Z;
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M!>R<#,P""I@8]E',.> T[IAGH$LD0!U*>(YK"$U OWLXPUH3.=#[=POH>'<
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M';FJK/:58[J,=?GIG%B?:HJ;%E!DF=$==<D%5ET+6R$CI:2#W9]AS&29D<V
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M+U!+ 0(4 Q0    ( .>#555<Y_E@J_L!  JT&0 0              "  0
M  !D9W@M,C R,C Y,S N:'1M4$L! A0#%     @ YX-55:42E;0)$   J9H
M !               ( !V?L! &1G>"TR,#(R,#DS,"YX<V102P$"% ,4
M" #G@U557XX'_W<<   H"P$ %               @ $0# ( 9&=X+3(P,C(P
M.3,P7V-A;"YX;6Q02P$"% ,4    " #G@U555S :!'I)  "J%P, %
M        @ &Y* ( 9&=X+3(P,C(P.3,P7V1E9BYX;6Q02P$"% ,4    " #G
M@U558SM:[$?(  #D*0@ %               @ %E<@( 9&=X+3(P,C(P.3,P
M7VQA8BYX;6Q02P$"% ,4    " #G@U552%%3,%5[  #]4 4 %
M    @ '>.@, 9&=X+3(P,C(P.3,P7W!R92YX;6Q02P$"% ,4    " #G@U55
MJ<:S[D18  "Q:0( %               @ %EM@, 9&=X,#DS,#(P,C)E>#$P
M,2YH=&U02P$"% ,4    " #G@U55*8F46B$&  !*6@  $P
M@ ';#@0 9&=X,#DS,#(P,C)E>#(R+FAT;5!+ 0(4 Q0    ( .>#555'&&QK
MUC$  .\6 0 3              "  2T5! !D9W@P.3,P,C R,F5X,S$N:'1M
M4$L! A0#%     @ YX-554+EE3='"   L2D  !0              ( !-$<$
M &1G># Y,S R,#(R97@S,3$N:'1M4$L! A0#%     @ Z(-556IR\4L\"
M7"D  !0              ( !K4\$ &1G># Y,S R,#(R97@S,3(N:'1M4$L!
M A0#%     @ Z(-5524Q?6BO!   >A,  !0              ( !&U@$ &1G
M># Y,S R,#(R97@S,C$N:'1M4$L! A0#%     @ Z(-5530SE/2I!   9A,
M !0              ( !_%P$ &1G># Y,S R,#(R97@S,C(N:'1M4$L%!@
0   -  T 4 ,  -=A!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
